data_2hug_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hug _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.6 p90 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.953 0.406 . . . . 2.9300000000000002 111.888 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -134.75 142.41 46.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.957 -0.565 . . . . 2.4100000000000001 111.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.547 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 31.7 p90 -89.78 122.26 32.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.034 -0.53 . . . . 2.6000000000000001 111.424 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -107.25 53.45 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.816 -0.629 . . . . 1.1100000000000001 110.651 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -106.41 176.79 5.05 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.934 0.873 . . . . 2.7999999999999998 112.779 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 54.4 t -104.07 -24.28 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.021 -1.445 . . . . 1.1200000000000001 111.505 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 5.3 t70 -150.52 -39.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.917 -0.583 . . . . 2.1899999999999999 111.114 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 47.4 mt-10 -152.47 162.7 40.83 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.197 0.443 . . . . 2.1800000000000002 112.197 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -131.73 -168.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.487 -0.56 . . . . 1.0800000000000001 109.487 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' CG2' ' CD2' ' A' ' 26' ' ' LEU . 69.4 t -150.24 -49.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.3500000000000001 110.836 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 43.6 tt0 -98.64 146.11 26.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.162 -0.472 . . . . 2.96 110.465 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 18.8 pttm -152.9 89.62 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.005 0.372 . . . . 2.6200000000000001 112.005 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -154.54 87.63 1.18 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 121.059 -0.256 . . . . 4.4199999999999999 111.104 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 23' ' ' VAL . . . -152.26 -137.74 2.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 118.956 -1.592 . . . . 0.40999999999999998 115.084 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.6 mttm -115.63 -122.49 0.29 Allowed 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.65 -0.775 . . . . 1.74 110.325 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -90.28 -42.13 5.32 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.036 -2.026 . . . . 0.64000000000000001 108.036 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 1.4 mptp? -140.67 7.29 2.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.023 -1.588 . . . . 3.8700000000000001 110.675 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 30.3 t0 -88.85 10.07 22.45 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.893 0.377 . . . . 1.22 111.091 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 25' ' ' TYR . 4.1 p -88.01 150.0 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 111.398 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.9 pt-20 -112.33 93.08 4.26 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.488 -0.778 . . . . 1.26 110.393 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.547 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 5.6 m-85 -88.16 -167.7 1.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.263 -0.643 . . . . 0.88 109.263 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' CD1' ' CD1' ' A' ' 37' ' ' TRP . 29.4 tp -126.48 160.63 30.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.064 -1.087 . . . . 1.6799999999999999 108.064 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -139.19 110.72 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 118.924 -1.111 . . . . 1.1899999999999999 113.529 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 52.0 mtt180 -84.85 74.19 10.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 105.668 -1.975 . . . . 3.8799999999999999 105.668 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 2.7 t90 -26.72 90.81 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 113.867 -1.515 . . . . 1.5600000000000001 111.833 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 83.5 tttt -27.39 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.352 -1.295 . . . . 3.1000000000000001 112.341 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 4.7 p-10 -120.01 56.76 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.796 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.56 -178.02 23.3 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.58999999999999997 112.628 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.06 -13.37 9.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.851 -0.69 . . . . 0.85999999999999999 112.567 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -126.65 162.49 25.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 2.1299999999999999 110.89 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -116.1 118.72 33.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 2.29 110.71 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 31.9 mt-10 -108.64 163.88 12.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.207 0.527 . . . . 2.27 111.68 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.53 ' CD1' ' CD1' ' A' ' 26' ' ' LEU . 16.2 m0 -87.95 148.37 24.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.83999999999999997 112.015 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 40.1 t -87.6 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.018 -0.992 . . . . 1.3799999999999999 109.751 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 86.9 tttt -80.76 106.89 13.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.284 0.564 . . . . 2.8700000000000001 112.436 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -99.22 39.32 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.298 -0.864 . . . . 0.39000000000000001 112.363 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.29 0.0 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.824 -0.436 . . . . 1.3 109.824 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -77.05 77.79 3.6 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.734 0.778 . . . . 2.1299999999999999 110.918 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 6.0 p -57.28 77.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.325 -1.761 . . . . 2.1499999999999999 112.663 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.447 ' HB2' ' CG2' ' A' ' 47' ' ' VAL . . . -92.43 49.25 1.47 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.872 -1.058 . . . . 1.1200000000000001 109.241 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 42.0 tt0 -48.28 -27.53 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.171 -0.922 . . . . 2.4399999999999999 110.187 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 15.8 t70 -75.02 -43.12 55.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.477 -0.783 . . . . 2.48 109.73 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.3 t -63.93 -46.79 93.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 109.34 -0.615 . . . . 1.5 109.34 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.4 -54.96 18.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.539 1.536 . . . . 1.3600000000000001 111.331 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 23.3 ttmm -60.27 -33.28 72.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.406 0.622 . . . . 3.7799999999999998 109.464 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.1 t70 -91.67 -11.4 37.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.276 -0.874 . . . . 2.0 110.428 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -84.02 -63.25 1.38 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.428 0.633 . . . . 2.3300000000000001 110.262 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.7 pt-20 -87.64 -46.68 9.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.046 -0.979 . . . . 1.77 110.83 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -80.99 -22.51 39.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 2.2999999999999998 111.425 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.441 -0.885 . . . . 1.6100000000000001 112.244 179.806 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.506 ' HD1' ' HH ' ' A' ' 25' ' ' TYR . 8.3 p90 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.649 0.261 . . . . 2.9300000000000002 110.39 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 10.4 tp10 -130.15 142.98 50.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 2.4100000000000001 110.935 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.524 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.6 p90 -88.27 109.37 19.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.6 0.714 . . . . 2.6000000000000001 112.034 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -95.02 50.82 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.758 -1.11 . . . . 1.1100000000000001 109.611 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.12 169.23 9.26 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.984 0.897 . . . . 2.7999999999999998 112.369 -178.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 29' ' ' TRP . 51.7 t -97.53 -34.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-N 113.769 -1.559 . . . . 1.1200000000000001 112.096 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 11.3 t70 -144.87 -33.67 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.508 0.558 . . . . 2.1899999999999999 112.508 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 33.2 mm-40 -154.07 159.79 41.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.297 0.481 . . . . 2.1800000000000002 112.297 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -136.4 -169.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 1.0800000000000001 110.485 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG2' HD12 ' A' ' 26' ' ' LEU . 94.0 t -149.97 -54.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.431 . . . . 1.3500000000000001 110.068 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 41.5 mt-10 -92.25 138.32 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 2.96 109.375 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.593 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 19.7 pttm -152.43 87.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.262 0.467 . . . . 2.6200000000000001 112.262 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -154.24 93.08 1.58 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.324 -0.235 . . . . 4.4199999999999999 111.422 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.28 -128.87 1.32 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.19 -1.481 . . . . 0.40999999999999998 114.786 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.6 mttm -121.55 -122.79 0.28 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.341 -0.93 . . . . 1.74 109.481 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -92.12 -40.58 5.14 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.291 -1.924 . . . . 0.64000000000000001 108.291 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 12.0 mptt -137.14 1.95 2.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.187 -1.507 . . . . 3.8700000000000001 110.922 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 35.9 t0 -87.6 9.48 21.09 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.12 0.486 . . . . 1.22 111.465 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 25' ' ' TYR . 9.3 p -89.36 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.867 -0.606 . . . . 1.1200000000000001 111.705 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.9 pt-20 -107.73 101.15 10.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.483 -0.781 . . . . 1.26 110.035 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' OH ' ' HB2' ' A' ' 16' ' ' LYS . 7.2 m-85 -107.02 150.14 26.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.822 -0.626 . . . . 0.88 110.302 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 ' CG2' ' A' ' 14' ' ' VAL . 2.1 tt -88.64 156.99 18.71 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.593 -0.892 . . . . 1.6799999999999999 108.593 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.0 m -141.21 112.04 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 114.07 1.137 . . . . 1.1899999999999999 114.07 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' TRP . 77.6 mtt180 -87.38 79.29 8.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.666 -1.975 . . . . 3.8799999999999999 105.666 175.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 10' ' ' VAL . 1.2 t90 -26.87 91.65 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.284 -1.326 . . . . 1.5600000000000001 112.246 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 61.6 tttp -27.62 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.308 -1.315 . . . . 3.1000000000000001 112.257 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.8 t70 -119.3 57.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 2.02 109.903 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -147.6 -145.25 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.58999999999999997 112.735 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -144.97 -45.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.949 -0.644 . . . . 0.85999999999999999 112.213 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.07 -177.33 4.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 2.1299999999999999 110.535 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.58 139.42 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 2.29 111.214 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -134.35 -177.46 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.081 -0.509 . . . . 2.27 110.779 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -104.25 146.27 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.83999999999999997 111.338 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 92.0 t -89.19 159.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.3799999999999999 109.792 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 23.5 ttmm -75.46 107.46 7.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.325 0.583 . . . . 2.8700000000000001 112.5 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -92.75 40.77 2.8 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.069 -0.969 . . . . 0.39000000000000001 112.392 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 1.9 t -116.85 3.94 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.044 -0.354 . . . . 1.3 110.044 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -75.85 76.49 2.78 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.879 0.847 . . . . 2.1299999999999999 110.799 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG12 ' HE3' ' A' ' 19' ' ' LYS . 58.6 t -58.12 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 113.219 -1.81 . . . . 2.1499999999999999 113.249 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 47' ' ' VAL . . . -91.75 51.34 1.83 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.595 -0.891 . . . . 1.1200000000000001 108.595 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -45.85 -27.28 0.83 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.196 -0.911 . . . . 2.4399999999999999 110.818 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.28 -46.94 63.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.775 -0.648 . . . . 2.48 109.785 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 59.7 t -58.98 -47.39 90.01 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-N 116.002 -0.545 . . . . 1.5 109.539 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.44 -56.69 9.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.175 1.39 . . . . 1.3600000000000001 110.976 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.6 ttmm -56.59 -35.3 68.07 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.289 0.566 . . . . 3.7799999999999998 109.682 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -91.56 -14.77 29.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.0 111.152 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.53 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -77.08 -59.95 2.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.718 0.771 . . . . 2.3300000000000001 110.453 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.1 pt-20 -90.19 -41.75 11.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.3 -1.318 . . . . 1.77 111.482 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -87.69 -30.78 20.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 111.524 -179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.492 -0.861 . . . . 1.6100000000000001 112.368 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.419 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.695 0.283 . . . . 2.9300000000000002 110.973 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 2.2 mp0 -130.94 150.51 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.882 0.372 . . . . 2.4100000000000001 111.202 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.505 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 50.3 p90 -92.5 113.64 25.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.802 0.668 . . . . 2.6000000000000001 112.802 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -100.55 54.14 0.88 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.949 -1.023 . . . . 1.1100000000000001 109.254 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.73 164.33 14.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.992 0.901 . . . . 2.7999999999999998 112.085 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 39.1 t -98.34 -22.07 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 114.004 -1.453 . . . . 1.1200000000000001 112.117 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 13.7 t70 -149.94 -40.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.385 0.513 . . . . 2.1899999999999999 112.385 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 8.2 mm-40 -154.23 163.31 40.32 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 111.942 0.349 . . . . 2.1800000000000002 111.942 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -136.93 -169.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.575 0.226 . . . . 1.0800000000000001 110.582 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 88.4 t -150.13 -59.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 1.3500000000000001 110.233 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 16.3 mm-40 -91.9 138.74 31.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.833 -0.622 . . . . 2.96 109.891 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 8.4 ptpp? -151.06 92.99 1.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.008 -0.277 . . . . 2.6200000000000001 111.652 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -154.44 91.12 1.38 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.352 -0.217 . . . . 4.4199999999999999 110.969 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.448 ' H ' ' HD2' ' A' ' 5' ' ' PHE . . . -153.16 -134.11 1.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 118.956 -1.592 . . . . 0.40999999999999998 115.111 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 69.0 mttm -117.28 -126.01 0.28 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.263 -0.968 . . . . 1.74 109.526 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.453 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.21 -38.7 6.66 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.551 -1.82 . . . . 0.64000000000000001 108.551 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 20.8 mmtp -140.51 2.5 1.83 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.215 -1.492 . . . . 3.8700000000000001 111.084 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 16.1 t70 -88.26 11.26 17.03 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.211 0.529 . . . . 1.22 111.462 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.51 HG12 ' CE1' ' A' ' 25' ' ' TYR . 6.3 p -88.75 154.03 3.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.802 -0.636 . . . . 1.1200000000000001 112.199 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.33 105.61 15.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.313 -0.858 . . . . 1.26 110.098 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.538 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 7.0 m-85 -110.52 150.82 28.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.654 . . . . 0.88 110.177 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 13' ' ' ILE . 1.8 tt -88.74 157.26 18.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.07 -0.715 . . . . 1.6799999999999999 109.07 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.9 m -143.07 110.55 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 114.428 1.27 . . . . 1.1899999999999999 114.428 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.2 ttp180 -82.1 72.97 9.16 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 105.465 -2.05 . . . . 3.8799999999999999 105.465 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -26.49 89.47 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.86 -1.518 . . . . 1.5600000000000001 112.207 -177.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' CB ' HG11 ' A' ' 10' ' ' VAL . 38.2 ttpt -29.21 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.596 -1.184 . . . . 3.1000000000000001 112.089 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.6 m-20 -117.95 56.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 2.02 109.796 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.13 -163.71 10.26 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.58999999999999997 112.72 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.34 -43.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.006 -0.616 . . . . 0.85999999999999999 112.054 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -97.75 -173.67 2.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 2.1299999999999999 110.518 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.6 t -142.69 144.1 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 2.29 111.087 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -147.68 -176.22 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 2.27 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 34.8 m0 -104.62 152.28 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.83999999999999997 111.589 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 72.1 t -88.95 161.06 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.993 -0.548 . . . . 1.3799999999999999 109.942 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.441 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 63.3 tttp -75.48 104.36 6.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.343 0.592 . . . . 2.8700000000000001 112.332 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.51 44.19 2.91 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.136 -0.938 . . . . 0.39000000000000001 112.511 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.412 ' HB ' ' HE3' ' A' ' 39' ' ' LYS . 2.0 t -120.18 8.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.835 -0.431 . . . . 1.3 109.835 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -75.81 75.81 2.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.43 0.633 . . . . 2.1299999999999999 110.433 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.435 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 60.5 t -57.87 73.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.609 -1.632 . . . . 2.1499999999999999 113.5 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.71 49.55 1.48 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.799 -0.815 . . . . 1.1200000000000001 108.799 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -44.16 -29.24 0.6 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.181 -0.918 . . . . 2.4399999999999999 110.734 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 12.1 t70 -70.53 -43.76 68.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.488 -0.778 . . . . 2.48 110.117 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.6 t -63.04 -47.57 92.06 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 109.514 -0.551 . . . . 1.5 109.514 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -65.88 -54.79 21.98 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.399 1.48 . . . . 1.3600000000000001 111.062 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 27.9 ttpp -60.12 -33.16 71.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.456 0.646 . . . . 3.7799999999999998 109.65 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 6.9 t70 -92.56 -9.37 41.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.278 -0.874 . . . . 2.0 110.652 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -86.53 -63.67 1.28 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.484 0.659 . . . . 2.3300000000000001 110.749 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.4 pt-20 -85.79 -42.95 13.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.892 -1.049 . . . . 1.77 110.763 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -87.61 -18.92 28.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.607 -0.724 . . . . 2.2999999999999998 111.42 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.454 -0.879 . . . . 1.6100000000000001 112.369 179.781 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.579 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.143 0.497 . . . . 2.9300000000000002 111.157 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 7.9 tp10 -154.11 124.32 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 2.4100000000000001 109.731 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 43.0 p90 -89.21 105.01 17.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.815 0.302 . . . . 2.6000000000000001 111.815 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB1' ' CG1' ' A' ' 38' ' ' VAL . . . -89.58 56.1 3.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.55 -0.537 . . . . 1.1100000000000001 109.55 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' CB ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.71 149.51 32.82 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.813 0.816 . . . . 2.7999999999999998 113.028 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 18.2 t -90.45 -32.49 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 114.222 -1.353 . . . . 1.1200000000000001 110.647 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.5 t70 -138.43 -43.15 0.5 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 2.1899999999999999 111.814 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.4 mm-40 -155.43 157.59 37.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.81 0.67 . . . . 2.1800000000000002 112.81 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -126.87 -165.9 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.325 -0.62 . . . . 1.0800000000000001 109.325 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.53 HG23 ' CB ' ' A' ' 26' ' ' LEU . 31.5 m -150.1 -51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 1.3500000000000001 111.199 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.1 tp10 -105.23 134.71 47.89 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.897 -0.592 . . . . 2.96 109.448 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.811 ' HE2' ' HH ' ' A' ' 25' ' ' TYR . 13.2 ptmm? -150.9 88.98 1.5 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.134 -0.627 . . . . 2.6200000000000001 112.63 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 15.0 ptp180 -153.6 91.34 1.47 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.85 -0.34 . . . . 4.4199999999999999 111.383 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.61 -135.28 2.18 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 118.876 -1.631 . . . . 0.40999999999999998 114.851 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.7 mttm -111.28 -120.26 0.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.46 -0.87 . . . . 1.74 109.909 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.436 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.95 -41.0 3.91 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 108.19 -1.964 . . . . 0.64000000000000001 108.19 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 46.2 mmtm -135.08 0.46 2.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 112.978 -1.611 . . . . 3.8700000000000001 110.871 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 12.3 t70 -88.54 9.88 22.33 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 121.297 0.57 . . . . 1.22 111.458 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' CA ' ' HA3' ' A' ' 18' ' ' GLY . 7.3 p -93.99 143.18 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.148 -0.933 . . . . 1.1200000000000001 110.58 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 11.8 pt-20 -104.9 119.4 38.92 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.421 -0.512 . . . . 1.26 110.865 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.811 ' HH ' ' HE2' ' A' ' 16' ' ' LYS . 19.4 m-85 -113.8 -175.23 2.63 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.652 -0.704 . . . . 0.88 110.237 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' CB ' HG23 ' A' ' 14' ' ' VAL . 2.1 tt -128.75 157.89 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.108 -0.951 . . . . 1.6799999999999999 108.502 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.18 113.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 118.848 -1.141 . . . . 1.1899999999999999 113.149 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -87.78 66.44 8.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 104.734 -2.321 . . . . 3.8799999999999999 104.734 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 16.7 t90 -25.97 89.71 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.263 -1.79 . . . . 1.5600000000000001 112.496 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 57.3 tttp -27.49 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.134 -1.394 . . . . 3.1000000000000001 112.392 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' OD2' ' CZ2' ' A' ' 29' ' ' TRP . 7.8 p-10 -119.81 57.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 2.02 109.903 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -140.85 -147.16 4.89 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.753 -0.658 . . . . 0.58999999999999997 112.887 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.67 -45.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.095 -0.574 . . . . 0.85999999999999999 112.197 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.72 172.21 7.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 2.1299999999999999 110.652 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.26 138.94 52.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 2.29 111.05 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -138.13 179.4 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 2.27 110.678 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 26.0 m0 -113.29 154.2 27.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.372 . . . . 0.83999999999999997 111.747 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' CG1' ' HB1' ' A' ' 8' ' ' ALA . 13.5 t -88.88 151.77 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.998 -0.546 . . . . 1.3799999999999999 110.042 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 38' ' ' VAL . 63.1 tttm -69.66 91.43 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 2.8700000000000001 111.175 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' HA3' ' CA ' ' A' ' 24' ' ' GLU . . . -90.11 42.48 2.95 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.759 -0.734 . . . . 0.39000000000000001 113.14 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.33 11.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.718 -0.475 . . . . 1.3 109.718 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -81.78 81.52 7.78 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.76 0.79 . . . . 2.1299999999999999 111.201 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 58.3 t -58.05 71.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.169 -1.832 . . . . 2.1499999999999999 112.243 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.94 51.85 1.9 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.281 -0.872 . . . . 1.1200000000000001 109.111 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.38 0.49 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.344 -0.843 . . . . 2.4399999999999999 110.489 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 18.2 m-20 -70.33 -48.46 56.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.425 -0.807 . . . . 2.48 109.99 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 51' ' ' TYR . 64.0 t -59.41 -42.25 87.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 116.385 -0.37 . . . . 1.5 110.286 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.64 -58.07 4.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.03 1.332 . . . . 1.3600000000000001 110.842 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' GLY . 40.6 ttmt -58.98 -30.05 67.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.397 0.618 . . . . 3.7799999999999998 109.406 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.9 t70 -91.67 -16.36 27.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.381 -0.827 . . . . 2.0 110.374 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -80.58 -67.7 0.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.591 0.71 . . . . 2.3300000000000001 110.362 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 12.8 pt-20 -86.31 -44.29 12.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.884 -1.053 . . . . 1.77 111.149 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 8.5 t70 -86.94 -9.1 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.781 -0.645 . . . . 2.2999999999999998 111.513 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.406 -0.902 . . . . 1.6100000000000001 112.123 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CB ' HG22 ' A' ' 23' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.765 0.317 . . . . 2.9300000000000002 111.402 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 8.2 tp10 -140.07 145.52 37.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.278 -0.419 . . . . 2.4100000000000001 110.972 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.499 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 17.9 p90 -88.39 124.6 34.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 2.6000000000000001 111.28 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . . . -107.15 49.54 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.459 -0.791 . . . . 1.1100000000000001 110.348 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -104.75 176.97 4.98 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.846 0.831 . . . . 2.7999999999999998 112.509 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.589 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 14.1 t -112.69 -14.5 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.157 -1.383 . . . . 1.1200000000000001 112.225 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 16.8 t70 -150.16 -44.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.395 . . . . 2.1899999999999999 111.171 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -153.16 173.84 15.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.039 -0.528 . . . . 2.1800000000000002 111.447 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -143.22 -171.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 1.0800000000000001 109.36 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG2' HD22 ' A' ' 26' ' ' LEU . 64.1 t -150.46 -48.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 1.3500000000000001 110.699 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 14.3 mm-40 -93.51 145.6 24.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.118 -0.492 . . . . 2.96 110.445 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 ptmt -152.83 86.32 1.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.7 -0.4 . . . . 2.6200000000000001 111.534 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -153.44 91.87 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 121.092 -0.243 . . . . 4.4199999999999999 111.43 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -151.31 -130.77 1.71 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.644 -1.265 . . . . 0.40999999999999998 114.912 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 51.1 mttm -116.58 -74.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.279 1.038 . . . . 1.74 110.644 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.2 -47.1 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 107.021 -2.431 . . . . 0.64000000000000001 107.021 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 50.6 mmtt -125.21 -10.46 7.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 112.954 -1.623 . . . . 3.8700000000000001 109.705 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' HIS . 11.0 t70 -87.06 11.2 14.33 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.141 0.495 . . . . 1.22 111.833 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' A' ' 25' ' ' TYR . 5.4 p -86.71 151.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.853 -0.612 . . . . 1.1200000000000001 110.852 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 91.29 3.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.573 -0.739 . . . . 1.26 110.658 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 5.5 m-85 -88.16 -166.31 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.011 -0.54 . . . . 0.88 109.973 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 37' ' ' TRP . 15.1 tp -127.78 159.78 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.711 -0.848 . . . . 1.6799999999999999 108.711 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.16 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 113.696 0.998 . . . . 1.1899999999999999 113.696 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 29' ' ' TRP . 82.7 mtt180 -88.78 65.72 7.77 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 104.439 -2.43 . . . . 3.8799999999999999 104.439 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 22.2 t90 -25.64 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.529 -1.669 . . . . 1.5600000000000001 111.965 -177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 65.8 tttm -28.49 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.051 -1.431 . . . . 3.1000000000000001 112.799 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.9 m-20 -108.49 49.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.806 0.336 . . . . 2.02 110.655 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.27 -162.17 10.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.16 -0.543 . . . . 0.58999999999999997 112.538 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.48 27.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.85999999999999999 112.589 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.48 179.43 7.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.936 0.398 . . . . 2.1299999999999999 111.078 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.79 130.44 54.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 2.29 110.742 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -134.36 137.84 44.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 2.27 111.045 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.549 ' CD1' ' CD1' ' A' ' 26' ' ' LEU . 7.7 m0 -89.08 148.82 23.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.47 0.652 . . . . 0.83999999999999997 111.889 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' A' ' 27' ' ' VAL . 14.6 t -87.23 158.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.947 -1.024 . . . . 1.3799999999999999 109.777 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.21 111.58 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.314 0.578 . . . . 2.8700000000000001 112.277 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.37 38.7 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.186 -0.915 . . . . 0.39000000000000001 112.844 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.34 -1.64 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 110.111 -0.329 . . . . 1.3 110.111 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.18 76.87 1.28 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.431 0.634 . . . . 2.1299999999999999 110.238 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 6.2 p -56.22 69.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 113.441 -1.709 . . . . 2.1499999999999999 114.086 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -89.5 51.23 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 1.1200000000000001 109.143 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -48.78 -27.13 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.311 -0.859 . . . . 2.4399999999999999 110.272 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 28.1 t70 -69.38 -48.36 61.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 2.48 110.058 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.618 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 35.4 t -59.69 -31.1 46.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 116.323 -0.399 . . . . 1.5 110.219 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.77 -59.47 2.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.875 1.27 . . . . 1.3600000000000001 109.903 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 8.0 mtmp? -57.51 -27.23 62.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.922 -0.77 . . . . 3.7799999999999998 108.922 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.5 t70 -92.71 -22.44 19.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.428 -0.805 . . . . 2.0 110.184 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.618 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.3 -70.17 0.38 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.858 0.837 . . . . 2.3300000000000001 110.468 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 16.1 pt-20 -84.94 -50.36 7.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.077 -1.419 . . . . 1.77 111.813 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.3 t70 -73.99 -24.73 59.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 2.2999999999999998 110.826 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 120.399 -0.905 . . . . 1.6100000000000001 111.773 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.439 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 N-CA-C 109.392 -0.595 . . . . 2.9300000000000002 109.392 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 23' ' ' VAL . 11.5 tp10 -140.88 129.16 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.009 0.433 . . . . 2.4100000000000001 111.586 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 40.5 p90 -95.49 103.52 15.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.666 -0.697 . . . . 2.6000000000000001 110.908 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.456 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -86.77 57.91 4.77 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.942 -0.762 . . . . 1.1100000000000001 108.942 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.546 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -107.13 149.44 27.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.716 -1.129 . . . . 2.7999999999999998 113.121 -177.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 29' ' ' TRP . 55.0 t -90.27 -36.1 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 113.068 -1.878 . . . . 1.1200000000000001 110.109 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB3' ' CA ' ' A' ' 30' ' ' LYS . 4.3 m-20 -141.13 -37.04 0.44 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 2.1899999999999999 112.125 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.1 mt-10 -153.52 168.98 24.33 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 112.15 0.426 . . . . 2.1800000000000002 112.15 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG21 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -138.71 -170.22 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.0800000000000001 109.807 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.491 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 65.7 t -152.32 -60.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.863 0.363 . . . . 1.3500000000000001 111.624 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 40.9 tt0 -92.33 93.33 8.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.96 112.043 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 21.0 pttm -104.87 90.54 3.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 2.6200000000000001 111.166 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -155.99 87.34 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.947 -0.301 . . . . 4.4199999999999999 111.55 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 23' ' ' VAL . . . -150.66 -138.38 2.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 118.896 -1.621 . . . . 0.40999999999999998 115.001 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 67.1 mttm -106.48 -113.32 0.27 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.858 -0.671 . . . . 1.74 110.106 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -101.17 -41.77 2.53 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 107.688 -2.165 . . . . 0.64000000000000001 107.688 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 36.6 mtmm -143.18 6.86 1.55 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.985 -1.608 . . . . 3.8700000000000001 110.882 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 40.5 t0 -89.96 13.01 15.83 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.214 0.53 . . . . 1.22 111.253 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 25' ' ' TYR . 7.9 p -88.07 156.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.536 -0.756 . . . . 1.1200000000000001 112.28 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 8.4 pt-20 -115.1 92.17 3.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.17 -0.923 . . . . 1.26 110.182 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.538 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 6.0 m-85 -88.74 -168.05 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.88 110.074 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -123.26 161.13 25.18 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.534 -0.913 . . . . 1.6799999999999999 108.534 178.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.8 OUTLIER -141.75 110.22 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 118.611 -1.236 . . . . 1.1899999999999999 113.701 178.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 79.0 mtt180 -87.15 77.55 9.05 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.14 -1.43 . . . . 3.8799999999999999 107.14 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.497 ' CD1' HG22 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -27.34 90.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.177 -1.374 . . . . 1.5600000000000001 112.114 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' N ' HG12 ' A' ' 10' ' ' VAL . 54.7 tptt -27.99 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.809 -1.087 . . . . 3.1000000000000001 112.23 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.1 m-20 -119.48 55.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.026 0.441 . . . . 2.02 110.041 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -143.01 -153.96 6.01 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.58999999999999997 112.734 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.09 21.2 1.24 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.811 -0.709 . . . . 0.85999999999999999 112.463 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -149.82 -172.33 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.1299999999999999 110.685 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -148.86 106.35 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 2.29 111.272 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -102.38 -169.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.973 -0.558 . . . . 2.27 110.553 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.4 m0 -114.21 152.79 30.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.439 0.638 . . . . 0.83999999999999997 112.406 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 67.3 t -88.17 163.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.108 -0.951 . . . . 1.3799999999999999 109.768 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 38' ' ' VAL . 35.9 tptt -82.81 107.53 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.914 0.709 . . . . 2.8700000000000001 112.914 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.97 29.43 9.98 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.219 -0.9 . . . . 0.39000000000000001 111.949 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.36 -3.11 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' ALA . 6.2 m170 -68.5 75.61 0.27 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.328 0.585 . . . . 2.1299999999999999 110.089 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.84 70.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.083 -1.417 . . . . 2.1499999999999999 113.7 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.01 50.89 1.73 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.666 -0.865 . . . . 1.1200000000000001 108.666 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -24.24 1.72 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.931 -1.031 . . . . 2.4399999999999999 110.657 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.6 m-20 -66.01 -48.68 70.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.183 -0.462 . . . . 2.48 110.115 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' CE2' ' A' ' 51' ' ' TYR . 43.8 t -58.63 -28.73 37.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.996 -0.547 . . . . 1.5 111.035 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -86.7 -59.11 2.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.788 1.235 . . . . 1.3600000000000001 110.162 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.0 ttmm -56.37 -28.49 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.044 -0.724 . . . . 3.7799999999999998 109.044 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 11.3 t70 -90.97 -25.24 19.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.448 -0.797 . . . . 2.0 109.504 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -70.1 -71.15 0.25 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.947 0.88 . . . . 2.3300000000000001 110.638 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.5 pt-20 -81.04 -45.91 15.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 113.95 -1.477 . . . . 1.77 111.796 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.67 -24.81 36.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.976 -0.557 . . . . 2.2999999999999998 111.59 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.465 -0.874 . . . . 1.6100000000000001 112.347 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 6.9 p90 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.764 0.316 . . . . 2.9300000000000002 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 9.6 tp10 -131.16 143.24 50.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 2.4100000000000001 110.391 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.522 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 46.3 p90 -89.06 107.44 19.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.312 0.577 . . . . 2.6000000000000001 112.43 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -90.23 53.09 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.248 -0.887 . . . . 1.1100000000000001 109.051 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.687 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -111.89 152.45 27.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 122.186 0.993 . . . . 2.7999999999999998 113.308 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 t -89.78 -34.42 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 113.52 -1.673 . . . . 1.1200000000000001 110.582 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 15.7 t70 -142.57 -38.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.942 -0.572 . . . . 2.1899999999999999 112.321 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.0 mm-40 -155.16 155.95 34.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.828 0.677 . . . . 2.1800000000000002 112.828 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.535 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -129.65 -169.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.882 0.372 . . . . 1.0800000000000001 110.595 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 26' ' ' LEU . 81.6 t -150.99 -55.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 1.3500000000000001 110.062 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.9 mt-10 -92.09 139.02 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 2.96 109.618 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 19.3 pttm -152.16 89.15 1.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.346 0.499 . . . . 2.6200000000000001 112.346 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 ptp180 -154.7 92.41 1.47 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.238 -0.289 . . . . 4.4199999999999999 111.189 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.95 -132.46 1.76 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.098 -1.525 . . . . 0.40999999999999998 114.975 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.7 mttm -117.85 -121.26 0.3 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.368 -0.916 . . . . 1.74 109.599 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.437 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.92 -42.05 4.5 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.801 -2.119 . . . . 0.64000000000000001 107.801 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -137.51 4.17 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.103 -1.549 . . . . 3.8700000000000001 110.94 177.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' CA ' ' A' ' 41' ' ' VAL . 29.9 t0 -87.67 10.1 19.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.158 0.504 . . . . 1.22 111.024 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.512 HG11 ' CE1' ' A' ' 25' ' ' TYR . 9.9 p -89.24 154.73 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.827 -0.624 . . . . 1.1200000000000001 111.406 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -110.64 99.04 8.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.396 -0.82 . . . . 1.26 110.101 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.546 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 8.2 m-85 -104.25 153.03 21.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.697 -0.683 . . . . 0.88 110.441 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' A' ' 14' ' ' VAL . 2.6 tt -88.71 156.94 18.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.527 -0.916 . . . . 1.6799999999999999 108.527 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.687 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -142.33 108.53 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 118.874 -1.131 . . . . 1.1899999999999999 113.907 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 30' ' ' LYS . 56.2 ttt180 -81.78 76.31 8.69 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.125 -1.806 . . . . 3.8799999999999999 106.125 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 3.6 t90 -27.54 89.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.156 -1.384 . . . . 1.5600000000000001 112.371 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' N ' HG13 ' A' ' 10' ' ' VAL . 58.7 tttm -28.67 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.665 -1.152 . . . . 3.1000000000000001 112.081 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . 21.8 t70 -120.15 57.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 2.02 109.832 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.32 -167.4 12.73 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.821 -0.627 . . . . 0.58999999999999997 112.821 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.43 -39.28 0.63 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.992 -0.623 . . . . 0.85999999999999999 112.205 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -113.12 164.08 13.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.664 0.268 . . . . 2.1299999999999999 110.554 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.19 143.15 47.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 2.29 111.156 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.18 178.61 6.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 2.27 110.735 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 12.5 m0 -100.01 148.5 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.83999999999999997 111.515 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.479 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 61.8 t -88.67 161.35 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.125 -0.488 . . . . 1.3799999999999999 109.777 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 22.5 ttmm -79.27 108.89 13.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.526 0.679 . . . . 2.8700000000000001 112.322 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.28 42.62 2.93 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.811 -1.086 . . . . 0.39000000000000001 112.466 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 t -115.45 -0.59 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.993 -0.373 . . . . 1.3 109.993 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.73 75.08 0.6 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.662 0.744 . . . . 2.1299999999999999 110.906 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 7.7 p -59.5 72.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 113.552 -1.658 . . . . 2.1499999999999999 113.376 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 51.48 1.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.532 -0.914 . . . . 1.1200000000000001 108.532 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 49' ' ' LYS . 42.5 tt0 -47.16 -25.95 1.02 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.165 -0.925 . . . . 2.4399999999999999 110.84 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 31.7 t70 -68.75 -40.37 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.939 -0.573 . . . . 2.48 109.926 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 HG13 ' CE1' ' A' ' 51' ' ' TYR . 91.3 t -66.47 -46.71 85.88 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 N-CA-C 109.67 -0.493 . . . . 1.5 109.67 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.09 -54.82 17.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.628 1.571 . . . . 1.3600000000000001 111.516 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 72.0 mmtt -61.0 -32.01 71.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.504 0.668 . . . . 3.7799999999999998 109.504 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.5 t70 -92.12 -11.88 34.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.376 -0.829 . . . . 2.0 110.46 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.4 m-30 -84.25 -63.63 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.39 0.614 . . . . 2.3300000000000001 110.684 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -87.45 -46.48 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.1 -0.955 . . . . 1.77 110.654 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.0 m-20 -81.91 -20.92 37.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 2.2999999999999998 111.431 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.218 0 C-N-CA 120.546 -0.835 . . . . 1.6100000000000001 112.278 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.029 ' CE1' ' CE2' ' A' ' 5' ' ' PHE . 6.1 p90 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.65 0.262 . . . . 2.9300000000000002 110.622 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 9.8 tp10 -111.07 131.33 55.16 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 2.4100000000000001 111.501 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 49.6 p90 -89.02 109.31 20.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.286 0.476 . . . . 2.6000000000000001 112.286 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . -91.99 56.1 2.8 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.063 -0.717 . . . . 1.1100000000000001 109.063 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -108.12 151.74 25.48 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.168 0.985 . . . . 2.7999999999999998 113.154 -176.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 84.5 t -89.66 -35.14 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 113.611 -1.632 . . . . 1.1200000000000001 110.477 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HB3' ' CA ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -141.27 -39.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.658 -0.701 . . . . 2.1899999999999999 111.997 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.7 mt-10 -154.46 157.79 38.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 2.1800000000000002 112.484 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.53 HG21 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.49 -168.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 1.0800000000000001 109.476 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 ' CG2' HD11 ' A' ' 26' ' ' LEU . 71.4 t -151.04 -45.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 1.3500000000000001 110.017 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.7 mt-10 -99.48 144.36 28.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.96 109.99 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.9 pttt -154.19 83.65 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.819 -0.352 . . . . 2.6200000000000001 111.784 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -154.03 86.64 1.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.714 -0.394 . . . . 4.4199999999999999 111.362 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.448 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.0 -131.38 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.055 -1.545 . . . . 0.40999999999999998 114.348 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 5' ' ' PHE . 55.9 mttt -124.51 -120.14 0.27 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.509 -0.846 . . . . 1.74 109.97 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.57 -41.27 4.5 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 108.904 -1.678 . . . . 0.64000000000000001 108.904 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 49.9 mttp -136.39 0.12 2.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.22 -1.49 . . . . 3.8700000000000001 111.029 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 19' ' ' LYS . 21.8 t0 -88.21 8.66 26.05 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.22 111.815 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 25' ' ' TYR . 7.6 p -87.99 147.69 5.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.936 -0.574 . . . . 1.1200000000000001 110.747 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.0 pt-20 -111.31 90.37 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.626 -0.715 . . . . 1.26 110.299 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 8.2 m-85 -89.21 -168.11 2.07 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.975 -0.557 . . . . 0.88 109.713 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 27' ' ' VAL . 1.7 tt -126.49 159.23 33.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.987 -1.116 . . . . 1.6799999999999999 107.987 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -139.5 114.2 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 118.619 -1.233 . . . . 1.1899999999999999 113.45 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.7 ttt85 -88.25 75.57 8.54 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.815 -1.55 . . . . 3.8799999999999999 106.815 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.541 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.7 m0 -27.9 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.395 -1.275 . . . . 1.5600000000000001 112.511 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' CB ' HG11 ' A' ' 10' ' ' VAL . 60.8 tttp -29.78 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.619 -1.173 . . . . 3.1000000000000001 111.938 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' TRP . 15.0 m-20 -125.75 51.36 1.75 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.931 -0.577 . . . . 2.02 109.91 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -130.98 -138.91 4.34 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.722 -0.672 . . . . 0.58999999999999997 112.538 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.2 -48.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.78 -0.724 . . . . 0.85999999999999999 112.677 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.67 179.51 4.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 2.1299999999999999 111.089 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.9 m -124.2 106.44 10.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.072 -0.513 . . . . 2.29 111.03 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.1 mp0 -101.47 -175.77 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 2.27 111.033 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 31.6 m0 -114.27 154.43 27.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.481 . . . . 0.83999999999999997 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 79.7 t -88.27 162.37 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.554 -0.748 . . . . 1.3799999999999999 109.591 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 19.8 tptm -80.76 99.88 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.698 0.629 . . . . 2.8700000000000001 112.698 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -98.42 26.06 25.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.445 -0.798 . . . . 0.39000000000000001 111.992 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.52 -3.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.687 -0.486 . . . . 1.3 109.687 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.482 ' CD2' ' HB3' ' A' ' 39' ' ' LYS . 93.1 m-70 -73.88 78.84 1.62 Allowed 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.52 0.676 . . . . 2.1299999999999999 109.919 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.55 69.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.636 -1.62 . . . . 2.1499999999999999 113.341 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.67 50.05 1.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.062 -0.972 . . . . 1.1200000000000001 109.127 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -45.53 -27.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.066 -0.97 . . . . 2.4399999999999999 110.655 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 11.2 m-20 -68.31 -47.69 66.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.272 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' TYR . 56.3 t -54.72 -40.38 51.28 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 116.375 -0.375 . . . . 1.5 110.517 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . . . -72.69 -59.75 2.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.751 1.22 . . . . 1.3600000000000001 110.497 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 4.5 tppp? -56.25 -28.66 59.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.338 -0.616 . . . . 3.7799999999999998 109.338 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.7 t70 -92.99 -21.82 19.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.355 -0.838 . . . . 2.0 110.482 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . 1.2 m-30 -74.19 -67.4 0.62 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.561 0.696 . . . . 2.3300000000000001 110.569 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 17.0 pt-20 -83.87 -48.41 10.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.696 -1.138 . . . . 1.77 111.474 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.452 ' CB ' ' HD3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -76.28 -36.88 58.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 111.501 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.456 -0.878 . . . . 1.6100000000000001 112.212 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' HB2' ' HH ' ' A' ' 25' ' ' TYR . 8.8 p90 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 120.94 0.4 . . . . 2.9300000000000002 110.994 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 9.0 tp10 -152.97 124.33 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.233 -0.654 . . . . 2.4100000000000001 109.233 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.549 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.5 p90 -87.45 104.42 16.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.466 0.543 . . . . 2.6000000000000001 112.466 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . . . -89.27 58.26 4.38 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.673 -0.862 . . . . 1.1100000000000001 108.673 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -117.21 148.07 41.94 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.261 1.029 . . . . 2.7999999999999998 113.33 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.51 HG21 ' CD1' ' A' ' 29' ' ' TRP . 46.5 t -88.48 -33.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 113.22 -1.809 . . . . 1.1200000000000001 110.334 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 11.7 t70 -144.68 -38.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.38 -0.827 . . . . 2.1899999999999999 111.77 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 10.8 mm-40 -154.48 162.71 41.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.458 0.54 . . . . 2.1800000000000002 112.458 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -132.23 -164.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.878 -0.601 . . . . 1.0800000000000001 109.857 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 98.1 t -149.98 -60.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.436 -0.579 . . . . 1.3500000000000001 109.436 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.5 tp10 -92.84 134.28 35.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.563 -0.902 . . . . 2.96 108.563 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.7 ptpt -151.32 79.13 1.29 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.786 0.662 . . . . 2.6200000000000001 112.786 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -153.86 95.32 1.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.95 -0.469 . . . . 4.4199999999999999 111.31 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.62 -130.52 1.56 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 118.891 -1.623 . . . . 0.40999999999999998 114.231 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.9 mttm -116.14 -120.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.86 -0.67 . . . . 1.74 109.741 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.39 -40.3 4.25 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 108.07 -2.012 . . . . 0.64000000000000001 108.07 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 19.5 mmtp -135.64 1.55 2.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 112.963 -1.618 . . . . 3.8700000000000001 110.878 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 22.1 t70 -88.74 9.44 24.42 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-O 121.301 0.572 . . . . 1.22 111.557 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.519 ' CG2' ' CE1' ' A' ' 25' ' ' TYR . 8.4 p -95.45 145.71 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.323 -0.853 . . . . 1.1200000000000001 111.268 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 1.3 pm0 -104.42 111.84 24.66 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.851 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 23.4 m-85 -113.97 147.84 37.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.808 -0.633 . . . . 0.88 110.375 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 27' ' ' VAL . 1.6 tt -90.24 159.52 16.66 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.975 -1.12 . . . . 1.6799999999999999 107.975 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.3 m -140.44 111.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 118.75 -1.18 . . . . 1.1899999999999999 113.517 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 30' ' ' LYS . 66.5 mtt180 -89.29 78.68 7.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.169 -1.419 . . . . 3.8799999999999999 107.169 176.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.51 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -27.8 89.71 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.254 -1.339 . . . . 1.5600000000000001 111.864 -178.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -28.74 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.918 -1.037 . . . . 3.1000000000000001 112.254 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 32.4 m-20 -118.3 55.7 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 2.02 109.901 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.24 -154.66 6.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.581 . . . . 0.58999999999999997 112.815 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.64 -45.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.038 -0.601 . . . . 0.85999999999999999 112.353 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.17 162.98 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 2.1299999999999999 110.824 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.31 137.3 52.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 2.29 110.97 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -130.67 167.18 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.689 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -107.05 147.16 30.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.83999999999999997 111.536 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 8' ' ' ALA . 65.0 t -88.84 159.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.3799999999999999 110.398 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 38' ' ' VAL . 82.8 tttt -79.6 96.43 6.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.078 0.466 . . . . 2.8700000000000001 111.899 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.1 44.83 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.559 -0.746 . . . . 0.39000000000000001 112.924 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.88 13.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.809 -0.441 . . . . 1.3 109.809 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -83.54 80.44 9.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.625 0.726 . . . . 2.1299999999999999 111.118 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.436 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 5.6 p -58.93 72.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.441 -1.708 . . . . 2.1499999999999999 112.406 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.94 51.51 1.84 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.108 -0.951 . . . . 1.1200000000000001 108.729 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -44.78 -28.26 0.61 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.277 -0.874 . . . . 2.4399999999999999 110.492 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.28 -50.19 55.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.746 . . . . 2.48 109.609 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 51' ' ' TYR . 98.0 t -57.05 -46.62 84.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 CA-C-N 115.88 -0.6 . . . . 1.5 109.903 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.76 -59.21 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.038 1.335 . . . . 1.3600000000000001 111.11 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 73.0 mmtt -55.01 -33.56 62.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.191 0.52 . . . . 3.7799999999999998 109.742 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.66 -19.43 22.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.802 -0.635 . . . . 2.0 110.738 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -73.2 -62.23 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.733 0.778 . . . . 2.3300000000000001 109.724 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -92.06 -49.87 5.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.241 -1.345 . . . . 1.77 111.414 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -75.43 -20.24 58.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 2.2999999999999998 111.435 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.886 . . . . 1.6100000000000001 112.085 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HD1' ' HH ' ' A' ' 25' ' ' TYR . 7.0 p90 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.758 0.313 . . . . 2.9300000000000002 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.439 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 10.6 tp10 -128.42 142.29 51.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 2.4100000000000001 110.731 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 52.5 p90 -88.91 114.56 25.67 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.691 0.758 . . . . 2.6000000000000001 112.124 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -101.85 55.46 0.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.568 -1.196 . . . . 1.1100000000000001 109.629 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.626 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.34 164.26 15.95 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.692 0.758 . . . . 2.7999999999999998 112.222 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 18.4 t -99.05 -19.22 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.415 -1.266 . . . . 1.1200000000000001 112.476 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 32.9 t70 -149.95 -43.13 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.046 0.388 . . . . 2.1899999999999999 112.046 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 48.5 mt-10 -154.26 166.46 33.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 116.423 -0.353 . . . . 2.1800000000000002 111.838 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.516 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -138.96 -171.66 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.5 0.191 . . . . 1.0800000000000001 110.501 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.449 ' CG2' HD13 ' A' ' 26' ' ' LEU . 77.1 t -146.18 -60.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 1.3500000000000001 110.05 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -94.36 136.71 34.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 2.96 109.717 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 41.8 pttt -150.85 94.66 2.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.791 0.293 . . . . 2.6200000000000001 111.791 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -155.98 92.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.229 -0.188 . . . . 4.4199999999999999 111.044 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 23' ' ' VAL . . . -152.82 -132.32 1.76 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 118.997 -1.573 . . . . 0.40999999999999998 114.8 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 98.7 mttt -116.75 -123.32 0.29 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.182 -1.009 . . . . 1.74 109.243 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.447 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.77 -41.75 4.32 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 108.202 -1.959 . . . . 0.64000000000000001 108.202 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HZ2' ' HH ' ' A' ' 51' ' ' TYR . 28.8 mmtt -132.3 -1.7 3.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.031 -1.584 . . . . 3.8700000000000001 110.766 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 27.0 t0 -87.71 10.18 19.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.016 0.436 . . . . 1.22 111.943 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 25' ' ' TYR . 8.3 p -89.85 153.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.811 -0.631 . . . . 1.1200000000000001 112.58 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -105.38 114.43 28.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.03 -0.986 . . . . 1.26 109.447 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.561 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 7.4 m-85 -120.11 149.14 42.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.309 -0.405 . . . . 0.88 110.06 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.6 tt -88.63 156.57 18.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.009 -0.738 . . . . 1.6799999999999999 109.009 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.22 110.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 113.826 1.047 . . . . 1.1899999999999999 113.826 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -81.91 69.5 8.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.056 -2.201 . . . . 3.8799999999999999 105.056 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.513 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 3.5 t90 -25.17 90.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 113.768 -1.56 . . . . 1.5600000000000001 112.317 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 11' ' ' ASP . 27.8 tptp -28.42 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.286 -1.324 . . . . 3.1000000000000001 112.196 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.1 m-20 -117.65 57.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 2.02 109.885 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -141.05 3.4 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.58999999999999997 112.641 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.99 -48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.85999999999999999 112.486 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -92.81 164.02 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 2.1299999999999999 110.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.62 109.78 16.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 2.29 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -112.57 178.92 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 2.27 110.899 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' NE1' ' OE1' ' A' ' 15' ' ' GLU . 36.9 m0 -102.02 149.23 24.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 0.83999999999999997 111.924 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.479 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 46.5 t -89.38 161.21 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 1.3799999999999999 109.883 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -72.75 103.08 3.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.546 0.572 . . . . 2.8700000000000001 112.546 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.27 42.13 2.85 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.452 -0.794 . . . . 0.39000000000000001 112.868 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 2.3 t -118.48 10.3 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.205 -0.294 . . . . 1.3 110.205 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -77.76 78.3 4.26 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.578 0.704 . . . . 2.1299999999999999 111.052 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.7 t -57.78 71.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 113.346 -1.752 . . . . 2.1499999999999999 113.065 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.54 49.83 1.53 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.789 -0.819 . . . . 1.1200000000000001 108.789 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -42.16 -30.61 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.17 -0.923 . . . . 2.4399999999999999 110.886 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 4.1 p30 -67.53 -47.0 71.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.376 -0.829 . . . . 2.48 109.968 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.546 ' CG1' ' CE1' ' A' ' 51' ' ' TYR . 48.6 t -60.29 -40.07 82.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 109.894 -0.41 . . . . 1.5 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.82 -57.71 5.2 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.205 1.402 . . . . 1.3600000000000001 110.999 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 7.5 mmpt? -60.59 -28.75 68.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.532 0.682 . . . . 3.7799999999999998 109.343 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.3 t70 -92.53 -14.31 28.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.353 -0.84 . . . . 2.0 110.174 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE1' ' CG1' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -83.44 -68.63 0.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.536 0.684 . . . . 2.3300000000000001 110.342 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.9 pt-20 -83.91 -47.25 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.677 -1.147 . . . . 1.77 111.048 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.9 t70 -82.06 -15.89 52.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 2.2999999999999998 111.101 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.534 -0.841 . . . . 1.6100000000000001 112.034 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 5.1 p90 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.908 0.385 . . . . 2.9300000000000002 110.473 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 2.3 tm-20 -153.15 128.0 9.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.151 -0.685 . . . . 2.4100000000000001 109.151 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.552 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 38.7 p90 -88.4 102.85 15.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 111.933 0.346 . . . . 2.6000000000000001 111.933 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -86.92 59.01 5.39 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.054 -0.721 . . . . 1.1100000000000001 109.054 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -112.09 149.55 31.97 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.32 1.057 . . . . 2.7999999999999998 113.261 -176.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 55.8 t -89.09 -37.35 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.161 -1.836 . . . . 1.1200000000000001 109.774 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 17.7 t70 -141.3 -37.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 2.1899999999999999 111.926 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 24.6 mm-40 -154.3 157.12 38.19 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.572 0.582 . . . . 2.1800000000000002 112.572 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -126.95 -166.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.826 -0.625 . . . . 1.0800000000000001 109.431 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 99.4 t -150.88 -48.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.274 0.559 . . . . 1.3500000000000001 109.513 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.5 mt-10 -99.97 144.91 28.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 2.96 109.643 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 22.6 pttm -154.38 78.36 1.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.371 0.508 . . . . 2.6200000000000001 112.371 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -153.22 90.94 1.47 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.302 -0.559 . . . . 4.4199999999999999 111.961 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.53 -132.42 1.71 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 118.95 -1.595 . . . . 0.40999999999999998 114.789 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' PHE . 66.3 mttm -116.59 -120.14 0.31 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.437 -0.882 . . . . 1.74 109.591 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -94.76 -40.41 4.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.067 -2.013 . . . . 0.64000000000000001 108.067 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 16.7 mtmm -136.88 -1.1 2.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.137 -1.531 . . . . 3.8700000000000001 111.41 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 15.9 t70 -85.66 8.9 17.87 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.262 0.553 . . . . 1.22 111.58 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 25' ' ' TYR . 11.4 p -89.15 143.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.368 -0.833 . . . . 1.1200000000000001 110.907 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 3.2 pt-20 -106.49 97.61 7.39 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.145 0.498 . . . . 1.26 111.188 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.552 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 18.5 m-85 -94.83 -169.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.598 -0.728 . . . . 0.88 109.774 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 2.2 tt -127.99 159.12 36.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.272 -1.01 . . . . 1.6799999999999999 108.272 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.24 112.76 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 118.388 -1.325 . . . . 1.1899999999999999 113.844 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 30' ' ' LYS . 19.8 ttm180 -88.94 77.05 7.78 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.708 -1.59 . . . . 3.8799999999999999 106.708 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 2.6 t90 -27.81 89.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.363 -1.29 . . . . 1.5600000000000001 112.273 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 39.5 ttmt -28.24 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.038 -0.983 . . . . 3.1000000000000001 112.15 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.2 t70 -117.58 55.96 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.817 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.27 -163.67 10.92 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.834 -0.621 . . . . 0.58999999999999997 112.669 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.55 35.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.902 -0.666 . . . . 0.85999999999999999 112.349 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -145.98 -169.05 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 2.1299999999999999 110.988 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.7 113.25 6.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.29 111.013 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -121.62 175.61 6.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 2.27 110.74 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -116.17 151.99 34.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.078 0.465 . . . . 0.83999999999999997 111.612 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 8' ' ' ALA . 88.9 t -88.57 152.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.679 -0.692 . . . . 1.3799999999999999 110.353 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' N ' HG13 ' A' ' 38' ' ' VAL . 22.7 tptm -72.58 97.1 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 2.8700000000000001 112.16 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -93.92 40.54 2.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.706 -0.759 . . . . 0.39000000000000001 113.014 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.43 ' CG2' ' HE2' ' A' ' 39' ' ' LYS . 1.1 t -120.45 4.16 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 1.3 109.801 177.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 14.0 m80 -80.5 81.44 6.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.821 0.82 . . . . 2.1299999999999999 110.722 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.445 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 61.8 t -56.57 74.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 112.754 -2.021 . . . . 2.1499999999999999 112.507 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.88 51.06 1.89 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.408 -0.815 . . . . 1.1200000000000001 109.268 177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 39.1 tt0 -47.77 -27.12 1.86 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.204 -0.907 . . . . 2.4399999999999999 110.116 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 8.4 m-20 -70.38 -46.87 63.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.471 -0.786 . . . . 2.48 109.882 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 60.1 t -61.8 -45.83 97.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.733 -0.469 . . . . 1.5 109.733 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.69 -57.82 5.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.439 1.496 . . . . 1.3600000000000001 111.432 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -57.87 -31.78 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.362 0.601 . . . . 3.7799999999999998 109.466 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.2 t70 -91.96 -16.51 26.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.351 -0.84 . . . . 2.0 110.563 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -79.14 -65.21 1.03 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.473 0.654 . . . . 2.3300000000000001 110.941 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.8 pt-20 -87.91 -45.78 9.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.839 -1.073 . . . . 1.77 111.191 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.1 m-20 -82.69 -19.18 38.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.795 -0.639 . . . . 2.2999999999999998 111.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.593 -0.813 . . . . 1.6100000000000001 112.368 179.786 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.536 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.039 0.447 . . . . 2.9300000000000002 111.485 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 8.2 tp10 -152.56 129.36 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.719 -0.673 . . . . 2.4100000000000001 109.31 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.537 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 53.3 p90 -87.5 109.85 19.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.629 0.603 . . . . 2.6000000000000001 112.629 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -92.07 50.11 1.62 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.661 -0.7 . . . . 1.1100000000000001 109.127 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.701 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -108.45 149.78 28.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.229 1.014 . . . . 2.7999999999999998 113.528 -177.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 61.1 t -89.34 -36.11 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.342 -1.754 . . . . 1.1200000000000001 110.11 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.63 ' CG ' ' O ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -141.61 -39.25 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.285 -0.87 . . . . 2.1899999999999999 111.706 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.8 mt-10 -155.04 158.26 38.84 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.593 0.59 . . . . 2.1800000000000002 112.593 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.514 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.35 -165.93 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.871 -0.604 . . . . 1.0800000000000001 109.611 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 94.1 t -150.59 -58.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.14 0.495 . . . . 1.3500000000000001 109.956 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 6.8 pt-20 -97.24 133.68 41.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 2.96 109.175 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 49.2 pttt -151.03 89.07 1.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.435 0.531 . . . . 2.6200000000000001 112.435 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -154.33 93.06 1.57 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.288 -0.257 . . . . 4.4199999999999999 110.902 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.11 -134.2 2.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 118.769 -1.681 . . . . 0.40999999999999998 114.757 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.9 mttm -114.17 -119.03 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.464 -0.868 . . . . 1.74 109.554 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -96.9 -41.97 3.42 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 107.83 -2.108 . . . . 0.64000000000000001 107.83 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 44.1 mmtt -132.96 0.2 3.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.118 -1.541 . . . . 3.8700000000000001 111.048 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 16.1 t70 -86.72 6.92 28.92 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 121.261 0.553 . . . . 1.22 111.668 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 25' ' ' TYR . 7.4 p -90.06 145.64 7.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.348 -0.842 . . . . 1.1200000000000001 111.32 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 40' ' ' GLY . 3.0 pt-20 -104.64 111.6 24.37 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.762 -0.654 . . . . 1.26 110.61 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 23.0 m-85 -114.02 148.97 36.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.722 -0.672 . . . . 0.88 110.676 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 27' ' ' VAL . 1.7 tt -89.7 159.15 17.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.922 -1.14 . . . . 1.6799999999999999 107.922 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -140.12 108.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.699 -1.2 . . . . 1.1899999999999999 113.448 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 30' ' ' LYS . 4.3 tpt180 -83.13 74.84 9.96 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.569 -1.641 . . . . 3.8799999999999999 106.569 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.63 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 4.3 t90 -27.83 89.4 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.665 1.228 . . . . 1.5600000000000001 112.091 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' HG11 ' A' ' 10' ' ' VAL . 34.9 ttpt -28.92 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.838 -1.073 . . . . 3.1000000000000001 112.168 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' TRP . 16.8 m-20 -119.61 56.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 2.02 109.816 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.12 -163.48 10.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.859 -0.61 . . . . 0.58999999999999997 112.886 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.26 27.99 1.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.937 -0.649 . . . . 0.85999999999999999 112.336 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -142.05 -178.48 5.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 2.1299999999999999 111.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' CZ ' ' A' ' 28' ' ' ARG . 65.0 m -135.77 111.23 9.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.821 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -124.96 172.58 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.27 111.052 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -114.85 150.36 35.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.83999999999999997 111.483 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 89.0 t -89.68 160.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.55 . . . . 1.3799999999999999 110.249 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' N ' HG13 ' A' ' 38' ' ' VAL . 24.2 ttmm -78.2 96.81 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.213 0.53 . . . . 2.8700000000000001 112.269 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.83 46.82 2.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.463 -0.789 . . . . 0.39000000000000001 112.509 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.51 3.24 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 1.3 110.368 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -75.04 79.56 2.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.689 0.756 . . . . 2.1299999999999999 110.699 -179.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 87.4 t -58.04 66.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 113.04 -1.891 . . . . 2.1499999999999999 113.362 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.42 53.67 2.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.857 -0.794 . . . . 1.1200000000000001 108.857 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -48.95 -24.55 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.113 -0.949 . . . . 2.4399999999999999 110.641 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.4 t70 -68.04 -49.8 59.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.606 . . . . 2.48 110.066 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.589 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 44.6 t -59.49 -32.01 47.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 116.287 -0.415 . . . . 1.5 110.594 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -80.03 -57.46 3.62 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.85 1.26 . . . . 1.3600000000000001 109.866 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 54' ' ' GLY . 16.3 tppt? -57.27 -29.57 63.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 3.7799999999999998 108.679 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.9 t70 -92.12 -22.84 19.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.202 -0.908 . . . . 2.0 110.234 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.79 -68.25 0.47 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.791 0.805 . . . . 2.3300000000000001 110.118 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -85.44 -50.4 7.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.266 -1.334 . . . . 1.77 111.765 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -74.47 -23.26 58.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 2.2999999999999998 111.482 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.456 -0.878 . . . . 1.6100000000000001 112.108 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' LYS . 10.9 p90 . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.957 0.408 . . . . 2.9300000000000002 111.167 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.477 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 19.8 mt-10 -150.85 145.62 25.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.883 -0.599 . . . . 2.4100000000000001 109.546 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 37.2 p90 -90.61 110.04 21.2 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.93 0.715 . . . . 2.6000000000000001 112.93 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.45 ' CB ' HG12 ' A' ' 38' ' ' VAL . . . -93.04 52.4 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.251 -0.886 . . . . 1.1100000000000001 108.897 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.24 158.45 22.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.286 1.041 . . . . 2.7999999999999998 113.244 -177.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 57.8 t -94.21 -36.42 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 113.199 -1.819 . . . . 1.1200000000000001 110.596 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 34.5 t70 -140.25 -38.9 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 2.1899999999999999 112.304 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -155.72 154.51 31.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.994 0.739 . . . . 2.1800000000000002 112.994 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.508 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.93 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.802 0.334 . . . . 1.0800000000000001 110.623 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG2' HD12 ' A' ' 26' ' ' LEU . 76.9 t -150.46 -58.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 1.3500000000000001 110.202 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.8 tp10 -94.15 135.14 35.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 2.96 109.683 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.0 ptpt -151.02 90.6 1.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.734 -0.386 . . . . 2.6200000000000001 111.904 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -153.51 92.6 1.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.142 -0.349 . . . . 4.4199999999999999 111.487 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.68 -134.51 2.06 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.116 -1.516 . . . . 0.40999999999999998 114.875 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.5 mttm -111.02 -122.08 0.28 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.56 -0.82 . . . . 1.74 109.828 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.05 -41.55 4.58 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 108.009 -2.037 . . . . 0.64000000000000001 108.009 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 10.6 mptt -136.58 2.57 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.094 -1.553 . . . . 3.8700000000000001 110.651 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 28.8 t0 -87.68 10.27 18.74 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.263 0.554 . . . . 1.22 111.53 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG13 ' CE1' ' A' ' 25' ' ' TYR . 12.2 p -91.31 153.84 3.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.302 -0.863 . . . . 1.1200000000000001 111.899 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.0 pt-20 -106.19 116.57 32.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 1.26 110.186 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 7' ' ' TYR . 10.8 m-85 -119.48 147.49 44.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.88 110.422 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 ' CG2' ' A' ' 14' ' ' VAL . 2.9 tt -88.49 156.74 18.93 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.563 -0.903 . . . . 1.6799999999999999 108.563 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.689 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 m -141.11 113.38 4.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 113.725 1.009 . . . . 1.1899999999999999 113.725 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -86.1 75.89 9.85 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 105.657 -1.979 . . . . 3.8799999999999999 105.657 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.9 t90 -26.34 90.19 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.011 -1.449 . . . . 1.5600000000000001 112.331 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' N ' HG11 ' A' ' 10' ' ' VAL . 55.5 tptt -29.09 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.722 -1.127 . . . . 3.1000000000000001 112.141 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.9 t70 -117.57 54.52 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.807 -0.442 . . . . 2.02 109.807 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.24 -160.29 9.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.878 -0.601 . . . . 0.58999999999999997 112.919 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.16 29.12 0.99 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.114 -0.565 . . . . 0.85999999999999999 112.128 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.96 176.73 9.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.697 0.284 . . . . 2.1299999999999999 110.868 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.0 m -137.28 125.63 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 2.29 110.832 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 37' ' ' TRP . 10.7 tp10 -143.11 164.15 30.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.961 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.401 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 18.9 m0 -94.91 146.76 24.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.83999999999999997 111.476 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 40.5 t -89.59 161.33 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 1.3799999999999999 109.812 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -67.57 110.62 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 2.8700000000000001 112.636 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -98.17 40.26 2.54 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.39000000000000001 111.96 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.401 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 t -117.5 4.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.248 . . . . 1.3 110.521 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -73.51 76.4 1.45 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.73 0.776 . . . . 2.1299999999999999 111.053 -179.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 6.4 p -59.11 72.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 113.394 -1.73 . . . . 2.1499999999999999 113.333 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.4 50.1 1.58 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 1.1200000000000001 108.511 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -42.74 -30.16 0.36 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.088 -0.96 . . . . 2.4399999999999999 111.055 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.27 -46.27 70.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.681 . . . . 2.48 110.069 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 68.2 t -58.61 -44.74 90.21 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-N 116.016 -0.538 . . . . 1.5 109.719 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.87 -59.41 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.324 1.449 . . . . 1.3600000000000001 111.386 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 11.9 mptt -56.49 -32.31 64.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.206 0.527 . . . . 3.7799999999999998 109.781 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -91.79 -18.13 24.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.817 -0.629 . . . . 2.0 110.626 178.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.519 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -74.64 -62.61 1.47 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.677 0.751 . . . . 2.3300000000000001 109.682 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.442 ' CG ' ' N ' ' A' ' 53' ' ' ASP . 12.6 pt-20 -90.85 -50.58 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.283 -1.326 . . . . 1.77 111.362 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' N ' ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -74.44 -20.77 59.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 2.2999999999999998 111.199 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.822 . . . . 1.6100000000000001 112.036 179.49 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.27 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.833 0.349 . . . . 2.9300000000000002 111.423 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 21.5 mt-10 -126.06 143.29 51.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 2.4100000000000001 110.973 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 50.3 p90 -89.58 112.58 23.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.522 0.677 . . . . 2.6000000000000001 111.567 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -101.51 56.2 0.83 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.922 -1.035 . . . . 1.1100000000000001 109.729 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.617 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -117.08 165.07 13.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.151 0.977 . . . . 2.7999999999999998 112.708 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 60.1 t -90.25 -30.15 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 113.665 -1.607 . . . . 1.1200000000000001 112.081 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 12.8 t70 -150.32 -35.89 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.262 0.468 . . . . 2.1899999999999999 112.262 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.9 mt-10 -152.71 165.38 35.48 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.78 -0.368 . . . . 2.1800000000000002 111.94 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -140.98 -170.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.842 0.353 . . . . 1.0800000000000001 110.374 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.449 ' CG2' HD21 ' A' ' 26' ' ' LEU . 76.6 t -150.12 -52.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 1.3500000000000001 110.038 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.4 tp10 -92.89 137.98 31.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 2.96 109.749 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 16.4 ptpt -152.52 89.36 1.41 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.852 -0.339 . . . . 2.6200000000000001 111.14 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -155.1 91.07 1.32 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.818 -0.353 . . . . 4.4199999999999999 111.022 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 23' ' ' VAL . . . -152.64 -131.59 1.69 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.269 -1.443 . . . . 0.40999999999999998 114.368 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 5' ' ' PHE . 98.7 mttt -119.76 -122.61 0.29 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.456 -0.872 . . . . 1.74 109.621 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.455 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -93.52 -39.57 4.98 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 108.406 -1.878 . . . . 0.64000000000000001 108.406 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -137.07 0.42 2.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.228 -1.486 . . . . 3.8700000000000001 111.18 177.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 12.9 t70 -87.35 10.33 17.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.996 0.427 . . . . 1.22 111.597 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 25' ' ' TYR . 4.9 p -88.6 150.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.286 0.565 . . . . 1.1200000000000001 111.876 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -109.08 101.9 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.23 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 6.7 m-85 -104.23 151.82 22.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.14 -0.482 . . . . 0.88 110.062 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 27' ' ' VAL . 1.7 tp -90.01 154.58 19.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.275 -1.009 . . . . 1.6799999999999999 108.275 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -136.39 109.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 114.101 1.148 . . . . 1.1899999999999999 114.101 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 53.2 mtt180 -82.84 77.78 9.53 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.627 -1.99 . . . . 3.8799999999999999 105.627 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.1 t90 -27.09 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.268 -1.333 . . . . 1.5600000000000001 111.95 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 59.0 tttm -27.17 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.271 -1.331 . . . . 3.1000000000000001 112.355 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.0 m-20 -120.9 57.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 2.02 109.89 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -160.49 9.1 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.895 -0.593 . . . . 0.58999999999999997 112.772 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.79 16.42 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.105 -0.569 . . . . 0.85999999999999999 112.287 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -137.53 178.23 7.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.806 0.336 . . . . 2.1299999999999999 110.777 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.24 108.93 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 2.29 110.965 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.33 166.88 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 2.27 111.069 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -89.01 145.78 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.651 . . . . 0.83999999999999997 111.753 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 89.1 t -88.76 162.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 1.3799999999999999 109.855 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 87.6 tttt -75.45 103.82 5.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.771 0.656 . . . . 2.8700000000000001 112.771 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.02 47.32 2.01 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.941 -1.027 . . . . 0.39000000000000001 112.2 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.04 0.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.853 -0.425 . . . . 1.3 109.853 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.61 78.39 0.81 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.772 0.796 . . . . 2.1299999999999999 110.004 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 94.9 t -57.33 69.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 113.047 -1.888 . . . . 2.1499999999999999 113.426 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.51 51.88 2.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.312 -0.625 . . . . 1.1200000000000001 109.312 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -47.34 -27.07 1.46 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.342 -0.845 . . . . 2.4399999999999999 110.477 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 7.9 m-20 -70.99 -43.51 67.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.451 -0.795 . . . . 2.48 110.123 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.501 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 95.7 t -65.18 -39.97 87.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 109.737 -0.468 . . . . 1.5 109.737 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -71.95 -58.07 3.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.104 1.362 . . . . 1.3600000000000001 110.741 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 16.8 tppt? -57.0 -30.66 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.228 -0.656 . . . . 3.7799999999999998 109.228 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.8 t70 -92.09 -20.42 21.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.349 -0.841 . . . . 2.0 110.386 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 1.1 m-30 -75.4 -67.19 0.68 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.479 0.657 . . . . 2.3300000000000001 110.606 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.0 pt-20 -86.46 -48.7 8.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.8 -1.091 . . . . 1.77 111.235 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 2.4 m-20 -77.52 -20.81 53.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.598 . . . . 2.2999999999999998 111.162 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.405 0 C-N-CA 120.595 -0.812 . . . . 1.6100000000000001 112.253 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.1 p90 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 120.792 0.33 . . . . 2.9300000000000002 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 1.2 mp0 -143.2 142.23 31.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.94 -0.573 . . . . 2.4100000000000001 110.087 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.512 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 53.7 p90 -88.82 111.71 22.36 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.65 0.738 . . . . 2.6000000000000001 111.741 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -95.26 46.14 1.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.759 -1.11 . . . . 1.1100000000000001 109.751 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.88 164.42 14.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.602 0.715 . . . . 2.7999999999999998 112.73 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 8.7 t -102.95 -20.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.687 -1.142 . . . . 1.1200000000000001 112.437 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 14.8 t70 -144.51 -44.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.027 0.38 . . . . 2.1899999999999999 112.027 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.1 mt-10 -155.68 162.72 40.52 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 112.053 0.39 . . . . 2.1800000000000002 112.053 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -134.49 -167.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.627 0.251 . . . . 1.0800000000000001 110.356 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' CG2' HD11 ' A' ' 26' ' ' LEU . 95.3 t -149.99 -53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.033 0.444 . . . . 1.3500000000000001 109.907 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 12.5 mm-40 -96.71 135.46 38.61 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 48.3 pttt -153.06 85.09 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.352 -0.539 . . . . 2.6200000000000001 112.37 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -154.44 95.49 1.81 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.101 0.41 . . . . 4.4199999999999999 111.658 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 23' ' ' VAL . . . -153.34 -128.64 1.3 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 118.863 -1.637 . . . . 0.40999999999999998 114.885 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 5' ' ' PHE . 97.8 mttt -119.44 -122.17 0.29 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.557 -0.821 . . . . 1.74 110.238 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.84 -40.56 5.88 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 108.804 -1.718 . . . . 0.64000000000000001 108.804 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -143.75 3.99 1.29 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.537 -1.332 . . . . 3.8700000000000001 111.43 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 20.3 t70 -88.41 11.67 16.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.322 0.582 . . . . 1.22 111.055 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 HG13 ' CE1' ' A' ' 25' ' ' TYR . 9.0 p -89.47 154.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.332 -0.849 . . . . 1.1200000000000001 112.249 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' CG ' ' HA3' ' A' ' 40' ' ' GLY . 46.7 mt-10 -96.83 128.09 43.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.11 -0.95 . . . . 1.26 108.956 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' CD2' ' HA ' ' A' ' 7' ' ' TYR . 11.4 m-85 -138.76 139.74 38.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 0.88 109.976 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD11 ' CG2' ' A' ' 14' ' ' VAL . 2.9 tt -89.91 157.39 17.89 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.247 -0.649 . . . . 1.6799999999999999 109.247 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 m -143.76 112.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 114.262 1.208 . . . . 1.1899999999999999 114.262 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' LYS . 86.5 mtt180 -85.53 66.4 9.65 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 104.566 -2.383 . . . . 3.8799999999999999 104.566 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 18.8 t90 -25.65 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.362 -1.745 . . . . 1.5600000000000001 112.218 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 62.4 tttp -28.33 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.264 -1.334 . . . . 3.1000000000000001 112.528 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.6 t70 -108.83 54.26 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.983 0.42 . . . . 2.02 109.99 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.28 -139.28 3.02 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.105 -0.569 . . . . 0.58999999999999997 112.803 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.36 -46.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.085 -0.579 . . . . 0.85999999999999999 111.885 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.57 163.96 12.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 2.1299999999999999 110.272 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.1 p -121.31 138.83 54.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 2.29 111.376 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -130.76 168.96 16.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 2.27 109.938 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 24.6 m0 -88.53 144.2 26.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.815 0.34 . . . . 0.83999999999999997 111.023 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 85.0 t -88.42 154.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 1.3799999999999999 110.115 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.407 ' N ' HG12 ' A' ' 38' ' ' VAL . 38.7 ttpt -66.18 103.88 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 2.8700000000000001 111.573 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' HA3' ' CG ' ' A' ' 24' ' ' GLU . . . -92.56 37.9 3.29 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.522 -0.763 . . . . 0.39000000000000001 112.408 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.69 8.5 8.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.69 -0.485 . . . . 1.3 109.69 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.7 76.81 1.54 Allowed 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.505 0.669 . . . . 2.1299999999999999 110.181 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 57.2 t -56.85 74.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 113.442 -1.708 . . . . 2.1499999999999999 113.439 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.98 49.54 1.44 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.581 -0.736 . . . . 1.1200000000000001 109.297 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 9.7 tp10 -48.16 -26.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.165 -0.925 . . . . 2.4399999999999999 110.339 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -73.79 -47.0 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.567 -0.742 . . . . 2.48 110.228 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 51' ' ' TYR . 85.0 t -58.06 -46.83 88.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 109.951 -0.389 . . . . 1.5 109.951 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.74 -58.49 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 125.068 1.347 . . . . 1.3600000000000001 111.125 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 37.9 ttpt -54.51 -33.74 60.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.533 . . . . 3.7799999999999998 109.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.9 -20.61 21.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.75 -0.659 . . . . 2.0 110.721 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 47' ' ' VAL . 1.3 m-30 -71.7 -62.19 1.51 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.69 0.757 . . . . 2.3300000000000001 110.479 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -91.82 -49.5 6.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.47 -1.241 . . . . 1.77 111.484 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -74.21 -25.12 59.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.835 -0.62 . . . . 2.2999999999999998 111.285 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.531 -0.842 . . . . 1.6100000000000001 112.272 179.788 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 108.676 -0.861 . . . . 2.9300000000000002 108.676 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 31.4 mt-10 -152.7 148.0 26.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.148 0.425 . . . . 2.4100000000000001 112.148 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.523 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 32.6 p90 -101.27 102.61 13.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.503 0.668 . . . . 2.6000000000000001 110.938 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -89.32 53.42 2.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.186 -0.915 . . . . 1.1100000000000001 110.303 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.92 167.78 10.82 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.468 0.651 . . . . 2.7999999999999998 111.614 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 12.6 t -106.32 -16.69 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 115.111 -0.95 . . . . 1.1200000000000001 112.387 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 17.3 t70 -148.3 -44.04 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.707 0.289 . . . . 2.1899999999999999 111.754 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 18.7 mm-40 -154.18 168.44 26.52 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.363 -0.381 . . . . 2.1800000000000002 111.593 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.46 -169.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.849 -0.426 . . . . 1.0800000000000001 109.849 178.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 26' ' ' LEU . 96.3 t -149.79 -59.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.091 0.472 . . . . 1.3500000000000001 109.97 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.5 tp10 -93.05 134.78 34.85 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.32 -0.622 . . . . 2.96 109.32 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 14.0 ptmt -150.83 92.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 2.6200000000000001 111.089 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -154.98 90.91 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.81 -0.356 . . . . 4.4199999999999999 111.706 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 5' ' ' PHE . . . -150.79 -134.98 2.29 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.057 -1.544 . . . . 0.40999999999999998 114.702 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 62.3 mttm -106.77 -90.52 0.43 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.823 -0.688 . . . . 1.74 110.802 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . -130.13 -44.38 0.18 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 107.755 -2.138 . . . . 0.64000000000000001 107.755 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' CE ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -132.56 -5.19 3.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.491 -1.354 . . . . 3.8700000000000001 110.793 176.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' CA ' ' O ' ' A' ' 42' ' ' HIS . 19.3 t70 -88.67 10.02 22.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.256 0.55 . . . . 1.22 111.397 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 HG12 ' CE1' ' A' ' 25' ' ' TYR . 11.5 p -89.01 158.15 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.472 -0.785 . . . . 1.1200000000000001 111.404 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -106.73 122.89 47.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.445 -0.798 . . . . 1.26 110.124 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 9.8 m-85 -128.45 146.07 50.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.037 -0.528 . . . . 0.88 110.186 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 14' ' ' VAL . 1.9 tt -88.72 157.81 18.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.318 -0.623 . . . . 1.6799999999999999 109.318 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 m -142.69 113.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 113.881 1.067 . . . . 1.1899999999999999 113.881 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -86.18 65.76 9.24 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.16 -2.533 . . . . 3.8799999999999999 104.16 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.58 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 20.2 t90 -25.81 89.75 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 1.5600000000000001 112.215 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 11' ' ' ASP . 88.8 tttt -28.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 114.113 -1.403 . . . . 3.1000000000000001 112.421 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' O ' ' CE2' ' A' ' 29' ' ' TRP . 11.7 m-20 -110.93 55.37 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.417 . . . . 2.02 110.142 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -149.11 -158.4 8.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.08 -0.581 . . . . 0.58999999999999997 112.688 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.5 21.18 1.34 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.902 -0.666 . . . . 0.85999999999999999 112.331 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.82 -173.84 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.299 . . . . 2.1299999999999999 110.798 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -145.61 136.34 24.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 2.29 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -149.96 176.88 10.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.816 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -98.11 148.52 23.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.83999999999999997 111.324 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.487 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 97.0 t -89.2 160.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.3799999999999999 109.79 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 88.2 tttt -68.95 104.25 2.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.37 0.605 . . . . 2.8700000000000001 112.174 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.65 37.99 3.29 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.108 -0.951 . . . . 0.39000000000000001 112.667 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.85 3.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.672 0.272 . . . . 1.3 110.304 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -69.75 77.6 0.45 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.578 0.704 . . . . 2.1299999999999999 109.826 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 48.7 t -56.91 75.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 113.717 -1.583 . . . . 2.1499999999999999 113.34 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.54 53.69 2.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.593 -0.891 . . . . 1.1200000000000001 108.593 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HG2' ' HE2' ' A' ' 49' ' ' LYS . 39.0 tt0 -49.72 -22.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.916 -1.038 . . . . 2.4399999999999999 110.435 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.03 -50.53 47.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 2.48 110.087 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 51' ' ' TYR . 43.5 t -57.79 -29.88 36.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.036 -0.529 . . . . 1.5 111.282 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -87.45 -58.11 2.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.155 1.382 . . . . 1.3600000000000001 109.97 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 25.4 ttmm -54.84 -31.12 59.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.307 -0.86 . . . . 3.7799999999999998 109.262 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -25.39 19.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.518 -0.764 . . . . 2.0 109.854 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' CD2' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.78 -65.18 0.71 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.144 0.974 . . . . 2.3300000000000001 110.374 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.1 pt-20 -90.22 -50.87 5.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.692 -1.595 . . . . 1.77 111.775 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -77.92 -9.4 59.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.696 -0.684 . . . . 2.2999999999999998 111.321 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.593 -0.813 . . . . 1.6100000000000001 112.041 179.128 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.63 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.827 0.346 . . . . 2.9300000000000002 111.282 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 2.6 mp0 -134.55 144.07 47.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 2.4100000000000001 111.067 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.0 p90 -89.52 105.38 17.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.17 0.509 . . . . 2.6000000000000001 111.902 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.457 ' CB ' HG12 ' A' ' 38' ' ' VAL . . . -89.9 53.35 2.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.457 -0.792 . . . . 1.1100000000000001 109.022 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.691 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.81 158.57 20.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.12 0.962 . . . . 2.7999999999999998 112.96 -177.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 57.9 t -97.21 -35.28 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 113.66 -1.609 . . . . 1.1200000000000001 110.503 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.6 t70 -139.3 -39.36 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.735 -0.666 . . . . 2.1899999999999999 112.048 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.4 mt-10 -155.98 157.36 36.07 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 112.787 0.662 . . . . 2.1800000000000002 112.787 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.52 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -130.29 -169.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 1.0800000000000001 109.972 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.442 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.4 t -150.24 -49.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 1.3500000000000001 110.13 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.9 tp10 -98.97 139.1 35.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.715 -0.675 . . . . 2.96 109.689 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.61 ' HE2' ' HH ' ' A' ' 25' ' ' TYR . 11.3 ptmm? -151.6 87.85 1.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.652 -0.419 . . . . 2.6200000000000001 112.1 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -153.74 92.36 1.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.042 -0.263 . . . . 4.4199999999999999 111.101 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.21 -130.21 1.57 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.15 -1.5 . . . . 0.40999999999999998 114.946 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 68.4 mttm -124.52 -121.62 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.894 0.878 . . . . 1.74 110.082 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.71 -40.03 6.07 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.141 -1.983 . . . . 0.64000000000000001 108.141 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 2.0 mptp? -143.87 7.02 1.42 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.187 -1.506 . . . . 3.8700000000000001 111.161 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 17.9 t70 -87.43 9.06 22.0 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.129 0.49 . . . . 1.22 111.066 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG11 ' CE1' ' A' ' 25' ' ' TYR . 7.2 p -88.4 152.87 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.6 -0.727 . . . . 1.1200000000000001 111.561 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.6 pt-20 -109.29 99.36 8.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.511 -0.768 . . . . 1.26 110.015 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.61 ' HH ' ' HE2' ' A' ' 16' ' ' LYS . 9.4 m-85 -104.44 149.94 24.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.76 -0.655 . . . . 0.88 110.182 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 HD13 ' CG2' ' A' ' 14' ' ' VAL . 2.7 tt -88.97 157.16 18.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.658 -0.867 . . . . 1.6799999999999999 108.658 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.691 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -143.21 110.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 118.953 -1.099 . . . . 1.1899999999999999 113.894 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 30' ' ' LYS . 77.2 mtt180 -83.91 75.71 10.09 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.895 -1.891 . . . . 3.8799999999999999 105.895 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 3.4 t90 -26.9 89.68 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.922 -1.49 . . . . 1.5600000000000001 112.28 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 60.3 tttp -29.02 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.654 -1.157 . . . . 3.1000000000000001 112.209 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 19.4 t70 -119.41 55.59 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 2.02 109.885 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -142.27 -140.4 3.75 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.58999999999999997 112.641 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.23 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.844 -0.693 . . . . 0.85999999999999999 112.331 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.69 -174.28 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 2.1299999999999999 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.8 m -143.97 126.39 15.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 2.29 110.915 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.06 179.68 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 2.27 110.89 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -100.19 150.91 22.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.83999999999999997 111.846 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.475 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 73.8 t -89.49 162.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.672 -0.694 . . . . 1.3799999999999999 109.768 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.455 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 88.4 tttt -78.34 104.53 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.739 0.644 . . . . 2.8700000000000001 112.739 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.62 45.05 2.73 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.076 -0.965 . . . . 0.39000000000000001 112.516 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.3 0.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.999 -0.371 . . . . 1.3 109.999 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -72.76 76.46 1.13 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.595 0.712 . . . . 2.1299999999999999 110.633 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.436 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 52.0 t -56.41 76.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 113.249 -1.796 . . . . 2.1499999999999999 113.227 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -91.56 49.59 1.6 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.206 -0.906 . . . . 1.1200000000000001 108.944 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -47.81 -27.83 2.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.13 -0.941 . . . . 2.4399999999999999 110.509 -178.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 12.0 t70 -77.95 -44.03 28.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 2.48 109.424 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 49.2 t -65.18 -27.72 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.099 -0.501 . . . . 1.5 110.704 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -93.92 -57.78 2.44 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.997 1.436 . . . . 1.3600000000000001 112.565 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 38.8 ttpt -51.73 -45.29 63.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.207 0.527 . . . . 3.7799999999999998 110.556 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 1.8 t70 -79.42 -20.6 47.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.104 -0.702 . . . . 2.0 109.104 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.64 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.421 -0.809 . . . . 2.3300000000000001 110.474 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -86.04 -48.71 8.4 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.324 -1.307 . . . . 1.77 111.684 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -77.34 -42.82 35.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.823 -0.626 . . . . 2.2999999999999998 111.541 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.172 0 C-N-CA 120.542 -0.837 . . . . 1.6100000000000001 112.394 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 9.3 p90 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.921 0.391 . . . . 2.9300000000000002 110.932 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.0 tp10 -142.43 145.11 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 2.4100000000000001 110.275 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.535 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 44.4 p90 -89.76 105.5 17.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.079 0.466 . . . . 2.6000000000000001 111.878 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' CB ' HG12 ' A' ' 38' ' ' VAL . . . -89.93 55.55 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.146 -0.687 . . . . 1.1100000000000001 109.146 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.31 163.17 15.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.087 0.946 . . . . 2.7999999999999998 112.433 -177.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 60.7 t -96.71 -37.54 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 113.595 -1.639 . . . . 1.1200000000000001 110.741 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 17.4 t70 -142.57 -34.56 0.44 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.038 -0.528 . . . . 2.1899999999999999 112.244 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 44.8 mt-10 -156.0 151.06 26.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.25 0.833 . . . . 2.1800000000000002 113.25 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.477 HG13 ' CD2' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -125.98 -171.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.331 -0.395 . . . . 1.0800000000000001 110.561 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 26' ' ' LEU . 94.7 t -147.19 -48.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 1.3500000000000001 110.069 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.9 mt-10 -97.72 141.77 30.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.821 -0.627 . . . . 2.96 109.751 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.4 ptmt -152.02 84.92 1.28 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.687 -0.405 . . . . 2.6200000000000001 111.898 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -153.38 97.12 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.085 -0.246 . . . . 4.4199999999999999 111.027 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -151.21 -130.23 1.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 118.94 -1.6 . . . . 0.40999999999999998 114.978 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 43' ' ' VAL . 54.1 mttm -117.04 -72.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.333 1.063 . . . . 1.74 110.738 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.31 -47.81 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 106.835 -2.506 . . . . 0.64000000000000001 106.835 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 1.8 mptt -127.6 -6.27 5.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.076 -1.562 . . . . 3.8700000000000001 109.831 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' N ' ' A' ' 42' ' ' HIS . 12.0 t70 -86.75 9.73 18.05 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.125 0.488 . . . . 1.22 111.291 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 25' ' ' TYR . 7.0 p -87.22 152.37 3.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.78 -0.645 . . . . 1.1200000000000001 111.086 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.99 94.56 5.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.654 -0.703 . . . . 1.26 110.689 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.535 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 7.0 m-85 -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.153 -0.476 . . . . 0.88 110.38 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 27' ' ' VAL . 2.2 tt -89.31 157.73 18.08 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.366 -0.976 . . . . 1.6799999999999999 108.366 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.724 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.41 110.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.022 -1.071 . . . . 1.1899999999999999 113.499 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' CD ' HD23 ' A' ' 26' ' ' LEU . 13.3 mmm180 -84.75 79.39 9.63 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.142 -1.799 . . . . 3.8799999999999999 106.142 175.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -27.19 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.535 -1.211 . . . . 1.5600000000000001 111.966 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 38.0 ttpt -27.62 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.307 -1.315 . . . . 3.1000000000000001 112.26 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' TRP . 6.0 m-20 -123.94 57.07 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.005 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -140.97 -159.65 7.99 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.017 -0.611 . . . . 0.58999999999999997 112.999 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.23 19.8 1.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.121 -0.561 . . . . 0.85999999999999999 112.376 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -139.9 -176.56 4.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.741 0.305 . . . . 2.1299999999999999 110.636 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . 29.0 p -150.19 111.16 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 2.29 111.232 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -123.99 -176.85 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 2.27 110.922 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -108.71 153.24 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.108 0.48 . . . . 0.83999999999999997 111.697 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 39' ' ' LYS . 49.0 t -88.43 162.18 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.704 -0.68 . . . . 1.3799999999999999 109.52 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 88.5 tttt -80.73 103.62 10.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.461 0.648 . . . . 2.8700000000000001 112.075 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -88.83 45.05 3.18 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.027 -0.988 . . . . 0.39000000000000001 112.647 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.2 0.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.076 -0.342 . . . . 1.3 110.076 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.471 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.85 77.83 0.88 Allowed 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.46 0.648 . . . . 2.1299999999999999 109.775 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.442 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 49.5 t -56.09 72.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.406 -1.724 . . . . 2.1499999999999999 113.805 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.62 49.52 1.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.565 -0.743 . . . . 1.1200000000000001 109.354 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.46 -28.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.209 -0.905 . . . . 2.4399999999999999 110.58 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 6.8 m-20 -66.7 -49.97 64.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.493 -0.776 . . . . 2.48 109.875 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 42.2 t -58.23 -30.52 40.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.117 -0.492 . . . . 1.5 110.593 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -79.32 -59.99 2.54 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.754 1.221 . . . . 1.3600000000000001 109.954 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.7 ttpt -56.97 -27.84 61.7 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.758 -0.83 . . . . 3.7799999999999998 108.758 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.2 t70 -91.85 -22.68 19.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.148 -0.933 . . . . 2.0 110.108 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.551 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.46 -71.09 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.837 0.827 . . . . 2.3300000000000001 110.087 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.3 pt-20 -81.53 -47.16 13.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.143 -1.39 . . . . 1.77 112.012 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.3 m-20 -80.78 -18.73 46.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.043 -0.526 . . . . 2.2999999999999998 111.703 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.408 -0.901 . . . . 1.6100000000000001 112.391 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.127 ' CE1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 121.032 0.444 . . . . 2.9300000000000002 111.6 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 9.4 tp10 -152.72 146.73 25.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.846 -0.615 . . . . 2.4100000000000001 109.717 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -89.52 109.0 19.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 2.6000000000000001 110.966 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' O ' ' OE2' ' A' ' 9' ' ' GLU . . . -94.32 33.13 1.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.482 -0.781 . . . . 1.1100000000000001 110.698 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 1.215 ' CD ' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -102.75 175.06 5.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.043 0.925 . . . . 2.7999999999999998 112.815 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 21.3 t -109.49 -17.52 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 113.699 -1.591 . . . . 1.1200000000000001 112.402 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 21.1 t70 -150.14 -43.33 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 2.1899999999999999 111.468 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.6 mt-10 -153.3 168.45 25.99 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.091 -0.504 . . . . 2.1800000000000002 111.545 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG22 ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -141.52 -169.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.695 -0.483 . . . . 1.0800000000000001 109.695 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' HD22 ' A' ' 26' ' ' LEU . 90.5 t -149.97 -57.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 1.3500000000000001 110.092 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 20.6 mm-40 -91.02 133.98 34.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.931 -0.577 . . . . 2.96 109.447 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 pttm -151.07 87.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.708 -0.397 . . . . 2.6200000000000001 111.442 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -153.65 94.79 1.82 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.752 0.279 . . . . 4.4199999999999999 111.752 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.07 -128.19 1.38 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 119.415 -1.374 . . . . 0.40999999999999998 114.065 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 86.0 mttt -109.49 -74.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.117 0.961 . . . . 1.74 110.659 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -151.7 -47.76 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 107.167 -2.373 . . . . 0.64000000000000001 107.167 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' CB ' ' HB3' ' A' ' 44' ' ' ALA . 2.1 ttpt -124.59 -9.62 7.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.067 -1.566 . . . . 3.8700000000000001 109.802 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 12.3 t70 -86.47 7.71 24.82 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 121.232 0.539 . . . . 1.22 111.376 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG11 ' CE1' ' A' ' 25' ' ' TYR . 10.8 p -89.25 157.71 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.409 -0.814 . . . . 1.1200000000000001 110.63 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.26 115.83 30.4 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 1.26 110.864 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.535 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 8.0 m-85 -115.71 148.5 39.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.607 -0.724 . . . . 0.88 110.131 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' CD1' ' CD1' ' A' ' 37' ' ' TRP . 18.3 tp -90.7 159.0 16.59 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.781 -1.192 . . . . 1.6799999999999999 107.781 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 1.215 HG13 ' CD ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -143.79 111.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 114.449 1.277 . . . . 1.1899999999999999 114.449 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 30' ' ' LYS . 81.7 mtt180 -83.23 70.0 10.04 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.068 -1.827 . . . . 3.8799999999999999 106.068 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 t90 -26.28 89.7 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 113.761 -1.563 . . . . 1.5600000000000001 112.036 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' CB ' HG12 ' A' ' 10' ' ' VAL . 63.8 tttm -28.46 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.368 -1.287 . . . . 3.1000000000000001 112.416 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.9 m-20 -111.76 54.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 2.02 110.076 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.13 -161.5 9.92 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 112.737 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.73 -38.9 0.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.984 -0.627 . . . . 0.85999999999999999 112.237 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -114.09 176.22 5.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 2.1299999999999999 110.628 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -126.67 130.53 50.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.361 . . . . 2.29 110.912 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 31.1 mm-40 -117.13 165.6 13.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.066 0.46 . . . . 2.27 111.591 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.534 ' CD1' ' CD1' ' A' ' 26' ' ' LEU . 12.3 m0 -87.97 140.32 29.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.617 -0.72 . . . . 0.83999999999999997 111.138 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 89.3 t -87.37 160.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 1.3799999999999999 110.127 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 40.2 ttmt -77.23 108.08 10.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.118 0.785 . . . . 2.8700000000000001 113.118 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -89.57 44.46 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.933 -1.03 . . . . 0.39000000000000001 112.487 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' VAL . 2.6 t -117.77 -5.19 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.332 . . . . 1.3 110.248 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -66.02 79.0 0.09 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.892 0.853 . . . . 2.1299999999999999 110.057 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 p -56.16 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 113.296 -1.774 . . . . 2.1499999999999999 113.756 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.86 49.15 1.41 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.8 -1.091 . . . . 1.1200000000000001 109.617 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 38.1 tt0 -45.18 -26.65 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.133 -0.939 . . . . 2.4399999999999999 111.312 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.5 -46.86 62.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.594 . . . . 2.48 110.059 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 25.4 t -56.03 -35.5 41.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 116.073 -0.512 . . . . 1.5 109.875 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.07 -60.65 2.28 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.835 1.254 . . . . 1.3600000000000001 110.344 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 26.5 ttpp -54.4 -30.6 52.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.25 -0.648 . . . . 3.7799999999999998 109.25 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -92.95 -22.79 19.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.671 -0.695 . . . . 2.0 110.869 178.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.9 -66.08 0.6 Allowed 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.255 1.026 . . . . 2.3300000000000001 109.018 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.28 -67.78 0.75 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.178 -1.828 . . . . 1.77 110.904 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -57.31 -43.2 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.027 -0.988 . . . . 2.2999999999999998 111.185 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.53 -0.843 . . . . 1.6100000000000001 112.164 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.934 -0.765 . . . . 2.9300000000000002 108.934 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -151.16 139.61 20.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 2.4100000000000001 111.798 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 47.1 p90 -91.42 106.58 18.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.174 0.511 . . . . 2.6000000000000001 110.921 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.476 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -88.69 60.58 5.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.954 -0.758 . . . . 1.1100000000000001 108.954 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.833 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -114.81 150.34 35.61 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.348 1.07 . . . . 2.7999999999999998 113.181 -177.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 57.8 t -89.53 -36.78 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.25 -1.795 . . . . 1.1200000000000001 109.212 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -144.47 -33.68 0.39 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.983 -1.008 . . . . 2.1899999999999999 111.615 177.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 43.7 mt-10 -152.81 159.17 43.06 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.131 0.419 . . . . 2.1800000000000002 112.131 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.524 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -128.67 -168.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.173 -0.677 . . . . 1.0800000000000001 109.173 178.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.522 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 89.6 t -151.38 -60.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.218 0.533 . . . . 1.3500000000000001 109.742 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 22.0 mm-40 -92.5 143.57 26.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.346 -0.843 . . . . 2.96 109.729 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.577 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.9 pttm -152.66 93.43 1.77 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.075 -0.25 . . . . 2.6200000000000001 111.297 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -155.16 88.64 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.469 -0.492 . . . . 4.4199999999999999 111.205 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 5' ' ' PHE . . . -150.92 -137.88 2.75 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 118.863 -1.636 . . . . 0.40999999999999998 115.269 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 90.6 mttt -108.36 -88.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.312 -0.944 . . . . 1.74 110.767 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -131.95 -44.79 0.15 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.928 -2.069 . . . . 0.64000000000000001 107.928 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -131.33 -6.3 3.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.26 -1.47 . . . . 3.8700000000000001 110.693 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CA ' ' O ' ' A' ' 42' ' ' HIS . 20.7 t70 -89.13 12.0 17.0 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 121.125 0.488 . . . . 1.22 111.347 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 25' ' ' TYR . 14.6 p -87.92 157.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.533 -0.758 . . . . 1.1200000000000001 111.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -108.83 109.4 20.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.285 -0.87 . . . . 1.26 110.256 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 11.1 m-85 -118.68 152.93 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.935 -0.575 . . . . 0.88 110.605 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 3.1 tt -87.68 157.07 19.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.828 -0.804 . . . . 1.6799999999999999 108.828 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.833 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.86 97.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.121 -0.631 . . . . 1.1899999999999999 112.087 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 30' ' ' LYS . 48.3 ttt180 -79.17 82.45 5.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.737 -1.209 . . . . 3.8799999999999999 107.737 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.2 t90 -28.66 91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.803 -1.089 . . . . 1.5600000000000001 112.085 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 18.6 pttp -26.97 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.55 -1.204 . . . . 3.1000000000000001 112.557 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 29' ' ' TRP . 18.0 m-20 -120.63 57.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 2.02 110.087 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -139.28 -143.54 4.43 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.845 -0.616 . . . . 0.58999999999999997 112.527 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.34 -48.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.855 -0.688 . . . . 0.85999999999999999 112.307 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.76 179.7 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 2.1299999999999999 110.804 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -125.94 138.11 53.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.382 . . . . 2.29 111.014 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.53 158.86 42.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.607 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 41.7 m0 -97.18 149.26 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.83999999999999997 111.368 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.476 HG13 ' CB ' ' A' ' 8' ' ' ALA . 77.0 t -88.77 159.31 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 1.3799999999999999 110.009 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.3 tppt? -79.17 110.86 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.27 0.557 . . . . 2.8700000000000001 112.159 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -87.95 36.76 3.33 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.232 -0.894 . . . . 0.39000000000000001 112.914 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 43' ' ' VAL . 3.1 t -112.39 0.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.34 -0.245 . . . . 1.3 110.34 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -66.86 76.27 0.12 Allowed 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.688 0.756 . . . . 2.1299999999999999 109.609 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 41' ' ' VAL . 7.1 p -57.17 75.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 113.715 -1.584 . . . . 2.1499999999999999 113.982 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 50.83 1.83 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.589 -0.893 . . . . 1.1200000000000001 108.589 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -24.14 1.93 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.982 -1.008 . . . . 2.4399999999999999 110.54 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 16.0 t70 -66.0 -49.77 66.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 2.48 109.91 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.531 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 60.3 t -55.05 -38.47 46.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 116.251 -0.431 . . . . 1.5 110.546 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -76.61 -59.86 2.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.188 1.395 . . . . 1.3600000000000001 110.665 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 5.2 tmmm? -56.73 -28.44 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.157 -0.683 . . . . 3.7799999999999998 109.157 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.9 t70 -91.54 -24.52 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.582 -0.736 . . . . 2.0 109.452 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.86 -70.28 0.3 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.817 0.817 . . . . 2.3300000000000001 110.59 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.0 pt-20 -82.4 -48.17 11.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.21 -1.359 . . . . 1.77 111.714 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -78.19 -25.49 47.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.839 -0.619 . . . . 2.2999999999999998 111.599 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.441 -0.885 . . . . 1.6100000000000001 112.313 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.735 -0.146 . . . . 3.3500000000000001 112.735 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 76.6 p 177.0 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 3.3900000000000001 111.059 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' NE2' ' CE2' ' A' ' 51' ' ' TYR . 4.9 pm0 -87.44 136.66 32.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.175 -0.466 . . . . 5.1100000000000003 109.852 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 2.1 t -90.91 48.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.371 -0.377 . . . . 3.6299999999999999 111.325 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.6 p90 171.07 154.14 0.06 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.953 0.406 . . . . 2.9300000000000002 111.888 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -134.75 142.41 46.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.957 -0.565 . . . . 2.4100000000000001 111.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.547 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 31.7 p90 -89.78 122.26 32.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.034 -0.53 . . . . 2.6000000000000001 111.424 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -107.25 53.45 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.816 -0.629 . . . . 1.1100000000000001 110.651 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -106.41 176.79 5.05 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.934 0.873 . . . . 2.7999999999999998 112.779 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 54.4 t -104.07 -24.28 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.021 -1.445 . . . . 1.1200000000000001 111.505 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 5.3 t70 -150.52 -39.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.917 -0.583 . . . . 2.1899999999999999 111.114 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 47.4 mt-10 -152.47 162.7 40.83 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.197 0.443 . . . . 2.1800000000000002 112.197 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -131.73 -168.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.487 -0.56 . . . . 1.0800000000000001 109.487 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' CG2' ' CD2' ' A' ' 26' ' ' LEU . 69.4 t -150.24 -49.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.3500000000000001 110.836 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 43.6 tt0 -98.64 146.11 26.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.162 -0.472 . . . . 2.96 110.465 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 18.8 pttm -152.9 89.62 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.005 0.372 . . . . 2.6200000000000001 112.005 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -154.54 87.63 1.18 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 121.059 -0.256 . . . . 4.4199999999999999 111.104 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 23' ' ' VAL . . . -152.26 -137.74 2.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 118.956 -1.592 . . . . 0.40999999999999998 115.084 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.6 mttm -115.63 -122.49 0.29 Allowed 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.65 -0.775 . . . . 1.74 110.325 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -90.28 -42.13 5.32 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.036 -2.026 . . . . 0.64000000000000001 108.036 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 1.4 mptp? -140.67 7.29 2.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.023 -1.588 . . . . 3.8700000000000001 110.675 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 30.3 t0 -88.85 10.07 22.45 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.893 0.377 . . . . 1.22 111.091 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 25' ' ' TYR . 4.1 p -88.01 150.0 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 111.398 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.9 pt-20 -112.33 93.08 4.26 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.488 -0.778 . . . . 1.26 110.393 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.547 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 5.6 m-85 -88.16 -167.7 1.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.263 -0.643 . . . . 0.88 109.263 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' CD1' ' CD1' ' A' ' 37' ' ' TRP . 29.4 tp -126.48 160.63 30.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.064 -1.087 . . . . 1.6799999999999999 108.064 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -139.19 110.72 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 118.924 -1.111 . . . . 1.1899999999999999 113.529 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 52.0 mtt180 -84.85 74.19 10.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 105.668 -1.975 . . . . 3.8799999999999999 105.668 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 2.7 t90 -26.72 90.81 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 113.867 -1.515 . . . . 1.5600000000000001 111.833 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 83.5 tttt -27.39 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.352 -1.295 . . . . 3.1000000000000001 112.341 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 4.7 p-10 -120.01 56.76 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.796 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.56 -178.02 23.3 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.58999999999999997 112.628 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.06 -13.37 9.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.851 -0.69 . . . . 0.85999999999999999 112.567 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -126.65 162.49 25.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 2.1299999999999999 110.89 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -116.1 118.72 33.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 2.29 110.71 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 31.9 mt-10 -108.64 163.88 12.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.207 0.527 . . . . 2.27 111.68 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.53 ' CD1' ' CD1' ' A' ' 26' ' ' LEU . 16.2 m0 -87.95 148.37 24.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.83999999999999997 112.015 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 40.1 t -87.6 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.018 -0.992 . . . . 1.3799999999999999 109.751 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 86.9 tttt -80.76 106.89 13.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.284 0.564 . . . . 2.8700000000000001 112.436 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -99.22 39.32 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.298 -0.864 . . . . 0.39000000000000001 112.363 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.29 0.0 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.824 -0.436 . . . . 1.3 109.824 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.502 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -77.05 77.79 3.6 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.734 0.778 . . . . 2.1299999999999999 110.918 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 6.0 p -57.28 77.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.325 -1.761 . . . . 2.1499999999999999 112.663 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.447 ' HB2' ' CG2' ' A' ' 47' ' ' VAL . . . -92.43 49.25 1.47 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.872 -1.058 . . . . 1.1200000000000001 109.241 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 42.0 tt0 -48.28 -27.53 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.171 -0.922 . . . . 2.4399999999999999 110.187 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 15.8 t70 -75.02 -43.12 55.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.477 -0.783 . . . . 2.48 109.73 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.3 t -63.93 -46.79 93.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 109.34 -0.615 . . . . 1.5 109.34 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.4 -54.96 18.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.539 1.536 . . . . 1.3600000000000001 111.331 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 23.3 ttmm -60.27 -33.28 72.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.406 0.622 . . . . 3.7799999999999998 109.464 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.1 t70 -91.67 -11.4 37.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.276 -0.874 . . . . 2.0 110.428 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -84.02 -63.25 1.38 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.428 0.633 . . . . 2.3300000000000001 110.262 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.7 pt-20 -87.64 -46.68 9.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.046 -0.979 . . . . 1.77 110.83 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -80.99 -22.51 39.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 2.2999999999999998 111.425 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.75 90.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.441 -0.885 . . . . 1.6100000000000001 112.244 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.31 -58.81 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 2.7999999999999998 110.861 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.38 63.32 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 2.9500000000000002 110.917 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.9 t80 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.23 -0.89 . . . . 2.23 110.859 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.504 ' CB ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.54 0.2 . . . . 5.5599999999999996 111.54 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' B' ' 1' ' ' ALA . 90.5 Cg_endo -77.12 110.04 2.94 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.925 1.75 . . . . 5.7699999999999996 112.569 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.09 106.11 1.66 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.49 2.126 . . . . 4.0999999999999996 112.216 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . 133.86 -91.09 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 2.1099999999999999 112.125 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.439 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 1.3 t -88.27 169.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 2.29 111.475 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.414 ' N ' ' OG1' ' B' ' 5' ' ' THR . . . -132.46 174.74 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.909 -0.587 . . . . 1.8600000000000001 110.988 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.445 ' CA ' ' HB1' ' A' ' 8' ' ' ALA . 40.1 ptt180 -124.3 125.19 43.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 7.9800000000000004 110.82 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.498 ' NH1' ' CE1' ' A' ' 7' ' ' TYR . 29.7 tpt180 -43.22 -58.14 2.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.937 0.398 . . . . 6.9800000000000004 111.314 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' B' ' 11' ' ' LYS . 62.1 mttp -154.88 -157.76 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.806 -0.634 . . . . 7.5599999999999996 109.322 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -52.43 -25.0 8.83 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.728 -0.471 . . . . 4.9100000000000001 109.728 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.502 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 88.6 mttt 55.11 100.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.708 -0.678 . . . . 4.8099999999999996 111.013 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 44' ' ' ALA . . . -81.69 117.23 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 2.0499999999999998 110.595 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 10.1 p-10 -129.08 54.45 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.973 0.416 . . . . 3.7999999999999998 110.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.209 -0.9 . . . . 4.3099999999999996 110.998 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.662 -0.175 . . . . 3.3500000000000001 112.662 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 71.2 p 176.38 -30.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.239 . . . . 3.3900000000000001 111.477 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -88.91 141.99 28.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.826 0.346 . . . . 5.1100000000000003 110.193 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.413 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 2.5 t -92.54 45.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 3.6299999999999999 110.035 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.506 ' HD1' ' HH ' ' A' ' 25' ' ' TYR . 8.3 p90 -177.48 142.31 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.772 -0.649 . . . . 2.9300000000000002 110.39 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 10.4 tp10 -130.15 142.98 50.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 2.4100000000000001 110.935 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.524 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.6 p90 -88.27 109.37 19.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.6 0.714 . . . . 2.6000000000000001 112.034 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -95.02 50.82 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.758 -1.11 . . . . 1.1100000000000001 109.611 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.12 169.23 9.26 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.984 0.897 . . . . 2.7999999999999998 112.369 -178.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 29' ' ' TRP . 51.7 t -97.53 -34.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-N 113.769 -1.559 . . . . 1.1200000000000001 112.096 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 11.3 t70 -144.87 -33.67 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.508 0.558 . . . . 2.1899999999999999 112.508 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 33.2 mm-40 -154.07 159.79 41.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.297 0.481 . . . . 2.1800000000000002 112.297 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -136.4 -169.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 1.0800000000000001 110.485 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG2' HD12 ' A' ' 26' ' ' LEU . 94.0 t -149.97 -54.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.431 . . . . 1.3500000000000001 110.068 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 41.5 mt-10 -92.25 138.32 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 2.96 109.375 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.593 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 19.7 pttm -152.43 87.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.262 0.467 . . . . 2.6200000000000001 112.262 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -154.24 93.08 1.58 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.324 -0.235 . . . . 4.4199999999999999 111.422 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.28 -128.87 1.32 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.19 -1.481 . . . . 0.40999999999999998 114.786 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.6 mttm -121.55 -122.79 0.28 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.341 -0.93 . . . . 1.74 109.481 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -92.12 -40.58 5.14 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.291 -1.924 . . . . 0.64000000000000001 108.291 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 12.0 mptt -137.14 1.95 2.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.187 -1.507 . . . . 3.8700000000000001 110.922 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 35.9 t0 -87.6 9.48 21.09 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.12 0.486 . . . . 1.22 111.465 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 25' ' ' TYR . 9.3 p -89.36 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.867 -0.606 . . . . 1.1200000000000001 111.705 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.9 pt-20 -107.73 101.15 10.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.483 -0.781 . . . . 1.26 110.035 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' OH ' ' HB2' ' A' ' 16' ' ' LYS . 7.2 m-85 -107.02 150.14 26.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.822 -0.626 . . . . 0.88 110.302 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 ' CG2' ' A' ' 14' ' ' VAL . 2.1 tt -88.64 156.99 18.71 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.593 -0.892 . . . . 1.6799999999999999 108.593 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.0 m -141.21 112.04 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 114.07 1.137 . . . . 1.1899999999999999 114.07 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' TRP . 77.6 mtt180 -87.38 79.29 8.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.666 -1.975 . . . . 3.8799999999999999 105.666 175.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 10' ' ' VAL . 1.2 t90 -26.87 91.65 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.284 -1.326 . . . . 1.5600000000000001 112.246 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 61.6 tttp -27.62 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.308 -1.315 . . . . 3.1000000000000001 112.257 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.8 t70 -119.3 57.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 2.02 109.903 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -147.6 -145.25 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.58999999999999997 112.735 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -144.97 -45.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.949 -0.644 . . . . 0.85999999999999999 112.213 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.07 -177.33 4.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 2.1299999999999999 110.535 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.58 139.42 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 2.29 111.214 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 21.9 mm-40 -134.35 -177.46 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.081 -0.509 . . . . 2.27 110.779 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -104.25 146.27 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.83999999999999997 111.338 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 92.0 t -89.19 159.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.3799999999999999 109.792 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 23.5 ttmm -75.46 107.46 7.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.325 0.583 . . . . 2.8700000000000001 112.5 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -92.75 40.77 2.8 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.069 -0.969 . . . . 0.39000000000000001 112.392 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 1.9 t -116.85 3.94 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.044 -0.354 . . . . 1.3 110.044 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.491 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.3 OUTLIER -75.85 76.49 2.78 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.879 0.847 . . . . 2.1299999999999999 110.799 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 58.6 t -58.12 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 113.219 -1.81 . . . . 2.1499999999999999 113.249 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 47' ' ' VAL . . . -91.75 51.34 1.83 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.595 -0.891 . . . . 1.1200000000000001 108.595 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -45.85 -27.28 0.83 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.196 -0.911 . . . . 2.4399999999999999 110.818 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.28 -46.94 63.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.775 -0.648 . . . . 2.48 109.785 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 59.7 t -58.98 -47.39 90.01 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-N 116.002 -0.545 . . . . 1.5 109.539 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.44 -56.69 9.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.175 1.39 . . . . 1.3600000000000001 110.976 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.6 ttmm -56.59 -35.3 68.07 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.289 0.566 . . . . 3.7799999999999998 109.682 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -91.56 -14.77 29.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.0 111.152 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.53 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -77.08 -59.95 2.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.718 0.771 . . . . 2.3300000000000001 110.453 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.1 pt-20 -90.19 -41.75 11.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.3 -1.318 . . . . 1.77 111.482 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -87.69 -30.78 20.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 111.524 -179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -65.03 -48.84 66.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.492 -0.861 . . . . 1.6100000000000001 112.368 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.9 tp -64.84 -71.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 2.7999999999999998 110.955 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.19 62.9 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 2.9500000000000002 111.058 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 t80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.867 . . . . 2.23 110.798 179.87 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.62 0.248 . . . . 5.5599999999999996 111.048 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.11 111.86 2.98 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.595 2.197 . . . . 5.7699999999999996 112.298 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 -29.52 67.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.403 2.069 . . . . 4.0999999999999996 112.355 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 36' ' ' GLU . . . -66.58 77.94 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.642 -0.79 . . . . 2.1099999999999999 112.311 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.414 ' HA ' ' CG1' ' A' ' 27' ' ' VAL . 68.0 p -152.14 160.56 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.885 0.374 . . . . 2.29 111.653 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -170.58 66.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.8600000000000001 110.795 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.436 ' HG2' ' CE ' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -45.08 131.28 7.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 7.9800000000000004 111.432 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.439 ' HD2' ' CG ' ' A' ' 6' ' ' GLU . 7.9 tpm_? -47.43 -70.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.225 0.454 . . . . 6.9800000000000004 112.225 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.414 ' HG3' ' HG3' ' B' ' 8' ' ' ARG . 30.0 mtpt -130.49 -162.39 1.21 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.148 0.499 . . . . 7.5599999999999996 112.151 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' B' ' 11' ' ' LYS . 26.9 ptt180 -57.3 -16.49 8.82 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 115.711 -0.677 . . . . 4.9100000000000001 111.817 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 2.8 mptt 78.91 90.94 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.973 0.416 . . . . 4.8099999999999996 110.44 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.97 -24.99 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 2.0499999999999998 111.9 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 13.6 t70 -108.8 -25.15 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 3.7999999999999998 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.476 ' OXT' ' CD2' ' A' ' 42' ' ' HIS . 77.8 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.183 -0.913 . . . . 4.3099999999999996 111.275 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.707 -0.157 . . . . 3.3500000000000001 112.707 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p 177.37 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 3.3900000000000001 111.187 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.544 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 14.6 mm100 -88.64 138.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.001 -0.37 . . . . 5.1100000000000003 110.001 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 1.241 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 2.0 t -91.79 48.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 3.6299999999999999 110.101 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.419 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER 175.41 144.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 2.9300000000000002 110.973 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.435 ' HB3' ' HG2' ' B' ' 8' ' ' ARG . 2.2 mp0 -130.94 150.51 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.882 0.372 . . . . 2.4100000000000001 111.202 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 50.3 p90 -92.5 113.64 25.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.802 0.668 . . . . 2.6000000000000001 112.802 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' CA ' ' HG3' ' B' ' 8' ' ' ARG . . . -100.55 54.14 0.88 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.949 -1.023 . . . . 1.1100000000000001 109.254 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.73 164.33 14.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.992 0.901 . . . . 2.7999999999999998 112.085 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 39.1 t -98.34 -22.07 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 114.004 -1.453 . . . . 1.1200000000000001 112.117 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 13.7 t70 -149.94 -40.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.385 0.513 . . . . 2.1899999999999999 112.385 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 8.2 mm-40 -154.23 163.31 40.32 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 111.942 0.349 . . . . 2.1800000000000002 111.942 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -136.93 -169.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.575 0.226 . . . . 1.0800000000000001 110.582 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 88.4 t -150.13 -59.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 1.3500000000000001 110.233 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 16.3 mm-40 -91.9 138.74 31.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.833 -0.622 . . . . 2.96 109.891 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 8.4 ptpp? -151.06 92.99 1.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.008 -0.277 . . . . 2.6200000000000001 111.652 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -154.44 91.12 1.38 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.352 -0.217 . . . . 4.4199999999999999 110.969 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.448 ' H ' ' HD2' ' A' ' 5' ' ' PHE . . . -153.16 -134.11 1.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 118.956 -1.592 . . . . 0.40999999999999998 115.111 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 69.0 mttm -117.28 -126.01 0.28 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.263 -0.968 . . . . 1.74 109.526 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.453 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.21 -38.7 6.66 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.551 -1.82 . . . . 0.64000000000000001 108.551 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 20.8 mmtp -140.51 2.5 1.83 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.215 -1.492 . . . . 3.8700000000000001 111.084 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 16.1 t70 -88.26 11.26 17.03 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.211 0.529 . . . . 1.22 111.462 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG12 ' CE1' ' A' ' 25' ' ' TYR . 6.3 p -88.75 154.03 3.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.802 -0.636 . . . . 1.1200000000000001 112.199 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -107.33 105.61 15.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.313 -0.858 . . . . 1.26 110.098 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.538 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 7.0 m-85 -110.52 150.82 28.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.654 . . . . 0.88 110.177 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 13' ' ' ILE . 1.8 tt -88.74 157.26 18.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.07 -0.715 . . . . 1.6799999999999999 109.07 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.9 m -143.07 110.55 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 114.428 1.27 . . . . 1.1899999999999999 114.428 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.2 ttp180 -82.1 72.97 9.16 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 105.465 -2.05 . . . . 3.8799999999999999 105.465 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.536 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -26.49 89.47 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.86 -1.518 . . . . 1.5600000000000001 112.207 -177.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' CB ' HG11 ' A' ' 10' ' ' VAL . 38.2 ttpt -29.21 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.596 -1.184 . . . . 3.1000000000000001 112.089 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.6 m-20 -117.95 56.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 2.02 109.796 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.13 -163.71 10.26 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.58999999999999997 112.72 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.34 -43.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.006 -0.616 . . . . 0.85999999999999999 112.054 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -97.75 -173.67 2.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 2.1299999999999999 110.518 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.6 t -142.69 144.1 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 2.29 111.087 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -147.68 -176.22 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 2.27 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 34.8 m0 -104.62 152.28 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.83999999999999997 111.589 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' B' ' 5' ' ' THR . 72.1 t -88.95 161.06 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.993 -0.548 . . . . 1.3799999999999999 109.942 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 63.3 tttp -75.48 104.36 6.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.343 0.592 . . . . 2.8700000000000001 112.332 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.51 44.19 2.91 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.136 -0.938 . . . . 0.39000000000000001 112.511 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.412 ' HB ' ' HE3' ' A' ' 39' ' ' LYS . 2.0 t -120.18 8.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.835 -0.431 . . . . 1.3 109.835 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.493 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -75.81 75.81 2.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.43 0.633 . . . . 2.1299999999999999 110.433 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.435 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 60.5 t -57.87 73.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.609 -1.632 . . . . 2.1499999999999999 113.5 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.71 49.55 1.48 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.799 -0.815 . . . . 1.1200000000000001 108.799 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -44.16 -29.24 0.6 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.181 -0.918 . . . . 2.4399999999999999 110.734 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 12.1 t70 -70.53 -43.76 68.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.488 -0.778 . . . . 2.48 110.117 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.6 t -63.04 -47.57 92.06 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 109.514 -0.551 . . . . 1.5 109.514 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -65.88 -54.79 21.98 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.399 1.48 . . . . 1.3600000000000001 111.062 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 27.9 ttpp -60.12 -33.16 71.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.456 0.646 . . . . 3.7799999999999998 109.65 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 6.9 t70 -92.56 -9.37 41.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.278 -0.874 . . . . 2.0 110.652 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -86.53 -63.67 1.28 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.484 0.659 . . . . 2.3300000000000001 110.749 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.4 pt-20 -85.79 -42.95 13.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.892 -1.049 . . . . 1.77 110.763 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -87.61 -18.92 28.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.607 -0.724 . . . . 2.2999999999999998 111.42 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.14 -28.91 47.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.454 -0.879 . . . . 1.6100000000000001 112.369 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.6 -64.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.771 0.32 . . . . 2.7999999999999998 110.41 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.38 58.14 4.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.056 0.455 . . . . 2.9500000000000002 110.709 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.344 -0.836 . . . . 2.23 110.88 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.537 0.208 . . . . 5.5599999999999996 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.05 118.32 4.37 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.651 2.234 . . . . 5.7699999999999996 112.305 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.26 86.55 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.528 2.152 . . . . 4.0999999999999996 112.556 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.9 64.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 2.1099999999999999 112.651 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 1.437 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 0.4 OUTLIER -152.13 172.29 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 2.29 111.556 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.93 -160.81 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.944 -0.571 . . . . 1.8600000000000001 110.71 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -140.31 133.88 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 7.9800000000000004 111.119 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.478 ' HG3' ' CA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -79.02 -33.5 44.81 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.091 -0.504 . . . . 6.9800000000000004 111.557 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' B' ' 11' ' ' LYS . 90.4 mttt -156.96 -171.64 3.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.6 0.238 . . . . 7.5599999999999996 111.143 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' B' ' 11' ' ' LYS . 24.3 ptt180 -52.36 -23.02 5.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.732 0.301 . . . . 4.9100000000000001 111.423 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.493 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 12.7 mmmm 80.95 89.49 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.007 0.432 . . . . 4.8099999999999996 110.331 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -15.32 22.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 2.0499999999999998 112.412 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 42' ' ' HIS . 4.7 p-10 -109.49 -24.77 10.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 3.7999999999999998 111.328 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 46.9 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.316 -0.85 . . . . 4.3099999999999996 111.118 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.554 -0.219 . . . . 3.3500000000000001 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t 174.14 -33.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.695 0.284 . . . . 3.3900000000000001 111.001 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.519 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mp0 -89.19 139.29 30.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.372 -0.376 . . . . 5.1100000000000003 110.067 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.999 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 1.5 t -89.68 50.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.971 0.415 . . . . 3.6299999999999999 110.307 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.579 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -179.36 177.63 0.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 2.9300000000000002 111.157 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 7.9 tp10 -154.11 124.32 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 2.4100000000000001 109.731 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 43.0 p90 -89.21 105.01 17.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.815 0.302 . . . . 2.6000000000000001 111.815 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB1' ' CG1' ' A' ' 38' ' ' VAL . . . -89.58 56.1 3.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.55 -0.537 . . . . 1.1100000000000001 109.55 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' CB ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.71 149.51 32.82 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.813 0.816 . . . . 2.7999999999999998 113.028 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 18.2 t -90.45 -32.49 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 114.222 -1.353 . . . . 1.1200000000000001 110.647 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.5 t70 -138.43 -43.15 0.5 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 2.1899999999999999 111.814 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.4 mm-40 -155.43 157.59 37.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.81 0.67 . . . . 2.1800000000000002 112.81 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -126.87 -165.9 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.325 -0.62 . . . . 1.0800000000000001 109.325 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.53 HG23 ' CB ' ' A' ' 26' ' ' LEU . 31.5 m -150.1 -51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 1.3500000000000001 111.199 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.1 tp10 -105.23 134.71 47.89 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.897 -0.592 . . . . 2.96 109.448 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.811 ' HE2' ' HH ' ' A' ' 25' ' ' TYR . 13.2 ptmm? -150.9 88.98 1.5 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.134 -0.627 . . . . 2.6200000000000001 112.63 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 15.0 ptp180 -153.6 91.34 1.47 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.85 -0.34 . . . . 4.4199999999999999 111.383 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.61 -135.28 2.18 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 118.876 -1.631 . . . . 0.40999999999999998 114.851 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.7 mttm -111.28 -120.26 0.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.46 -0.87 . . . . 1.74 109.909 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.436 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.95 -41.0 3.91 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 108.19 -1.964 . . . . 0.64000000000000001 108.19 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 46.2 mmtm -135.08 0.46 2.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 112.978 -1.611 . . . . 3.8700000000000001 110.871 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 12.3 t70 -88.54 9.88 22.33 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 121.297 0.57 . . . . 1.22 111.458 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' CA ' ' HA3' ' A' ' 18' ' ' GLY . 7.3 p -93.99 143.18 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.148 -0.933 . . . . 1.1200000000000001 110.58 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 11.8 pt-20 -104.9 119.4 38.92 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.421 -0.512 . . . . 1.26 110.865 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.811 ' HH ' ' HE2' ' A' ' 16' ' ' LYS . 19.4 m-85 -113.8 -175.23 2.63 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.652 -0.704 . . . . 0.88 110.237 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' CB ' HG23 ' A' ' 14' ' ' VAL . 2.1 tt -128.75 157.89 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.108 -0.951 . . . . 1.6799999999999999 108.502 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.18 113.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 118.848 -1.141 . . . . 1.1899999999999999 113.149 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -87.78 66.44 8.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 104.734 -2.321 . . . . 3.8799999999999999 104.734 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 16.7 t90 -25.97 89.71 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.263 -1.79 . . . . 1.5600000000000001 112.496 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 57.3 tttp -27.49 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.134 -1.394 . . . . 3.1000000000000001 112.392 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' OD2' ' CZ2' ' A' ' 29' ' ' TRP . 7.8 p-10 -119.81 57.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 2.02 109.903 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -140.85 -147.16 4.89 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.753 -0.658 . . . . 0.58999999999999997 112.887 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.67 -45.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.095 -0.574 . . . . 0.85999999999999999 112.197 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.72 172.21 7.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 2.1299999999999999 110.652 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.26 138.94 52.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 2.29 111.05 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.444 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 11.1 mm-40 -138.13 179.4 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 2.27 110.678 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 26.0 m0 -113.29 154.2 27.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.372 . . . . 0.83999999999999997 111.747 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' CG1' ' HB1' ' A' ' 8' ' ' ALA . 13.5 t -88.88 151.77 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.998 -0.546 . . . . 1.3799999999999999 110.042 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 38' ' ' VAL . 63.1 tttm -69.66 91.43 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 2.8700000000000001 111.175 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' HA3' ' CA ' ' A' ' 24' ' ' GLU . . . -90.11 42.48 2.95 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.759 -0.734 . . . . 0.39000000000000001 113.14 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.33 11.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.718 -0.475 . . . . 1.3 109.718 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.49 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -81.78 81.52 7.78 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.76 0.79 . . . . 2.1299999999999999 111.201 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 58.3 t -58.05 71.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.169 -1.832 . . . . 2.1499999999999999 112.243 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.94 51.85 1.9 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.281 -0.872 . . . . 1.1200000000000001 109.111 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.38 0.49 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.344 -0.843 . . . . 2.4399999999999999 110.489 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 18.2 m-20 -70.33 -48.46 56.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.425 -0.807 . . . . 2.48 109.99 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 51' ' ' TYR . 64.0 t -59.41 -42.25 87.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 116.385 -0.37 . . . . 1.5 110.286 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.64 -58.07 4.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.03 1.332 . . . . 1.3600000000000001 110.842 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' GLY . 40.6 ttmt -58.98 -30.05 67.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.397 0.618 . . . . 3.7799999999999998 109.406 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.9 t70 -91.67 -16.36 27.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.381 -0.827 . . . . 2.0 110.374 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -80.58 -67.7 0.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.591 0.71 . . . . 2.3300000000000001 110.362 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 12.8 pt-20 -86.31 -44.29 12.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.884 -1.053 . . . . 1.77 111.149 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 8.5 t70 -86.94 -9.1 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.781 -0.645 . . . . 2.2999999999999998 111.513 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -84.85 -33.85 17.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.406 -0.902 . . . . 1.6100000000000001 112.123 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.5 tp -83.93 -66.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 2.7999999999999998 110.845 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -87.64 60.07 5.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 2.9500000000000002 110.904 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 t80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.291 -0.861 . . . . 2.23 111.002 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.647 0.261 . . . . 5.5599999999999996 111.009 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.87 149.32 34.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.643 2.229 . . . . 5.7699999999999996 112.222 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.473 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 55.6 Cg_endo -69.18 76.69 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.191 . . . . 4.0999999999999996 112.45 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 36' ' ' GLU . . . -143.37 12.67 2.27 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.048 -0.596 . . . . 2.1099999999999999 112.717 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 1.219 ' HB ' ' OG1' ' B' ' 5' ' ' THR . 30.3 m -152.67 147.48 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 2.29 111.642 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.442 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -148.99 -76.28 0.16 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.843 0.682 . . . . 1.8600000000000001 112.843 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' B' ' 7' ' ' ARG . 5.7 mmp_? -59.85 -102.02 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.627 0.232 . . . . 7.9800000000000004 111.627 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.633 ' NH1' ' CG2' ' B' ' 5' ' ' THR . 28.2 mtp180 55.25 169.07 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.17 0.441 . . . . 6.9800000000000004 110.198 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' B' ' 11' ' ' LYS . 66.6 mttm -144.66 -168.71 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.62 0.247 . . . . 7.5599999999999996 111.274 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -45.93 -28.88 1.23 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 121.036 0.446 . . . . 4.9100000000000001 111.122 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.49 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 30.6 mttp 74.69 100.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 4.8099999999999996 110.542 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.0 -26.53 66.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 111.326 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 17.7 t70 -113.08 78.22 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 3.7999999999999998 110.948 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.249 -0.882 . . . . 4.3099999999999996 110.868 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 120.158 -0.246 . . . . 3.3500000000000001 112.534 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 t 174.74 -24.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.212 0.506 . . . . 3.3900000000000001 112.355 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' CG ' ' CE1' ' A' ' 5' ' ' PHE . 34.3 tt0 -87.25 133.95 33.61 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 110.148 -0.316 . . . . 5.1100000000000003 110.148 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 8.4 t -92.6 53.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.337 0.495 . . . . 3.6299999999999999 112.337 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CE1' ' CG ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER 163.97 162.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.765 0.317 . . . . 2.9300000000000002 111.402 179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 8.2 tp10 -140.07 145.52 37.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.278 -0.419 . . . . 2.4100000000000001 110.972 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.499 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 17.9 p90 -88.39 124.6 34.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 2.6000000000000001 111.28 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' B' ' 7' ' ' ARG . . . -107.15 49.54 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.459 -0.791 . . . . 1.1100000000000001 110.348 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -104.75 176.97 4.98 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.846 0.831 . . . . 2.7999999999999998 112.509 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.589 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 14.1 t -112.69 -14.5 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.157 -1.383 . . . . 1.1200000000000001 112.225 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 16.8 t70 -150.16 -44.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.395 . . . . 2.1899999999999999 111.171 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -153.16 173.84 15.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.039 -0.528 . . . . 2.1800000000000002 111.447 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -143.22 -171.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 1.0800000000000001 109.36 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG2' HD22 ' A' ' 26' ' ' LEU . 64.1 t -150.46 -48.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 1.3500000000000001 110.699 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 14.3 mm-40 -93.51 145.6 24.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.118 -0.492 . . . . 2.96 110.445 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 ptmt -152.83 86.32 1.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.7 -0.4 . . . . 2.6200000000000001 111.534 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -153.44 91.87 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 121.092 -0.243 . . . . 4.4199999999999999 111.43 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -151.31 -130.77 1.71 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.644 -1.265 . . . . 0.40999999999999998 114.912 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 51.1 mttm -116.58 -74.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.279 1.038 . . . . 1.74 110.644 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.2 -47.1 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 107.021 -2.431 . . . . 0.64000000000000001 107.021 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 50.6 mmtt -125.21 -10.46 7.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 112.954 -1.623 . . . . 3.8700000000000001 109.705 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' HIS . 11.0 t70 -87.06 11.2 14.33 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.141 0.495 . . . . 1.22 111.833 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 HG21 ' CE1' ' A' ' 25' ' ' TYR . 5.4 p -86.71 151.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.853 -0.612 . . . . 1.1200000000000001 110.852 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 91.29 3.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.573 -0.739 . . . . 1.26 110.658 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 5.5 m-85 -88.16 -166.31 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.011 -0.54 . . . . 0.88 109.973 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.549 ' CD1' ' CD1' ' A' ' 37' ' ' TRP . 15.1 tp -127.78 159.78 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.711 -0.848 . . . . 1.6799999999999999 108.711 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.16 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 113.696 0.998 . . . . 1.1899999999999999 113.696 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 29' ' ' TRP . 82.7 mtt180 -88.78 65.72 7.77 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 104.439 -2.43 . . . . 3.8799999999999999 104.439 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 22.2 t90 -25.64 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.529 -1.669 . . . . 1.5600000000000001 111.965 -177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 65.8 tttm -28.49 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.051 -1.431 . . . . 3.1000000000000001 112.799 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.9 m-20 -108.49 49.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.806 0.336 . . . . 2.02 110.655 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.27 -162.17 10.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.16 -0.543 . . . . 0.58999999999999997 112.538 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.48 27.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.85999999999999999 112.589 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.48 179.43 7.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.936 0.398 . . . . 2.1299999999999999 111.078 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.79 130.44 54.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 2.29 110.742 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -134.36 137.84 44.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 2.27 111.045 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.549 ' CD1' ' CD1' ' A' ' 26' ' ' LEU . 7.7 m0 -89.08 148.82 23.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.47 0.652 . . . . 0.83999999999999997 111.889 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' A' ' 27' ' ' VAL . 14.6 t -87.23 158.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.947 -1.024 . . . . 1.3799999999999999 109.777 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.21 111.58 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.314 0.578 . . . . 2.8700000000000001 112.277 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.37 38.7 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.186 -0.915 . . . . 0.39000000000000001 112.844 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.34 -1.64 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 110.111 -0.329 . . . . 1.3 110.111 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.18 76.87 1.28 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.431 0.634 . . . . 2.1299999999999999 110.238 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' B' ' 13' ' ' ASP . 6.2 p -56.22 69.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 113.441 -1.709 . . . . 2.1499999999999999 114.086 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -89.5 51.23 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 1.1200000000000001 109.143 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -48.78 -27.13 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.311 -0.859 . . . . 2.4399999999999999 110.272 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 28.1 t70 -69.38 -48.36 61.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 2.48 110.058 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.618 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 35.4 t -59.69 -31.1 46.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 116.323 -0.399 . . . . 1.5 110.219 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.77 -59.47 2.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.875 1.27 . . . . 1.3600000000000001 109.903 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 8.0 mtmp? -57.51 -27.23 62.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.922 -0.77 . . . . 3.7799999999999998 108.922 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.5 t70 -92.71 -22.44 19.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.428 -0.805 . . . . 2.0 110.184 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.618 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.3 -70.17 0.38 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.858 0.837 . . . . 2.3300000000000001 110.468 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 16.1 pt-20 -84.94 -50.36 7.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.077 -1.419 . . . . 1.77 111.813 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.3 t70 -73.99 -24.73 59.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 2.2999999999999998 110.826 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -58.48 -40.27 94.16 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.399 -0.905 . . . . 1.6100000000000001 111.773 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 12.6 mt -86.54 -54.96 4.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 2.7999999999999998 110.267 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.2 60.67 5.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 2.9500000000000002 110.776 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.221 -0.895 . . . . 2.23 110.767 -179.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.478 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 111.834 0.309 . . . . 5.5599999999999996 111.834 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 84.7 Cg_exo -46.42 102.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.386 2.057 . . . . 5.7699999999999996 112.68 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.26 100.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.559 2.173 . . . . 4.0999999999999996 112.322 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.9 -95.19 1.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 2.1099999999999999 112.402 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.447 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 9.8 t -89.61 167.32 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 2.29 111.293 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.46 51.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 1.8600000000000001 111.154 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 52.8 ptt85 -42.74 136.93 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.094 -0.503 . . . . 7.9800000000000004 111.45 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.407 ' HG2' ' HD2' ' A' ' 21' ' ' LYS . 25.8 tpt180 -51.87 142.45 15.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.462 -0.495 . . . . 6.9800000000000004 109.738 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -125.09 43.75 2.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.039 0.385 . . . . 7.5599999999999996 112.039 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -112.72 -28.96 7.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.905 0.383 . . . . 4.9100000000000001 110.197 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 42' ' ' HIS . 18.5 tptm 42.03 67.03 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.53 . . . . 4.8099999999999996 111.39 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . . . -52.34 -23.17 5.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.489 -0.778 . . . . 2.0499999999999998 111.807 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . 7.5 t70 -108.4 -71.37 0.76 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.98 -0.555 . . . . 3.7999999999999998 111.268 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' B' ' 11' ' ' LYS . 23.2 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.244 -0.884 . . . . 4.3099999999999996 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.761 -0.136 . . . . 3.3500000000000001 112.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HA ' ' CA ' ' A' ' 52' ' ' GLU . 45.8 p -149.24 -57.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.399 . . . . 3.3900000000000001 110.797 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.06 117.21 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 5.1100000000000003 110.569 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.28 -53.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 3.6299999999999999 111.798 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.439 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 58.09 -174.19 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.392 -0.595 . . . . 2.9300000000000002 109.392 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 23' ' ' VAL . 11.5 tp10 -140.88 129.16 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.009 0.433 . . . . 2.4100000000000001 111.586 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 40.5 p90 -95.49 103.52 15.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.666 -0.697 . . . . 2.6000000000000001 110.908 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -86.77 57.91 4.77 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.942 -0.762 . . . . 1.1100000000000001 108.942 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.546 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -107.13 149.44 27.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.716 -1.129 . . . . 2.7999999999999998 113.121 -177.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 29' ' ' TRP . 55.0 t -90.27 -36.1 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 113.068 -1.878 . . . . 1.1200000000000001 110.109 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB3' ' CA ' ' A' ' 30' ' ' LYS . 4.3 m-20 -141.13 -37.04 0.44 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 2.1899999999999999 112.125 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.1 mt-10 -153.52 168.98 24.33 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 112.15 0.426 . . . . 2.1800000000000002 112.15 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG21 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -138.71 -170.22 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 1.0800000000000001 109.807 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.491 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 65.7 t -152.32 -60.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.863 0.363 . . . . 1.3500000000000001 111.624 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 40.9 tt0 -92.33 93.33 8.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.96 112.043 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 21.0 pttm -104.87 90.54 3.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 2.6200000000000001 111.166 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -155.99 87.34 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.947 -0.301 . . . . 4.4199999999999999 111.55 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 23' ' ' VAL . . . -150.66 -138.38 2.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 118.896 -1.621 . . . . 0.40999999999999998 115.001 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 67.1 mttm -106.48 -113.32 0.27 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.858 -0.671 . . . . 1.74 110.106 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -101.17 -41.77 2.53 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 107.688 -2.165 . . . . 0.64000000000000001 107.688 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.747 ' HB3' ' HD3' ' B' ' 11' ' ' LYS . 36.6 mtmm -143.18 6.86 1.55 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.985 -1.608 . . . . 3.8700000000000001 110.882 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 40.5 t0 -89.96 13.01 15.83 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.214 0.53 . . . . 1.22 111.253 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 25' ' ' TYR . 7.9 p -88.07 156.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.536 -0.756 . . . . 1.1200000000000001 112.28 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 8.4 pt-20 -115.1 92.17 3.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.17 -0.923 . . . . 1.26 110.182 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.538 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 6.0 m-85 -88.74 -168.05 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.88 110.074 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -123.26 161.13 25.18 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.534 -0.913 . . . . 1.6799999999999999 108.534 178.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.8 OUTLIER -141.75 110.22 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 118.611 -1.236 . . . . 1.1899999999999999 113.701 178.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 79.0 mtt180 -87.15 77.55 9.05 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.14 -1.43 . . . . 3.8799999999999999 107.14 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.497 ' CD1' HG22 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -27.34 90.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.177 -1.374 . . . . 1.5600000000000001 112.114 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' N ' HG12 ' A' ' 10' ' ' VAL . 54.7 tptt -27.99 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.809 -1.087 . . . . 3.1000000000000001 112.23 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.1 m-20 -119.48 55.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.026 0.441 . . . . 2.02 110.041 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -143.01 -153.96 6.01 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.58999999999999997 112.734 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.09 21.2 1.24 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.811 -0.709 . . . . 0.85999999999999999 112.463 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -149.82 -172.33 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.1299999999999999 110.685 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -148.86 106.35 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 2.29 111.272 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 1.1 mp0 -102.38 -169.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.973 -0.558 . . . . 2.27 110.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.4 m0 -114.21 152.79 30.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.439 0.638 . . . . 0.83999999999999997 112.406 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 67.3 t -88.17 163.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.108 -0.951 . . . . 1.3799999999999999 109.768 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 38' ' ' VAL . 35.9 tptt -82.81 107.53 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.914 0.709 . . . . 2.8700000000000001 112.914 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.97 29.43 9.98 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.219 -0.9 . . . . 0.39000000000000001 111.949 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.36 -3.11 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 1.188 ' O ' ' HE3' ' B' ' 11' ' ' LYS . 6.2 m170 -68.5 75.61 0.27 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.328 0.585 . . . . 2.1299999999999999 110.089 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' N ' ' HB2' ' B' ' 13' ' ' ASP . 39.9 t -58.84 70.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.083 -1.417 . . . . 2.1499999999999999 113.7 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.01 50.89 1.73 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.666 -0.865 . . . . 1.1200000000000001 108.666 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -24.24 1.72 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.931 -1.031 . . . . 2.4399999999999999 110.657 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.6 m-20 -66.01 -48.68 70.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.183 -0.462 . . . . 2.48 110.115 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' CE2' ' A' ' 51' ' ' TYR . 43.8 t -58.63 -28.73 37.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.996 -0.547 . . . . 1.5 111.035 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -86.7 -59.11 2.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.788 1.235 . . . . 1.3600000000000001 110.162 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.0 ttmm -56.37 -28.49 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.044 -0.724 . . . . 3.7799999999999998 109.044 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 11.3 t70 -90.97 -25.24 19.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.448 -0.797 . . . . 2.0 109.504 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -70.1 -71.15 0.25 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.947 0.88 . . . . 2.3300000000000001 110.638 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 11.5 pt-20 -81.04 -45.91 15.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 113.95 -1.477 . . . . 1.77 111.796 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.67 -24.81 36.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.976 -0.557 . . . . 2.2999999999999998 111.59 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -79.12 -53.74 4.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.465 -0.874 . . . . 1.6100000000000001 112.347 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.32 -56.93 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 2.7999999999999998 110.468 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.93 53.99 2.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 2.9500000000000002 110.618 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.251 -0.88 . . . . 2.23 110.84 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.607 0.242 . . . . 5.5599999999999996 111.111 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 81.5 Cg_exo -47.66 102.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.629 2.219 . . . . 5.7699999999999996 112.277 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.38 -30.05 91.73 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.712 2.275 . . . . 4.0999999999999996 112.66 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 36' ' ' GLU . . . -60.14 92.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.553 -0.832 . . . . 2.1099999999999999 112.573 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.433 ' N ' HG23 ' A' ' 27' ' ' VAL . 56.2 p -152.85 151.35 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.44 0.163 . . . . 2.29 111.44 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 8' ' ' ALA . . . -155.25 -80.4 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.361 0.875 . . . . 1.8600000000000001 113.361 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 37.7 mmt180 -49.02 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.316 0.487 . . . . 7.9800000000000004 112.316 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.433 ' NH2' HG22 ' B' ' 5' ' ' THR . 68.0 mtt180 59.73 160.61 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.206 -0.597 . . . . 6.9800000000000004 110.123 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -136.86 -162.73 1.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.668 0.27 . . . . 7.5599999999999996 110.799 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' B' ' 11' ' ' LYS . 31.8 ptt180 -46.2 -26.8 0.84 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.418 -0.355 . . . . 4.9100000000000001 111.259 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 1.188 ' HE3' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER 79.66 99.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.921 -0.581 . . . . 4.8099999999999996 110.512 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -96.86 29.3 3.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.703 -0.681 . . . . 2.0499999999999998 110.745 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.952 ' HB3' ' HE2' ' B' ' 11' ' ' LYS . 5.6 p-10 -108.42 45.15 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 3.7999999999999998 110.568 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.182 -0.913 . . . . 4.3099999999999996 111.064 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.682 -0.167 . . . . 3.3500000000000001 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t 175.15 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.649 0.262 . . . . 3.3900000000000001 111.494 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.82 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.118 -0.327 . . . . 5.1100000000000003 110.118 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 2.3 t -91.83 48.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.906 0.384 . . . . 3.6299999999999999 110.586 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 6.9 p90 178.64 148.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 2.9300000000000002 111.202 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HG2' ' CG ' ' B' ' 9' ' ' LYS . 9.6 tp10 -131.16 143.24 50.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 2.4100000000000001 110.391 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.522 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 46.3 p90 -89.06 107.44 19.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.312 0.577 . . . . 2.6000000000000001 112.43 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -90.23 53.09 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.248 -0.887 . . . . 1.1100000000000001 109.051 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.687 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -111.89 152.45 27.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 122.186 0.993 . . . . 2.7999999999999998 113.308 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 62.1 t -89.78 -34.42 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 113.52 -1.673 . . . . 1.1200000000000001 110.582 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 15.7 t70 -142.57 -38.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.942 -0.572 . . . . 2.1899999999999999 112.321 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.0 mm-40 -155.16 155.95 34.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.828 0.677 . . . . 2.1800000000000002 112.828 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.535 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -129.65 -169.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.882 0.372 . . . . 1.0800000000000001 110.595 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 26' ' ' LEU . 81.6 t -150.99 -55.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 1.3500000000000001 110.062 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.9 mt-10 -92.09 139.02 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 2.96 109.618 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 19.3 pttm -152.16 89.15 1.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.346 0.499 . . . . 2.6200000000000001 112.346 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 11.4 ptp180 -154.7 92.41 1.47 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.238 -0.289 . . . . 4.4199999999999999 111.189 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.95 -132.46 1.76 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.098 -1.525 . . . . 0.40999999999999998 114.975 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.7 mttm -117.85 -121.26 0.3 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.368 -0.916 . . . . 1.74 109.599 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.92 -42.05 4.5 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.801 -2.119 . . . . 0.64000000000000001 107.801 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -137.51 4.17 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.103 -1.549 . . . . 3.8700000000000001 110.94 177.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' CA ' ' A' ' 41' ' ' VAL . 29.9 t0 -87.67 10.1 19.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.158 0.504 . . . . 1.22 111.024 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.512 HG11 ' CE1' ' A' ' 25' ' ' TYR . 9.9 p -89.24 154.73 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.827 -0.624 . . . . 1.1200000000000001 111.406 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -110.64 99.04 8.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.396 -0.82 . . . . 1.26 110.101 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.546 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 8.2 m-85 -104.25 153.03 21.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.697 -0.683 . . . . 0.88 110.441 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' A' ' 14' ' ' VAL . 2.6 tt -88.71 156.94 18.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.527 -0.916 . . . . 1.6799999999999999 108.527 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.687 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -142.33 108.53 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 118.874 -1.131 . . . . 1.1899999999999999 113.907 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 30' ' ' LYS . 56.2 ttt180 -81.78 76.31 8.69 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.125 -1.806 . . . . 3.8799999999999999 106.125 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 3.6 t90 -27.54 89.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.156 -1.384 . . . . 1.5600000000000001 112.371 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' N ' HG13 ' A' ' 10' ' ' VAL . 58.7 tttm -28.67 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.665 -1.152 . . . . 3.1000000000000001 112.081 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . 21.8 t70 -120.15 57.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 2.02 109.832 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.32 -167.4 12.73 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.821 -0.627 . . . . 0.58999999999999997 112.821 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.43 -39.28 0.63 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.992 -0.623 . . . . 0.85999999999999999 112.205 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -113.12 164.08 13.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.664 0.268 . . . . 2.1299999999999999 110.554 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.19 143.15 47.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 2.29 111.156 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' CB ' ' HA3' ' B' ' 4' ' ' GLY . 0.5 OUTLIER -136.18 178.61 6.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 2.27 110.735 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 12.5 m0 -100.01 148.5 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.83999999999999997 111.515 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.479 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 61.8 t -88.67 161.35 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.125 -0.488 . . . . 1.3799999999999999 109.777 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 22.5 ttmm -79.27 108.89 13.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.526 0.679 . . . . 2.8700000000000001 112.322 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.28 42.62 2.93 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.811 -1.086 . . . . 0.39000000000000001 112.466 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 t -115.45 -0.59 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.993 -0.373 . . . . 1.3 109.993 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.73 75.08 0.6 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.662 0.744 . . . . 2.1299999999999999 110.906 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 7.7 p -59.5 72.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 113.552 -1.658 . . . . 2.1499999999999999 113.376 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 51.48 1.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.532 -0.914 . . . . 1.1200000000000001 108.532 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 49' ' ' LYS . 42.5 tt0 -47.16 -25.95 1.02 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.165 -0.925 . . . . 2.4399999999999999 110.84 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 31.7 t70 -68.75 -40.37 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.939 -0.573 . . . . 2.48 109.926 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG13 ' CE1' ' A' ' 51' ' ' TYR . 91.3 t -66.47 -46.71 85.88 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 N-CA-C 109.67 -0.493 . . . . 1.5 109.67 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.09 -54.82 17.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.628 1.571 . . . . 1.3600000000000001 111.516 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 72.0 mmtt -61.0 -32.01 71.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.504 0.668 . . . . 3.7799999999999998 109.504 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.5 t70 -92.12 -11.88 34.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.376 -0.829 . . . . 2.0 110.46 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.4 m-30 -84.25 -63.63 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.39 0.614 . . . . 2.3300000000000001 110.684 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -87.45 -46.48 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.1 -0.955 . . . . 1.77 110.654 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.0 m-20 -81.91 -20.92 37.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 2.2999999999999998 111.431 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.15 -41.65 59.75 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.546 -0.835 . . . . 1.6100000000000001 112.278 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -76.15 -63.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 2.7999999999999998 110.586 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 60.84 6.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 2.9500000000000002 110.762 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.5 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.232 -0.889 . . . . 2.23 110.935 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.48 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 111.922 0.341 . . . . 5.5599999999999996 111.922 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.491 ' N ' ' CD ' ' B' ' 3' ' ' PRO . 88.7 Cg_exo -44.68 -43.7 14.41 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.366 2.044 . . . . 5.7699999999999996 113.141 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' B' ' 2' ' ' PRO . 2.9 Cg_exo -76.35 117.06 4.48 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.775 2.317 . . . . 4.0999999999999996 112.022 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 36' ' ' GLU . . . 99.64 12.77 39.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.502 -0.856 . . . . 2.1099999999999999 112.697 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.45 ' HA ' ' CG2' ' A' ' 38' ' ' VAL . 88.4 m -151.8 155.19 37.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.009 0.433 . . . . 2.29 112.132 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' ALA . . . -171.06 47.45 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.839 -0.619 . . . . 1.8600000000000001 111.724 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.434 ' N ' ' HB2' ' A' ' 8' ' ' ALA . 34.7 ptt180 -47.68 132.55 14.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.317 -0.253 . . . . 7.9800000000000004 110.317 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.416 ' NH1' ' OH ' ' A' ' 7' ' ' TYR . 7.4 ptp180 -133.95 59.75 1.72 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.012 0.745 . . . . 6.9800000000000004 113.012 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.454 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.85 -179.75 7.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.784 -0.451 . . . . 7.5599999999999996 109.784 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -63.93 -28.39 69.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.24 0.543 . . . . 4.9100000000000001 110.024 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' B' ' 9' ' ' LYS . 22.3 mttp 71.52 46.65 0.39 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.335 -0.848 . . . . 4.8099999999999996 110.049 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -34.8 -33.07 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.383 -0.826 . . . . 2.0499999999999998 112.41 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 11' ' ' LYS . 17.1 t70 -115.9 76.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 3.7999999999999998 110.833 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.279 -0.867 . . . . 4.3099999999999996 110.935 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.46 ' HA2' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.646 -0.181 . . . . 3.3500000000000001 112.646 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 31.9 t 177.12 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.686 0.279 . . . . 3.3900000000000001 111.165 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.68 138.06 31.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.358 -0.383 . . . . 5.1100000000000003 110.511 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 1.053 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -95.92 45.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.24 0.543 . . . . 3.6299999999999999 109.796 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.053 ' CE2' ' O ' ' A' ' 4' ' ' VAL . 6.1 p90 -179.19 117.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.591 -0.731 . . . . 2.9300000000000002 110.622 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 9.8 tp10 -111.07 131.33 55.16 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 2.4100000000000001 111.501 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 7' ' ' TYR . 49.6 p90 -89.02 109.31 20.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.286 0.476 . . . . 2.6000000000000001 112.286 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . -91.99 56.1 2.8 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.063 -0.717 . . . . 1.1100000000000001 109.063 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -108.12 151.74 25.48 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.168 0.985 . . . . 2.7999999999999998 113.154 -176.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 84.5 t -89.66 -35.14 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 113.611 -1.632 . . . . 1.1200000000000001 110.477 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HB3' ' CA ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -141.27 -39.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.658 -0.701 . . . . 2.1899999999999999 111.997 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.7 mt-10 -154.46 157.79 38.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 2.1800000000000002 112.484 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.53 HG21 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.49 -168.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 1.0800000000000001 109.476 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 ' CG2' HD11 ' A' ' 26' ' ' LEU . 71.4 t -151.04 -45.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 1.3500000000000001 110.017 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.7 mt-10 -99.48 144.36 28.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.96 109.99 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.9 pttt -154.19 83.65 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.819 -0.352 . . . . 2.6200000000000001 111.784 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -154.03 86.64 1.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.714 -0.394 . . . . 4.4199999999999999 111.362 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.448 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.0 -131.38 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.055 -1.545 . . . . 0.40999999999999998 114.348 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 5' ' ' PHE . 55.9 mttt -124.51 -120.14 0.27 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.509 -0.846 . . . . 1.74 109.97 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.57 -41.27 4.5 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 108.904 -1.678 . . . . 0.64000000000000001 108.904 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.053 ' HB3' ' HD3' ' B' ' 11' ' ' LYS . 49.9 mttp -136.39 0.12 2.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.22 -1.49 . . . . 3.8700000000000001 111.029 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 19' ' ' LYS . 21.8 t0 -88.21 8.66 26.05 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.22 111.815 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 25' ' ' TYR . 7.6 p -87.99 147.69 5.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.936 -0.574 . . . . 1.1200000000000001 110.747 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.0 pt-20 -111.31 90.37 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.626 -0.715 . . . . 1.26 110.299 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 8.2 m-85 -89.21 -168.11 2.07 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.975 -0.557 . . . . 0.88 109.713 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 27' ' ' VAL . 1.7 tt -126.49 159.23 33.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.987 -1.116 . . . . 1.6799999999999999 107.987 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -139.5 114.2 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 118.619 -1.233 . . . . 1.1899999999999999 113.45 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.7 ttt85 -88.25 75.57 8.54 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.815 -1.55 . . . . 3.8799999999999999 106.815 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.541 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.7 m0 -27.9 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.395 -1.275 . . . . 1.5600000000000001 112.511 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' CB ' HG11 ' A' ' 10' ' ' VAL . 60.8 tttp -29.78 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.619 -1.173 . . . . 3.1000000000000001 111.938 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' TRP . 15.0 m-20 -125.75 51.36 1.75 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.931 -0.577 . . . . 2.02 109.91 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -130.98 -138.91 4.34 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.722 -0.672 . . . . 0.58999999999999997 112.538 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.2 -48.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.78 -0.724 . . . . 0.85999999999999999 112.677 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.67 179.51 4.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 2.1299999999999999 111.089 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.9 m -124.2 106.44 10.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.072 -0.513 . . . . 2.29 111.03 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 1.1 mp0 -101.47 -175.77 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 2.27 111.033 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 31.6 m0 -114.27 154.43 27.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.481 . . . . 0.83999999999999997 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.616 ' HA ' ' HG1' ' B' ' 5' ' ' THR . 79.7 t -88.27 162.37 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.554 -0.748 . . . . 1.3799999999999999 109.591 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 19.8 tptm -80.76 99.88 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.698 0.629 . . . . 2.8700000000000001 112.698 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -98.42 26.06 25.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.445 -0.798 . . . . 0.39000000000000001 111.992 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.52 -3.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.687 -0.486 . . . . 1.3 109.687 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.591 ' O ' ' HE3' ' B' ' 11' ' ' LYS . 93.1 m-70 -73.88 78.84 1.62 Allowed 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.52 0.676 . . . . 2.1299999999999999 109.919 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.55 69.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.636 -1.62 . . . . 2.1499999999999999 113.341 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.67 50.05 1.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.062 -0.972 . . . . 1.1200000000000001 109.127 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -45.53 -27.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.066 -0.97 . . . . 2.4399999999999999 110.655 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 11.2 m-20 -68.31 -47.69 66.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.272 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' TYR . 56.3 t -54.72 -40.38 51.28 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 116.375 -0.375 . . . . 1.5 110.517 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . . . -72.69 -59.75 2.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.751 1.22 . . . . 1.3600000000000001 110.497 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 4.5 tppp? -56.25 -28.66 59.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.338 -0.616 . . . . 3.7799999999999998 109.338 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.7 t70 -92.99 -21.82 19.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.355 -0.838 . . . . 2.0 110.482 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . 1.2 m-30 -74.19 -67.4 0.62 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.561 0.696 . . . . 2.3300000000000001 110.569 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 17.0 pt-20 -83.87 -48.41 10.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.696 -1.138 . . . . 1.77 111.474 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.452 ' CB ' ' HD3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -76.28 -36.88 58.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 111.501 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -51.64 -43.26 53.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.456 -0.878 . . . . 1.6100000000000001 112.212 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.4 mp -84.02 -57.5 3.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 2.7999999999999998 110.558 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.49 63.04 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 2.9500000000000002 110.848 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.2 t80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.252 -0.88 . . . . 2.23 110.933 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.622 0.248 . . . . 5.5599999999999996 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.83 112.67 3.15 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.693 2.262 . . . . 5.7699999999999996 112.306 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.33 93.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.704 2.269 . . . . 4.0999999999999996 112.895 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.462 ' CA ' ' HB2' ' A' ' 36' ' ' GLU . . . -147.67 86.65 0.16 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.952 -0.642 . . . . 2.1099999999999999 112.083 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 1.269 ' HB ' ' OG1' ' B' ' 5' ' ' THR . 95.1 m -152.04 151.25 30.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 2.29 111.983 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' ALA . . . -146.53 -76.29 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.513 0.56 . . . . 1.8600000000000001 112.513 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 7' ' ' TYR . 22.5 ttm180 -59.43 -103.3 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 119.702 -0.19 . . . . 7.9800000000000004 111.381 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 52.28 177.35 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.466 -0.493 . . . . 6.9800000000000004 110.48 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.436 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 45.3 mttp -151.77 -159.19 0.99 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.749 0.309 . . . . 7.5599999999999996 111.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' B' ' 11' ' ' LYS . 16.3 ptm180 -44.43 -27.95 0.5 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.261 -0.427 . . . . 4.9100000000000001 111.257 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 1.053 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER 80.94 99.28 0.06 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.931 -0.577 . . . . 4.8099999999999996 110.962 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -93.44 51.81 1.66 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 2.0499999999999998 110.835 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.39 31.83 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.03 0.443 . . . . 3.7999999999999998 110.551 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.233 -0.889 . . . . 4.3099999999999996 110.904 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.632 -0.187 . . . . 3.3500000000000001 112.632 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 70.5 p 177.66 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.738 0.304 . . . . 3.3900000000000001 111.201 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -88.71 146.41 25.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.764 -0.458 . . . . 5.1100000000000003 109.764 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 18' ' ' GLY . 14.0 p -89.32 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.038 -0.528 . . . . 3.6299999999999999 110.249 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' HB2' ' HH ' ' A' ' 25' ' ' TYR . 8.8 p90 -175.55 174.97 2.18 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.833 -0.621 . . . . 2.9300000000000002 110.994 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 9.0 tp10 -152.97 124.33 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.233 -0.654 . . . . 2.4100000000000001 109.233 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.5 p90 -87.45 104.42 16.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.466 0.543 . . . . 2.6000000000000001 112.466 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' CG2' ' A' ' 38' ' ' VAL . . . -89.27 58.26 4.38 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.673 -0.862 . . . . 1.1100000000000001 108.673 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -117.21 148.07 41.94 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.261 1.029 . . . . 2.7999999999999998 113.33 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.51 HG21 ' CD1' ' A' ' 29' ' ' TRP . 46.5 t -88.48 -33.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 113.22 -1.809 . . . . 1.1200000000000001 110.334 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 11.7 t70 -144.68 -38.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.38 -0.827 . . . . 2.1899999999999999 111.77 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 10.8 mm-40 -154.48 162.71 41.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.458 0.54 . . . . 2.1800000000000002 112.458 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -132.23 -164.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.878 -0.601 . . . . 1.0800000000000001 109.857 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 98.1 t -149.98 -60.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.436 -0.579 . . . . 1.3500000000000001 109.436 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.5 tp10 -92.84 134.28 35.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.563 -0.902 . . . . 2.96 108.563 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.7 ptpt -151.32 79.13 1.29 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.786 0.662 . . . . 2.6200000000000001 112.786 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -153.86 95.32 1.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.95 -0.469 . . . . 4.4199999999999999 111.31 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.62 -130.52 1.56 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 118.891 -1.623 . . . . 0.40999999999999998 114.231 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.9 mttm -116.14 -120.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.86 -0.67 . . . . 1.74 109.741 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.39 -40.3 4.25 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 108.07 -2.012 . . . . 0.64000000000000001 108.07 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 19.5 mmtp -135.64 1.55 2.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 112.963 -1.618 . . . . 3.8700000000000001 110.878 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 22.1 t70 -88.74 9.44 24.42 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-O 121.301 0.572 . . . . 1.22 111.557 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.519 ' CG2' ' CE1' ' A' ' 25' ' ' TYR . 8.4 p -95.45 145.71 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.323 -0.853 . . . . 1.1200000000000001 111.268 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 1.3 pm0 -104.42 111.84 24.66 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.851 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 23.4 m-85 -113.97 147.84 37.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.808 -0.633 . . . . 0.88 110.375 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 27' ' ' VAL . 1.6 tt -90.24 159.52 16.66 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.975 -1.12 . . . . 1.6799999999999999 107.975 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.3 m -140.44 111.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 118.75 -1.18 . . . . 1.1899999999999999 113.517 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 30' ' ' LYS . 66.5 mtt180 -89.29 78.68 7.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.169 -1.419 . . . . 3.8799999999999999 107.169 176.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.51 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -27.8 89.71 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.254 -1.339 . . . . 1.5600000000000001 111.864 -178.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -28.74 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.918 -1.037 . . . . 3.1000000000000001 112.254 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 32.4 m-20 -118.3 55.7 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 2.02 109.901 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.24 -154.66 6.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.581 . . . . 0.58999999999999997 112.815 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.64 -45.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.038 -0.601 . . . . 0.85999999999999999 112.353 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.17 162.98 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 2.1299999999999999 110.824 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.31 137.3 52.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 2.29 110.97 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 18.3 mm-40 -130.67 167.18 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.689 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -107.05 147.16 30.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.83999999999999997 111.536 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 8' ' ' ALA . 65.0 t -88.84 159.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.3799999999999999 110.398 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 38' ' ' VAL . 82.8 tttt -79.6 96.43 6.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.078 0.466 . . . . 2.8700000000000001 111.899 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.1 44.83 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.559 -0.746 . . . . 0.39000000000000001 112.924 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.88 13.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.809 -0.441 . . . . 1.3 109.809 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.486 ' CE1' ' HE2' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -83.54 80.44 9.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.625 0.726 . . . . 2.1299999999999999 111.118 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 5.6 p -58.93 72.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.441 -1.708 . . . . 2.1499999999999999 112.406 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.94 51.51 1.84 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.108 -0.951 . . . . 1.1200000000000001 108.729 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -44.78 -28.26 0.61 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.277 -0.874 . . . . 2.4399999999999999 110.492 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.28 -50.19 55.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.746 . . . . 2.48 109.609 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 51' ' ' TYR . 98.0 t -57.05 -46.62 84.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 CA-C-N 115.88 -0.6 . . . . 1.5 109.903 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.76 -59.21 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.038 1.335 . . . . 1.3600000000000001 111.11 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 73.0 mmtt -55.01 -33.56 62.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.191 0.52 . . . . 3.7799999999999998 109.742 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.66 -19.43 22.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.802 -0.635 . . . . 2.0 110.738 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -73.2 -62.23 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.733 0.778 . . . . 2.3300000000000001 109.724 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -92.06 -49.87 5.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.241 -1.345 . . . . 1.77 111.414 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.4 OUTLIER -75.43 -20.24 58.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 2.2999999999999998 111.435 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -67.96 -42.99 84.16 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.886 . . . . 1.6100000000000001 112.085 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 77.4 mt -81.49 -64.1 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.886 0.374 . . . . 2.7999999999999998 110.626 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -83.98 61.7 6.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 2.9500000000000002 110.654 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.321 -0.847 . . . . 2.23 110.901 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.555 0.217 . . . . 5.5599999999999996 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.19 139.47 29.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.508 2.138 . . . . 5.7699999999999996 112.179 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.94 71.44 4.2 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.507 2.138 . . . . 4.0999999999999996 112.285 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 38' ' ' VAL . . . 47.47 97.16 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 2.1099999999999999 112.657 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.447 ' N ' HG21 ' A' ' 27' ' ' VAL . 82.4 p -154.31 145.61 22.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 2.29 111.63 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.442 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -144.96 -86.03 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.647 0.61 . . . . 1.8600000000000001 112.647 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 7' ' ' TYR . 31.3 mmm180 -52.34 -101.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.534 -0.303 . . . . 7.9800000000000004 111.636 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 53.65 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.436 -0.505 . . . . 6.9800000000000004 110.193 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -147.97 -165.88 2.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.67 0.271 . . . . 7.5599999999999996 110.961 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' B' ' 11' ' ' LYS . 30.0 ptt180 -49.18 -23.63 1.38 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.524 -0.307 . . . . 4.9100000000000001 111.415 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.486 ' HE2' ' CE1' ' A' ' 42' ' ' HIS . 27.5 mmmt 82.39 83.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.385 -0.37 . . . . 4.8099999999999996 110.629 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.63 -30.72 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 2.0499999999999998 111.204 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -109.67 62.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 3.7999999999999998 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.22 -0.895 . . . . 4.3099999999999996 110.912 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.751 -0.14 . . . . 3.3500000000000001 112.751 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.9 p 178.25 -34.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 3.3900000000000001 110.978 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -89.05 139.5 30.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.58 -0.526 . . . . 5.1100000000000003 109.58 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.67 50.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 3.6299999999999999 110.335 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HD1' ' HH ' ' A' ' 25' ' ' TYR . 7.0 p90 177.78 144.38 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.877 -0.601 . . . . 2.9300000000000002 110.93 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 10.6 tp10 -128.42 142.29 51.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 2.4100000000000001 110.731 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 52.5 p90 -88.91 114.56 25.67 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.691 0.758 . . . . 2.6000000000000001 112.124 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -101.85 55.46 0.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.568 -1.196 . . . . 1.1100000000000001 109.629 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.626 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.34 164.26 15.95 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.692 0.758 . . . . 2.7999999999999998 112.222 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 18.4 t -99.05 -19.22 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.415 -1.266 . . . . 1.1200000000000001 112.476 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 32.9 t70 -149.95 -43.13 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.046 0.388 . . . . 2.1899999999999999 112.046 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 48.5 mt-10 -154.26 166.46 33.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 116.423 -0.353 . . . . 2.1800000000000002 111.838 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.516 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -138.96 -171.66 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.5 0.191 . . . . 1.0800000000000001 110.501 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.449 ' CG2' HD13 ' A' ' 26' ' ' LEU . 77.1 t -146.18 -60.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 1.3500000000000001 110.05 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -94.36 136.71 34.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 2.96 109.717 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 41.8 pttt -150.85 94.66 2.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.791 0.293 . . . . 2.6200000000000001 111.791 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -155.98 92.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.229 -0.188 . . . . 4.4199999999999999 111.044 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 23' ' ' VAL . . . -152.82 -132.32 1.76 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 118.997 -1.573 . . . . 0.40999999999999998 114.8 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 98.7 mttt -116.75 -123.32 0.29 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.182 -1.009 . . . . 1.74 109.243 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.447 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.77 -41.75 4.32 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 108.202 -1.959 . . . . 0.64000000000000001 108.202 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HZ2' ' HH ' ' A' ' 51' ' ' TYR . 28.8 mmtt -132.3 -1.7 3.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.031 -1.584 . . . . 3.8700000000000001 110.766 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 27.0 t0 -87.71 10.18 19.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.016 0.436 . . . . 1.22 111.943 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 25' ' ' TYR . 8.3 p -89.85 153.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.811 -0.631 . . . . 1.1200000000000001 112.58 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -105.38 114.43 28.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.03 -0.986 . . . . 1.26 109.447 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.561 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 7.4 m-85 -120.11 149.14 42.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.309 -0.405 . . . . 0.88 110.06 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.6 tt -88.63 156.57 18.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.009 -0.738 . . . . 1.6799999999999999 109.009 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.22 110.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 113.826 1.047 . . . . 1.1899999999999999 113.826 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -81.91 69.5 8.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.056 -2.201 . . . . 3.8799999999999999 105.056 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.513 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 3.5 t90 -25.17 90.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 113.768 -1.56 . . . . 1.5600000000000001 112.317 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 11' ' ' ASP . 27.8 tptp -28.42 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.286 -1.324 . . . . 3.1000000000000001 112.196 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.1 m-20 -117.65 57.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 2.02 109.885 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -141.05 3.4 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.58999999999999997 112.641 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.99 -48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.85999999999999999 112.486 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -92.81 164.02 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 2.1299999999999999 110.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.62 109.78 16.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 2.29 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' CG ' ' HB2' ' B' ' 2' ' ' PRO . 11.3 mm-40 -112.57 178.92 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 2.27 110.899 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' NE1' ' OE1' ' A' ' 15' ' ' GLU . 36.9 m0 -102.02 149.23 24.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 0.83999999999999997 111.924 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.479 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 46.5 t -89.38 161.21 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 1.3799999999999999 109.883 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' NH1' ' B' ' 8' ' ' ARG . 40.4 tptt -72.75 103.08 3.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.546 0.572 . . . . 2.8700000000000001 112.546 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.27 42.13 2.85 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.452 -0.794 . . . . 0.39000000000000001 112.868 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 2.3 t -118.48 10.3 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.205 -0.294 . . . . 1.3 110.205 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CE1' ' CE ' ' B' ' 11' ' ' LYS . 0.3 OUTLIER -77.76 78.3 4.26 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.578 0.704 . . . . 2.1299999999999999 111.052 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.7 t -57.78 71.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 113.346 -1.752 . . . . 2.1499999999999999 113.065 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.54 49.83 1.53 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.789 -0.819 . . . . 1.1200000000000001 108.789 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -42.16 -30.61 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.17 -0.923 . . . . 2.4399999999999999 110.886 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 4.1 p30 -67.53 -47.0 71.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.376 -0.829 . . . . 2.48 109.968 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.546 ' CG1' ' CE1' ' A' ' 51' ' ' TYR . 48.6 t -60.29 -40.07 82.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 109.894 -0.41 . . . . 1.5 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.82 -57.71 5.2 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.205 1.402 . . . . 1.3600000000000001 110.999 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 7.5 mmpt? -60.59 -28.75 68.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.532 0.682 . . . . 3.7799999999999998 109.343 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.3 t70 -92.53 -14.31 28.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.353 -0.84 . . . . 2.0 110.174 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE1' ' CG1' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -83.44 -68.63 0.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.536 0.684 . . . . 2.3300000000000001 110.342 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.9 pt-20 -83.91 -47.25 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.677 -1.147 . . . . 1.77 111.048 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.9 t70 -82.06 -15.89 52.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 2.2999999999999998 111.101 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -78.51 -36.12 30.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.534 -0.841 . . . . 1.6100000000000001 112.034 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.31 -59.4 2.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 2.7999999999999998 110.296 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -89.53 61.95 5.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 2.9500000000000002 110.584 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.21 -0.9 . . . . 2.23 110.855 -179.874 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.62 0.248 . . . . 5.5599999999999996 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.422 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . 66.6 Cg_exo -51.44 148.52 19.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.622 2.215 . . . . 5.7699999999999996 112.44 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.01 122.78 11.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.615 2.21 . . . . 4.0999999999999996 112.304 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.31 64.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 2.1099999999999999 112.439 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.439 ' HA ' ' CG1' ' A' ' 27' ' ' VAL . 4.0 t -151.68 174.29 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 2.29 112.032 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 8' ' ' ALA . . . -170.45 -174.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.386 -0.825 . . . . 1.8600000000000001 110.259 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.4 ' HG3' ' HD3' ' B' ' 11' ' ' LYS . 59.6 ttp180 -129.0 125.12 36.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.637 -0.256 . . . . 7.9800000000000004 111.489 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.435 ' NH1' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -47.37 -64.88 0.67 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.692 0.282 . . . . 6.9800000000000004 111.296 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -156.62 -166.89 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 7.5599999999999996 110.617 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -44.52 -28.7 0.61 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 4.9100000000000001 111.451 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' CE ' ' CE1' ' A' ' 42' ' ' HIS . 28.0 mtmm 75.66 102.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 4.8099999999999996 110.869 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 47' ' ' VAL . . . -63.59 -23.83 67.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 2.0499999999999998 111.218 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.81 57.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 3.7999999999999998 110.866 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.268 -0.872 . . . . 4.3099999999999996 110.913 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.709 -0.156 . . . . 3.3500000000000001 112.709 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t 175.12 -31.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.677 0.275 . . . . 3.3900000000000001 111.383 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -88.98 141.68 28.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 5.1100000000000003 110.488 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 18' ' ' GLY . 9.6 p -89.98 47.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 3.6299999999999999 110.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 5.1 p90 179.82 171.61 1.06 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.75 -0.659 . . . . 2.9300000000000002 110.473 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 2.3 tm-20 -153.15 128.0 9.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.151 -0.685 . . . . 2.4100000000000001 109.151 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.552 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 38.7 p90 -88.4 102.85 15.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 111.933 0.346 . . . . 2.6000000000000001 111.933 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -86.92 59.01 5.39 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.054 -0.721 . . . . 1.1100000000000001 109.054 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -112.09 149.55 31.97 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.32 1.057 . . . . 2.7999999999999998 113.261 -176.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 55.8 t -89.09 -37.35 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.161 -1.836 . . . . 1.1200000000000001 109.774 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 17.7 t70 -141.3 -37.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 2.1899999999999999 111.926 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 24.6 mm-40 -154.3 157.12 38.19 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.572 0.582 . . . . 2.1800000000000002 112.572 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -126.95 -166.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.826 -0.625 . . . . 1.0800000000000001 109.431 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 99.4 t -150.88 -48.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.274 0.559 . . . . 1.3500000000000001 109.513 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.5 mt-10 -99.97 144.91 28.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 2.96 109.643 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 22.6 pttm -154.38 78.36 1.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.371 0.508 . . . . 2.6200000000000001 112.371 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -153.22 90.94 1.47 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.302 -0.559 . . . . 4.4199999999999999 111.961 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.53 -132.42 1.71 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 118.95 -1.595 . . . . 0.40999999999999998 114.789 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 5' ' ' PHE . 66.3 mttm -116.59 -120.14 0.31 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.437 -0.882 . . . . 1.74 109.591 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -94.76 -40.41 4.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.067 -2.013 . . . . 0.64000000000000001 108.067 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 16.7 mtmm -136.88 -1.1 2.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.137 -1.531 . . . . 3.8700000000000001 111.41 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 15.9 t70 -85.66 8.9 17.87 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.262 0.553 . . . . 1.22 111.58 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 25' ' ' TYR . 11.4 p -89.15 143.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.368 -0.833 . . . . 1.1200000000000001 110.907 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 3.2 pt-20 -106.49 97.61 7.39 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.145 0.498 . . . . 1.26 111.188 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.552 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 18.5 m-85 -94.83 -169.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.598 -0.728 . . . . 0.88 109.774 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 2.2 tt -127.99 159.12 36.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.272 -1.01 . . . . 1.6799999999999999 108.272 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.24 112.76 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 118.388 -1.325 . . . . 1.1899999999999999 113.844 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 30' ' ' LYS . 19.8 ttm180 -88.94 77.05 7.78 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.708 -1.59 . . . . 3.8799999999999999 106.708 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 2.6 t90 -27.81 89.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.363 -1.29 . . . . 1.5600000000000001 112.273 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 39.5 ttmt -28.24 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.038 -0.983 . . . . 3.1000000000000001 112.15 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.2 t70 -117.58 55.96 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.817 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.27 -163.67 10.92 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.834 -0.621 . . . . 0.58999999999999997 112.669 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.55 35.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.902 -0.666 . . . . 0.85999999999999999 112.349 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -145.98 -169.05 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 2.1299999999999999 110.988 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.7 113.25 6.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.29 111.013 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 7.9 mm-40 -121.62 175.61 6.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 2.27 110.74 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -116.17 151.99 34.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.078 0.465 . . . . 0.83999999999999997 111.612 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 8' ' ' ALA . 88.9 t -88.57 152.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.679 -0.692 . . . . 1.3799999999999999 110.353 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' N ' HG13 ' A' ' 38' ' ' VAL . 22.7 tptm -72.58 97.1 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 2.8700000000000001 112.16 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -93.92 40.54 2.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.706 -0.759 . . . . 0.39000000000000001 113.014 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.43 ' CG2' ' HE2' ' A' ' 39' ' ' LYS . 1.1 t -120.45 4.16 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 1.3 109.801 177.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' B' ' 11' ' ' LYS . 14.0 m80 -80.5 81.44 6.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.821 0.82 . . . . 2.1299999999999999 110.722 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.445 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 61.8 t -56.57 74.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 112.754 -2.021 . . . . 2.1499999999999999 112.507 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.88 51.06 1.89 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.408 -0.815 . . . . 1.1200000000000001 109.268 177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 39.1 tt0 -47.77 -27.12 1.86 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.204 -0.907 . . . . 2.4399999999999999 110.116 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 8.4 m-20 -70.38 -46.87 63.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.471 -0.786 . . . . 2.48 109.882 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 60.1 t -61.8 -45.83 97.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.733 -0.469 . . . . 1.5 109.733 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.69 -57.82 5.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.439 1.496 . . . . 1.3600000000000001 111.432 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -57.87 -31.78 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.362 0.601 . . . . 3.7799999999999998 109.466 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.2 t70 -91.96 -16.51 26.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.351 -0.84 . . . . 2.0 110.563 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -79.14 -65.21 1.03 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.473 0.654 . . . . 2.3300000000000001 110.941 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.8 pt-20 -87.91 -45.78 9.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.839 -1.073 . . . . 1.77 111.191 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.1 m-20 -82.69 -19.18 38.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.795 -0.639 . . . . 2.2999999999999998 111.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.67 -34.17 44.76 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.593 -0.813 . . . . 1.6100000000000001 112.368 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -80.21 -70.41 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.328 . . . . 2.7999999999999998 110.686 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.0 64.4 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 2.9500000000000002 111.027 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.222 -0.894 . . . . 2.23 110.867 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.559 0.219 . . . . 5.5599999999999996 111.039 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -44.29 105.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.67 2.246 . . . . 5.7699999999999996 112.447 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.61 67.46 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.521 2.147 . . . . 4.0999999999999996 112.387 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 27' ' ' VAL . . . -129.49 36.74 2.31 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.87 -0.681 . . . . 2.1099999999999999 112.535 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.445 ' HA ' HG23 ' A' ' 38' ' ' VAL . 53.3 p -152.78 153.46 33.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.948 0.351 . . . . 2.29 111.948 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.445 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -158.82 -81.28 0.06 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.522 0.934 . . . . 1.8600000000000001 113.522 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 7' ' ' TYR . 23.9 tpt180 -42.21 -94.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.811 0.671 . . . . 7.9800000000000004 112.811 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.45 ' CG ' ' HG3' ' A' ' 6' ' ' GLU . 18.6 mmm180 -98.9 118.65 36.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.336 -0.546 . . . . 6.9800000000000004 112.217 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.81 50.5 1.12 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.396 -0.82 . . . . 7.5599999999999996 110.741 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -110.0 -20.08 12.85 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.766 0.317 . . . . 4.9100000000000001 111.049 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.482 ' HG3' ' CD2' ' A' ' 42' ' ' HIS . 3.4 mppt? 65.6 95.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 4.8099999999999996 111.121 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.87 -25.95 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.0499999999999998 110.586 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 12.1 t70 -110.69 -33.3 6.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.799 -0.637 . . . . 3.7999999999999998 110.819 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.281 -0.866 . . . . 4.3099999999999996 110.816 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.215 0 CA-C-O 120.293 -0.171 . . . . 3.3500000000000001 112.838 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 8.3 p 163.58 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.262 0.468 . . . . 3.3900000000000001 112.262 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.708 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 18.1 mp0 -87.55 142.52 27.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.061 0.458 . . . . 5.1100000000000003 110.633 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 1.373 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -89.52 48.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.683 -0.69 . . . . 3.6299999999999999 110.78 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.536 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -177.59 173.77 1.61 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.923 -0.581 . . . . 2.9300000000000002 111.485 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 8.2 tp10 -152.56 129.36 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.719 -0.673 . . . . 2.4100000000000001 109.31 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.537 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 53.3 p90 -87.5 109.85 19.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.629 0.603 . . . . 2.6000000000000001 112.629 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -92.07 50.11 1.62 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.661 -0.7 . . . . 1.1100000000000001 109.127 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.701 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -108.45 149.78 28.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.229 1.014 . . . . 2.7999999999999998 113.528 -177.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 61.1 t -89.34 -36.11 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.342 -1.754 . . . . 1.1200000000000001 110.11 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.63 ' CG ' ' O ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -141.61 -39.25 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.285 -0.87 . . . . 2.1899999999999999 111.706 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.8 mt-10 -155.04 158.26 38.84 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.593 0.59 . . . . 2.1800000000000002 112.593 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.514 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.35 -165.93 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.871 -0.604 . . . . 1.0800000000000001 109.611 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 94.1 t -150.59 -58.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.14 0.495 . . . . 1.3500000000000001 109.956 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 6.8 pt-20 -97.24 133.68 41.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 2.96 109.175 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 49.2 pttt -151.03 89.07 1.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.435 0.531 . . . . 2.6200000000000001 112.435 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -154.33 93.06 1.57 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.288 -0.257 . . . . 4.4199999999999999 110.902 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.11 -134.2 2.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 118.769 -1.681 . . . . 0.40999999999999998 114.757 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' PHE . 67.9 mttm -114.17 -119.03 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.464 -0.868 . . . . 1.74 109.554 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -96.9 -41.97 3.42 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 107.83 -2.108 . . . . 0.64000000000000001 107.83 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.617 ' CB ' ' CD ' ' B' ' 11' ' ' LYS . 44.1 mmtt -132.96 0.2 3.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.118 -1.541 . . . . 3.8700000000000001 111.048 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 16.1 t70 -86.72 6.92 28.92 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 121.261 0.553 . . . . 1.22 111.668 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 25' ' ' TYR . 7.4 p -90.06 145.64 7.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.348 -0.842 . . . . 1.1200000000000001 111.32 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 40' ' ' GLY . 3.0 pt-20 -104.64 111.6 24.37 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.762 -0.654 . . . . 1.26 110.61 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 23.0 m-85 -114.02 148.97 36.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.722 -0.672 . . . . 0.88 110.676 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 27' ' ' VAL . 1.7 tt -89.7 159.15 17.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.922 -1.14 . . . . 1.6799999999999999 107.922 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -140.12 108.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.699 -1.2 . . . . 1.1899999999999999 113.448 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 30' ' ' LYS . 4.3 tpt180 -83.13 74.84 9.96 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.569 -1.641 . . . . 3.8799999999999999 106.569 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.63 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 4.3 t90 -27.83 89.4 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.665 1.228 . . . . 1.5600000000000001 112.091 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' N ' HG11 ' A' ' 10' ' ' VAL . 34.9 ttpt -28.92 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.838 -1.073 . . . . 3.1000000000000001 112.168 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' TRP . 16.8 m-20 -119.61 56.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 2.02 109.816 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.12 -163.48 10.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.859 -0.61 . . . . 0.58999999999999997 112.886 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.26 27.99 1.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.937 -0.649 . . . . 0.85999999999999999 112.336 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -142.05 -178.48 5.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 2.1299999999999999 111.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' CZ ' ' A' ' 28' ' ' ARG . 65.0 m -135.77 111.23 9.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.821 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -124.96 172.58 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.27 111.052 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -114.85 150.36 35.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.83999999999999997 111.483 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 89.0 t -89.68 160.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.55 . . . . 1.3799999999999999 110.249 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' N ' HG13 ' A' ' 38' ' ' VAL . 24.2 ttmm -78.2 96.81 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.213 0.53 . . . . 2.8700000000000001 112.269 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.83 46.82 2.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.463 -0.789 . . . . 0.39000000000000001 112.509 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.51 3.24 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 1.3 110.368 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -75.04 79.56 2.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.689 0.756 . . . . 2.1299999999999999 110.699 -179.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 87.4 t -58.04 66.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 113.04 -1.891 . . . . 2.1499999999999999 113.362 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.42 53.67 2.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.857 -0.794 . . . . 1.1200000000000001 108.857 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -48.95 -24.55 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.113 -0.949 . . . . 2.4399999999999999 110.641 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.4 t70 -68.04 -49.8 59.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.606 . . . . 2.48 110.066 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.589 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 44.6 t -59.49 -32.01 47.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 116.287 -0.415 . . . . 1.5 110.594 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -80.03 -57.46 3.62 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.85 1.26 . . . . 1.3600000000000001 109.866 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 54' ' ' GLY . 16.3 tppt? -57.27 -29.57 63.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 3.7799999999999998 108.679 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.9 t70 -92.12 -22.84 19.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.202 -0.908 . . . . 2.0 110.234 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.79 -68.25 0.47 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.791 0.805 . . . . 2.3300000000000001 110.118 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -85.44 -50.4 7.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.266 -1.334 . . . . 1.77 111.765 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -74.47 -23.26 58.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 2.2999999999999998 111.482 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -65.23 -47.31 81.87 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.456 -0.878 . . . . 1.6100000000000001 112.108 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.1 mt -77.7 -63.78 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 2.7999999999999998 110.514 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -82.56 60.61 5.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 2.9500000000000002 110.47 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.2 t80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.264 -0.874 . . . . 2.23 110.931 -179.557 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.687 0.279 . . . . 5.5599999999999996 111.021 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.28 104.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.722 2.281 . . . . 5.7699999999999996 112.387 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.53 127.04 13.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.505 2.137 . . . . 4.0999999999999996 112.308 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.428 ' CA ' HG23 ' A' ' 27' ' ' VAL . . . -64.13 96.84 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 2.1099999999999999 112.027 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 1.228 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 2.2 m -153.06 147.34 25.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.529 0.566 . . . . 2.29 112.529 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 10' ' ' VAL . . . -148.18 -86.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 1.8600000000000001 110.819 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -77.4 -153.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.014 -0.365 . . . . 7.9800000000000004 110.014 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.457 ' NH2' ' ND1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER 41.65 71.74 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.596 0.236 . . . . 6.9800000000000004 111.539 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -147.83 49.75 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 7.5599999999999996 112.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.431 ' CD ' ' HE3' ' A' ' 21' ' ' LYS . 14.6 ptm180 -115.59 -25.4 7.89 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.819 0.342 . . . . 4.9100000000000001 110.217 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 1.617 ' CD ' ' CB ' ' A' ' 21' ' ' LYS . 27.6 mttp 48.6 78.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 4.8099999999999996 111.509 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.897 ' H ' ' CG ' ' B' ' 11' ' ' LYS . . . -73.81 -28.54 61.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.153 0.501 . . . . 2.0499999999999998 110.037 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 24.0 t70 -111.17 42.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 3.7999999999999998 110.413 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.421 ' OG ' ' CB ' ' B' ' 11' ' ' LYS . 68.6 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.192 -0.909 . . . . 4.3099999999999996 110.889 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.802 -0.119 . . . . 3.3500000000000001 112.802 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 91.5 p -179.71 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.725 0.298 . . . . 3.3900000000000001 110.96 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.14 140.92 29.0 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.579 -0.526 . . . . 5.1100000000000003 109.579 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 1.6 t -88.72 55.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.281 -0.418 . . . . 3.6299999999999999 110.486 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' LYS . 10.9 p90 174.42 170.25 0.23 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.9300000000000002 111.167 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.477 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 19.8 mt-10 -150.85 145.62 25.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.883 -0.599 . . . . 2.4100000000000001 109.546 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.531 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 37.2 p90 -90.61 110.04 21.2 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.93 0.715 . . . . 2.6000000000000001 112.93 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.45 ' CB ' HG12 ' A' ' 38' ' ' VAL . . . -93.04 52.4 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.251 -0.886 . . . . 1.1100000000000001 108.897 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.24 158.45 22.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.286 1.041 . . . . 2.7999999999999998 113.244 -177.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 57.8 t -94.21 -36.42 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 113.199 -1.819 . . . . 1.1200000000000001 110.596 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 34.5 t70 -140.25 -38.9 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 2.1899999999999999 112.304 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -155.72 154.51 31.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.994 0.739 . . . . 2.1800000000000002 112.994 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.508 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.93 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.802 0.334 . . . . 1.0800000000000001 110.623 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG2' HD12 ' A' ' 26' ' ' LEU . 76.9 t -150.46 -58.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 1.3500000000000001 110.202 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.8 tp10 -94.15 135.14 35.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 2.96 109.683 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.0 ptpt -151.02 90.6 1.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.734 -0.386 . . . . 2.6200000000000001 111.904 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -153.51 92.6 1.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.142 -0.349 . . . . 4.4199999999999999 111.487 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.68 -134.51 2.06 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.116 -1.516 . . . . 0.40999999999999998 114.875 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.5 mttm -111.02 -122.08 0.28 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.56 -0.82 . . . . 1.74 109.828 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.05 -41.55 4.58 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 108.009 -2.037 . . . . 0.64000000000000001 108.009 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 10.6 mptt -136.58 2.57 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.094 -1.553 . . . . 3.8700000000000001 110.651 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 28.8 t0 -87.68 10.27 18.74 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.263 0.554 . . . . 1.22 111.53 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG13 ' CE1' ' A' ' 25' ' ' TYR . 12.2 p -91.31 153.84 3.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.302 -0.863 . . . . 1.1200000000000001 111.899 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.0 pt-20 -106.19 116.57 32.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 1.26 110.186 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 7' ' ' TYR . 10.8 m-85 -119.48 147.49 44.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.88 110.422 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 ' CG2' ' A' ' 14' ' ' VAL . 2.9 tt -88.49 156.74 18.93 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.563 -0.903 . . . . 1.6799999999999999 108.563 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.689 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 m -141.11 113.38 4.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 113.725 1.009 . . . . 1.1899999999999999 113.725 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -86.1 75.89 9.85 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 105.657 -1.979 . . . . 3.8799999999999999 105.657 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.9 t90 -26.34 90.19 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.011 -1.449 . . . . 1.5600000000000001 112.331 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' N ' HG11 ' A' ' 10' ' ' VAL . 55.5 tptt -29.09 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.722 -1.127 . . . . 3.1000000000000001 112.141 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.9 t70 -117.57 54.52 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.807 -0.442 . . . . 2.02 109.807 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.24 -160.29 9.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.878 -0.601 . . . . 0.58999999999999997 112.919 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.16 29.12 0.99 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.114 -0.565 . . . . 0.85999999999999999 112.128 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.96 176.73 9.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.697 0.284 . . . . 2.1299999999999999 110.868 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.0 m -137.28 125.63 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 2.29 110.832 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 37' ' ' TRP . 10.7 tp10 -143.11 164.15 30.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.961 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.401 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 18.9 m0 -94.91 146.76 24.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.83999999999999997 111.476 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 40.5 t -89.59 161.33 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 1.3799999999999999 109.812 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -67.57 110.62 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 2.8700000000000001 112.636 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -98.17 40.26 2.54 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.39000000000000001 111.96 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 t -117.5 4.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.248 . . . . 1.3 110.521 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -73.51 76.4 1.45 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.73 0.776 . . . . 2.1299999999999999 111.053 -179.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 6.4 p -59.11 72.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 113.394 -1.73 . . . . 2.1499999999999999 113.333 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.4 50.1 1.58 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 1.1200000000000001 108.511 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -42.74 -30.16 0.36 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.088 -0.96 . . . . 2.4399999999999999 111.055 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.27 -46.27 70.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.681 . . . . 2.48 110.069 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 68.2 t -58.61 -44.74 90.21 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-N 116.016 -0.538 . . . . 1.5 109.719 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.87 -59.41 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.324 1.449 . . . . 1.3600000000000001 111.386 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 11.9 mptt -56.49 -32.31 64.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.206 0.527 . . . . 3.7799999999999998 109.781 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -91.79 -18.13 24.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.817 -0.629 . . . . 2.0 110.626 178.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.519 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -74.64 -62.61 1.47 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.677 0.751 . . . . 2.3300000000000001 109.682 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.442 ' CG ' ' N ' ' A' ' 53' ' ' ASP . 12.6 pt-20 -90.85 -50.58 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.283 -1.326 . . . . 1.77 111.362 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' N ' ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -74.44 -20.77 59.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 2.2999999999999998 111.199 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.29 91.75 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.822 . . . . 1.6100000000000001 112.036 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 43.5 mt -82.58 -61.78 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 2.7999999999999998 110.531 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -87.68 61.81 6.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 2.9500000000000002 110.598 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.278 -0.868 . . . . 2.23 110.878 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.687 0.28 . . . . 5.5599999999999996 111.04 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.43 110.15 3.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.75 2.3 . . . . 5.7699999999999996 112.529 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.23 62.93 5.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.525 2.15 . . . . 4.0999999999999996 112.243 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.78 76.14 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.667 -0.778 . . . . 2.1099999999999999 112.578 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.426 ' HA ' ' CG1' ' A' ' 27' ' ' VAL . 74.1 p -151.95 166.31 31.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 2.29 111.691 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 8' ' ' ALA . . . -162.03 -166.33 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.628 -0.714 . . . . 1.8600000000000001 110.27 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -154.51 113.26 3.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 7.9800000000000004 111.69 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.453 ' CG ' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -58.4 -47.6 83.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.786 -0.643 . . . . 6.9800000000000004 111.717 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -151.1 -173.66 4.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 7.5599999999999996 111.351 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.6 ptt180 -53.94 -30.1 45.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.08 0.467 . . . . 4.9100000000000001 110.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 81.4 mttt 83.35 100.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.408 -0.815 . . . . 4.8099999999999996 110.455 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.18 -24.73 1.84 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 2.0499999999999998 111.395 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.468 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 19.9 t70 -109.65 49.03 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 3.7999999999999998 110.851 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 4.3099999999999996 110.886 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.707 -0.157 . . . . 3.3500000000000001 112.707 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.7 p 178.47 -33.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.781 0.324 . . . . 3.3900000000000001 111.066 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.758 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 97.0 mt-30 -88.62 140.71 29.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.834 -0.432 . . . . 5.1100000000000003 109.834 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 1.644 HG12 ' CE2' ' A' ' 5' ' ' PHE . 10.8 p -89.02 49.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.14 -0.482 . . . . 3.6299999999999999 110.811 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.644 ' CE2' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 175.06 146.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.912 -0.586 . . . . 2.9300000000000002 111.423 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' CG1' ' A' ' 23' ' ' VAL . 21.5 mt-10 -126.06 143.29 51.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 2.4100000000000001 110.973 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 50.3 p90 -89.58 112.58 23.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.522 0.677 . . . . 2.6000000000000001 111.567 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' B' ' 7' ' ' ARG . . . -101.51 56.2 0.83 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.922 -1.035 . . . . 1.1100000000000001 109.729 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.617 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -117.08 165.07 13.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.151 0.977 . . . . 2.7999999999999998 112.708 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 60.1 t -90.25 -30.15 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 113.665 -1.607 . . . . 1.1200000000000001 112.081 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 12.8 t70 -150.32 -35.89 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.262 0.468 . . . . 2.1899999999999999 112.262 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.9 mt-10 -152.71 165.38 35.48 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.78 -0.368 . . . . 2.1800000000000002 111.94 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -140.98 -170.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.842 0.353 . . . . 1.0800000000000001 110.374 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.449 ' CG2' HD21 ' A' ' 26' ' ' LEU . 76.6 t -150.12 -52.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 1.3500000000000001 110.038 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.4 tp10 -92.89 137.98 31.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 2.96 109.749 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 16.4 ptpt -152.52 89.36 1.41 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.852 -0.339 . . . . 2.6200000000000001 111.14 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -155.1 91.07 1.32 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.818 -0.353 . . . . 4.4199999999999999 111.022 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 23' ' ' VAL . . . -152.64 -131.59 1.69 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.269 -1.443 . . . . 0.40999999999999998 114.368 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 5' ' ' PHE . 98.7 mttt -119.76 -122.61 0.29 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.456 -0.872 . . . . 1.74 109.621 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -93.52 -39.57 4.98 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 108.406 -1.878 . . . . 0.64000000000000001 108.406 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -137.07 0.42 2.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.228 -1.486 . . . . 3.8700000000000001 111.18 177.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 12.9 t70 -87.35 10.33 17.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.996 0.427 . . . . 1.22 111.597 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 25' ' ' TYR . 4.9 p -88.6 150.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.286 0.565 . . . . 1.1200000000000001 111.876 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -109.08 101.9 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.23 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 6.7 m-85 -104.23 151.82 22.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.14 -0.482 . . . . 0.88 110.062 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 27' ' ' VAL . 1.7 tp -90.01 154.58 19.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.275 -1.009 . . . . 1.6799999999999999 108.275 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -136.39 109.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 114.101 1.148 . . . . 1.1899999999999999 114.101 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 53.2 mtt180 -82.84 77.78 9.53 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.627 -1.99 . . . . 3.8799999999999999 105.627 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.1 t90 -27.09 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.268 -1.333 . . . . 1.5600000000000001 111.95 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 59.0 tttm -27.17 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.271 -1.331 . . . . 3.1000000000000001 112.355 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.0 m-20 -120.9 57.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 2.02 109.89 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -160.49 9.1 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.895 -0.593 . . . . 0.58999999999999997 112.772 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.79 16.42 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.105 -0.569 . . . . 0.85999999999999999 112.287 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -137.53 178.23 7.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.806 0.336 . . . . 2.1299999999999999 110.777 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.24 108.93 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 2.29 110.965 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.33 166.88 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 2.27 111.069 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -89.01 145.78 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.651 . . . . 0.83999999999999997 111.753 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 89.1 t -88.76 162.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 1.3799999999999999 109.855 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 87.6 tttt -75.45 103.82 5.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.771 0.656 . . . . 2.8700000000000001 112.771 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.02 47.32 2.01 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.941 -1.027 . . . . 0.39000000000000001 112.2 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.04 0.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.853 -0.425 . . . . 1.3 109.853 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.61 78.39 0.81 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.772 0.796 . . . . 2.1299999999999999 110.004 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.447 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 94.9 t -57.33 69.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 113.047 -1.888 . . . . 2.1499999999999999 113.426 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.51 51.88 2.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.312 -0.625 . . . . 1.1200000000000001 109.312 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -47.34 -27.07 1.46 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.342 -0.845 . . . . 2.4399999999999999 110.477 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 7.9 m-20 -70.99 -43.51 67.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.451 -0.795 . . . . 2.48 110.123 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.501 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 95.7 t -65.18 -39.97 87.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 109.737 -0.468 . . . . 1.5 109.737 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -71.95 -58.07 3.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.104 1.362 . . . . 1.3600000000000001 110.741 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 16.8 tppt? -57.0 -30.66 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.228 -0.656 . . . . 3.7799999999999998 109.228 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.8 t70 -92.09 -20.42 21.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.349 -0.841 . . . . 2.0 110.386 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 1.1 m-30 -75.4 -67.19 0.68 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.479 0.657 . . . . 2.3300000000000001 110.606 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.0 pt-20 -86.46 -48.7 8.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.8 -1.091 . . . . 1.77 111.235 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 2.4 m-20 -77.52 -20.81 53.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.598 . . . . 2.2999999999999998 111.162 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -82.52 -32.19 28.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.595 -0.812 . . . . 1.6100000000000001 112.253 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -68.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 2.7999999999999998 110.472 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.52 55.87 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.077 0.465 . . . . 2.9500000000000002 110.799 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.135 -0.936 . . . . 2.23 110.844 -179.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.689 0.28 . . . . 5.5599999999999996 111.056 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.21 151.42 17.18 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.559 2.173 . . . . 5.7699999999999996 112.341 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.15 60.7 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.716 2.277 . . . . 4.0999999999999996 112.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.13 46.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.69 . . . . 2.1099999999999999 112.249 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 1.14 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 15.4 p -150.72 161.21 43.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.43 . . . . 2.29 111.532 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.98 43.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.8600000000000001 110.787 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.649 ' H ' HG23 ' B' ' 5' ' ' THR . 7.0 ptp180 -38.34 135.02 0.8 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.25 -0.432 . . . . 7.9800000000000004 111.659 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.444 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 22.5 tpt180 -43.92 -44.39 7.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.876 0.37 . . . . 6.9800000000000004 110.546 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 8' ' ' ARG . 81.4 tttt 85.07 -19.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.399 -0.819 . . . . 7.5599999999999996 112.314 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -50.58 -31.84 16.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.985 0.422 . . . . 4.9100000000000001 110.132 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt 38.92 53.69 2.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.748 -0.66 . . . . 4.8099999999999996 111.968 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.489 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -48.6 -28.55 3.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 2.0499999999999998 110.746 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 24.1 t70 -111.51 53.24 0.72 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.561 -0.745 . . . . 3.7999999999999998 110.604 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.245 -0.884 . . . . 4.3099999999999996 110.998 -179.801 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 120.234 -0.203 . . . . 3.3500000000000001 112.661 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 80.9 p 176.29 -29.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.731 0.265 . . . . 3.3900000000000001 111.605 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.36 143.29 27.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.045 0.45 . . . . 5.1100000000000003 110.491 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 18' ' ' GLY . 13.8 p -92.95 40.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.804 -0.635 . . . . 3.6299999999999999 110.54 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.1 p90 178.86 160.07 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.065 -0.516 . . . . 2.9300000000000002 111.254 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 1.2 mp0 -143.2 142.23 31.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.94 -0.573 . . . . 2.4100000000000001 110.087 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.512 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 53.7 p90 -88.82 111.71 22.36 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.65 0.738 . . . . 2.6000000000000001 111.741 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -95.26 46.14 1.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.759 -1.11 . . . . 1.1100000000000001 109.751 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.88 164.42 14.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.602 0.715 . . . . 2.7999999999999998 112.73 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 8.7 t -102.95 -20.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.687 -1.142 . . . . 1.1200000000000001 112.437 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 14.8 t70 -144.51 -44.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.027 0.38 . . . . 2.1899999999999999 112.027 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.1 mt-10 -155.68 162.72 40.52 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 112.053 0.39 . . . . 2.1800000000000002 112.053 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -134.49 -167.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.627 0.251 . . . . 1.0800000000000001 110.356 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.452 ' CG2' HD11 ' A' ' 26' ' ' LEU . 95.3 t -149.99 -53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.033 0.444 . . . . 1.3500000000000001 109.907 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 12.5 mm-40 -96.71 135.46 38.61 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 48.3 pttt -153.06 85.09 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.352 -0.539 . . . . 2.6200000000000001 112.37 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -154.44 95.49 1.81 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.101 0.41 . . . . 4.4199999999999999 111.658 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 23' ' ' VAL . . . -153.34 -128.64 1.3 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 118.863 -1.637 . . . . 0.40999999999999998 114.885 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 5' ' ' PHE . 97.8 mttt -119.44 -122.17 0.29 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.557 -0.821 . . . . 1.74 110.238 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.84 -40.56 5.88 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 108.804 -1.718 . . . . 0.64000000000000001 108.804 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -143.75 3.99 1.29 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.537 -1.332 . . . . 3.8700000000000001 111.43 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 20.3 t70 -88.41 11.67 16.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.322 0.582 . . . . 1.22 111.055 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 HG13 ' CE1' ' A' ' 25' ' ' TYR . 9.0 p -89.47 154.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.332 -0.849 . . . . 1.1200000000000001 112.249 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' CG ' ' HA3' ' A' ' 40' ' ' GLY . 46.7 mt-10 -96.83 128.09 43.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.11 -0.95 . . . . 1.26 108.956 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' CD2' ' HA ' ' A' ' 7' ' ' TYR . 11.4 m-85 -138.76 139.74 38.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 0.88 109.976 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD11 ' CG2' ' A' ' 14' ' ' VAL . 2.9 tt -89.91 157.39 17.89 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.247 -0.649 . . . . 1.6799999999999999 109.247 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 m -143.76 112.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 114.262 1.208 . . . . 1.1899999999999999 114.262 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' LYS . 86.5 mtt180 -85.53 66.4 9.65 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 104.566 -2.383 . . . . 3.8799999999999999 104.566 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 18.8 t90 -25.65 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.362 -1.745 . . . . 1.5600000000000001 112.218 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 62.4 tttp -28.33 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.264 -1.334 . . . . 3.1000000000000001 112.528 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.6 t70 -108.83 54.26 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.983 0.42 . . . . 2.02 109.99 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.28 -139.28 3.02 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.105 -0.569 . . . . 0.58999999999999997 112.803 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.36 -46.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.085 -0.579 . . . . 0.85999999999999999 111.885 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.57 163.96 12.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 2.1299999999999999 110.272 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.1 p -121.31 138.83 54.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 2.29 111.376 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -130.76 168.96 16.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 2.27 109.938 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 24.6 m0 -88.53 144.2 26.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.815 0.34 . . . . 0.83999999999999997 111.023 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 85.0 t -88.42 154.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 1.3799999999999999 110.115 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' N ' HG12 ' A' ' 38' ' ' VAL . 38.7 ttpt -66.18 103.88 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 2.8700000000000001 111.573 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' HA3' ' CG ' ' A' ' 24' ' ' GLU . . . -92.56 37.9 3.29 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.522 -0.763 . . . . 0.39000000000000001 112.408 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.69 8.5 8.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.69 -0.485 . . . . 1.3 109.69 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -73.7 76.81 1.54 Allowed 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.505 0.669 . . . . 2.1299999999999999 110.181 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 57.2 t -56.85 74.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 113.442 -1.708 . . . . 2.1499999999999999 113.439 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.98 49.54 1.44 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.581 -0.736 . . . . 1.1200000000000001 109.297 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 9.7 tp10 -48.16 -26.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.165 -0.925 . . . . 2.4399999999999999 110.339 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -73.79 -47.0 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.567 -0.742 . . . . 2.48 110.228 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 51' ' ' TYR . 85.0 t -58.06 -46.83 88.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 109.951 -0.389 . . . . 1.5 109.951 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.74 -58.49 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 125.068 1.347 . . . . 1.3600000000000001 111.125 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 37.9 ttpt -54.51 -33.74 60.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.533 . . . . 3.7799999999999998 109.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.9 -20.61 21.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.75 -0.659 . . . . 2.0 110.721 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 47' ' ' VAL . 1.3 m-30 -71.7 -62.19 1.51 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.69 0.757 . . . . 2.3300000000000001 110.479 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -91.82 -49.5 6.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.47 -1.241 . . . . 1.77 111.484 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -74.21 -25.12 59.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.835 -0.62 . . . . 2.2999999999999998 111.285 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.86 -47.14 88.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.531 -0.842 . . . . 1.6100000000000001 112.272 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.17 -72.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 2.7999999999999998 110.665 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -77.49 61.47 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 2.9500000000000002 110.603 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 91.1 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.215 -0.898 . . . . 2.23 110.893 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.633 0.254 . . . . 5.5599999999999996 111.031 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.04 112.23 0.87 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.6 2.2 . . . . 5.7699999999999996 112.34 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.64 -38.75 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.596 2.197 . . . . 4.0999999999999996 112.383 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.441 ' CA ' HG23 ' A' ' 27' ' ' VAL . . . 47.57 84.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.986 -0.626 . . . . 2.1099999999999999 112.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.442 ' N ' HG21 ' A' ' 27' ' ' VAL . 73.5 p -151.89 157.83 42.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.032 0.444 . . . . 2.29 111.674 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' A' ' 10' ' ' VAL . . . -148.95 -42.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.848 -0.614 . . . . 1.8600000000000001 111.748 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 75.43 117.43 0.06 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.261 -0.427 . . . . 7.9800000000000004 110.77 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 -53.95 10.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.916 0.339 . . . . 6.9800000000000004 111.916 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -135.15 -168.07 2.11 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.873 -0.331 . . . . 7.5599999999999996 111.389 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -46.53 -28.21 1.35 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.339 -0.391 . . . . 4.9100000000000001 111.238 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 6.3 mtmp? 76.45 94.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 4.8099999999999996 110.312 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 44' ' ' ALA . . . -101.99 99.59 9.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.074 -0.512 . . . . 2.0499999999999998 111.234 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.483 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 6.2 p-10 -122.84 47.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.962 0.41 . . . . 3.7999999999999998 110.838 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 4.3099999999999996 110.994 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.788 -0.125 . . . . 3.3500000000000001 112.788 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 52' ' ' GLU . 57.8 p -167.4 -53.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 3.3900000000000001 110.434 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 5' ' ' PHE . 24.9 tt0 -105.41 108.41 19.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.684 . . . . 5.1100000000000003 109.89 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' C ' ' CG ' ' A' ' 5' ' ' PHE . 62.0 t -142.94 -56.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.916 0.71 . . . . 3.6299999999999999 112.916 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 3' ' ' GLN . 0.2 OUTLIER 68.66 -158.06 0.19 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.676 -0.861 . . . . 2.9300000000000002 108.676 -177.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 31.4 mt-10 -152.7 148.0 26.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.148 0.425 . . . . 2.4100000000000001 112.148 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.523 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 32.6 p90 -101.27 102.61 13.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.503 0.668 . . . . 2.6000000000000001 110.938 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -89.32 53.42 2.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.186 -0.915 . . . . 1.1100000000000001 110.303 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.92 167.78 10.82 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.468 0.651 . . . . 2.7999999999999998 111.614 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 12.6 t -106.32 -16.69 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 115.111 -0.95 . . . . 1.1200000000000001 112.387 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 17.3 t70 -148.3 -44.04 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.707 0.289 . . . . 2.1899999999999999 111.754 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 18.7 mm-40 -154.18 168.44 26.52 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.363 -0.381 . . . . 2.1800000000000002 111.593 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.46 -169.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.849 -0.426 . . . . 1.0800000000000001 109.849 178.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 26' ' ' LEU . 96.3 t -149.79 -59.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.091 0.472 . . . . 1.3500000000000001 109.97 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.5 tp10 -93.05 134.78 34.85 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.32 -0.622 . . . . 2.96 109.32 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 14.0 ptmt -150.83 92.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 2.6200000000000001 111.089 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -154.98 90.91 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.81 -0.356 . . . . 4.4199999999999999 111.706 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 5' ' ' PHE . . . -150.79 -134.98 2.29 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.057 -1.544 . . . . 0.40999999999999998 114.702 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 62.3 mttm -106.77 -90.52 0.43 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.823 -0.688 . . . . 1.74 110.802 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . -130.13 -44.38 0.18 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 107.755 -2.138 . . . . 0.64000000000000001 107.755 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' CE ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -132.56 -5.19 3.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.491 -1.354 . . . . 3.8700000000000001 110.793 176.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' CA ' ' O ' ' A' ' 42' ' ' HIS . 19.3 t70 -88.67 10.02 22.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.256 0.55 . . . . 1.22 111.397 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 HG12 ' CE1' ' A' ' 25' ' ' TYR . 11.5 p -89.01 158.15 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.472 -0.785 . . . . 1.1200000000000001 111.404 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -106.73 122.89 47.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.445 -0.798 . . . . 1.26 110.124 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 9.8 m-85 -128.45 146.07 50.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.037 -0.528 . . . . 0.88 110.186 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 14' ' ' VAL . 1.9 tt -88.72 157.81 18.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.318 -0.623 . . . . 1.6799999999999999 109.318 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 m -142.69 113.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 113.881 1.067 . . . . 1.1899999999999999 113.881 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -86.18 65.76 9.24 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.16 -2.533 . . . . 3.8799999999999999 104.16 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.58 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 20.2 t90 -25.81 89.75 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 1.5600000000000001 112.215 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 11' ' ' ASP . 88.8 tttt -28.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 114.113 -1.403 . . . . 3.1000000000000001 112.421 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' O ' ' CE2' ' A' ' 29' ' ' TRP . 11.7 m-20 -110.93 55.37 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.417 . . . . 2.02 110.142 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -149.11 -158.4 8.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.08 -0.581 . . . . 0.58999999999999997 112.688 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.5 21.18 1.34 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.902 -0.666 . . . . 0.85999999999999999 112.331 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.82 -173.84 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.299 . . . . 2.1299999999999999 110.798 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -145.61 136.34 24.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 2.29 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -149.96 176.88 10.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.816 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -98.11 148.52 23.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.83999999999999997 111.324 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.487 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 97.0 t -89.2 160.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 1.3799999999999999 109.79 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 88.2 tttt -68.95 104.25 2.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.37 0.605 . . . . 2.8700000000000001 112.174 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.65 37.99 3.29 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.108 -0.951 . . . . 0.39000000000000001 112.667 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.85 3.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.672 0.272 . . . . 1.3 110.304 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.498 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -69.75 77.6 0.45 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.578 0.704 . . . . 2.1299999999999999 109.826 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 48.7 t -56.91 75.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 113.717 -1.583 . . . . 2.1499999999999999 113.34 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.54 53.69 2.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.593 -0.891 . . . . 1.1200000000000001 108.593 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HG2' ' HE2' ' A' ' 49' ' ' LYS . 39.0 tt0 -49.72 -22.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.916 -1.038 . . . . 2.4399999999999999 110.435 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.03 -50.53 47.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 2.48 110.087 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 51' ' ' TYR . 43.5 t -57.79 -29.88 36.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.036 -0.529 . . . . 1.5 111.282 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -87.45 -58.11 2.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.155 1.382 . . . . 1.3600000000000001 109.97 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 25.4 ttmm -54.84 -31.12 59.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.307 -0.86 . . . . 3.7799999999999998 109.262 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -25.39 19.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.518 -0.764 . . . . 2.0 109.854 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' CD2' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.78 -65.18 0.71 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.144 0.974 . . . . 2.3300000000000001 110.374 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' CB ' ' HB2' ' A' ' 2' ' ' SER . 13.1 pt-20 -90.22 -50.87 5.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.692 -1.595 . . . . 1.77 111.775 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -77.92 -9.4 59.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.696 -0.684 . . . . 2.2999999999999998 111.321 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.12 -37.61 6.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.593 -0.813 . . . . 1.6100000000000001 112.041 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.35 -64.0 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 2.7999999999999998 110.489 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.22 58.74 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 2.9500000000000002 110.653 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.28 -0.867 . . . . 2.23 110.902 -179.717 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.477 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 111.82 0.304 . . . . 5.5599999999999996 111.82 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 58.0 Cg_exo -51.29 102.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.184 1.923 . . . . 5.7699999999999996 112.248 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.89 -51.41 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.835 2.356 . . . . 4.0999999999999996 112.165 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.39 62.26 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 2.1099999999999999 112.495 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.442 ' N ' HG21 ' A' ' 27' ' ' VAL . 50.8 p -152.33 173.9 14.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 2.29 111.777 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.87 -158.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 1.8600000000000001 110.85 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -162.09 124.9 2.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.662 -0.244 . . . . 7.9800000000000004 110.775 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.17 -35.19 49.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.494 -0.321 . . . . 6.9800000000000004 111.293 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -139.33 -171.06 3.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.606 0.241 . . . . 7.5599999999999996 110.67 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -53.31 -25.32 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.408 . . . . 4.9100000000000001 110.496 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 37.4 mtmt 76.36 90.25 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.654 -0.703 . . . . 4.8099999999999996 110.295 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -90.5 83.93 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 2.0499999999999998 110.885 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.482 ' OD1' ' CE1' ' A' ' 42' ' ' HIS . 11.2 p-10 -109.59 101.67 10.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 3.7999999999999998 110.626 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.17 -0.919 . . . . 4.3099999999999996 111.31 -179.586 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 112.433 -0.267 . . . . 3.3500000000000001 112.433 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 9.4 t 169.32 -10.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.132 0.79 . . . . 3.3900000000000001 113.132 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.35 138.66 31.29 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.849 -0.426 . . . . 5.1100000000000003 109.849 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 1.216 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 9.8 p -96.32 43.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 3.6299999999999999 110.571 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.63 ' CD1' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -177.92 152.96 0.79 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.887 -0.597 . . . . 2.9300000000000002 111.282 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 2.6 mp0 -134.55 144.07 47.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 2.4100000000000001 111.067 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.0 p90 -89.52 105.38 17.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.17 0.509 . . . . 2.6000000000000001 111.902 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.457 ' CB ' HG12 ' A' ' 38' ' ' VAL . . . -89.9 53.35 2.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.457 -0.792 . . . . 1.1100000000000001 109.022 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.691 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.81 158.57 20.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.12 0.962 . . . . 2.7999999999999998 112.96 -177.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 57.9 t -97.21 -35.28 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 113.66 -1.609 . . . . 1.1200000000000001 110.503 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.6 t70 -139.3 -39.36 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.735 -0.666 . . . . 2.1899999999999999 112.048 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.4 mt-10 -155.98 157.36 36.07 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 112.787 0.662 . . . . 2.1800000000000002 112.787 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.52 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -130.29 -169.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 1.0800000000000001 109.972 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.442 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.4 t -150.24 -49.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 1.3500000000000001 110.13 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.9 tp10 -98.97 139.1 35.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.715 -0.675 . . . . 2.96 109.689 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.61 ' HE2' ' HH ' ' A' ' 25' ' ' TYR . 11.3 ptmm? -151.6 87.85 1.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.652 -0.419 . . . . 2.6200000000000001 112.1 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -153.74 92.36 1.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.042 -0.263 . . . . 4.4199999999999999 111.101 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.21 -130.21 1.57 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.15 -1.5 . . . . 0.40999999999999998 114.946 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 68.4 mttm -124.52 -121.62 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.894 0.878 . . . . 1.74 110.082 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.71 -40.03 6.07 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.141 -1.983 . . . . 0.64000000000000001 108.141 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 2.0 mptp? -143.87 7.02 1.42 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.187 -1.506 . . . . 3.8700000000000001 111.161 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 17.9 t70 -87.43 9.06 22.0 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.129 0.49 . . . . 1.22 111.066 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG11 ' CE1' ' A' ' 25' ' ' TYR . 7.2 p -88.4 152.87 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.6 -0.727 . . . . 1.1200000000000001 111.561 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.6 pt-20 -109.29 99.36 8.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.511 -0.768 . . . . 1.26 110.015 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.61 ' HH ' ' HE2' ' A' ' 16' ' ' LYS . 9.4 m-85 -104.44 149.94 24.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.76 -0.655 . . . . 0.88 110.182 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 HD13 ' CG2' ' A' ' 14' ' ' VAL . 2.7 tt -88.97 157.16 18.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.658 -0.867 . . . . 1.6799999999999999 108.658 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.691 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -143.21 110.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 118.953 -1.099 . . . . 1.1899999999999999 113.894 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 30' ' ' LYS . 77.2 mtt180 -83.91 75.71 10.09 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.895 -1.891 . . . . 3.8799999999999999 105.895 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 3.4 t90 -26.9 89.68 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.922 -1.49 . . . . 1.5600000000000001 112.28 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 60.3 tttp -29.02 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.654 -1.157 . . . . 3.1000000000000001 112.209 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 19.4 t70 -119.41 55.59 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 2.02 109.885 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -142.27 -140.4 3.75 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.58999999999999997 112.641 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.23 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.844 -0.693 . . . . 0.85999999999999999 112.331 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.69 -174.28 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 2.1299999999999999 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.8 m -143.97 126.39 15.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 2.29 110.915 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HA3' ' B' ' 4' ' ' GLY . 43.1 mt-10 -132.06 179.68 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 2.27 110.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -100.19 150.91 22.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.83999999999999997 111.846 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.475 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 73.8 t -89.49 162.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.672 -0.694 . . . . 1.3799999999999999 109.768 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.455 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 88.4 tttt -78.34 104.53 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.739 0.644 . . . . 2.8700000000000001 112.739 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.62 45.05 2.73 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.076 -0.965 . . . . 0.39000000000000001 112.516 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -118.3 0.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.999 -0.371 . . . . 1.3 109.999 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -72.76 76.46 1.13 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.595 0.712 . . . . 2.1299999999999999 110.633 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 52.0 t -56.41 76.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 113.249 -1.796 . . . . 2.1499999999999999 113.227 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -91.56 49.59 1.6 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.206 -0.906 . . . . 1.1200000000000001 108.944 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -47.81 -27.83 2.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.13 -0.941 . . . . 2.4399999999999999 110.509 -178.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 12.0 t70 -77.95 -44.03 28.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 2.48 109.424 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 49.2 t -65.18 -27.72 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.099 -0.501 . . . . 1.5 110.704 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -93.92 -57.78 2.44 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.997 1.436 . . . . 1.3600000000000001 112.565 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 38.8 ttpt -51.73 -45.29 63.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.207 0.527 . . . . 3.7799999999999998 110.556 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 1.8 t70 -79.42 -20.6 47.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.104 -0.702 . . . . 2.0 109.104 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.64 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.421 -0.809 . . . . 2.3300000000000001 110.474 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -86.04 -48.71 8.4 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.324 -1.307 . . . . 1.77 111.684 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -77.34 -42.82 35.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.823 -0.626 . . . . 2.2999999999999998 111.541 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -50.32 -52.14 28.89 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.542 -0.837 . . . . 1.6100000000000001 112.394 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.06 -69.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 2.7999999999999998 110.803 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 63.63 6.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 2.9500000000000002 110.831 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.5 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.184 -0.912 . . . . 2.23 110.919 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.302 0.096 . . . . 5.5599999999999996 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.59 109.91 2.39 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.297 1.998 . . . . 5.7699999999999996 112.153 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.54 91.73 1.05 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.442 2.095 . . . . 4.0999999999999996 112.403 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.422 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 47.35 81.04 0.05 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.888 -0.672 . . . . 2.1099999999999999 112.476 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.985 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -151.82 159.9 43.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 2.29 111.687 -179.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.07 -47.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 1.8600000000000001 110.444 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.447 ' CB ' ' HE3' ' B' ' 11' ' ' LYS . 72.2 mtm180 68.36 118.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 7.9800000000000004 111.685 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -69.23 -42.41 75.71 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 6.9800000000000004 110.838 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -147.88 -168.69 3.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.549 -0.296 . . . . 7.5599999999999996 110.44 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' B' ' 11' ' ' LYS . 12.6 ptm180 -52.95 -25.11 10.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.351 . . . . 4.9100000000000001 110.691 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 86.6 mttt 69.24 93.05 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.9 -0.591 . . . . 4.8099999999999996 110.785 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 44' ' ' ALA . . . -82.69 121.41 26.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 2.0499999999999998 110.755 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' CD2' ' A' ' 42' ' ' HIS . 5.3 p-10 -126.29 53.33 1.64 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.974 0.416 . . . . 3.7999999999999998 111.021 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 4.3099999999999996 110.856 179.744 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 120.309 -0.162 . . . . 3.3500000000000001 112.757 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 p 179.87 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.154 0.428 . . . . 3.3900000000000001 112.154 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.7 pt20 -87.03 130.77 34.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.153 -0.314 . . . . 5.1100000000000003 110.153 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 5' ' ' PHE . 10.7 p -89.88 66.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.046 0.45 . . . . 3.6299999999999999 111.751 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 9.3 p90 165.67 164.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.912 -0.585 . . . . 2.9300000000000002 110.932 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 11.0 tp10 -142.43 145.11 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 2.4100000000000001 110.275 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.535 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 44.4 p90 -89.76 105.5 17.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.079 0.466 . . . . 2.6000000000000001 111.878 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' CB ' HG12 ' A' ' 38' ' ' VAL . . . -89.93 55.55 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.146 -0.687 . . . . 1.1100000000000001 109.146 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.31 163.17 15.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.087 0.946 . . . . 2.7999999999999998 112.433 -177.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 60.7 t -96.71 -37.54 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 113.595 -1.639 . . . . 1.1200000000000001 110.741 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 17.4 t70 -142.57 -34.56 0.44 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.038 -0.528 . . . . 2.1899999999999999 112.244 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 44.8 mt-10 -156.0 151.06 26.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.25 0.833 . . . . 2.1800000000000002 113.25 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.477 HG13 ' CD2' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -125.98 -171.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.331 -0.395 . . . . 1.0800000000000001 110.561 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 26' ' ' LEU . 94.7 t -147.19 -48.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 1.3500000000000001 110.069 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.9 mt-10 -97.72 141.77 30.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.821 -0.627 . . . . 2.96 109.751 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.4 ptmt -152.02 84.92 1.28 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.687 -0.405 . . . . 2.6200000000000001 111.898 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -153.38 97.12 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.085 -0.246 . . . . 4.4199999999999999 111.027 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -151.21 -130.23 1.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 118.94 -1.6 . . . . 0.40999999999999998 114.978 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 43' ' ' VAL . 54.1 mttm -117.04 -72.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.333 1.063 . . . . 1.74 110.738 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.31 -47.81 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 106.835 -2.506 . . . . 0.64000000000000001 106.835 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 1.8 mptt -127.6 -6.27 5.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.076 -1.562 . . . . 3.8700000000000001 109.831 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' N ' ' A' ' 42' ' ' HIS . 12.0 t70 -86.75 9.73 18.05 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.125 0.488 . . . . 1.22 111.291 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 25' ' ' TYR . 7.0 p -87.22 152.37 3.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.78 -0.645 . . . . 1.1200000000000001 111.086 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.99 94.56 5.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.654 -0.703 . . . . 1.26 110.689 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.535 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 7.0 m-85 -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.153 -0.476 . . . . 0.88 110.38 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 27' ' ' VAL . 2.2 tt -89.31 157.73 18.08 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.366 -0.976 . . . . 1.6799999999999999 108.366 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.724 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.41 110.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.022 -1.071 . . . . 1.1899999999999999 113.499 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' CD ' HD23 ' A' ' 26' ' ' LEU . 13.3 mmm180 -84.75 79.39 9.63 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.142 -1.799 . . . . 3.8799999999999999 106.142 175.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -27.19 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.535 -1.211 . . . . 1.5600000000000001 111.966 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 38.0 ttpt -27.62 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.307 -1.315 . . . . 3.1000000000000001 112.26 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' TRP . 6.0 m-20 -123.94 57.07 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.005 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -140.97 -159.65 7.99 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.017 -0.611 . . . . 0.58999999999999997 112.999 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.23 19.8 1.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.121 -0.561 . . . . 0.85999999999999999 112.376 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -139.9 -176.56 4.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.741 0.305 . . . . 2.1299999999999999 110.636 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . 29.0 p -150.19 111.16 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 2.29 111.232 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 6.5 mm-40 -123.99 -176.85 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 2.27 110.922 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.426 ' O ' ' CG2' ' B' ' 5' ' ' THR . 4.7 m-90 -108.71 153.24 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.108 0.48 . . . . 0.83999999999999997 111.697 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 39' ' ' LYS . 49.0 t -88.43 162.18 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.704 -0.68 . . . . 1.3799999999999999 109.52 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 88.5 tttt -80.73 103.62 10.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.461 0.648 . . . . 2.8700000000000001 112.075 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -88.83 45.05 3.18 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.027 -0.988 . . . . 0.39000000000000001 112.647 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.2 0.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.076 -0.342 . . . . 1.3 110.076 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.471 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.85 77.83 0.88 Allowed 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.46 0.648 . . . . 2.1299999999999999 109.775 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.442 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 49.5 t -56.09 72.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.406 -1.724 . . . . 2.1499999999999999 113.805 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.62 49.52 1.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.565 -0.743 . . . . 1.1200000000000001 109.354 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.46 -28.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.209 -0.905 . . . . 2.4399999999999999 110.58 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 6.8 m-20 -66.7 -49.97 64.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.493 -0.776 . . . . 2.48 109.875 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 42.2 t -58.23 -30.52 40.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.117 -0.492 . . . . 1.5 110.593 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -79.32 -59.99 2.54 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.754 1.221 . . . . 1.3600000000000001 109.954 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.7 ttpt -56.97 -27.84 61.7 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.758 -0.83 . . . . 3.7799999999999998 108.758 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.2 t70 -91.85 -22.68 19.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.148 -0.933 . . . . 2.0 110.108 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.551 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.46 -71.09 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.837 0.827 . . . . 2.3300000000000001 110.087 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.3 pt-20 -81.53 -47.16 13.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.143 -1.39 . . . . 1.77 112.012 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.3 m-20 -80.78 -18.73 46.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.043 -0.526 . . . . 2.2999999999999998 111.703 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 50' ' ' ASP . . . -75.19 -43.16 26.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.408 -0.901 . . . . 1.6100000000000001 112.391 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.5 tp -76.08 -63.64 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 2.7999999999999998 110.534 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -87.94 59.77 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 2.9500000000000002 110.492 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 54.9 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.307 -0.854 . . . . 2.23 110.929 -179.828 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 111.803 0.298 . . . . 5.5599999999999996 111.803 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 74.0 Cg_exo -47.67 107.2 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.225 1.95 . . . . 5.7699999999999996 112.3 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.17 67.66 4.19 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.488 2.125 . . . . 4.0999999999999996 112.358 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.426 ' CA ' ' HB2' ' A' ' 36' ' ' GLU . . . 137.99 61.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.677 -0.773 . . . . 2.1099999999999999 112.517 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.435 ' HA ' ' CG1' ' A' ' 27' ' ' VAL . 28.1 p -152.42 174.23 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.089 0.471 . . . . 2.29 111.782 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.44 42.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.673 -0.694 . . . . 1.8600000000000001 110.628 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.458 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 12.4 ptm180 -41.84 134.97 2.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.824 -0.625 . . . . 7.9800000000000004 111.932 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -55.21 133.7 49.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.489 -0.56 . . . . 6.9800000000000004 109.489 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' B' ' 9' ' ' LYS . 3.4 ptmm? -111.85 34.29 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.183 0.438 . . . . 7.5599999999999996 112.183 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.443 ' HD3' ' CE ' ' A' ' 21' ' ' LYS . 12.2 ptm180 -97.66 -21.07 17.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 4.9100000000000001 110.417 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.424 ' HD3' ' N ' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 36.35 63.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.459 0.54 . . . . 4.8099999999999996 112.459 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.473 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -52.65 -28.45 21.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.143 0.497 . . . . 2.0499999999999998 110.282 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . 22.7 t70 -109.39 38.25 2.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.423 -0.808 . . . . 3.7999999999999998 110.317 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.246 -0.883 . . . . 4.3099999999999996 111.008 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.718 -0.153 . . . . 3.3500000000000001 112.718 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 83.5 p 179.52 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.089 0.403 . . . . 3.3900000000000001 112.089 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 1.249 ' C ' ' HE1' ' A' ' 5' ' ' PHE . 27.5 mt-30 -88.79 137.96 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.799 -0.445 . . . . 5.1100000000000003 109.799 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 1.374 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 13.5 p -89.54 72.41 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.047 0.388 . . . . 3.6299999999999999 112.047 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.374 ' CE1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER 163.39 177.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.032 0.444 . . . . 2.9300000000000002 111.6 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 9.4 tp10 -152.72 146.73 25.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.846 -0.615 . . . . 2.4100000000000001 109.717 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -89.52 109.0 19.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 2.6000000000000001 110.966 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' O ' ' OE2' ' A' ' 9' ' ' GLU . . . -94.32 33.13 1.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.482 -0.781 . . . . 1.1100000000000001 110.698 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 1.233 ' OE2' ' N ' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -102.75 175.06 5.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.043 0.925 . . . . 2.7999999999999998 112.815 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 21.3 t -109.49 -17.52 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 113.699 -1.591 . . . . 1.1200000000000001 112.402 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 21.1 t70 -150.14 -43.33 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 2.1899999999999999 111.468 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.6 mt-10 -153.3 168.45 25.99 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.091 -0.504 . . . . 2.1800000000000002 111.545 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG22 ' HB3' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -141.52 -169.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.695 -0.483 . . . . 1.0800000000000001 109.695 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' HD22 ' A' ' 26' ' ' LEU . 90.5 t -149.97 -57.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 1.3500000000000001 110.092 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 20.6 mm-40 -91.02 133.98 34.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.931 -0.577 . . . . 2.96 109.447 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 pttm -151.07 87.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.708 -0.397 . . . . 2.6200000000000001 111.442 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -153.65 94.79 1.82 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.752 0.279 . . . . 4.4199999999999999 111.752 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.07 -128.19 1.38 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 119.415 -1.374 . . . . 0.40999999999999998 114.065 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 86.0 mttt -109.49 -74.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.117 0.961 . . . . 1.74 110.659 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -151.7 -47.76 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 107.167 -2.373 . . . . 0.64000000000000001 107.167 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' CB ' ' HB3' ' A' ' 44' ' ' ALA . 2.1 ttpt -124.59 -9.62 7.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.067 -1.566 . . . . 3.8700000000000001 109.802 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' A' ' 19' ' ' LYS . 12.3 t70 -86.47 7.71 24.82 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 121.232 0.539 . . . . 1.22 111.376 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG11 ' CE1' ' A' ' 25' ' ' TYR . 10.8 p -89.25 157.71 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.409 -0.814 . . . . 1.1200000000000001 110.63 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.26 115.83 30.4 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 1.26 110.864 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.535 ' CZ ' ' CB ' ' A' ' 16' ' ' LYS . 8.0 m-85 -115.71 148.5 39.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.607 -0.724 . . . . 0.88 110.131 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' CD1' ' CD1' ' A' ' 37' ' ' TRP . 18.3 tp -90.7 159.0 16.59 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.781 -1.192 . . . . 1.6799999999999999 107.781 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 1.215 HG13 ' CD ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -143.79 111.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 114.449 1.277 . . . . 1.1899999999999999 114.449 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 30' ' ' LYS . 81.7 mtt180 -83.23 70.0 10.04 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.068 -1.827 . . . . 3.8799999999999999 106.068 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 t90 -26.28 89.7 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 113.761 -1.563 . . . . 1.5600000000000001 112.036 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' CB ' HG12 ' A' ' 10' ' ' VAL . 63.8 tttm -28.46 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.368 -1.287 . . . . 3.1000000000000001 112.416 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.9 m-20 -111.76 54.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 2.02 110.076 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.13 -161.5 9.92 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.58999999999999997 112.737 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.73 -38.9 0.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.984 -0.627 . . . . 0.85999999999999999 112.237 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -114.09 176.22 5.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 2.1299999999999999 110.628 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -126.67 130.53 50.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.361 . . . . 2.29 110.912 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 31.1 mm-40 -117.13 165.6 13.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.066 0.46 . . . . 2.27 111.591 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.534 ' CD1' ' CD1' ' A' ' 26' ' ' LEU . 12.3 m0 -87.97 140.32 29.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.617 -0.72 . . . . 0.83999999999999997 111.138 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' CG2' ' CG1' ' A' ' 27' ' ' VAL . 89.3 t -87.37 160.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 1.3799999999999999 110.127 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 40.2 ttmt -77.23 108.08 10.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.118 0.785 . . . . 2.8700000000000001 113.118 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -89.57 44.46 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.933 -1.03 . . . . 0.39000000000000001 112.487 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' VAL . 2.6 t -117.77 -5.19 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.332 . . . . 1.3 110.248 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -66.02 79.0 0.09 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.892 0.853 . . . . 2.1299999999999999 110.057 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 6.1 p -56.16 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 113.296 -1.774 . . . . 2.1499999999999999 113.756 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -92.86 49.15 1.41 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.8 -1.091 . . . . 1.1200000000000001 109.617 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 38.1 tt0 -45.18 -26.65 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.133 -0.939 . . . . 2.4399999999999999 111.312 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.5 -46.86 62.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.594 . . . . 2.48 110.059 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 25.4 t -56.03 -35.5 41.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 116.073 -0.512 . . . . 1.5 109.875 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.07 -60.65 2.28 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.835 1.254 . . . . 1.3600000000000001 110.344 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 26.5 ttpp -54.4 -30.6 52.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.25 -0.648 . . . . 3.7799999999999998 109.25 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -92.95 -22.79 19.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.671 -0.695 . . . . 2.0 110.869 178.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.9 -66.08 0.6 Allowed 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.255 1.026 . . . . 2.3300000000000001 109.018 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 2' ' ' SER . 33.3 mt-10 -81.28 -67.78 0.75 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.178 -1.828 . . . . 1.77 110.904 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -57.31 -43.2 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.027 -0.988 . . . . 2.2999999999999998 111.185 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -52.75 -39.34 54.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.53 -0.843 . . . . 1.6100000000000001 112.164 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.8 tp -84.38 -59.26 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.783 0.325 . . . . 2.7999999999999998 110.287 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.87 60.01 4.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 2.9500000000000002 110.55 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.7 t80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.216 -0.897 . . . . 2.23 110.943 -179.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.732 0.301 . . . . 5.5599999999999996 111.072 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.444 ' CB ' ' CD ' ' B' ' 3' ' ' PRO . 2.2 Cg_endo -42.92 -58.12 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.952 2.434 . . . . 5.7699999999999996 112.577 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' B' ' 2' ' ' PRO . 26.9 Cg_endo -62.77 92.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.34 2.027 . . . . 4.0999999999999996 112.217 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . 131.86 -41.79 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 2.1099999999999999 112.45 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.709 HG21 ' H ' ' B' ' 7' ' ' ARG . 4.8 p -88.57 172.3 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 2.29 111.433 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 1.233 ' N ' ' OE2' ' A' ' 9' ' ' GLU . . . -141.68 57.03 1.5 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.218 -0.447 . . . . 1.8600000000000001 111.851 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.709 ' H ' HG21 ' B' ' 5' ' ' THR . 39.1 ptt180 -48.86 129.08 16.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.443 -0.344 . . . . 7.9800000000000004 110.637 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 1.083 HH22 ' CD ' ' B' ' 9' ' ' LYS . 28.0 tpt180 -50.55 164.85 0.11 Allowed 'General case' 0 C--N 1.338 0.093 0 N-CA-C 109.927 -0.397 . . . . 6.9800000000000004 109.927 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 1.083 ' CD ' HH22 ' B' ' 8' ' ' ARG . 0.0 OUTLIER -136.1 46.29 2.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.765 0.654 . . . . 7.5599999999999996 112.765 -178.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.434 ' HG2' ' CD ' ' A' ' 21' ' ' LYS . 17.5 ptp180 -99.9 -36.87 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.113 0.482 . . . . 4.9100000000000001 110.074 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.434 ' HD3' ' NE2' ' A' ' 42' ' ' HIS . 11.4 mmmm 49.54 85.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.699 -0.682 . . . . 4.8099999999999996 111.129 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -88.28 -27.87 21.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 2.0499999999999998 110.54 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 7.3 t70 -135.7 159.84 40.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 3.7999999999999998 110.878 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.283 -0.865 . . . . 4.3099999999999996 110.865 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.698 -0.161 . . . . 3.3500000000000001 112.698 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 52' ' ' GLU . 58.1 p -153.26 -57.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 3.3900000000000001 110.558 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.92 118.94 37.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.983 -0.553 . . . . 5.1100000000000003 110.143 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.5 t -146.36 -54.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.056 0.391 . . . . 3.6299999999999999 112.056 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER 63.59 -163.31 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.934 -0.765 . . . . 2.9300000000000002 108.934 -178.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -151.16 139.61 20.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 2.4100000000000001 111.798 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 47.1 p90 -91.42 106.58 18.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.174 0.511 . . . . 2.6000000000000001 110.921 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.476 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -88.69 60.58 5.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.954 -0.758 . . . . 1.1100000000000001 108.954 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.833 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -114.81 150.34 35.61 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.348 1.07 . . . . 2.7999999999999998 113.181 -177.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 57.8 t -89.53 -36.78 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.25 -1.795 . . . . 1.1200000000000001 109.212 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -144.47 -33.68 0.39 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.983 -1.008 . . . . 2.1899999999999999 111.615 177.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 43.7 mt-10 -152.81 159.17 43.06 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.131 0.419 . . . . 2.1800000000000002 112.131 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.524 ' CG2' ' CB ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -128.67 -168.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.173 -0.677 . . . . 1.0800000000000001 109.173 178.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.522 ' N ' ' HB3' ' A' ' 26' ' ' LEU . 89.6 t -151.38 -60.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.218 0.533 . . . . 1.3500000000000001 109.742 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 22.0 mm-40 -92.5 143.57 26.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.346 -0.843 . . . . 2.96 109.729 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.577 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.9 pttm -152.66 93.43 1.77 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.075 -0.25 . . . . 2.6200000000000001 111.297 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -155.16 88.64 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.469 -0.492 . . . . 4.4199999999999999 111.205 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 5' ' ' PHE . . . -150.92 -137.88 2.75 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 118.863 -1.636 . . . . 0.40999999999999998 115.269 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 22' ' ' ASP . 90.6 mttt -108.36 -88.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.312 -0.944 . . . . 1.74 110.767 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -131.95 -44.79 0.15 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.928 -2.069 . . . . 0.64000000000000001 107.928 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -131.33 -6.3 3.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.26 -1.47 . . . . 3.8700000000000001 110.693 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CA ' ' O ' ' A' ' 42' ' ' HIS . 20.7 t70 -89.13 12.0 17.0 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 121.125 0.488 . . . . 1.22 111.347 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.508 HG22 ' CD1' ' A' ' 25' ' ' TYR . 14.6 p -87.92 157.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.533 -0.758 . . . . 1.1200000000000001 111.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -108.83 109.4 20.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.285 -0.87 . . . . 1.26 110.256 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 11.1 m-85 -118.68 152.93 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.935 -0.575 . . . . 0.88 110.605 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 3.1 tt -87.68 157.07 19.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.828 -0.804 . . . . 1.6799999999999999 108.828 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.833 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.86 97.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.121 -0.631 . . . . 1.1899999999999999 112.087 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 30' ' ' LYS . 48.3 ttt180 -79.17 82.45 5.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.737 -1.209 . . . . 3.8799999999999999 107.737 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.2 t90 -28.66 91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.803 -1.089 . . . . 1.5600000000000001 112.085 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 11' ' ' ASP . 18.6 pttp -26.97 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.55 -1.204 . . . . 3.1000000000000001 112.557 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 29' ' ' TRP . 18.0 m-20 -120.63 57.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 2.02 110.087 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -139.28 -143.54 4.43 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.845 -0.616 . . . . 0.58999999999999997 112.527 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.34 -48.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.855 -0.688 . . . . 0.85999999999999999 112.307 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.76 179.7 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 2.1299999999999999 110.804 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -125.94 138.11 53.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.382 . . . . 2.29 111.014 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' B' ' 3' ' ' PRO . 9.5 tp10 -133.53 158.86 42.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.607 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 41.7 m0 -97.18 149.26 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.83999999999999997 111.368 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.476 HG13 ' CB ' ' A' ' 8' ' ' ALA . 77.0 t -88.77 159.31 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 1.3799999999999999 110.009 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.3 tppt? -79.17 110.86 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.27 0.557 . . . . 2.8700000000000001 112.159 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -87.95 36.76 3.33 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.232 -0.894 . . . . 0.39000000000000001 112.914 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 43' ' ' VAL . 3.1 t -112.39 0.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.34 -0.245 . . . . 1.3 110.34 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 1.132 ' NE2' ' CG ' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -66.86 76.27 0.12 Allowed 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.688 0.756 . . . . 2.1299999999999999 109.609 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 41' ' ' VAL . 7.1 p -57.17 75.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 113.715 -1.584 . . . . 2.1499999999999999 113.982 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 50.83 1.83 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.589 -0.893 . . . . 1.1200000000000001 108.589 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -24.14 1.93 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.982 -1.008 . . . . 2.4399999999999999 110.54 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 16.0 t70 -66.0 -49.77 66.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 2.48 109.91 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.531 ' CG1' ' CE2' ' A' ' 51' ' ' TYR . 60.3 t -55.05 -38.47 46.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 116.251 -0.431 . . . . 1.5 110.546 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -76.61 -59.86 2.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.188 1.395 . . . . 1.3600000000000001 110.665 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 5.2 tmmm? -56.73 -28.44 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.157 -0.683 . . . . 3.7799999999999998 109.157 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.9 t70 -91.54 -24.52 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.582 -0.736 . . . . 2.0 109.452 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.86 -70.28 0.3 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.817 0.817 . . . . 2.3300000000000001 110.59 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' CB ' ' HB2' ' A' ' 2' ' ' SER . 13.0 pt-20 -82.4 -48.17 11.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.21 -1.359 . . . . 1.77 111.714 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -78.19 -25.49 47.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.839 -0.619 . . . . 2.2999999999999998 111.599 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -77.0 -55.65 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.441 -0.885 . . . . 1.6100000000000001 112.313 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.54 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 2.7999999999999998 110.564 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -87.99 58.42 4.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 2.9500000000000002 110.577 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.236 -0.888 . . . . 2.23 110.949 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.66 0.267 . . . . 5.5599999999999996 111.038 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.33 111.66 2.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 5.7699999999999996 112.348 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 41.0 Cg_endo -67.92 62.42 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.58 2.187 . . . . 4.0999999999999996 112.272 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.426 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . 148.97 94.91 0.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.728 -0.749 . . . . 2.1099999999999999 112.518 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 27' ' ' VAL . 64.1 p -154.55 151.61 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.813 0.34 . . . . 2.29 111.739 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -150.02 -61.51 0.21 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.211 -0.45 . . . . 1.8600000000000001 111.841 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? 62.34 129.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.027 -0.36 . . . . 7.9800000000000004 110.027 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.522 ' CZ ' ' CE2' ' A' ' 7' ' ' TYR . 13.5 ptt180 -132.67 46.2 2.65 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.671 0.619 . . . . 6.9800000000000004 112.671 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -154.48 177.71 10.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.901 -0.319 . . . . 7.5599999999999996 110.791 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -68.39 -27.19 66.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.182 0.515 . . . . 4.9100000000000001 110.564 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 1.132 ' CG ' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER 77.4 67.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.325 -0.852 . . . . 4.8099999999999996 109.941 -179.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -39.84 -28.91 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.519 -0.764 . . . . 2.0499999999999998 112.225 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 43' ' ' VAL . 22.3 t70 -108.97 -28.37 9.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 3.7999999999999998 111.006 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.465 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 47.8 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.189 -0.91 . . . . 4.3099999999999996 111.11 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.6 p90 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.953 0.406 . . . . 2.16 111.888 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -134.75 142.41 46.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.957 -0.565 . . . . 2.41 111.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 31.7 p90 -89.78 122.26 32.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.73 111.424 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.776 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -107.25 53.45 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.816 -0.629 . . . . 0.38 110.651 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.696 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -106.41 176.79 5.05 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.934 0.873 . . . . 2.8 112.779 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.714 HG12 ' CB ' ' A' ' 30' ' ' LYS . 54.4 t -104.07 -24.28 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.021 -1.445 . . . . 0.42 111.505 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 5.3 t70 -150.52 -39.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.917 -0.583 . . . . 2.19 111.114 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 47.4 mt-10 -152.47 162.7 40.83 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.197 0.443 . . . . 2.18 112.197 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -131.73 -168.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.487 -0.56 . . . . 0.34 109.487 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 HD23 ' A' ' 26' ' ' LEU . 69.4 t -150.24 -49.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.67 110.836 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 43.6 tt0 -98.64 146.11 26.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.162 -0.472 . . . . 2.96 110.465 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 18.8 pttm -152.9 89.62 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.005 0.372 . . . . 2.13 112.005 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.78 ' C ' HG23 ' A' ' 23' ' ' VAL . 30.4 ttm180 -154.54 87.63 1.18 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 121.059 -0.256 . . . . 3.83 111.104 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.797 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.26 -137.74 2.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.084 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.6 mttm -115.63 -122.49 0.29 Allowed 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.65 -0.775 . . . . 1.13 110.325 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -90.28 -42.13 5.32 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.036 -2.026 . . . . 0.51 108.036 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 1.4 mptp? -140.67 7.29 2.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.023 -1.588 . . . . 3.41 110.675 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 30.3 t0 -88.85 10.07 22.45 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.893 0.377 . . . . 1.22 111.091 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.797 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.1 p -88.01 150.0 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 116.021 -0.536 . . . . 0.34 111.398 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.9 pt-20 -112.33 93.08 4.26 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.488 -0.778 . . . . 1.26 110.393 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 5.6 m-85 -88.16 -167.7 1.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.263 -0.643 . . . . 0.65 109.263 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.844 HD13 ' CD1' ' A' ' 37' ' ' TRP . 29.4 tp -126.48 160.63 30.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.064 -1.087 . . . . 0.96 108.064 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -139.19 110.72 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 118.924 -1.111 . . . . 0.4 113.529 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 52.0 mtt180 -84.85 74.19 10.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 105.668 -1.975 . . . . 3.27 105.668 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.7 t90 -26.72 90.81 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 113.867 -1.515 . . . . 1.31 111.833 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.714 ' CB ' HG12 ' A' ' 10' ' ' VAL . 83.5 tttt -27.39 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.352 -1.295 . . . . 2.46 112.341 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 4.7 p-10 -120.01 56.76 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.796 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.56 -178.02 23.3 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.59 112.628 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.06 -13.37 9.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.851 -0.69 . . . . 0.86 112.567 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -126.65 162.49 25.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 2.13 110.89 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 28' ' ' ARG . 61.2 m -116.1 118.72 33.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 1.6 110.71 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.782 ' O ' HD12 ' A' ' 26' ' ' LEU . 31.9 mt-10 -108.64 163.88 12.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.207 0.527 . . . . 2.27 111.68 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.844 ' CD1' HD13 ' A' ' 26' ' ' LEU . 16.2 m0 -87.95 148.37 24.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.71 112.015 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.776 HG11 ' HB3' ' A' ' 8' ' ' ALA . 40.1 t -87.6 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.018 -0.992 . . . . 0.65 109.751 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 86.9 tttt -80.76 106.89 13.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.284 0.564 . . . . 2.32 112.436 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -99.22 39.32 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.298 -0.864 . . . . 0.35 112.363 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.29 0.0 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.824 -0.436 . . . . 0.68 109.824 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -77.05 77.79 3.6 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.734 0.778 . . . . 1.35 110.918 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 43' ' ' VAL . 6.0 p -57.28 77.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.325 -1.761 . . . . 1.49 112.663 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -92.43 49.25 1.47 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.872 -1.058 . . . . 0.48 109.241 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 42.0 tt0 -48.28 -27.53 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.171 -0.922 . . . . 2.44 110.187 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 15.8 t70 -75.02 -43.12 55.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.477 -0.783 . . . . 2.48 109.73 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 51' ' ' TYR . 95.3 t -63.93 -46.79 93.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 109.34 -0.615 . . . . 0.88 109.34 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.4 -54.96 18.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.539 1.536 . . . . 0.99 111.331 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 23.3 ttmm -60.27 -33.28 72.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.406 0.622 . . . . 3.35 109.464 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.1 t70 -91.67 -11.4 37.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.276 -0.874 . . . . 2.0 110.428 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -84.02 -63.25 1.38 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.428 0.633 . . . . 1.87 110.262 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.7 pt-20 -87.64 -46.68 9.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.046 -0.979 . . . . 1.77 110.83 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -80.99 -22.51 39.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 2.3 111.425 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.244 179.806 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.3 p90 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.649 0.261 . . . . 2.16 110.39 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.567 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.4 tp10 -130.15 142.98 50.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 2.41 110.935 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.6 p90 -88.27 109.37 19.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.6 0.714 . . . . 1.73 112.034 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -95.02 50.82 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.758 -1.11 . . . . 0.38 109.611 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.12 169.23 9.26 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.984 0.897 . . . . 2.8 112.369 -178.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.912 HG12 ' CB ' ' A' ' 30' ' ' LYS . 51.7 t -97.53 -34.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-N 113.769 -1.559 . . . . 0.42 112.096 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 11.3 t70 -144.87 -33.67 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.508 0.558 . . . . 2.19 112.508 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 33.2 mm-40 -154.07 159.79 41.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.297 0.481 . . . . 2.18 112.297 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.4 -169.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.34 110.485 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG23 HD22 ' A' ' 26' ' ' LEU . 94.0 t -149.97 -54.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.431 . . . . 0.67 110.068 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 41.5 mt-10 -92.25 138.32 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 2.96 109.375 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 19.7 pttm -152.43 87.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.262 0.467 . . . . 2.13 112.262 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.783 ' C ' HG23 ' A' ' 23' ' ' VAL . 73.4 mtp180 -154.24 93.08 1.58 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.324 -0.235 . . . . 3.83 111.422 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.709 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.28 -128.87 1.32 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.19 -1.481 . . . . 0.41 114.786 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.6 mttm -121.55 -122.79 0.28 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.341 -0.93 . . . . 1.13 109.481 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.12 -40.58 5.14 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.291 -1.924 . . . . 0.51 108.291 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 12.0 mptt -137.14 1.95 2.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.187 -1.507 . . . . 3.41 110.922 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.665 ' OD2' HG22 ' A' ' 43' ' ' VAL . 35.9 t0 -87.6 9.48 21.09 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.12 0.486 . . . . 1.22 111.465 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.3 p -89.36 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.867 -0.606 . . . . 0.34 111.705 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.9 pt-20 -107.73 101.15 10.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.483 -0.781 . . . . 1.26 110.035 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.675 ' HE1' HG21 ' A' ' 23' ' ' VAL . 7.2 m-85 -107.02 150.14 26.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.822 -0.626 . . . . 0.65 110.302 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.1 tt -88.64 156.99 18.71 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.593 -0.892 . . . . 0.96 108.593 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.0 m -141.21 112.04 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 114.07 1.137 . . . . 0.4 114.07 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' TRP . 77.6 mtt180 -87.38 79.29 8.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.666 -1.975 . . . . 3.27 105.666 175.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.565 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.2 t90 -26.87 91.65 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.284 -1.326 . . . . 1.31 112.246 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.912 ' CB ' HG12 ' A' ' 10' ' ' VAL . 61.6 tttp -27.62 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.308 -1.315 . . . . 2.46 112.257 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.8 t70 -119.3 57.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 2.02 109.903 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -147.6 -145.25 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.59 112.735 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -144.97 -45.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.949 -0.644 . . . . 0.86 112.213 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.07 -177.33 4.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 2.13 110.535 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.58 139.42 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 1.6 111.214 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -134.35 -177.46 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.081 -0.509 . . . . 2.27 110.779 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -104.25 146.27 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.71 111.338 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 25' ' ' TYR . 92.0 t -89.19 159.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.65 109.792 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' N ' HG12 ' A' ' 38' ' ' VAL . 23.5 ttmm -75.46 107.46 7.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.325 0.583 . . . . 2.32 112.5 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.75 40.77 2.8 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.069 -0.969 . . . . 0.35 112.392 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 1.9 t -116.85 3.94 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.044 -0.354 . . . . 0.68 110.044 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -75.85 76.49 2.78 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.879 0.847 . . . . 1.35 110.799 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG22 ' OD2' ' A' ' 22' ' ' ASP . 58.6 t -58.12 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 113.219 -1.81 . . . . 1.49 113.249 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.75 51.34 1.83 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.595 -0.891 . . . . 0.48 108.595 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -45.85 -27.28 0.83 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.196 -0.911 . . . . 2.44 110.818 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.28 -46.94 63.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.775 -0.648 . . . . 2.48 109.785 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.584 HG23 ' HB1' ' A' ' 44' ' ' ALA . 59.7 t -58.98 -47.39 90.01 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-N 116.002 -0.545 . . . . 0.88 109.539 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.44 -56.69 9.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.175 1.39 . . . . 0.99 110.976 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.6 ttmm -56.59 -35.3 68.07 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.289 0.566 . . . . 3.35 109.682 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -91.56 -14.77 29.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.0 111.152 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.556 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -77.08 -59.95 2.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.718 0.771 . . . . 1.87 110.453 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.1 pt-20 -90.19 -41.75 11.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.3 -1.318 . . . . 1.77 111.482 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -87.69 -30.78 20.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.752 -0.658 . . . . 2.3 111.524 -179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.492 -0.861 . . . . 1.61 112.368 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.695 0.283 . . . . 2.16 110.973 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.2 mp0 -130.94 150.51 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.882 0.372 . . . . 2.41 111.202 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.519 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 50.3 p90 -92.5 113.64 25.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.802 0.668 . . . . 1.73 112.802 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -100.55 54.14 0.88 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.949 -1.023 . . . . 0.38 109.254 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.73 164.33 14.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.992 0.901 . . . . 2.8 112.085 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 29' ' ' TRP . 39.1 t -98.34 -22.07 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 114.004 -1.453 . . . . 0.42 112.117 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 13.7 t70 -149.94 -40.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.385 0.513 . . . . 2.19 112.385 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 8.2 mm-40 -154.23 163.31 40.32 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 111.942 0.349 . . . . 2.18 111.942 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.93 -169.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.575 0.226 . . . . 0.34 110.582 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.4 t -150.13 -59.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.67 110.233 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 16.3 mm-40 -91.9 138.74 31.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.833 -0.622 . . . . 2.96 109.891 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 8.4 ptpp? -151.06 92.99 1.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.008 -0.277 . . . . 2.13 111.652 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.769 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.8 ttt180 -154.44 91.12 1.38 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.352 -0.217 . . . . 3.83 110.969 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.751 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.16 -134.11 1.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.111 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 69.0 mttm -117.28 -126.01 0.28 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.263 -0.968 . . . . 1.13 109.526 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.21 -38.7 6.66 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.551 -1.82 . . . . 0.51 108.551 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 20.8 mmtp -140.51 2.5 1.83 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.215 -1.492 . . . . 3.41 111.084 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 16.1 t70 -88.26 11.26 17.03 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.211 0.529 . . . . 1.22 111.462 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' C ' ' A' ' 17' ' ' ARG . 6.3 p -88.75 154.03 3.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.802 -0.636 . . . . 0.34 112.199 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.9 pt-20 -107.33 105.61 15.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.313 -0.858 . . . . 1.26 110.098 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.709 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 m-85 -110.52 150.82 28.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.654 . . . . 0.65 110.177 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.8 tt -88.74 157.26 18.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.07 -0.715 . . . . 0.96 109.07 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.9 m -143.07 110.55 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 114.428 1.27 . . . . 0.4 114.428 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.2 ttp180 -82.1 72.97 9.16 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 105.465 -2.05 . . . . 3.27 105.465 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.787 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -26.49 89.47 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.86 -1.518 . . . . 1.31 112.207 -177.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.726 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.2 ttpt -29.21 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.596 -1.184 . . . . 2.46 112.089 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.6 m-20 -117.95 56.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 2.02 109.796 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.13 -163.71 10.26 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.59 112.72 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.34 -43.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.006 -0.616 . . . . 0.86 112.054 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -97.75 -173.67 2.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 2.13 110.518 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 26' ' ' LEU . 44.6 t -142.69 144.1 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 1.6 111.087 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -147.68 -176.22 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 2.27 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 34.8 m0 -104.62 152.28 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.71 111.589 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 25' ' ' TYR . 72.1 t -88.95 161.06 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.993 -0.548 . . . . 0.65 109.942 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.3 tttp -75.48 104.36 6.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.343 0.592 . . . . 2.32 112.332 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.51 44.19 2.91 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.136 -0.938 . . . . 0.35 112.511 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.426 ' HB ' ' HE3' ' A' ' 39' ' ' LYS . 2.0 t -120.18 8.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.835 -0.431 . . . . 0.68 109.835 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -75.81 75.81 2.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.43 0.633 . . . . 1.35 110.433 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 60.5 t -57.87 73.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.609 -1.632 . . . . 1.49 113.5 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.71 49.55 1.48 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.799 -0.815 . . . . 0.48 108.799 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -44.16 -29.24 0.6 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.181 -0.918 . . . . 2.44 110.734 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 12.1 t70 -70.53 -43.76 68.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.488 -0.778 . . . . 2.48 110.117 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.6 t -63.04 -47.57 92.06 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 109.514 -0.551 . . . . 0.88 109.514 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -65.88 -54.79 21.98 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.99 111.062 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 27.9 ttpp -60.12 -33.16 71.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.456 0.646 . . . . 3.35 109.65 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 6.9 t70 -92.56 -9.37 41.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.278 -0.874 . . . . 2.0 110.652 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -86.53 -63.67 1.28 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.484 0.659 . . . . 1.87 110.749 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.4 pt-20 -85.79 -42.95 13.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.892 -1.049 . . . . 1.77 110.763 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -87.61 -18.92 28.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.607 -0.724 . . . . 2.3 111.42 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.454 -0.879 . . . . 1.61 112.369 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.579 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.143 0.497 . . . . 2.16 111.157 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.017 ' H ' HG11 ' A' ' 23' ' ' VAL . 7.9 tp10 -154.11 124.32 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 2.41 109.731 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 43.0 p90 -89.21 105.01 17.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.815 0.302 . . . . 1.73 111.815 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.788 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.58 56.1 3.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.55 -0.537 . . . . 0.38 109.55 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.616 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.71 149.51 32.82 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.813 0.816 . . . . 2.8 113.028 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 18.2 t -90.45 -32.49 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 114.222 -1.353 . . . . 0.42 110.647 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.5 t70 -138.43 -43.15 0.5 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 2.19 111.814 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.4 mm-40 -155.43 157.59 37.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.81 0.67 . . . . 2.18 112.81 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -126.87 -165.9 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.325 -0.62 . . . . 0.34 109.325 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.802 HG22 ' CB ' ' A' ' 26' ' ' LEU . 31.5 m -150.1 -51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.67 111.199 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.1 tp10 -105.23 134.71 47.89 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.897 -0.592 . . . . 2.96 109.448 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 13.2 ptmm? -150.9 88.98 1.5 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.134 -0.627 . . . . 2.13 112.63 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 15.0 ptp180 -153.6 91.34 1.47 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.85 -0.34 . . . . 3.83 111.383 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.61 -135.28 2.18 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 118.876 -1.631 . . . . 0.41 114.851 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.7 mttm -111.28 -120.26 0.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.46 -0.87 . . . . 1.13 109.909 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.95 -41.0 3.91 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 108.19 -1.964 . . . . 0.51 108.19 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 46.2 mmtm -135.08 0.46 2.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 112.978 -1.611 . . . . 3.41 110.871 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -88.54 9.88 22.33 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 121.297 0.57 . . . . 1.22 111.458 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.017 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.3 p -93.99 143.18 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.148 -0.933 . . . . 0.34 110.58 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 11.8 pt-20 -104.9 119.4 38.92 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.421 -0.512 . . . . 1.26 110.865 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 19.4 m-85 -113.8 -175.23 2.63 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.652 -0.704 . . . . 0.65 110.237 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CB ' HG22 ' A' ' 14' ' ' VAL . 2.1 tt -128.75 157.89 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.108 -0.951 . . . . 0.96 108.502 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.18 113.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 118.848 -1.141 . . . . 0.4 113.149 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -87.78 66.44 8.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 104.734 -2.321 . . . . 3.27 104.734 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 16.7 t90 -25.97 89.71 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.263 -1.79 . . . . 1.31 112.496 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 57.3 tttp -27.49 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.134 -1.394 . . . . 2.46 112.392 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' OD2' ' CZ2' ' A' ' 29' ' ' TRP . 7.8 p-10 -119.81 57.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 2.02 109.903 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -140.85 -147.16 4.89 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.753 -0.658 . . . . 0.59 112.887 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.67 -45.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.095 -0.574 . . . . 0.86 112.197 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.72 172.21 7.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 2.13 110.652 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.26 138.94 52.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 1.6 111.05 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -138.13 179.4 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 2.27 110.678 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 26.0 m0 -113.29 154.2 27.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.372 . . . . 0.71 111.747 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 8' ' ' ALA . 13.5 t -88.88 151.77 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.998 -0.546 . . . . 0.65 110.042 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.66 91.43 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 2.32 111.175 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 24' ' ' GLU . . . -90.11 42.48 2.95 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.759 -0.734 . . . . 0.35 113.14 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.33 11.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -81.78 81.52 7.78 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.76 0.79 . . . . 1.35 111.201 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 58.3 t -58.05 71.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.169 -1.832 . . . . 1.49 112.243 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.85 1.9 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.281 -0.872 . . . . 0.48 109.111 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.38 0.49 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.344 -0.843 . . . . 2.44 110.489 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 18.2 m-20 -70.33 -48.46 56.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.425 -0.807 . . . . 2.48 109.99 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.559 HG23 ' HB1' ' A' ' 44' ' ' ALA . 64.0 t -59.41 -42.25 87.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 116.385 -0.37 . . . . 0.88 110.286 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.64 -58.07 4.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.03 1.332 . . . . 0.99 110.842 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' GLY . 40.6 ttmt -58.98 -30.05 67.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.397 0.618 . . . . 3.35 109.406 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.9 t70 -91.67 -16.36 27.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.381 -0.827 . . . . 2.0 110.374 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -80.58 -67.7 0.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.591 0.71 . . . . 1.87 110.362 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 12.8 pt-20 -86.31 -44.29 12.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.884 -1.053 . . . . 1.77 111.149 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 8.5 t70 -86.94 -9.1 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.781 -0.645 . . . . 2.3 111.513 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.406 -0.902 . . . . 1.61 112.123 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.765 0.317 . . . . 2.16 111.402 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -140.07 145.52 37.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.278 -0.419 . . . . 2.41 110.972 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 17.9 p90 -88.39 124.6 34.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 1.73 111.28 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.723 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -107.15 49.54 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.459 -0.791 . . . . 0.38 110.348 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.75 176.97 4.98 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.846 0.831 . . . . 2.8 112.509 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 14.1 t -112.69 -14.5 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.157 -1.383 . . . . 0.42 112.225 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 16.8 t70 -150.16 -44.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.395 . . . . 2.19 111.171 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -153.16 173.84 15.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.039 -0.528 . . . . 2.18 111.447 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -143.22 -171.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.34 109.36 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.71 HG23 HD23 ' A' ' 26' ' ' LEU . 64.1 t -150.46 -48.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.67 110.699 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 14.3 mm-40 -93.51 145.6 24.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.118 -0.492 . . . . 2.96 110.445 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 20.0 ptmt -152.83 86.32 1.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.7 -0.4 . . . . 2.13 111.534 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.851 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.0 mmt180 -153.44 91.87 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 121.092 -0.243 . . . . 3.83 111.43 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.778 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.31 -130.77 1.71 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.644 -1.265 . . . . 0.41 114.912 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HE3' HG23 ' A' ' 43' ' ' VAL . 51.1 mttm -116.58 -74.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.279 1.038 . . . . 1.13 110.644 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.2 -47.1 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 107.021 -2.431 . . . . 0.51 107.021 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HE2' HG11 ' A' ' 47' ' ' VAL . 50.6 mmtt -125.21 -10.46 7.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 112.954 -1.623 . . . . 3.41 109.705 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 11.0 t70 -87.06 11.2 14.33 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.141 0.495 . . . . 1.22 111.833 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 17' ' ' ARG . 5.4 p -86.71 151.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.853 -0.612 . . . . 0.34 110.852 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 91.29 3.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.573 -0.739 . . . . 1.26 110.658 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 5.5 m-85 -88.16 -166.31 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.011 -0.54 . . . . 0.65 109.973 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 13' ' ' ILE . 15.1 tp -127.78 159.78 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.711 -0.848 . . . . 0.96 108.711 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -141.16 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 113.696 0.998 . . . . 0.4 113.696 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 29' ' ' TRP . 82.7 mtt180 -88.78 65.72 7.77 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 104.439 -2.43 . . . . 3.27 104.439 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 22.2 t90 -25.64 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.529 -1.669 . . . . 1.31 111.965 -177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 65.8 tttm -28.49 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.051 -1.431 . . . . 2.46 112.799 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.9 m-20 -108.49 49.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.806 0.336 . . . . 2.02 110.655 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.27 -162.17 10.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.16 -0.543 . . . . 0.59 112.538 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.48 27.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.86 112.589 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.48 179.43 7.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.936 0.398 . . . . 2.13 111.078 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.79 130.44 54.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 1.6 110.742 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.8 mm-40 -134.36 137.84 44.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 2.27 111.045 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.67 ' CD1' HD13 ' A' ' 26' ' ' LEU . 7.7 m0 -89.08 148.82 23.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.47 0.652 . . . . 0.71 111.889 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.723 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 14.6 t -87.23 158.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.947 -1.024 . . . . 0.65 109.777 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 88.2 tttt -81.21 111.58 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.314 0.578 . . . . 2.32 112.277 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 23' ' ' VAL . . . -96.37 38.7 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.186 -0.915 . . . . 0.35 112.844 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 1.9 t -114.34 -1.64 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 110.111 -0.329 . . . . 0.68 110.111 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.18 76.87 1.28 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.431 0.634 . . . . 1.35 110.238 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.2 p -56.22 69.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 113.441 -1.709 . . . . 1.49 114.086 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -89.5 51.23 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.48 109.143 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -48.78 -27.13 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.311 -0.859 . . . . 2.44 110.272 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 28.1 t70 -69.38 -48.36 61.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 2.48 110.058 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.876 HG11 ' HE2' ' A' ' 21' ' ' LYS . 35.4 t -59.69 -31.1 46.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 116.323 -0.399 . . . . 0.88 110.219 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.77 -59.47 2.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.875 1.27 . . . . 0.99 109.903 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 8.0 mtmp? -57.51 -27.23 62.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.922 -0.77 . . . . 3.35 108.922 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.5 t70 -92.71 -22.44 19.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.428 -0.805 . . . . 2.0 110.184 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.866 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.3 -70.17 0.38 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.858 0.837 . . . . 1.87 110.468 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 16.1 pt-20 -84.94 -50.36 7.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.077 -1.419 . . . . 1.77 111.813 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.3 t70 -73.99 -24.73 59.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.826 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 120.399 -0.905 . . . . 1.61 111.773 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 N-CA-C 109.392 -0.595 . . . . 2.16 109.392 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' H ' ' CG1' ' A' ' 23' ' ' VAL . 11.5 tp10 -140.88 129.16 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.009 0.433 . . . . 2.41 111.586 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 40.5 p90 -95.49 103.52 15.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.666 -0.697 . . . . 1.73 110.908 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -86.77 57.91 4.77 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.942 -0.762 . . . . 0.38 108.942 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.617 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -107.13 149.44 27.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.716 -1.129 . . . . 2.8 113.121 -177.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.747 HG12 ' CB ' ' A' ' 30' ' ' LYS . 55.0 t -90.27 -36.1 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 113.068 -1.878 . . . . 0.42 110.109 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 4.3 m-20 -141.13 -37.04 0.44 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 2.19 112.125 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.1 mt-10 -153.52 168.98 24.33 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 112.15 0.426 . . . . 2.18 112.15 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.79 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -138.71 -170.22 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 0.34 109.807 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.986 ' CG2' HD13 ' A' ' 26' ' ' LEU . 65.7 t -152.32 -60.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.863 0.363 . . . . 0.67 111.624 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 40.9 tt0 -92.33 93.33 8.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.96 112.043 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 21.0 pttm -104.87 90.54 3.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 2.13 111.166 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.772 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.5 ttt180 -155.99 87.34 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.947 -0.301 . . . . 3.83 111.55 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.696 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.66 -138.38 2.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 118.896 -1.621 . . . . 0.41 115.001 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 67.1 mttm -106.48 -113.32 0.27 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.858 -0.671 . . . . 1.13 110.106 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -101.17 -41.77 2.53 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 107.688 -2.165 . . . . 0.51 107.688 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 36.6 mtmm -143.18 6.86 1.55 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.985 -1.608 . . . . 3.41 110.882 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 40.5 t0 -89.96 13.01 15.83 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.214 0.53 . . . . 1.22 111.253 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.772 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.9 p -88.07 156.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.536 -0.756 . . . . 0.34 112.28 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 8.4 pt-20 -115.1 92.17 3.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.17 -0.923 . . . . 1.26 110.182 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.627 ' HE1' HG21 ' A' ' 23' ' ' VAL . 6.0 m-85 -88.74 -168.05 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.65 110.074 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.986 HD13 ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -123.26 161.13 25.18 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.534 -0.913 . . . . 0.96 108.534 178.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -141.75 110.22 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 118.611 -1.236 . . . . 0.4 113.701 178.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 79.0 mtt180 -87.15 77.55 9.05 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.14 -1.43 . . . . 3.27 107.14 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.691 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -27.34 90.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.177 -1.374 . . . . 1.31 112.114 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.747 ' CB ' HG12 ' A' ' 10' ' ' VAL . 54.7 tptt -27.99 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.809 -1.087 . . . . 2.46 112.23 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.1 m-20 -119.48 55.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.026 0.441 . . . . 2.02 110.041 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -143.01 -153.96 6.01 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.59 112.734 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.09 21.2 1.24 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.811 -0.709 . . . . 0.86 112.463 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -149.82 -172.33 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.13 110.685 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HB2' HD11 ' A' ' 26' ' ' LEU . 27.8 p -148.86 106.35 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 1.6 111.272 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.1 mp0 -102.38 -169.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.973 -0.558 . . . . 2.27 110.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.4 m0 -114.21 152.79 30.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.439 0.638 . . . . 0.71 112.406 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 67.3 t -88.17 163.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.108 -0.951 . . . . 0.65 109.768 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 38' ' ' VAL . 35.9 tptt -82.81 107.53 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.914 0.709 . . . . 2.32 112.914 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.97 29.43 9.98 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.219 -0.9 . . . . 0.35 111.949 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.495 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.5 t -103.36 -3.11 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.71 -0.478 . . . . 0.68 109.71 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 6.2 m170 -68.5 75.61 0.27 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.328 0.585 . . . . 1.35 110.089 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' VAL . 39.9 t -58.84 70.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.083 -1.417 . . . . 1.49 113.7 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.01 50.89 1.73 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.666 -0.865 . . . . 0.48 108.666 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.27 -24.24 1.72 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.931 -1.031 . . . . 2.44 110.657 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.6 m-20 -66.01 -48.68 70.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.183 -0.462 . . . . 2.48 110.115 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.616 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.8 t -58.63 -28.73 37.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.88 111.035 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -86.7 -59.11 2.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.99 110.162 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 24.0 ttmm -56.37 -28.49 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.044 -0.724 . . . . 3.35 109.044 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 11.3 t70 -90.97 -25.24 19.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.448 -0.797 . . . . 2.0 109.504 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -70.1 -71.15 0.25 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.947 0.88 . . . . 1.87 110.638 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.5 pt-20 -81.04 -45.91 15.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 113.95 -1.477 . . . . 1.77 111.796 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.67 -24.81 36.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.976 -0.557 . . . . 2.3 111.59 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.465 -0.874 . . . . 1.61 112.347 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 6.9 p90 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.764 0.316 . . . . 2.16 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.563 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.6 tp10 -131.16 143.24 50.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 2.41 110.391 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 46.3 p90 -89.06 107.44 19.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.312 0.577 . . . . 1.73 112.43 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -90.23 53.09 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.248 -0.887 . . . . 0.38 109.051 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.89 152.45 27.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 122.186 0.993 . . . . 2.8 113.308 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG12 ' CB ' ' A' ' 30' ' ' LYS . 62.1 t -89.78 -34.42 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 113.52 -1.673 . . . . 0.42 110.582 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 15.7 t70 -142.57 -38.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.942 -0.572 . . . . 2.19 112.321 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.0 mm-40 -155.16 155.95 34.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.828 0.677 . . . . 2.18 112.828 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -129.65 -169.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.882 0.372 . . . . 0.34 110.595 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG2' HD13 ' A' ' 26' ' ' LEU . 81.6 t -150.99 -55.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.67 110.062 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.9 mt-10 -92.09 139.02 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 2.96 109.618 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 19.3 pttm -152.16 89.15 1.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.346 0.499 . . . . 2.13 112.346 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' C ' HG23 ' A' ' 23' ' ' VAL . 11.4 ptp180 -154.7 92.41 1.47 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.238 -0.289 . . . . 3.83 111.189 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.95 -132.46 1.76 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.098 -1.525 . . . . 0.41 114.975 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.7 mttm -117.85 -121.26 0.3 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.368 -0.916 . . . . 1.13 109.599 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.92 -42.05 4.5 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.801 -2.119 . . . . 0.51 107.801 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -137.51 4.17 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.103 -1.549 . . . . 3.41 110.94 177.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 29.9 t0 -87.67 10.1 19.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.158 0.504 . . . . 1.22 111.024 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.9 p -89.24 154.73 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.827 -0.624 . . . . 0.34 111.406 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -110.64 99.04 8.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.396 -0.82 . . . . 1.26 110.101 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 38' ' ' VAL . 8.2 m-85 -104.25 153.03 21.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.697 -0.683 . . . . 0.65 110.441 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.6 tt -88.71 156.94 18.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.527 -0.916 . . . . 0.96 108.527 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -142.33 108.53 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 118.874 -1.131 . . . . 0.4 113.907 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 56.2 ttt180 -81.78 76.31 8.69 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.125 -1.806 . . . . 3.27 106.125 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.6 t90 -27.54 89.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.156 -1.384 . . . . 1.31 112.371 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.849 ' CB ' HG12 ' A' ' 10' ' ' VAL . 58.7 tttm -28.67 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.665 -1.152 . . . . 2.46 112.081 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . 21.8 t70 -120.15 57.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 2.02 109.832 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.32 -167.4 12.73 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.821 -0.627 . . . . 0.59 112.821 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.43 -39.28 0.63 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.992 -0.623 . . . . 0.86 112.205 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -113.12 164.08 13.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.664 0.268 . . . . 2.13 110.554 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.19 143.15 47.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.6 111.156 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.18 178.61 6.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 2.27 110.735 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 12.5 m0 -100.01 148.5 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.71 111.515 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 25' ' ' TYR . 61.8 t -88.67 161.35 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.65 109.777 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' HG12 ' A' ' 38' ' ' VAL . 22.5 ttmm -79.27 108.89 13.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.526 0.679 . . . . 2.32 112.322 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.28 42.62 2.93 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.811 -1.086 . . . . 0.35 112.466 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 t -115.45 -0.59 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.993 -0.373 . . . . 0.68 109.993 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.73 75.08 0.6 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.662 0.744 . . . . 1.35 110.906 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG23 ' HE3' ' A' ' 19' ' ' LYS . 7.7 p -59.5 72.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 113.552 -1.658 . . . . 1.49 113.376 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.12 51.48 1.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.532 -0.914 . . . . 0.48 108.532 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG2' ' CG ' ' A' ' 49' ' ' LYS . 42.5 tt0 -47.16 -25.95 1.02 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.84 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 31.7 t70 -68.75 -40.37 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.939 -0.573 . . . . 2.48 109.926 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 51' ' ' TYR . 91.3 t -66.47 -46.71 85.88 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 N-CA-C 109.67 -0.493 . . . . 0.88 109.67 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.09 -54.82 17.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.628 1.571 . . . . 0.99 111.516 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 72.0 mmtt -61.0 -32.01 71.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.504 0.668 . . . . 3.35 109.504 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.5 t70 -92.12 -11.88 34.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.376 -0.829 . . . . 2.0 110.46 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.568 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.4 m-30 -84.25 -63.63 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.39 0.614 . . . . 1.87 110.684 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -87.45 -46.48 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.1 -0.955 . . . . 1.77 110.654 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.0 m-20 -81.91 -20.92 37.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 2.3 111.431 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.218 0 C-N-CA 120.546 -0.835 . . . . 1.61 112.278 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.029 ' CE1' ' CE2' ' A' ' 5' ' ' PHE . 6.1 p90 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.65 0.262 . . . . 2.16 110.622 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.557 ' N ' HG11 ' A' ' 23' ' ' VAL . 9.8 tp10 -111.07 131.33 55.16 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 2.41 111.501 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' A' ' 13' ' ' ILE . 49.6 p90 -89.02 109.31 20.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.286 0.476 . . . . 1.73 112.286 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -91.99 56.1 2.8 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.38 109.063 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.12 151.74 25.48 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.168 0.985 . . . . 2.8 113.154 -176.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.786 HG12 ' CB ' ' A' ' 30' ' ' LYS . 84.5 t -89.66 -35.14 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 113.611 -1.632 . . . . 0.42 110.477 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -141.27 -39.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.658 -0.701 . . . . 2.19 111.997 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.7 mt-10 -154.46 157.79 38.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 2.18 112.484 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.49 -168.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.34 109.476 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 26' ' ' LEU . 71.4 t -151.04 -45.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 0.67 110.017 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.7 mt-10 -99.48 144.36 28.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.96 109.99 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.9 pttt -154.19 83.65 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.819 -0.352 . . . . 2.13 111.784 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.675 ' C ' HG23 ' A' ' 23' ' ' VAL . 74.9 ttt180 -154.03 86.64 1.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.714 -0.394 . . . . 3.83 111.362 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.691 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.0 -131.38 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.055 -1.545 . . . . 0.41 114.348 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 55.9 mttt -124.51 -120.14 0.27 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.509 -0.846 . . . . 1.13 109.97 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.57 -41.27 4.5 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 108.904 -1.678 . . . . 0.51 108.904 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 49.9 mttp -136.39 0.12 2.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.22 -1.49 . . . . 3.41 111.029 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 19' ' ' LYS . 21.8 t0 -88.21 8.66 26.05 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.22 111.815 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.703 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.6 p -87.99 147.69 5.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.936 -0.574 . . . . 0.34 110.747 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.0 pt-20 -111.31 90.37 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.626 -0.715 . . . . 1.26 110.299 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.703 ' HE1' HG21 ' A' ' 23' ' ' VAL . 8.2 m-85 -89.21 -168.11 2.07 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.975 -0.557 . . . . 0.65 109.713 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.795 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tt -126.49 159.23 33.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.987 -1.116 . . . . 0.96 107.987 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -139.5 114.2 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 118.619 -1.233 . . . . 0.4 113.45 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.641 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 54.7 ttt85 -88.25 75.57 8.54 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.815 -1.55 . . . . 3.27 106.815 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.7 m0 -27.9 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.395 -1.275 . . . . 1.31 112.511 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.786 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.8 tttp -29.78 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.619 -1.173 . . . . 2.46 111.938 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' TRP . 15.0 m-20 -125.75 51.36 1.75 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.931 -0.577 . . . . 2.02 109.91 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -130.98 -138.91 4.34 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.722 -0.672 . . . . 0.59 112.538 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.2 -48.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.78 -0.724 . . . . 0.86 112.677 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.67 179.51 4.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 2.13 111.089 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.9 m -124.2 106.44 10.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.072 -0.513 . . . . 1.6 111.03 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.1 mp0 -101.47 -175.77 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 2.27 111.033 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 31.6 m0 -114.27 154.43 27.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.481 . . . . 0.71 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 79.7 t -88.27 162.37 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.554 -0.748 . . . . 0.65 109.591 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' HG12 ' A' ' 38' ' ' VAL . 19.8 tptm -80.76 99.88 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.698 0.629 . . . . 2.32 112.698 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -98.42 26.06 25.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.445 -0.798 . . . . 0.35 111.992 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.52 -3.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.687 -0.486 . . . . 0.68 109.687 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' ALA . 93.1 m-70 -73.88 78.84 1.62 Allowed 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.52 0.676 . . . . 1.35 109.919 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 43' ' ' VAL . 9.0 p -58.55 69.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.636 -1.62 . . . . 1.49 113.341 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.699 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.67 50.05 1.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.062 -0.972 . . . . 0.48 109.127 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -45.53 -27.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.066 -0.97 . . . . 2.44 110.655 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 11.2 m-20 -68.31 -47.69 66.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.272 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.699 HG23 ' HB1' ' A' ' 44' ' ' ALA . 56.3 t -54.72 -40.38 51.28 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 116.375 -0.375 . . . . 0.88 110.517 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -72.69 -59.75 2.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.751 1.22 . . . . 0.99 110.497 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 4.5 tppp? -56.25 -28.66 59.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.338 -0.616 . . . . 3.35 109.338 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.7 t70 -92.99 -21.82 19.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.355 -0.838 . . . . 2.0 110.482 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -74.19 -67.4 0.62 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.561 0.696 . . . . 1.87 110.569 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 17.0 pt-20 -83.87 -48.41 10.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.696 -1.138 . . . . 1.77 111.474 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' CB ' ' HD3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -76.28 -36.88 58.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 2.3 111.501 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.212 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.8 p90 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 120.94 0.4 . . . . 2.16 110.994 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.949 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.0 tp10 -152.97 124.33 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.233 -0.654 . . . . 2.41 109.233 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.562 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.5 p90 -87.45 104.42 16.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.466 0.543 . . . . 1.73 112.466 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -89.27 58.26 4.38 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.673 -0.862 . . . . 0.38 108.673 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.752 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.21 148.07 41.94 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.261 1.029 . . . . 2.8 113.33 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 30' ' ' LYS . 46.5 t -88.48 -33.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 113.22 -1.809 . . . . 0.42 110.334 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 11.7 t70 -144.68 -38.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.38 -0.827 . . . . 2.19 111.77 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 10.8 mm-40 -154.48 162.71 41.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.458 0.54 . . . . 2.18 112.458 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.23 -164.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.34 109.857 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.017 ' CG2' HD13 ' A' ' 26' ' ' LEU . 98.1 t -149.98 -60.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.5 tp10 -92.84 134.28 35.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.563 -0.902 . . . . 2.96 108.563 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.7 ptpt -151.32 79.13 1.29 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.786 0.662 . . . . 2.13 112.786 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -153.86 95.32 1.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.95 -0.469 . . . . 3.83 111.31 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.62 -130.52 1.56 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 118.891 -1.623 . . . . 0.41 114.231 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.9 mttm -116.14 -120.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.86 -0.67 . . . . 1.13 109.741 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.39 -40.3 4.25 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 108.07 -2.012 . . . . 0.51 108.07 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 19.5 mmtp -135.64 1.55 2.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 112.963 -1.618 . . . . 3.41 110.878 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 42' ' ' HIS . 22.1 t70 -88.74 9.44 24.42 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-O 121.301 0.572 . . . . 1.22 111.557 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.949 HG11 ' H ' ' A' ' 6' ' ' GLU . 8.4 p -95.45 145.71 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.323 -0.853 . . . . 0.34 111.268 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 1.3 pm0 -104.42 111.84 24.66 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.851 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.758 ' HE1' HG21 ' A' ' 23' ' ' VAL . 23.4 m-85 -113.97 147.84 37.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.808 -0.633 . . . . 0.65 110.375 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.017 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.6 tt -90.24 159.52 16.66 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.975 -1.12 . . . . 0.96 107.975 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.3 m -140.44 111.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 118.75 -1.18 . . . . 0.4 113.517 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HG2' HD21 ' A' ' 26' ' ' LEU . 66.5 mtt180 -89.29 78.68 7.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.169 -1.419 . . . . 3.27 107.169 176.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HD1' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -27.8 89.71 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.254 -1.339 . . . . 1.31 111.864 -178.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.639 ' HB3' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -28.74 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.918 -1.037 . . . . 2.46 112.254 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 32.4 m-20 -118.3 55.7 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 2.02 109.901 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.24 -154.66 6.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.581 . . . . 0.59 112.815 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.64 -45.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.353 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.17 162.98 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 2.13 110.824 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.31 137.3 52.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.6 110.97 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -130.67 167.18 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.689 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 37.4 m0 -107.05 147.16 30.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.71 111.536 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.729 HG21 ' HB3' ' A' ' 8' ' ' ALA . 65.0 t -88.84 159.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.65 110.398 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.536 ' N ' HG12 ' A' ' 38' ' ' VAL . 82.8 tttt -79.6 96.43 6.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.078 0.466 . . . . 2.32 111.899 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.1 44.83 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.559 -0.746 . . . . 0.35 112.924 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.88 13.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.809 -0.441 . . . . 0.68 109.809 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -83.54 80.44 9.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.625 0.726 . . . . 1.35 111.118 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 43' ' ' VAL . 5.6 p -58.93 72.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.441 -1.708 . . . . 1.49 112.406 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.51 1.84 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.108 -0.951 . . . . 0.48 108.729 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 41.1 tt0 -44.78 -28.26 0.61 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.277 -0.874 . . . . 2.44 110.492 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.28 -50.19 55.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.746 . . . . 2.48 109.609 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 98.0 t -57.05 -46.62 84.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 CA-C-N 115.88 -0.6 . . . . 0.88 109.903 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -67.76 -59.21 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.99 111.11 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 73.0 mmtt -55.01 -33.56 62.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.191 0.52 . . . . 3.35 109.742 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.66 -19.43 22.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.802 -0.635 . . . . 2.0 110.738 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -73.2 -62.23 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.733 0.778 . . . . 1.87 109.724 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -92.06 -49.87 5.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.241 -1.345 . . . . 1.77 111.414 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -75.43 -20.24 58.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 2.3 111.435 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.886 . . . . 1.61 112.085 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 7.0 p90 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.758 0.313 . . . . 2.16 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.6 tp10 -128.42 142.29 51.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 2.41 110.731 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 52.5 p90 -88.91 114.56 25.67 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.691 0.758 . . . . 1.73 112.124 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.672 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -101.85 55.46 0.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.568 -1.196 . . . . 0.38 109.629 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -119.34 164.26 15.95 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.692 0.758 . . . . 2.8 112.222 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' HB3' ' A' ' 30' ' ' LYS . 18.4 t -99.05 -19.22 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.415 -1.266 . . . . 0.42 112.476 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 32.9 t70 -149.95 -43.13 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.046 0.388 . . . . 2.19 112.046 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 48.5 mt-10 -154.26 166.46 33.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 116.423 -0.353 . . . . 2.18 111.838 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -138.96 -171.66 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.5 0.191 . . . . 0.34 110.501 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.576 ' CG2' HD13 ' A' ' 26' ' ' LEU . 77.1 t -146.18 -60.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.67 110.05 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -94.36 136.71 34.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 2.96 109.717 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 41.8 pttt -150.85 94.66 2.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.791 0.293 . . . . 2.13 111.791 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' VAL . 80.7 mtp180 -155.98 92.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.229 -0.188 . . . . 3.83 111.044 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.714 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.82 -132.32 1.76 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 118.997 -1.573 . . . . 0.41 114.8 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.743 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -116.75 -123.32 0.29 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.182 -1.009 . . . . 1.13 109.243 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.77 -41.75 4.32 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 108.202 -1.959 . . . . 0.51 108.202 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.565 ' HE2' HG11 ' A' ' 47' ' ' VAL . 28.8 mmtt -132.3 -1.7 3.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.031 -1.584 . . . . 3.41 110.766 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.563 ' OD2' HG22 ' A' ' 43' ' ' VAL . 27.0 t0 -87.71 10.18 19.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.016 0.436 . . . . 1.22 111.943 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 17' ' ' ARG . 8.3 p -89.85 153.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.811 -0.631 . . . . 0.34 112.58 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 7.7 pt-20 -105.38 114.43 28.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.03 -0.986 . . . . 1.26 109.447 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.742 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 m-85 -120.11 149.14 42.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.309 -0.405 . . . . 0.65 110.06 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.6 tt -88.63 156.57 18.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.009 -0.738 . . . . 0.96 109.009 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.629 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.22 110.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 113.826 1.047 . . . . 0.4 113.826 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 12' ' ' GLU . 62.7 mtp180 -81.91 69.5 8.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.056 -2.201 . . . . 3.27 105.056 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.635 ' CD1' HG21 ' A' ' 10' ' ' VAL . 3.5 t90 -25.17 90.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 113.768 -1.56 . . . . 1.31 112.317 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.695 ' HB3' HG12 ' A' ' 10' ' ' VAL . 27.8 tptp -28.42 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.286 -1.324 . . . . 2.46 112.196 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.1 m-20 -117.65 57.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 2.02 109.885 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -141.05 3.4 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.59 112.641 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.99 -48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.86 112.486 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -92.81 164.02 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 2.13 110.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.62 109.78 16.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 1.6 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -112.57 178.92 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 2.27 110.899 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 36.9 m0 -102.02 149.23 24.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 0.71 111.924 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 25' ' ' TYR . 46.5 t -89.38 161.21 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.65 109.883 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.4 tptt -72.75 103.08 3.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.546 0.572 . . . . 2.32 112.546 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.27 42.13 2.85 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.452 -0.794 . . . . 0.35 112.868 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.3 t -118.48 10.3 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.205 -0.294 . . . . 0.68 110.205 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -77.76 78.3 4.26 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.578 0.704 . . . . 1.35 111.052 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.743 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 97.7 t -57.78 71.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 113.346 -1.752 . . . . 1.49 113.065 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.54 49.83 1.53 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.789 -0.819 . . . . 0.48 108.789 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -42.16 -30.61 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.17 -0.923 . . . . 2.44 110.886 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 4.1 p30 -67.53 -47.0 71.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.376 -0.829 . . . . 2.48 109.968 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HB1' ' A' ' 44' ' ' ALA . 48.6 t -60.29 -40.07 82.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 109.894 -0.41 . . . . 0.88 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.82 -57.71 5.2 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.205 1.402 . . . . 0.99 110.999 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 7.5 mmpt? -60.59 -28.75 68.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.532 0.682 . . . . 3.35 109.343 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.3 t70 -92.53 -14.31 28.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.353 -0.84 . . . . 2.0 110.174 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE1' ' CG1' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -83.44 -68.63 0.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.536 0.684 . . . . 1.87 110.342 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.9 pt-20 -83.91 -47.25 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.677 -1.147 . . . . 1.77 111.048 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.9 t70 -82.06 -15.89 52.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 2.3 111.101 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.534 -0.841 . . . . 1.61 112.034 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 5.1 p90 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.908 0.385 . . . . 2.16 110.473 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.005 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.3 tm-20 -153.15 128.0 9.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.151 -0.685 . . . . 2.41 109.151 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.566 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 38.7 p90 -88.4 102.85 15.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 111.933 0.346 . . . . 1.73 111.933 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.813 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -86.92 59.01 5.39 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.054 -0.721 . . . . 0.38 109.054 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.667 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.09 149.55 31.97 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.32 1.057 . . . . 2.8 113.261 -176.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.737 HG12 ' CB ' ' A' ' 30' ' ' LYS . 55.8 t -89.09 -37.35 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.161 -1.836 . . . . 0.42 109.774 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 17.7 t70 -141.3 -37.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 2.19 111.926 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 24.6 mm-40 -154.3 157.12 38.19 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.572 0.582 . . . . 2.18 112.572 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.95 -166.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.826 -0.625 . . . . 0.34 109.431 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 99.4 t -150.88 -48.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.274 0.559 . . . . 0.67 109.513 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.5 mt-10 -99.97 144.91 28.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 2.96 109.643 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 22.6 pttm -154.38 78.36 1.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.371 0.508 . . . . 2.13 112.371 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.6 ttm180 -153.22 90.94 1.47 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.302 -0.559 . . . . 3.83 111.961 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.53 -132.42 1.71 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 118.95 -1.595 . . . . 0.41 114.789 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.3 mttm -116.59 -120.14 0.31 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.437 -0.882 . . . . 1.13 109.591 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -94.76 -40.41 4.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.067 -2.013 . . . . 0.51 108.067 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 16.7 mtmm -136.88 -1.1 2.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.137 -1.531 . . . . 3.41 111.41 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 15.9 t70 -85.66 8.9 17.87 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.262 0.553 . . . . 1.22 111.58 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.005 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.4 p -89.15 143.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.368 -0.833 . . . . 0.34 110.907 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 3.2 pt-20 -106.49 97.61 7.39 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.145 0.498 . . . . 1.26 111.188 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 18.5 m-85 -94.83 -169.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.598 -0.728 . . . . 0.65 109.774 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 2.2 tt -127.99 159.12 36.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.272 -1.01 . . . . 0.96 108.272 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.24 112.76 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 118.388 -1.325 . . . . 0.4 113.844 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 30' ' ' LYS . 19.8 ttm180 -88.94 77.05 7.78 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.708 -1.59 . . . . 3.27 106.708 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.573 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.6 t90 -27.81 89.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.363 -1.29 . . . . 1.31 112.273 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 39.5 ttmt -28.24 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.038 -0.983 . . . . 2.46 112.15 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.2 t70 -117.58 55.96 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.817 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.27 -163.67 10.92 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.834 -0.621 . . . . 0.59 112.669 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.55 35.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.349 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -145.98 -169.05 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 2.13 110.988 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.7 113.25 6.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.6 111.013 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mm-40 -121.62 175.61 6.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 2.27 110.74 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 27.5 m0 -116.17 151.99 34.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.078 0.465 . . . . 0.71 111.612 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.813 HG11 ' HB3' ' A' ' 8' ' ' ALA . 88.9 t -88.57 152.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.679 -0.692 . . . . 0.65 110.353 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HE2' ' CG2' ' A' ' 41' ' ' VAL . 22.7 tptm -72.58 97.1 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 2.32 112.16 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -93.92 40.54 2.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.706 -0.759 . . . . 0.35 113.014 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' CG2' ' HE2' ' A' ' 39' ' ' LYS . 1.1 t -120.45 4.16 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.68 109.801 177.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 14.0 m80 -80.5 81.44 6.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.821 0.82 . . . . 1.35 110.722 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 61.8 t -56.57 74.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 112.754 -2.021 . . . . 1.49 112.507 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -90.88 51.06 1.89 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.408 -0.815 . . . . 0.48 109.268 177.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 39.1 tt0 -47.77 -27.12 1.86 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.204 -0.907 . . . . 2.44 110.116 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 8.4 m-20 -70.38 -46.87 63.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.471 -0.786 . . . . 2.48 109.882 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.533 HG13 ' CE1' ' A' ' 51' ' ' TYR . 60.1 t -61.8 -45.83 97.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.733 -0.469 . . . . 0.88 109.733 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.69 -57.82 5.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.439 1.496 . . . . 0.99 111.432 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -57.87 -31.78 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.362 0.601 . . . . 3.35 109.466 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.2 t70 -91.96 -16.51 26.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.351 -0.84 . . . . 2.0 110.563 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -79.14 -65.21 1.03 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.473 0.654 . . . . 1.87 110.941 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.8 pt-20 -87.91 -45.78 9.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.839 -1.073 . . . . 1.77 111.191 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.1 m-20 -82.69 -19.18 38.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.795 -0.639 . . . . 2.3 111.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.368 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.536 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.039 0.447 . . . . 2.16 111.485 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.961 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -152.56 129.36 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.719 -0.673 . . . . 2.41 109.31 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 53.3 p90 -87.5 109.85 19.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.629 0.603 . . . . 1.73 112.629 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -92.07 50.11 1.62 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.661 -0.7 . . . . 0.38 109.127 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.77 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.45 149.78 28.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.229 1.014 . . . . 2.8 113.528 -177.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.737 HG12 ' CB ' ' A' ' 30' ' ' LYS . 61.1 t -89.34 -36.11 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.342 -1.754 . . . . 0.42 110.11 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.63 ' CG ' ' O ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -141.61 -39.25 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.285 -0.87 . . . . 2.19 111.706 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.8 mt-10 -155.04 158.26 38.84 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.593 0.59 . . . . 2.18 112.593 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.77 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.35 -165.93 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.34 109.611 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 26' ' ' LEU . 94.1 t -150.59 -58.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.14 0.495 . . . . 0.67 109.956 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 6.8 pt-20 -97.24 133.68 41.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 2.96 109.175 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 49.2 pttt -151.03 89.07 1.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.435 0.531 . . . . 2.13 112.435 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -154.33 93.06 1.57 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.288 -0.257 . . . . 3.83 110.902 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.11 -134.2 2.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 118.769 -1.681 . . . . 0.41 114.757 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.9 mttm -114.17 -119.03 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.464 -0.868 . . . . 1.13 109.554 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -96.9 -41.97 3.42 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 107.83 -2.108 . . . . 0.51 107.83 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 44.1 mmtt -132.96 0.2 3.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.118 -1.541 . . . . 3.41 111.048 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 16.1 t70 -86.72 6.92 28.92 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 121.261 0.553 . . . . 1.22 111.668 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.961 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.4 p -90.06 145.64 7.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.348 -0.842 . . . . 0.34 111.32 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' HA3' ' A' ' 40' ' ' GLY . 3.0 pt-20 -104.64 111.6 24.37 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.762 -0.654 . . . . 1.26 110.61 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.62 ' O ' HG23 ' A' ' 38' ' ' VAL . 23.0 m-85 -114.02 148.97 36.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.722 -0.672 . . . . 0.65 110.676 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.981 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.7 tt -89.7 159.15 17.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.922 -1.14 . . . . 0.96 107.922 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -140.12 108.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.699 -1.2 . . . . 0.4 113.448 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 30' ' ' LYS . 4.3 tpt180 -83.13 74.84 9.96 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.569 -1.641 . . . . 3.27 106.569 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.63 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 4.3 t90 -27.83 89.4 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.665 1.228 . . . . 1.31 112.091 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 34.9 ttpt -28.92 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.838 -1.073 . . . . 2.46 112.168 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' TRP . 16.8 m-20 -119.61 56.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 2.02 109.816 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.12 -163.48 10.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.859 -0.61 . . . . 0.59 112.886 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.26 27.99 1.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.937 -0.649 . . . . 0.86 112.336 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -142.05 -178.48 5.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 2.13 111.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' CZ ' ' A' ' 28' ' ' ARG . 65.0 m -135.77 111.23 9.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 1.6 110.821 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -124.96 172.58 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.27 111.052 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -114.85 150.36 35.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.71 111.483 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 ' HB3' ' A' ' 8' ' ' ALA . 89.0 t -89.68 160.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.55 . . . . 0.65 110.249 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 38' ' ' VAL . 24.2 ttmm -78.2 96.81 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.213 0.53 . . . . 2.32 112.269 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.83 46.82 2.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.463 -0.789 . . . . 0.35 112.509 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.51 3.24 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 0.68 110.368 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -75.04 79.56 2.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.689 0.756 . . . . 1.35 110.699 -179.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.4 t -58.04 66.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 113.04 -1.891 . . . . 1.49 113.362 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.42 53.67 2.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.857 -0.794 . . . . 0.48 108.857 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -48.95 -24.55 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.113 -0.949 . . . . 2.44 110.641 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.4 t70 -68.04 -49.8 59.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.606 . . . . 2.48 110.066 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG12 ' CE2' ' A' ' 51' ' ' TYR . 44.6 t -59.49 -32.01 47.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 116.287 -0.415 . . . . 0.88 110.594 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -80.03 -57.46 3.62 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.85 1.26 . . . . 0.99 109.866 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.3 tppt? -57.27 -29.57 63.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 3.35 108.679 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.9 t70 -92.12 -22.84 19.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.202 -0.908 . . . . 2.0 110.234 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.814 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.79 -68.25 0.47 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.791 0.805 . . . . 1.87 110.118 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -85.44 -50.4 7.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.266 -1.334 . . . . 1.77 111.765 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -74.47 -23.26 58.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 2.3 111.482 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.108 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' LYS . 10.9 p90 . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.957 0.408 . . . . 2.16 111.167 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.888 ' H ' HG11 ' A' ' 23' ' ' VAL . 19.8 mt-10 -150.85 145.62 25.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.883 -0.599 . . . . 2.41 109.546 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 37.2 p90 -90.61 110.04 21.2 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.93 0.715 . . . . 1.73 112.93 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.673 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -93.04 52.4 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.251 -0.886 . . . . 0.38 108.897 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.708 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.24 158.45 22.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.286 1.041 . . . . 2.8 113.244 -177.363 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.841 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.8 t -94.21 -36.42 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 113.199 -1.819 . . . . 0.42 110.596 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 34.5 t70 -140.25 -38.9 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 2.19 112.304 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -155.72 154.51 31.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.994 0.739 . . . . 2.18 112.994 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.93 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.802 0.334 . . . . 0.34 110.623 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 26' ' ' LEU . 76.9 t -150.46 -58.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.67 110.202 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.8 tp10 -94.15 135.14 35.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 2.96 109.683 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 17.0 ptpt -151.02 90.6 1.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.734 -0.386 . . . . 2.13 111.904 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' C ' HG23 ' A' ' 23' ' ' VAL . 13.7 ptm180 -153.51 92.6 1.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.142 -0.349 . . . . 3.83 111.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.68 -134.51 2.06 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.116 -1.516 . . . . 0.41 114.875 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HE3' HG23 ' A' ' 43' ' ' VAL . 68.5 mttm -111.02 -122.08 0.28 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.56 -0.82 . . . . 1.13 109.828 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.05 -41.55 4.58 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 108.009 -2.037 . . . . 0.51 108.009 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 10.6 mptt -136.58 2.57 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.094 -1.553 . . . . 3.41 110.651 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 28.8 t0 -87.68 10.27 18.74 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.263 0.554 . . . . 1.22 111.53 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.888 HG11 ' H ' ' A' ' 6' ' ' GLU . 12.2 p -91.31 153.84 3.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.302 -0.863 . . . . 0.34 111.899 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.0 pt-20 -106.19 116.57 32.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 1.26 110.186 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 38' ' ' VAL . 10.8 m-85 -119.48 147.49 44.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.65 110.422 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -88.49 156.74 18.93 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.563 -0.903 . . . . 0.96 108.563 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.708 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 m -141.11 113.38 4.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 113.725 1.009 . . . . 0.4 113.725 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -86.1 75.89 9.85 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 105.657 -1.979 . . . . 3.27 105.657 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.582 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.9 t90 -26.34 90.19 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.011 -1.449 . . . . 1.31 112.331 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.841 ' CB ' HG12 ' A' ' 10' ' ' VAL . 55.5 tptt -29.09 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.722 -1.127 . . . . 2.46 112.141 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.9 t70 -117.57 54.52 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.807 -0.442 . . . . 2.02 109.807 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.24 -160.29 9.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.878 -0.601 . . . . 0.59 112.919 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.16 29.12 0.99 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.114 -0.565 . . . . 0.86 112.128 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.96 176.73 9.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.697 0.284 . . . . 2.13 110.868 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.0 m -137.28 125.63 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 1.6 110.832 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.11 164.15 30.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.961 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 18.9 m0 -94.91 146.76 24.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.71 111.476 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 25' ' ' TYR . 40.5 t -89.59 161.33 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.65 109.812 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' N ' HG12 ' A' ' 38' ' ' VAL . 2.6 ttmp? -67.57 110.62 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 2.32 112.636 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -98.17 40.26 2.54 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.35 111.96 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 t -117.5 4.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.248 . . . . 0.68 110.521 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -73.51 76.4 1.45 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.73 0.776 . . . . 1.35 111.053 -179.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.4 p -59.11 72.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 113.394 -1.73 . . . . 1.49 113.333 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.4 50.1 1.58 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.48 108.511 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.4 tt0 -42.74 -30.16 0.36 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.088 -0.96 . . . . 2.44 111.055 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.27 -46.27 70.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.681 . . . . 2.48 110.069 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 51' ' ' TYR . 68.2 t -58.61 -44.74 90.21 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-N 116.016 -0.538 . . . . 0.88 109.719 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.87 -59.41 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.324 1.449 . . . . 0.99 111.386 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 11.9 mptt -56.49 -32.31 64.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.206 0.527 . . . . 3.35 109.781 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -91.79 -18.13 24.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.817 -0.629 . . . . 2.0 110.626 178.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -74.64 -62.61 1.47 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.677 0.751 . . . . 1.87 109.682 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 12.6 pt-20 -90.85 -50.58 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.283 -1.326 . . . . 1.77 111.362 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -74.44 -20.77 59.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 2.3 111.199 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.822 . . . . 1.61 112.036 179.49 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.27 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.833 0.349 . . . . 2.16 111.423 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.533 ' H ' HG11 ' A' ' 23' ' ' VAL . 21.5 mt-10 -126.06 143.29 51.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 2.41 110.973 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.527 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.3 p90 -89.58 112.58 23.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.522 0.677 . . . . 1.73 111.567 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.687 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -101.51 56.2 0.83 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.922 -1.035 . . . . 0.38 109.729 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.722 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.08 165.07 13.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.151 0.977 . . . . 2.8 112.708 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.888 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.1 t -90.25 -30.15 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 113.665 -1.607 . . . . 0.42 112.081 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 12.8 t70 -150.32 -35.89 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.262 0.468 . . . . 2.19 112.262 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.9 mt-10 -152.71 165.38 35.48 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.78 -0.368 . . . . 2.18 111.94 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -140.98 -170.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.842 0.353 . . . . 0.34 110.374 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.613 ' CG2' HD22 ' A' ' 26' ' ' LEU . 76.6 t -150.12 -52.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.67 110.038 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.4 tp10 -92.89 137.98 31.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 2.96 109.749 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 16.4 ptpt -152.52 89.36 1.41 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.852 -0.339 . . . . 2.13 111.14 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' VAL . 12.5 tpp180 -155.1 91.07 1.32 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.818 -0.353 . . . . 3.83 111.022 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.743 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.64 -131.59 1.69 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.269 -1.443 . . . . 0.41 114.368 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.77 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -119.76 -122.61 0.29 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.456 -0.872 . . . . 1.13 109.621 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.52 -39.57 4.98 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 108.406 -1.878 . . . . 0.51 108.406 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -137.07 0.42 2.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.228 -1.486 . . . . 3.41 111.18 177.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.9 t70 -87.35 10.33 17.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.996 0.427 . . . . 1.22 111.597 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.743 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.9 p -88.6 150.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.286 0.565 . . . . 0.34 111.876 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -109.08 101.9 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.23 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.7 m-85 -104.23 151.82 22.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.14 -0.482 . . . . 0.65 110.062 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tp -90.01 154.58 19.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.275 -1.009 . . . . 0.96 108.275 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -136.39 109.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 114.101 1.148 . . . . 0.4 114.101 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 53.2 mtt180 -82.84 77.78 9.53 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.627 -1.99 . . . . 3.27 105.627 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.624 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.1 t90 -27.09 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.268 -1.333 . . . . 1.31 111.95 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.888 ' CB ' HG12 ' A' ' 10' ' ' VAL . 59.0 tttm -27.17 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.271 -1.331 . . . . 2.46 112.355 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.0 m-20 -120.9 57.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 2.02 109.89 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -160.49 9.1 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.895 -0.593 . . . . 0.59 112.772 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.79 16.42 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.105 -0.569 . . . . 0.86 112.287 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -137.53 178.23 7.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.806 0.336 . . . . 2.13 110.777 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.24 108.93 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.965 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.33 166.88 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 2.27 111.069 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 40.4 m0 -89.01 145.78 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.651 . . . . 0.71 111.753 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 8' ' ' ALA . 89.1 t -88.76 162.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.65 109.855 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.6 tttt -75.45 103.82 5.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.771 0.656 . . . . 2.32 112.771 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.02 47.32 2.01 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.941 -1.027 . . . . 0.35 112.2 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.04 0.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.853 -0.425 . . . . 0.68 109.853 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.61 78.39 0.81 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.772 0.796 . . . . 1.35 110.004 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.77 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 94.9 t -57.33 69.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 113.047 -1.888 . . . . 1.49 113.426 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.51 51.88 2.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.312 -0.625 . . . . 0.48 109.312 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -47.34 -27.07 1.46 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.342 -0.845 . . . . 2.44 110.477 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 7.9 m-20 -70.99 -43.51 67.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.451 -0.795 . . . . 2.48 110.123 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.506 HG13 ' CE1' ' A' ' 51' ' ' TYR . 95.7 t -65.18 -39.97 87.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 109.737 -0.468 . . . . 0.88 109.737 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -71.95 -58.07 3.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.104 1.362 . . . . 0.99 110.741 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.8 tppt? -57.0 -30.66 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.228 -0.656 . . . . 3.35 109.228 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.8 t70 -92.09 -20.42 21.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.349 -0.841 . . . . 2.0 110.386 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.1 m-30 -75.4 -67.19 0.68 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.479 0.657 . . . . 1.87 110.606 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.0 pt-20 -86.46 -48.7 8.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.8 -1.091 . . . . 1.77 111.235 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 2.4 m-20 -77.52 -20.81 53.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.598 . . . . 2.3 111.162 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.405 0 C-N-CA 120.595 -0.812 . . . . 1.61 112.253 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.1 p90 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 120.792 0.33 . . . . 2.16 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.907 ' H ' HG11 ' A' ' 23' ' ' VAL . 1.2 mp0 -143.2 142.23 31.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.94 -0.573 . . . . 2.41 110.087 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.525 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 53.7 p90 -88.82 111.71 22.36 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.65 0.738 . . . . 1.73 111.741 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -95.26 46.14 1.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.759 -1.11 . . . . 0.38 109.751 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.671 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.88 164.42 14.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.602 0.715 . . . . 2.8 112.73 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 8.7 t -102.95 -20.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.687 -1.142 . . . . 0.42 112.437 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 14.8 t70 -144.51 -44.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.027 0.38 . . . . 2.19 112.027 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.1 mt-10 -155.68 162.72 40.52 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 112.053 0.39 . . . . 2.18 112.053 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.49 -167.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.627 0.251 . . . . 0.34 110.356 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 26' ' ' LEU . 95.3 t -149.99 -53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.033 0.444 . . . . 0.67 109.907 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 12.5 mm-40 -96.71 135.46 38.61 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 48.3 pttt -153.06 85.09 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.352 -0.539 . . . . 2.13 112.37 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.588 ' C ' HG23 ' A' ' 23' ' ' VAL . 58.5 ttt85 -154.44 95.49 1.81 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.101 0.41 . . . . 3.83 111.658 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.485 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.34 -128.64 1.3 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 118.863 -1.637 . . . . 0.41 114.885 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 97.8 mttt -119.44 -122.17 0.29 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.557 -0.821 . . . . 1.13 110.238 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.84 -40.56 5.88 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 108.804 -1.718 . . . . 0.51 108.804 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -143.75 3.99 1.29 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.537 -1.332 . . . . 3.41 111.43 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 20.3 t70 -88.41 11.67 16.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.322 0.582 . . . . 1.22 111.055 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.907 HG11 ' H ' ' A' ' 6' ' ' GLU . 9.0 p -89.47 154.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.332 -0.849 . . . . 0.34 112.249 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' HA3' ' A' ' 40' ' ' GLY . 46.7 mt-10 -96.83 128.09 43.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.11 -0.95 . . . . 1.26 108.956 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.665 ' HD2' HG21 ' A' ' 13' ' ' ILE . 11.4 m-85 -138.76 139.74 38.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 0.65 109.976 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.883 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -89.91 157.39 17.89 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.247 -0.649 . . . . 0.96 109.247 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 m -143.76 112.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 114.262 1.208 . . . . 0.4 114.262 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 86.5 mtt180 -85.53 66.4 9.65 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 104.566 -2.383 . . . . 3.27 104.566 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 18.8 t90 -25.65 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.362 -1.745 . . . . 1.31 112.218 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HB3' HG12 ' A' ' 10' ' ' VAL . 62.4 tttp -28.33 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.264 -1.334 . . . . 2.46 112.528 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.6 t70 -108.83 54.26 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.983 0.42 . . . . 2.02 109.99 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.28 -139.28 3.02 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.105 -0.569 . . . . 0.59 112.803 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.36 -46.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.085 -0.579 . . . . 0.86 111.885 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.57 163.96 12.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 2.13 110.272 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 28.1 p -121.31 138.83 54.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 1.6 111.376 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -130.76 168.96 16.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 2.27 109.938 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 24.6 m0 -88.53 144.2 26.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.815 0.34 . . . . 0.71 111.023 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 25' ' ' TYR . 85.0 t -88.42 154.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.65 110.115 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 38' ' ' VAL . 38.7 ttpt -66.18 103.88 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 2.32 111.573 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 24' ' ' GLU . . . -92.56 37.9 3.29 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.522 -0.763 . . . . 0.35 112.408 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.69 8.5 8.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.69 -0.485 . . . . 0.68 109.69 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.7 76.81 1.54 Allowed 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.505 0.669 . . . . 1.35 110.181 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 57.2 t -56.85 74.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 113.442 -1.708 . . . . 1.49 113.439 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -92.98 49.54 1.44 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.48 109.297 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 9.7 tp10 -48.16 -26.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.339 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -73.79 -47.0 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.567 -0.742 . . . . 2.48 110.228 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 51' ' ' TYR . 85.0 t -58.06 -46.83 88.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 109.951 -0.389 . . . . 0.88 109.951 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -68.74 -58.49 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 125.068 1.347 . . . . 0.99 111.125 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.9 ttpt -54.51 -33.74 60.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.533 . . . . 3.35 109.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.9 -20.61 21.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.75 -0.659 . . . . 2.0 110.721 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.3 m-30 -71.7 -62.19 1.51 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.69 0.757 . . . . 1.87 110.479 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -91.82 -49.5 6.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.47 -1.241 . . . . 1.77 111.484 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -74.21 -25.12 59.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.835 -0.62 . . . . 2.3 111.285 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.531 -0.842 . . . . 1.61 112.272 179.788 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 108.676 -0.861 . . . . 2.16 108.676 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.797 ' H ' HG11 ' A' ' 23' ' ' VAL . 31.4 mt-10 -152.7 148.0 26.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.148 0.425 . . . . 2.41 112.148 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.549 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 32.6 p90 -101.27 102.61 13.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.503 0.668 . . . . 1.73 110.938 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.643 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.32 53.42 2.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.186 -0.915 . . . . 0.38 110.303 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.92 167.78 10.82 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.468 0.651 . . . . 2.8 111.614 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 12.6 t -106.32 -16.69 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 115.111 -0.95 . . . . 0.42 112.387 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 17.3 t70 -148.3 -44.04 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.707 0.289 . . . . 2.19 111.754 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 18.7 mm-40 -154.18 168.44 26.52 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.363 -0.381 . . . . 2.18 111.593 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -139.46 -169.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.849 -0.426 . . . . 0.34 109.849 178.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 26' ' ' LEU . 96.3 t -149.79 -59.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.091 0.472 . . . . 0.67 109.97 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.5 tp10 -93.05 134.78 34.85 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.32 -0.622 . . . . 2.96 109.32 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 14.0 ptmt -150.83 92.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 2.13 111.089 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.628 ' C ' HG23 ' A' ' 23' ' ' VAL . 98.1 mtt180 -154.98 90.91 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.81 -0.356 . . . . 3.83 111.706 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.79 -134.98 2.29 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.057 -1.544 . . . . 0.41 114.702 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 62.3 mttm -106.77 -90.52 0.43 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.823 -0.688 . . . . 1.13 110.802 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -130.13 -44.38 0.18 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 107.755 -2.138 . . . . 0.51 107.755 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HA ' ' CE ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -132.56 -5.19 3.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.491 -1.354 . . . . 3.41 110.793 176.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 19.3 t70 -88.67 10.02 22.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.256 0.55 . . . . 1.22 111.397 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.797 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.5 p -89.01 158.15 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.472 -0.785 . . . . 0.34 111.404 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 23' ' ' VAL . 10.4 pt-20 -106.73 122.89 47.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.445 -0.798 . . . . 1.26 110.124 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 38' ' ' VAL . 9.8 m-85 -128.45 146.07 50.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.037 -0.528 . . . . 0.65 110.186 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.9 tt -88.72 157.81 18.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.318 -0.623 . . . . 0.96 109.318 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 m -142.69 113.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 113.881 1.067 . . . . 0.4 113.881 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -86.18 65.76 9.24 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.16 -2.533 . . . . 3.27 104.16 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.642 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 20.2 t90 -25.81 89.75 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 1.31 112.215 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HB3' HG12 ' A' ' 10' ' ' VAL . 88.8 tttt -28.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 114.113 -1.403 . . . . 2.46 112.421 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' O ' ' CE2' ' A' ' 29' ' ' TRP . 11.7 m-20 -110.93 55.37 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.417 . . . . 2.02 110.142 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -149.11 -158.4 8.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.08 -0.581 . . . . 0.59 112.688 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.5 21.18 1.34 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.331 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.82 -173.84 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.299 . . . . 2.13 110.798 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -145.61 136.34 24.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 1.6 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -149.96 176.88 10.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.816 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -98.11 148.52 23.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.71 111.324 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' TYR . 97.0 t -89.2 160.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 0.65 109.79 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.2 tttt -68.95 104.25 2.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.37 0.605 . . . . 2.32 112.174 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.65 37.99 3.29 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.108 -0.951 . . . . 0.35 112.667 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.5 t -115.85 3.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.672 0.272 . . . . 0.68 110.304 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -69.75 77.6 0.45 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.578 0.704 . . . . 1.35 109.826 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 48.7 t -56.91 75.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 113.717 -1.583 . . . . 1.49 113.34 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.54 53.69 2.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.593 -0.891 . . . . 0.48 108.593 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 49' ' ' LYS . 39.0 tt0 -49.72 -22.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.916 -1.038 . . . . 2.44 110.435 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.03 -50.53 47.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 2.48 110.087 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.5 t -57.79 -29.88 36.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.88 111.282 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -87.45 -58.11 2.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.155 1.382 . . . . 0.99 109.97 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 25.4 ttmm -54.84 -31.12 59.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.307 -0.86 . . . . 3.35 109.262 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -91.16 -25.39 19.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.518 -0.764 . . . . 2.0 109.854 178.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.78 -65.18 0.71 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.144 0.974 . . . . 1.87 110.374 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.1 pt-20 -90.22 -50.87 5.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.692 -1.595 . . . . 1.77 111.775 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.0 OUTLIER -77.92 -9.4 59.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.696 -0.684 . . . . 2.3 111.321 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.041 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.63 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.827 0.346 . . . . 2.16 111.282 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.709 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.6 mp0 -134.55 144.07 47.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 2.41 111.067 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.0 p90 -89.52 105.38 17.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.17 0.509 . . . . 1.73 111.902 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.9 53.35 2.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.457 -0.792 . . . . 0.38 109.022 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.739 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.81 158.57 20.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.12 0.962 . . . . 2.8 112.96 -177.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.818 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.9 t -97.21 -35.28 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 113.66 -1.609 . . . . 0.42 110.503 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.6 t70 -139.3 -39.36 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.735 -0.666 . . . . 2.19 112.048 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.4 mt-10 -155.98 157.36 36.07 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 112.787 0.662 . . . . 2.18 112.787 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.29 -169.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.34 109.972 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.4 t -150.24 -49.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.67 110.13 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.9 tp10 -98.97 139.1 35.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.715 -0.675 . . . . 2.96 109.689 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 11.3 ptmm? -151.6 87.85 1.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.652 -0.419 . . . . 2.13 112.1 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.647 ' C ' HG23 ' A' ' 23' ' ' VAL . 79.7 ttt180 -153.74 92.36 1.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.042 -0.263 . . . . 3.83 111.101 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.21 -130.21 1.57 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.15 -1.5 . . . . 0.41 114.946 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 68.4 mttm -124.52 -121.62 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.894 0.878 . . . . 1.13 110.082 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.71 -40.03 6.07 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.141 -1.983 . . . . 0.51 108.141 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 2.0 mptp? -143.87 7.02 1.42 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.187 -1.506 . . . . 3.41 111.161 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 17.9 t70 -87.43 9.06 22.0 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.129 0.49 . . . . 1.22 111.066 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.2 p -88.4 152.87 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.6 -0.727 . . . . 0.34 111.561 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.6 pt-20 -109.29 99.36 8.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.511 -0.768 . . . . 1.26 110.015 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HE1' HG21 ' A' ' 23' ' ' VAL . 9.4 m-85 -104.44 149.94 24.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.76 -0.655 . . . . 0.65 110.182 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.784 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 tt -88.97 157.16 18.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.658 -0.867 . . . . 0.96 108.658 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -143.21 110.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 118.953 -1.099 . . . . 0.4 113.894 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 77.2 mtt180 -83.91 75.71 10.09 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.895 -1.891 . . . . 3.27 105.895 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.588 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.4 t90 -26.9 89.68 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.922 -1.49 . . . . 1.31 112.28 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.818 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.3 tttp -29.02 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.654 -1.157 . . . . 2.46 112.209 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 19.4 t70 -119.41 55.59 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 2.02 109.885 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -142.27 -140.4 3.75 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.59 112.641 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.23 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.844 -0.693 . . . . 0.86 112.331 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.69 -174.28 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 2.13 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.8 m -143.97 126.39 15.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.6 110.915 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.06 179.68 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 2.27 110.89 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.9 m0 -100.19 150.91 22.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.71 111.846 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 25' ' ' TYR . 73.8 t -89.49 162.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.672 -0.694 . . . . 0.65 109.768 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.4 tttt -78.34 104.53 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.739 0.644 . . . . 2.32 112.739 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.62 45.05 2.73 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.076 -0.965 . . . . 0.35 112.516 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -118.3 0.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.999 -0.371 . . . . 0.68 109.999 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -72.76 76.46 1.13 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.595 0.712 . . . . 1.35 110.633 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 52.0 t -56.41 76.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 113.249 -1.796 . . . . 1.49 113.227 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -91.56 49.59 1.6 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.206 -0.906 . . . . 0.48 108.944 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -47.81 -27.83 2.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.13 -0.941 . . . . 2.44 110.509 -178.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 12.0 t70 -77.95 -44.03 28.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 2.48 109.424 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 49.2 t -65.18 -27.72 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.099 -0.501 . . . . 0.88 110.704 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -93.92 -57.78 2.44 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.997 1.436 . . . . 0.99 112.565 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 38.8 ttpt -51.73 -45.29 63.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.207 0.527 . . . . 3.35 110.556 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 1.8 t70 -79.42 -20.6 47.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.104 -0.702 . . . . 2.0 109.104 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.421 -0.809 . . . . 1.87 110.474 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -86.04 -48.71 8.4 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.324 -1.307 . . . . 1.77 111.684 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -77.34 -42.82 35.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.823 -0.626 . . . . 2.3 111.541 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.172 0 C-N-CA 120.542 -0.837 . . . . 1.61 112.394 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.431 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 9.3 p90 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.921 0.391 . . . . 2.16 110.932 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.583 ' H ' HG11 ' A' ' 23' ' ' VAL . 11.0 tp10 -142.43 145.11 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 2.41 110.275 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 44.4 p90 -89.76 105.5 17.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.079 0.466 . . . . 1.73 111.878 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.773 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.93 55.55 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.146 -0.687 . . . . 0.38 109.146 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.743 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.31 163.17 15.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.087 0.946 . . . . 2.8 112.433 -177.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.828 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.7 t -96.71 -37.54 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 113.595 -1.639 . . . . 0.42 110.741 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 17.4 t70 -142.57 -34.56 0.44 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.038 -0.528 . . . . 2.19 112.244 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 44.8 mt-10 -156.0 151.06 26.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.25 0.833 . . . . 2.18 113.25 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -125.98 -171.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.331 -0.395 . . . . 0.34 110.561 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 26' ' ' LEU . 94.7 t -147.19 -48.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.069 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.9 mt-10 -97.72 141.77 30.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.821 -0.627 . . . . 2.96 109.751 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.4 ptmt -152.02 84.92 1.28 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.687 -0.405 . . . . 2.13 111.898 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.881 ' C ' HG23 ' A' ' 23' ' ' VAL . 51.9 ttp180 -153.38 97.12 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.085 -0.246 . . . . 3.83 111.027 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.21 -130.23 1.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 118.94 -1.6 . . . . 0.41 114.978 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.967 ' HE3' HG13 ' A' ' 43' ' ' VAL . 54.1 mttm -117.04 -72.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.333 1.063 . . . . 1.13 110.738 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.31 -47.81 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 106.835 -2.506 . . . . 0.51 106.835 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 1.8 mptt -127.6 -6.27 5.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.076 -1.562 . . . . 3.41 109.831 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.0 t70 -86.75 9.73 18.05 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.125 0.488 . . . . 1.22 111.291 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.881 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.0 p -87.22 152.37 3.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.78 -0.645 . . . . 0.34 111.086 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.99 94.56 5.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.654 -0.703 . . . . 1.26 110.689 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.657 ' HD2' HG21 ' A' ' 13' ' ' ILE . 7.0 m-85 -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.153 -0.476 . . . . 0.65 110.38 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.81 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.2 tt -89.31 157.73 18.08 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.366 -0.976 . . . . 0.96 108.366 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.743 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.41 110.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.022 -1.071 . . . . 0.4 113.499 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' CD ' HD21 ' A' ' 26' ' ' LEU . 13.3 mmm180 -84.75 79.39 9.63 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.142 -1.799 . . . . 3.27 106.142 175.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.823 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -27.19 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.535 -1.211 . . . . 1.31 111.966 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.828 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.0 ttpt -27.62 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.307 -1.315 . . . . 2.46 112.26 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' TRP . 6.0 m-20 -123.94 57.07 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.005 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -140.97 -159.65 7.99 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.017 -0.611 . . . . 0.59 112.999 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.23 19.8 1.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.121 -0.561 . . . . 0.86 112.376 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -139.9 -176.56 4.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.741 0.305 . . . . 2.13 110.636 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . 29.0 p -150.19 111.16 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 1.6 111.232 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -123.99 -176.85 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 2.27 110.922 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 m-90 -108.71 153.24 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.108 0.48 . . . . 0.71 111.697 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 8' ' ' ALA . 49.0 t -88.43 162.18 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.704 -0.68 . . . . 0.65 109.52 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.5 tttt -80.73 103.62 10.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.461 0.648 . . . . 2.32 112.075 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -88.83 45.05 3.18 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.027 -0.988 . . . . 0.35 112.647 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -120.2 0.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.076 -0.342 . . . . 0.68 110.076 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.85 77.83 0.88 Allowed 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.46 0.648 . . . . 1.35 109.775 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.967 HG13 ' HE3' ' A' ' 19' ' ' LYS . 49.5 t -56.09 72.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.406 -1.724 . . . . 1.49 113.805 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.62 49.52 1.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.565 -0.743 . . . . 0.48 109.354 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.46 -28.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.209 -0.905 . . . . 2.44 110.58 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 6.8 m-20 -66.7 -49.97 64.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.493 -0.776 . . . . 2.48 109.875 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.806 HG12 ' CD2' ' A' ' 51' ' ' TYR . 42.2 t -58.23 -30.52 40.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.593 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -79.32 -59.99 2.54 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.754 1.221 . . . . 0.99 109.954 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.7 ttpt -56.97 -27.84 61.7 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.758 -0.83 . . . . 3.35 108.758 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.2 t70 -91.85 -22.68 19.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.148 -0.933 . . . . 2.0 110.108 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.806 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.46 -71.09 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.837 0.827 . . . . 1.87 110.087 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.3 pt-20 -81.53 -47.16 13.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.143 -1.39 . . . . 1.77 112.012 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.3 m-20 -80.78 -18.73 46.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.043 -0.526 . . . . 2.3 111.703 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.408 -0.901 . . . . 1.61 112.391 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.127 ' CE1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 121.032 0.444 . . . . 2.16 111.6 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.748 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.4 tp10 -152.72 146.73 25.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.846 -0.615 . . . . 2.41 109.717 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -89.52 109.0 19.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 1.73 110.966 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' O ' ' OE2' ' A' ' 9' ' ' GLU . . . -94.32 33.13 1.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.482 -0.781 . . . . 0.38 110.698 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 1.163 ' CD ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -102.75 175.06 5.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.043 0.925 . . . . 2.8 112.815 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.669 HG21 ' CD1' ' A' ' 29' ' ' TRP . 21.3 t -109.49 -17.52 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 113.699 -1.591 . . . . 0.42 112.402 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 21.1 t70 -150.14 -43.33 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 2.19 111.468 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.6 mt-10 -153.3 168.45 25.99 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.091 -0.504 . . . . 2.18 111.545 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -141.52 -169.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.695 -0.483 . . . . 0.34 109.695 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.713 HG23 HD23 ' A' ' 26' ' ' LEU . 90.5 t -149.97 -57.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.67 110.092 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 20.6 mm-40 -91.02 133.98 34.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.931 -0.577 . . . . 2.96 109.447 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 pttm -151.07 87.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.708 -0.397 . . . . 2.13 111.442 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.636 ' C ' HG23 ' A' ' 23' ' ' VAL . 2.3 mpt_? -153.65 94.79 1.82 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.752 0.279 . . . . 3.83 111.752 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.07 -128.19 1.38 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 119.415 -1.374 . . . . 0.41 114.065 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.902 ' NZ ' HG23 ' A' ' 43' ' ' VAL . 86.0 mttt -109.49 -74.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.117 0.961 . . . . 1.13 110.659 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -151.7 -47.76 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 107.167 -2.373 . . . . 0.51 107.167 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 44' ' ' ALA . 2.1 ttpt -124.59 -9.62 7.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.067 -1.566 . . . . 3.41 109.802 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -86.47 7.71 24.82 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 121.232 0.539 . . . . 1.22 111.376 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG11 ' H ' ' A' ' 6' ' ' GLU . 10.8 p -89.25 157.71 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.409 -0.814 . . . . 0.34 110.63 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.7 pt-20 -110.26 115.83 30.4 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 1.26 110.864 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 13' ' ' ILE . 8.0 m-85 -115.71 148.5 39.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.607 -0.724 . . . . 0.65 110.131 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 37' ' ' TRP . 18.3 tp -90.7 159.0 16.59 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.781 -1.192 . . . . 0.96 107.781 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.163 HG11 ' CD ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -143.79 111.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 114.449 1.277 . . . . 0.4 114.449 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 81.7 mtt180 -83.23 70.0 10.04 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.068 -1.827 . . . . 3.27 106.068 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.2 t90 -26.28 89.7 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 113.761 -1.563 . . . . 1.31 112.036 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HB3' HG12 ' A' ' 10' ' ' VAL . 63.8 tttm -28.46 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.368 -1.287 . . . . 2.46 112.416 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.9 m-20 -111.76 54.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 2.02 110.076 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.13 -161.5 9.92 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.59 112.737 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.73 -38.9 0.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.984 -0.627 . . . . 0.86 112.237 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -114.09 176.22 5.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 2.13 110.628 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 26.9 p -126.67 130.53 50.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.361 . . . . 1.6 110.912 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.779 ' C ' HD12 ' A' ' 26' ' ' LEU . 31.1 mm-40 -117.13 165.6 13.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.066 0.46 . . . . 2.27 111.591 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CD1' HD13 ' A' ' 26' ' ' LEU . 12.3 m0 -87.97 140.32 29.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.617 -0.72 . . . . 0.71 111.138 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 25' ' ' TYR . 89.3 t -87.37 160.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.65 110.127 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.2 ttmt -77.23 108.08 10.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.118 0.785 . . . . 2.32 113.118 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -89.57 44.46 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.933 -1.03 . . . . 0.35 112.487 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG23 ' HG3' ' A' ' 39' ' ' LYS . 2.6 t -117.77 -5.19 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.332 . . . . 0.68 110.248 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -66.02 79.0 0.09 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.892 0.853 . . . . 1.35 110.057 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.902 HG23 ' NZ ' ' A' ' 19' ' ' LYS . 6.1 p -56.16 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 113.296 -1.774 . . . . 1.49 113.756 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.86 49.15 1.41 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.8 -1.091 . . . . 0.48 109.617 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 38.1 tt0 -45.18 -26.65 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.133 -0.939 . . . . 2.44 111.312 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.5 -46.86 62.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.594 . . . . 2.48 110.059 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.903 HG12 ' CE2' ' A' ' 51' ' ' TYR . 25.4 t -56.03 -35.5 41.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 116.073 -0.512 . . . . 0.88 109.875 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.07 -60.65 2.28 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.835 1.254 . . . . 0.99 110.344 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 26.5 ttpp -54.4 -30.6 52.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.25 -0.648 . . . . 3.35 109.25 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -92.95 -22.79 19.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.671 -0.695 . . . . 2.0 110.869 178.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.903 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.9 -66.08 0.6 Allowed 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.255 1.026 . . . . 1.87 109.018 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.28 -67.78 0.75 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.178 -1.828 . . . . 1.77 110.904 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -57.31 -43.2 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.027 -0.988 . . . . 2.3 111.185 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.53 -0.843 . . . . 1.61 112.164 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.934 -0.765 . . . . 2.16 108.934 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.752 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -151.16 139.61 20.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 2.41 111.798 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 47.1 p90 -91.42 106.58 18.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.174 0.511 . . . . 1.73 110.921 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.772 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -88.69 60.58 5.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.954 -0.758 . . . . 0.38 108.954 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.903 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -114.81 150.34 35.61 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.348 1.07 . . . . 2.8 113.181 -177.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.887 HG23 ' CG2' ' A' ' 27' ' ' VAL . 57.8 t -89.53 -36.78 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.25 -1.795 . . . . 0.42 109.212 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -144.47 -33.68 0.39 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.983 -1.008 . . . . 2.19 111.615 177.271 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' HD23 ' A' ' 26' ' ' LEU . 43.7 mt-10 -152.81 159.17 43.06 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.131 0.419 . . . . 2.18 112.131 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -128.67 -168.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.173 -0.677 . . . . 0.34 109.173 178.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.6 t -151.38 -60.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.218 0.533 . . . . 0.67 109.742 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 22.0 mm-40 -92.5 143.57 26.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.346 -0.843 . . . . 2.96 109.729 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.9 pttm -152.66 93.43 1.77 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.075 -0.25 . . . . 2.13 111.297 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.626 ' C ' HG23 ' A' ' 23' ' ' VAL . 1.7 tmt_? -155.16 88.64 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.469 -0.492 . . . . 3.83 111.205 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.589 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.92 -137.88 2.75 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 118.863 -1.636 . . . . 0.41 115.269 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 22' ' ' ASP . 90.6 mttt -108.36 -88.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.312 -0.944 . . . . 1.13 110.767 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -131.95 -44.79 0.15 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.928 -2.069 . . . . 0.51 107.928 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -131.33 -6.3 3.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.26 -1.47 . . . . 3.41 110.693 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 20.7 t70 -89.13 12.0 17.0 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 121.125 0.488 . . . . 1.22 111.347 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.752 HG11 ' H ' ' A' ' 6' ' ' GLU . 14.6 p -87.92 157.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.533 -0.758 . . . . 0.34 111.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.0 pt-20 -108.83 109.4 20.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.285 -0.87 . . . . 1.26 110.256 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.741 ' HE1' HG21 ' A' ' 23' ' ' VAL . 11.1 m-85 -118.68 152.93 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.935 -0.575 . . . . 0.65 110.605 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 3.1 tt -87.68 157.07 19.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.828 -0.804 . . . . 0.96 108.828 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.86 97.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.121 -0.631 . . . . 0.4 112.087 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 30' ' ' LYS . 48.3 ttt180 -79.17 82.45 5.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.737 -1.209 . . . . 3.27 107.737 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t90 -28.66 91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.803 -1.089 . . . . 1.31 112.085 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 18.6 pttp -26.97 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.55 -1.204 . . . . 2.46 112.557 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 29' ' ' TRP . 18.0 m-20 -120.63 57.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 2.02 110.087 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -139.28 -143.54 4.43 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.845 -0.616 . . . . 0.59 112.527 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.34 -48.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.855 -0.688 . . . . 0.86 112.307 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.76 179.7 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 2.13 110.804 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 26' ' ' LEU . 26.9 p -125.94 138.11 53.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.382 . . . . 1.6 111.014 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.53 158.86 42.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.607 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 41.7 m0 -97.18 149.26 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.71 111.368 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.783 HG23 HG12 ' A' ' 27' ' ' VAL . 77.0 t -88.77 159.31 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.65 110.009 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.3 tppt? -79.17 110.86 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.27 0.557 . . . . 2.32 112.159 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -87.95 36.76 3.33 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.232 -0.894 . . . . 0.35 112.914 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 39' ' ' LYS . 3.1 t -112.39 0.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.34 -0.245 . . . . 0.68 110.34 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -66.86 76.27 0.12 Allowed 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.688 0.756 . . . . 1.35 109.609 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.1 p -57.17 75.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 113.715 -1.584 . . . . 1.49 113.982 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 50.83 1.83 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.589 -0.893 . . . . 0.48 108.589 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -24.14 1.93 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.982 -1.008 . . . . 2.44 110.54 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 16.0 t70 -66.0 -49.77 66.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 2.48 109.91 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.822 HG12 ' CD2' ' A' ' 51' ' ' TYR . 60.3 t -55.05 -38.47 46.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 116.251 -0.431 . . . . 0.88 110.546 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -76.61 -59.86 2.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.188 1.395 . . . . 0.99 110.665 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.2 tmmm? -56.73 -28.44 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.157 -0.683 . . . . 3.35 109.157 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.9 t70 -91.54 -24.52 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.582 -0.736 . . . . 2.0 109.452 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.86 -70.28 0.3 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.817 0.817 . . . . 1.87 110.59 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.0 pt-20 -82.4 -48.17 11.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.21 -1.359 . . . . 1.77 111.714 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -78.19 -25.49 47.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.839 -0.619 . . . . 2.3 111.599 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.313 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.735 -0.146 . . . . 2.97 112.735 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p 177.0 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 3.15 111.059 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.44 136.66 32.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.175 -0.466 . . . . 4.57 109.852 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG22 ' CD ' ' A' ' 52' ' ' GLU . 2.1 t -90.91 48.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.371 -0.377 . . . . 3.08 111.325 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.6 p90 171.07 154.14 0.06 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.953 0.406 . . . . 2.16 111.888 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -134.75 142.41 46.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.957 -0.565 . . . . 2.41 111.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 31.7 p90 -89.78 122.26 32.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.73 111.424 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.776 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -107.25 53.45 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.816 -0.629 . . . . 0.38 110.651 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.696 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -106.41 176.79 5.05 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.934 0.873 . . . . 2.8 112.779 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.714 HG12 ' CB ' ' A' ' 30' ' ' LYS . 54.4 t -104.07 -24.28 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.021 -1.445 . . . . 0.42 111.505 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 5.3 t70 -150.52 -39.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.917 -0.583 . . . . 2.19 111.114 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 47.4 mt-10 -152.47 162.7 40.83 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.197 0.443 . . . . 2.18 112.197 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -131.73 -168.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.487 -0.56 . . . . 0.34 109.487 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 HD23 ' A' ' 26' ' ' LEU . 69.4 t -150.24 -49.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.67 110.836 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 43.6 tt0 -98.64 146.11 26.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.162 -0.472 . . . . 2.96 110.465 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 18.8 pttm -152.9 89.62 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.005 0.372 . . . . 2.13 112.005 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.78 ' C ' HG23 ' A' ' 23' ' ' VAL . 30.4 ttm180 -154.54 87.63 1.18 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 121.059 -0.256 . . . . 3.83 111.104 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.797 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.26 -137.74 2.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.084 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.6 mttm -115.63 -122.49 0.29 Allowed 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.65 -0.775 . . . . 1.13 110.325 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -90.28 -42.13 5.32 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.036 -2.026 . . . . 0.51 108.036 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 1.4 mptp? -140.67 7.29 2.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.023 -1.588 . . . . 3.41 110.675 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 30.3 t0 -88.85 10.07 22.45 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.893 0.377 . . . . 1.22 111.091 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.797 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.1 p -88.01 150.0 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 116.021 -0.536 . . . . 0.34 111.398 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.9 pt-20 -112.33 93.08 4.26 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.488 -0.778 . . . . 1.26 110.393 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 5.6 m-85 -88.16 -167.7 1.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.263 -0.643 . . . . 0.65 109.263 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.844 HD13 ' CD1' ' A' ' 37' ' ' TRP . 29.4 tp -126.48 160.63 30.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.064 -1.087 . . . . 0.96 108.064 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -139.19 110.72 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 118.924 -1.111 . . . . 0.4 113.529 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 52.0 mtt180 -84.85 74.19 10.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 105.668 -1.975 . . . . 3.27 105.668 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.7 t90 -26.72 90.81 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 113.867 -1.515 . . . . 1.31 111.833 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.714 ' CB ' HG12 ' A' ' 10' ' ' VAL . 83.5 tttt -27.39 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.352 -1.295 . . . . 2.46 112.341 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 4.7 p-10 -120.01 56.76 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.796 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.56 -178.02 23.3 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.59 112.628 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.06 -13.37 9.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.851 -0.69 . . . . 0.86 112.567 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -126.65 162.49 25.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 2.13 110.89 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 28' ' ' ARG . 61.2 m -116.1 118.72 33.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 1.6 110.71 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.782 ' O ' HD12 ' A' ' 26' ' ' LEU . 31.9 mt-10 -108.64 163.88 12.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.207 0.527 . . . . 2.27 111.68 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.844 ' CD1' HD13 ' A' ' 26' ' ' LEU . 16.2 m0 -87.95 148.37 24.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.71 112.015 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.776 HG11 ' HB3' ' A' ' 8' ' ' ALA . 40.1 t -87.6 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.018 -0.992 . . . . 0.65 109.751 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 86.9 tttt -80.76 106.89 13.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.284 0.564 . . . . 2.32 112.436 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -99.22 39.32 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.298 -0.864 . . . . 0.35 112.363 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.29 0.0 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.824 -0.436 . . . . 0.68 109.824 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.519 ' CG ' ' HB3' ' B' ' 11' ' ' LYS . 0.7 OUTLIER -77.05 77.79 3.6 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.734 0.778 . . . . 1.35 110.918 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 43' ' ' VAL . 6.0 p -57.28 77.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.325 -1.761 . . . . 1.49 112.663 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 12' ' ' ALA . . . -92.43 49.25 1.47 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.872 -1.058 . . . . 0.48 109.241 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 42.0 tt0 -48.28 -27.53 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.171 -0.922 . . . . 2.44 110.187 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 15.8 t70 -75.02 -43.12 55.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.477 -0.783 . . . . 2.48 109.73 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 51' ' ' TYR . 95.3 t -63.93 -46.79 93.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 109.34 -0.615 . . . . 0.88 109.34 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.4 -54.96 18.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.539 1.536 . . . . 0.99 111.331 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 23.3 ttmm -60.27 -33.28 72.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.406 0.622 . . . . 3.35 109.464 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.1 t70 -91.67 -11.4 37.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.276 -0.874 . . . . 2.0 110.428 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -84.02 -63.25 1.38 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.428 0.633 . . . . 1.87 110.262 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.7 pt-20 -87.64 -46.68 9.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.046 -0.979 . . . . 1.77 110.83 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -80.99 -22.51 39.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 2.3 111.425 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.75 90.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.244 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.31 -58.81 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 2.34 110.861 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.38 63.32 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 2.95 110.917 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.9 t80 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.23 -0.89 . . . . 2.23 110.859 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.54 0.2 . . . . 5.2 111.54 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' B' ' 1' ' ' ALA . 90.5 Cg_endo -77.12 110.04 2.94 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.925 1.75 . . . . 5.12 112.569 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.09 106.11 1.66 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.49 2.126 . . . . 3.56 112.216 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . 133.86 -91.09 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 2.11 112.125 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.506 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.3 t -88.27 169.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 1.85 111.475 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.588 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -132.46 174.74 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.909 -0.587 . . . . 1.86 110.988 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.43 ' CA ' ' HE3' ' B' ' 11' ' ' LYS . 40.1 ptt180 -124.3 125.19 43.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 7.29 110.82 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.498 ' NH1' ' CE1' ' A' ' 7' ' ' TYR . 29.7 tpt180 -43.22 -58.14 2.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.937 0.398 . . . . 6.23 111.314 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' B' ' 11' ' ' LYS . 62.1 mttp -154.88 -157.76 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.806 -0.634 . . . . 7.18 109.322 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -52.43 -25.0 8.83 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.728 -0.471 . . . . 4.33 109.728 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.519 ' HB3' ' CG ' ' A' ' 42' ' ' HIS . 88.6 mttt 55.11 100.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.708 -0.678 . . . . 4.49 111.013 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -81.69 117.23 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 2.05 110.595 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.422 ' OD1' ' CE1' ' A' ' 42' ' ' HIS . 10.1 p-10 -129.08 54.45 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.973 0.416 . . . . 3.8 110.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.209 -0.9 . . . . 3.91 110.998 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.662 -0.175 . . . . 2.97 112.662 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 71.2 p 176.38 -30.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.239 . . . . 3.15 111.477 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -88.91 141.99 28.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.826 0.346 . . . . 4.57 110.193 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 18' ' ' GLY . 2.5 t -92.54 45.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 3.08 110.035 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.3 p90 -177.48 142.31 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.772 -0.649 . . . . 2.16 110.39 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.4 tp10 -130.15 142.98 50.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 2.41 110.935 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.6 p90 -88.27 109.37 19.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.6 0.714 . . . . 1.73 112.034 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -95.02 50.82 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.758 -1.11 . . . . 0.38 109.611 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.12 169.23 9.26 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.984 0.897 . . . . 2.8 112.369 -178.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.912 HG12 ' CB ' ' A' ' 30' ' ' LYS . 51.7 t -97.53 -34.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-N 113.769 -1.559 . . . . 0.42 112.096 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 11.3 t70 -144.87 -33.67 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.508 0.558 . . . . 2.19 112.508 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 33.2 mm-40 -154.07 159.79 41.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.297 0.481 . . . . 2.18 112.297 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.4 -169.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.34 110.485 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG23 HD22 ' A' ' 26' ' ' LEU . 94.0 t -149.97 -54.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.431 . . . . 0.67 110.068 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 41.5 mt-10 -92.25 138.32 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 2.96 109.375 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 19.7 pttm -152.43 87.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.262 0.467 . . . . 2.13 112.262 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.783 ' C ' HG23 ' A' ' 23' ' ' VAL . 73.4 mtp180 -154.24 93.08 1.58 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.324 -0.235 . . . . 3.83 111.422 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.709 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.28 -128.87 1.32 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.19 -1.481 . . . . 0.41 114.786 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.6 mttm -121.55 -122.79 0.28 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.341 -0.93 . . . . 1.13 109.481 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.12 -40.58 5.14 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.291 -1.924 . . . . 0.51 108.291 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 12.0 mptt -137.14 1.95 2.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.187 -1.507 . . . . 3.41 110.922 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.665 ' OD2' HG22 ' A' ' 43' ' ' VAL . 35.9 t0 -87.6 9.48 21.09 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.12 0.486 . . . . 1.22 111.465 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.3 p -89.36 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.867 -0.606 . . . . 0.34 111.705 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.9 pt-20 -107.73 101.15 10.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.483 -0.781 . . . . 1.26 110.035 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.675 ' HE1' HG21 ' A' ' 23' ' ' VAL . 7.2 m-85 -107.02 150.14 26.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.822 -0.626 . . . . 0.65 110.302 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.1 tt -88.64 156.99 18.71 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.593 -0.892 . . . . 0.96 108.593 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.0 m -141.21 112.04 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 114.07 1.137 . . . . 0.4 114.07 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' TRP . 77.6 mtt180 -87.38 79.29 8.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.666 -1.975 . . . . 3.27 105.666 175.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.565 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.2 t90 -26.87 91.65 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.284 -1.326 . . . . 1.31 112.246 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.912 ' CB ' HG12 ' A' ' 10' ' ' VAL . 61.6 tttp -27.62 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.308 -1.315 . . . . 2.46 112.257 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.8 t70 -119.3 57.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 2.02 109.903 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -147.6 -145.25 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.59 112.735 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -144.97 -45.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.949 -0.644 . . . . 0.86 112.213 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.07 -177.33 4.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 2.13 110.535 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.58 139.42 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 1.6 111.214 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 21.9 mm-40 -134.35 -177.46 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.081 -0.509 . . . . 2.27 110.779 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -104.25 146.27 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.71 111.338 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 25' ' ' TYR . 92.0 t -89.19 159.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.65 109.792 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' N ' HG12 ' A' ' 38' ' ' VAL . 23.5 ttmm -75.46 107.46 7.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.325 0.583 . . . . 2.32 112.5 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.75 40.77 2.8 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.069 -0.969 . . . . 0.35 112.392 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 1.9 t -116.85 3.94 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.044 -0.354 . . . . 0.68 110.044 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 2.7 m-70 -75.85 76.49 2.78 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.879 0.847 . . . . 1.35 110.799 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG22 ' OD2' ' A' ' 22' ' ' ASP . 58.6 t -58.12 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 113.219 -1.81 . . . . 1.49 113.249 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.75 51.34 1.83 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.595 -0.891 . . . . 0.48 108.595 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -45.85 -27.28 0.83 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.196 -0.911 . . . . 2.44 110.818 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.28 -46.94 63.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.775 -0.648 . . . . 2.48 109.785 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.584 HG23 ' HB1' ' A' ' 44' ' ' ALA . 59.7 t -58.98 -47.39 90.01 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-N 116.002 -0.545 . . . . 0.88 109.539 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.44 -56.69 9.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.175 1.39 . . . . 0.99 110.976 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.6 ttmm -56.59 -35.3 68.07 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.289 0.566 . . . . 3.35 109.682 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -91.56 -14.77 29.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.0 111.152 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.556 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -77.08 -59.95 2.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.718 0.771 . . . . 1.87 110.453 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' SER . 15.1 pt-20 -90.19 -41.75 11.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.3 -1.318 . . . . 1.77 111.482 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -87.69 -30.78 20.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.752 -0.658 . . . . 2.3 111.524 -179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -65.03 -48.84 66.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.492 -0.861 . . . . 1.61 112.368 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.9 tp -64.84 -71.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 2.34 110.955 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.19 62.9 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 2.95 111.058 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 t80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.867 . . . . 2.23 110.798 179.87 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.62 0.248 . . . . 5.2 111.048 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.11 111.86 2.98 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.595 2.197 . . . . 5.12 112.298 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 -29.52 67.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.403 2.069 . . . . 3.56 112.355 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.511 ' C ' HG22 ' A' ' 27' ' ' VAL . . . -66.58 77.94 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.642 -0.79 . . . . 2.11 112.311 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.58 ' HA ' HG22 ' A' ' 38' ' ' VAL . 68.0 p -152.14 160.56 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.885 0.374 . . . . 1.85 111.653 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -170.58 66.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.86 110.795 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.585 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -45.08 131.28 7.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 7.29 111.432 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.473 ' HG3' ' HG3' ' B' ' 9' ' ' LYS . 7.9 tpm_? -47.43 -70.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.225 0.454 . . . . 6.23 112.225 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.473 ' HG3' ' HG3' ' B' ' 8' ' ' ARG . 30.0 mtpt -130.49 -162.39 1.21 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.148 0.499 . . . . 7.18 112.151 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.418 ' O ' ' HD2' ' B' ' 11' ' ' LYS . 26.9 ptt180 -57.3 -16.49 8.82 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 115.711 -0.677 . . . . 4.33 111.817 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.444 ' CE ' ' HG2' ' B' ' 7' ' ' ARG . 2.8 mptt 78.91 90.94 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.973 0.416 . . . . 4.49 110.44 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.97 -24.99 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 2.05 111.9 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 13.6 t70 -108.8 -25.15 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 3.8 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.482 ' HA ' ' CE1' ' A' ' 42' ' ' HIS . 77.8 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.183 -0.913 . . . . 3.91 111.275 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.707 -0.157 . . . . 2.97 112.707 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 77.3 p 177.37 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 3.15 111.187 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 14.6 mm100 -88.64 138.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.001 -0.37 . . . . 4.57 110.001 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.245 ' N ' ' HE1' ' A' ' 5' ' ' PHE . 2.0 t -91.79 48.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 3.08 110.101 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER 175.41 144.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 2.16 110.973 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.2 mp0 -130.94 150.51 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.882 0.372 . . . . 2.41 111.202 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 50.3 p90 -92.5 113.64 25.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.802 0.668 . . . . 1.73 112.802 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.83 ' HB2' ' NE ' ' B' ' 8' ' ' ARG . . . -100.55 54.14 0.88 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.949 -1.023 . . . . 0.38 109.254 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.73 164.33 14.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.992 0.901 . . . . 2.8 112.085 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 29' ' ' TRP . 39.1 t -98.34 -22.07 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 114.004 -1.453 . . . . 0.42 112.117 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 13.7 t70 -149.94 -40.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.385 0.513 . . . . 2.19 112.385 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 8.2 mm-40 -154.23 163.31 40.32 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 111.942 0.349 . . . . 2.18 111.942 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.93 -169.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.575 0.226 . . . . 0.34 110.582 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.4 t -150.13 -59.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.67 110.233 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 16.3 mm-40 -91.9 138.74 31.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.833 -0.622 . . . . 2.96 109.891 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 8.4 ptpp? -151.06 92.99 1.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.008 -0.277 . . . . 2.13 111.652 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.769 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.8 ttt180 -154.44 91.12 1.38 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.352 -0.217 . . . . 3.83 110.969 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.751 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.16 -134.11 1.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.111 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 69.0 mttm -117.28 -126.01 0.28 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.263 -0.968 . . . . 1.13 109.526 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.21 -38.7 6.66 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.551 -1.82 . . . . 0.51 108.551 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 20.8 mmtp -140.51 2.5 1.83 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.215 -1.492 . . . . 3.41 111.084 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 16.1 t70 -88.26 11.26 17.03 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.211 0.529 . . . . 1.22 111.462 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' C ' ' A' ' 17' ' ' ARG . 6.3 p -88.75 154.03 3.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.802 -0.636 . . . . 0.34 112.199 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.9 pt-20 -107.33 105.61 15.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.313 -0.858 . . . . 1.26 110.098 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.709 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 m-85 -110.52 150.82 28.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.654 . . . . 0.65 110.177 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.8 tt -88.74 157.26 18.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.07 -0.715 . . . . 0.96 109.07 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.9 m -143.07 110.55 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 114.428 1.27 . . . . 0.4 114.428 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.2 ttp180 -82.1 72.97 9.16 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 105.465 -2.05 . . . . 3.27 105.465 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.787 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -26.49 89.47 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.86 -1.518 . . . . 1.31 112.207 -177.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.726 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.2 ttpt -29.21 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.596 -1.184 . . . . 2.46 112.089 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.6 m-20 -117.95 56.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 2.02 109.796 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.13 -163.71 10.26 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.59 112.72 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.34 -43.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.006 -0.616 . . . . 0.86 112.054 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -97.75 -173.67 2.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 2.13 110.518 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 26' ' ' LEU . 44.6 t -142.69 144.1 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 1.6 111.087 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -147.68 -176.22 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 2.27 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 34.8 m0 -104.62 152.28 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.71 111.589 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 25' ' ' TYR . 72.1 t -88.95 161.06 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.993 -0.548 . . . . 0.65 109.942 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.3 tttp -75.48 104.36 6.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.343 0.592 . . . . 2.32 112.332 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.51 44.19 2.91 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.136 -0.938 . . . . 0.35 112.511 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.426 ' HB ' ' HE3' ' A' ' 39' ' ' LYS . 2.0 t -120.18 8.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.835 -0.431 . . . . 0.68 109.835 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -75.81 75.81 2.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.43 0.633 . . . . 1.35 110.433 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 60.5 t -57.87 73.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.609 -1.632 . . . . 1.49 113.5 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.71 49.55 1.48 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.799 -0.815 . . . . 0.48 108.799 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -44.16 -29.24 0.6 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.181 -0.918 . . . . 2.44 110.734 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 12.1 t70 -70.53 -43.76 68.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.488 -0.778 . . . . 2.48 110.117 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.6 t -63.04 -47.57 92.06 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 109.514 -0.551 . . . . 0.88 109.514 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -65.88 -54.79 21.98 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.99 111.062 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 27.9 ttpp -60.12 -33.16 71.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.456 0.646 . . . . 3.35 109.65 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 6.9 t70 -92.56 -9.37 41.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.278 -0.874 . . . . 2.0 110.652 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -86.53 -63.67 1.28 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.484 0.659 . . . . 1.87 110.749 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' CD ' HG22 ' A' ' 4' ' ' VAL . 14.4 pt-20 -85.79 -42.95 13.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.892 -1.049 . . . . 1.77 110.763 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -87.61 -18.92 28.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.607 -0.724 . . . . 2.3 111.42 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -80.14 -28.91 47.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.454 -0.879 . . . . 1.61 112.369 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 55' ' ' LEU . 1.6 tm? -86.6 -64.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.771 0.32 . . . . 2.34 110.41 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 pt-20 -88.38 58.14 4.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.056 0.455 . . . . 2.95 110.709 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.344 -0.836 . . . . 2.23 110.88 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.537 0.208 . . . . 5.2 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.05 118.32 4.37 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.651 2.234 . . . . 5.12 112.305 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.26 86.55 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.528 2.152 . . . . 3.56 112.556 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.506 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 159.9 64.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 2.11 112.651 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . 1.437 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 0.4 OUTLIER -152.13 172.29 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 1.85 111.556 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 8' ' ' ALA . . . -170.93 -160.81 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.944 -0.571 . . . . 1.86 110.71 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -140.31 133.88 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 7.29 111.119 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.83 ' NE ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -79.02 -33.5 44.81 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.091 -0.504 . . . . 6.23 111.557 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' B' ' 11' ' ' LYS . 90.4 mttt -156.96 -171.64 3.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.6 0.238 . . . . 7.18 111.143 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' B' ' 11' ' ' LYS . 24.3 ptt180 -52.36 -23.02 5.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.732 0.301 . . . . 4.33 111.423 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 12.7 mmmm 80.95 89.49 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.007 0.432 . . . . 4.49 110.331 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -60.13 -15.32 22.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 2.05 112.412 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 42' ' ' HIS . 4.7 p-10 -109.49 -24.77 10.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 3.8 111.328 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 46.9 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.316 -0.85 . . . . 3.91 111.118 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.554 -0.219 . . . . 2.97 112.554 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 27.4 t 174.14 -33.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.695 0.284 . . . . 3.15 111.001 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mp0 -89.19 139.29 30.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.372 -0.376 . . . . 4.57 110.067 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.999 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 1.5 t -89.68 50.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.971 0.415 . . . . 3.08 110.307 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.579 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -179.36 177.63 0.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 2.16 111.157 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.017 ' H ' HG11 ' A' ' 23' ' ' VAL . 7.9 tp10 -154.11 124.32 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 2.41 109.731 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 43.0 p90 -89.21 105.01 17.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.815 0.302 . . . . 1.73 111.815 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.788 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.58 56.1 3.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.55 -0.537 . . . . 0.38 109.55 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.616 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.71 149.51 32.82 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.813 0.816 . . . . 2.8 113.028 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.682 ' CG2' ' HB2' ' B' ' 6' ' ' ALA . 18.2 t -90.45 -32.49 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 114.222 -1.353 . . . . 0.42 110.647 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.5 t70 -138.43 -43.15 0.5 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 2.19 111.814 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.4 mm-40 -155.43 157.59 37.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.81 0.67 . . . . 2.18 112.81 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -126.87 -165.9 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.325 -0.62 . . . . 0.34 109.325 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.802 HG22 ' CB ' ' A' ' 26' ' ' LEU . 31.5 m -150.1 -51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.67 111.199 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.1 tp10 -105.23 134.71 47.89 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.897 -0.592 . . . . 2.96 109.448 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 13.2 ptmm? -150.9 88.98 1.5 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.134 -0.627 . . . . 2.13 112.63 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 15.0 ptp180 -153.6 91.34 1.47 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.85 -0.34 . . . . 3.83 111.383 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 4' ' ' VAL . . . -152.61 -135.28 2.18 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 118.876 -1.631 . . . . 0.41 114.851 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.7 mttm -111.28 -120.26 0.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.46 -0.87 . . . . 1.13 109.909 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.95 -41.0 3.91 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 108.19 -1.964 . . . . 0.51 108.19 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 46.2 mmtm -135.08 0.46 2.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 112.978 -1.611 . . . . 3.41 110.871 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -88.54 9.88 22.33 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 121.297 0.57 . . . . 1.22 111.458 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.017 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.3 p -93.99 143.18 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.148 -0.933 . . . . 0.34 110.58 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 11.8 pt-20 -104.9 119.4 38.92 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.421 -0.512 . . . . 1.26 110.865 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 19.4 m-85 -113.8 -175.23 2.63 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.652 -0.704 . . . . 0.65 110.237 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CB ' HG22 ' A' ' 14' ' ' VAL . 2.1 tt -128.75 157.89 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.108 -0.951 . . . . 0.96 108.502 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.587 HG22 ' HA2' ' B' ' 4' ' ' GLY . 0.7 OUTLIER -141.18 113.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 118.848 -1.141 . . . . 0.4 113.149 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -87.78 66.44 8.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 104.734 -2.321 . . . . 3.27 104.734 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 16.7 t90 -25.97 89.71 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.263 -1.79 . . . . 1.31 112.496 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 57.3 tttp -27.49 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.134 -1.394 . . . . 2.46 112.392 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' OD2' ' CZ2' ' A' ' 29' ' ' TRP . 7.8 p-10 -119.81 57.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 2.02 109.903 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -140.85 -147.16 4.89 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.753 -0.658 . . . . 0.59 112.887 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.67 -45.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.095 -0.574 . . . . 0.86 112.197 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.72 172.21 7.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 2.13 110.652 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.26 138.94 52.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 1.6 111.05 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 11.1 mm-40 -138.13 179.4 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 2.27 110.678 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 26.0 m0 -113.29 154.2 27.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.372 . . . . 0.71 111.747 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 8' ' ' ALA . 13.5 t -88.88 151.77 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.998 -0.546 . . . . 0.65 110.042 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.66 91.43 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 2.32 111.175 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 24' ' ' GLU . . . -90.11 42.48 2.95 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.759 -0.734 . . . . 0.35 113.14 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.33 11.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.507 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -81.78 81.52 7.78 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.76 0.79 . . . . 1.35 111.201 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 58.3 t -58.05 71.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.169 -1.832 . . . . 1.49 112.243 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.85 1.9 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.281 -0.872 . . . . 0.48 109.111 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.38 0.49 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.344 -0.843 . . . . 2.44 110.489 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 18.2 m-20 -70.33 -48.46 56.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.425 -0.807 . . . . 2.48 109.99 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.559 HG23 ' HB1' ' A' ' 44' ' ' ALA . 64.0 t -59.41 -42.25 87.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 116.385 -0.37 . . . . 0.88 110.286 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.64 -58.07 4.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.03 1.332 . . . . 0.99 110.842 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' GLY . 40.6 ttmt -58.98 -30.05 67.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.397 0.618 . . . . 3.35 109.406 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.9 t70 -91.67 -16.36 27.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.381 -0.827 . . . . 2.0 110.374 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -80.58 -67.7 0.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.591 0.71 . . . . 1.87 110.362 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' CD ' HG22 ' A' ' 4' ' ' VAL . 12.8 pt-20 -86.31 -44.29 12.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.884 -1.053 . . . . 1.77 111.149 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 8.5 t70 -86.94 -9.1 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.781 -0.645 . . . . 2.3 111.513 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -84.85 -33.85 17.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.406 -0.902 . . . . 1.61 112.123 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.5 tp -83.93 -66.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 2.34 110.845 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -87.64 60.07 5.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 2.95 110.904 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 t80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.291 -0.861 . . . . 2.23 111.002 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.647 0.261 . . . . 5.2 111.009 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.87 149.32 34.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.643 2.229 . . . . 5.12 112.222 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.49 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 55.6 Cg_endo -69.18 76.69 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.191 . . . . 3.56 112.45 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -143.37 12.67 2.27 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.048 -0.596 . . . . 2.11 112.717 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . 1.015 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 30.3 m -152.67 147.48 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 1.85 111.642 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.682 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -148.99 -76.28 0.16 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.843 0.682 . . . . 1.86 112.843 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' B' ' 7' ' ' ARG . 5.7 mmp_? -59.85 -102.02 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.627 0.232 . . . . 7.29 111.627 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.843 ' NH1' HG21 ' B' ' 5' ' ' THR . 28.2 mtp180 55.25 169.07 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.17 0.441 . . . . 6.23 110.198 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' B' ' 11' ' ' LYS . 66.6 mttm -144.66 -168.71 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.62 0.247 . . . . 7.18 111.274 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -45.93 -28.88 1.23 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 121.036 0.446 . . . . 4.33 111.122 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 30.6 mttp 74.69 100.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 4.49 110.542 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.554 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -60.0 -26.53 66.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 2.05 111.326 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 17.7 t70 -113.08 78.22 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 3.8 110.948 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.249 -0.882 . . . . 3.91 110.868 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 120.158 -0.246 . . . . 2.97 112.534 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 15.5 t 174.74 -24.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.212 0.506 . . . . 3.15 112.355 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' CG ' ' CE1' ' A' ' 5' ' ' PHE . 28.8 tt0 -87.25 133.95 33.61 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 110.148 -0.316 . . . . 4.57 110.148 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 8.4 t -92.6 53.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.337 0.495 . . . . 3.08 112.337 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.8 OUTLIER 163.97 162.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.765 0.317 . . . . 2.16 111.402 179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -140.07 145.52 37.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.278 -0.419 . . . . 2.41 110.972 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 17.9 p90 -88.39 124.6 34.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 1.73 111.28 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.723 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -107.15 49.54 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.459 -0.791 . . . . 0.38 110.348 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.75 176.97 4.98 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.846 0.831 . . . . 2.8 112.509 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 14.1 t -112.69 -14.5 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.157 -1.383 . . . . 0.42 112.225 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 16.8 t70 -150.16 -44.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.395 . . . . 2.19 111.171 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -153.16 173.84 15.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.039 -0.528 . . . . 2.18 111.447 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -143.22 -171.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.34 109.36 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.71 HG23 HD23 ' A' ' 26' ' ' LEU . 64.1 t -150.46 -48.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.67 110.699 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 14.3 mm-40 -93.51 145.6 24.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.118 -0.492 . . . . 2.96 110.445 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 20.0 ptmt -152.83 86.32 1.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.7 -0.4 . . . . 2.13 111.534 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.851 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.0 mmt180 -153.44 91.87 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 121.092 -0.243 . . . . 3.83 111.43 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.778 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.31 -130.77 1.71 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.644 -1.265 . . . . 0.41 114.912 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HE3' HG23 ' A' ' 43' ' ' VAL . 51.1 mttm -116.58 -74.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.279 1.038 . . . . 1.13 110.644 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.2 -47.1 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 107.021 -2.431 . . . . 0.51 107.021 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HE2' HG11 ' A' ' 47' ' ' VAL . 50.6 mmtt -125.21 -10.46 7.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 112.954 -1.623 . . . . 3.41 109.705 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 11.0 t70 -87.06 11.2 14.33 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.141 0.495 . . . . 1.22 111.833 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 17' ' ' ARG . 5.4 p -86.71 151.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.853 -0.612 . . . . 0.34 110.852 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 91.29 3.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.573 -0.739 . . . . 1.26 110.658 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 5.5 m-85 -88.16 -166.31 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.011 -0.54 . . . . 0.65 109.973 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 13' ' ' ILE . 15.1 tp -127.78 159.78 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.711 -0.848 . . . . 0.96 108.711 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -141.16 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 113.696 0.998 . . . . 0.4 113.696 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 29' ' ' TRP . 82.7 mtt180 -88.78 65.72 7.77 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 104.439 -2.43 . . . . 3.27 104.439 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 22.2 t90 -25.64 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.529 -1.669 . . . . 1.31 111.965 -177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 65.8 tttm -28.49 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.051 -1.431 . . . . 2.46 112.799 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.9 m-20 -108.49 49.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.806 0.336 . . . . 2.02 110.655 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.27 -162.17 10.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.16 -0.543 . . . . 0.59 112.538 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.48 27.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.86 112.589 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.48 179.43 7.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.936 0.398 . . . . 2.13 111.078 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.79 130.44 54.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 1.6 110.742 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.8 mm-40 -134.36 137.84 44.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 2.27 111.045 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.67 ' CD1' HD13 ' A' ' 26' ' ' LEU . 7.7 m0 -89.08 148.82 23.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.47 0.652 . . . . 0.71 111.889 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.723 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 14.6 t -87.23 158.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.947 -1.024 . . . . 0.65 109.777 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 88.2 tttt -81.21 111.58 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.314 0.578 . . . . 2.32 112.277 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 23' ' ' VAL . . . -96.37 38.7 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.186 -0.915 . . . . 0.35 112.844 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 1.9 t -114.34 -1.64 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 110.111 -0.329 . . . . 0.68 110.111 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.651 ' CE1' ' HD3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -73.18 76.87 1.28 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.431 0.634 . . . . 1.35 110.238 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.2 p -56.22 69.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 113.441 -1.709 . . . . 1.49 114.086 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -89.5 51.23 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.48 109.143 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -48.78 -27.13 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.311 -0.859 . . . . 2.44 110.272 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 28.1 t70 -69.38 -48.36 61.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 2.48 110.058 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.876 HG11 ' HE2' ' A' ' 21' ' ' LYS . 35.4 t -59.69 -31.1 46.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 116.323 -0.399 . . . . 0.88 110.219 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.77 -59.47 2.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.875 1.27 . . . . 0.99 109.903 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 8.0 mtmp? -57.51 -27.23 62.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.922 -0.77 . . . . 3.35 108.922 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.5 t70 -92.71 -22.44 19.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.428 -0.805 . . . . 2.0 110.184 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.866 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.3 -70.17 0.38 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.858 0.837 . . . . 1.87 110.468 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 16.1 pt-20 -84.94 -50.36 7.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.077 -1.419 . . . . 1.77 111.813 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.3 t70 -73.99 -24.73 59.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.826 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -58.48 -40.27 94.16 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.399 -0.905 . . . . 1.61 111.773 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 12.6 mt -86.54 -54.96 4.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 2.34 110.267 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.2 60.67 5.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 2.95 110.776 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.221 -0.895 . . . . 2.23 110.767 -179.915 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 111.834 0.309 . . . . 5.2 111.834 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' B' ' 1' ' ' ALA . 84.7 Cg_exo -46.42 102.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.386 2.057 . . . . 5.12 112.68 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.26 100.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.559 2.173 . . . . 3.56 112.322 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.9 -95.19 1.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 2.11 112.402 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.496 ' HA ' HG21 ' A' ' 27' ' ' VAL . 9.8 t -89.61 167.32 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 1.85 111.293 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.592 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -121.46 51.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 1.86 111.154 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.551 ' HA ' HG13 ' A' ' 38' ' ' VAL . 52.8 ptt85 -42.74 136.93 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.094 -0.503 . . . . 7.29 111.45 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.436 ' HG2' ' HD2' ' A' ' 21' ' ' LYS . 25.8 tpt180 -51.87 142.45 15.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.462 -0.495 . . . . 6.23 109.738 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -125.09 43.75 2.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.039 0.385 . . . . 7.18 112.039 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.401 ' HG2' ' HG3' ' B' ' 8' ' ' ARG . 17.1 ptm180 -112.72 -28.96 7.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.905 0.383 . . . . 4.33 110.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.651 ' HD3' ' CE1' ' A' ' 42' ' ' HIS . 18.5 tptm 42.03 67.03 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.53 . . . . 4.49 111.39 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.457 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . . . -52.34 -23.17 5.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.489 -0.778 . . . . 2.05 111.807 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.488 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . 7.5 t70 -108.4 -71.37 0.76 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.98 -0.555 . . . . 3.8 111.268 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' B' ' 11' ' ' LYS . 23.2 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.244 -0.884 . . . . 3.91 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.761 -0.136 . . . . 2.97 112.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.439 ' HA ' ' CA ' ' A' ' 52' ' ' GLU . 45.8 p -149.24 -57.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.399 . . . . 3.15 110.797 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -102.06 117.21 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 4.57 110.569 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.28 -53.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 3.08 111.798 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 58.09 -174.19 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.392 -0.595 . . . . 2.16 109.392 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' H ' ' CG1' ' A' ' 23' ' ' VAL . 11.5 tp10 -140.88 129.16 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.009 0.433 . . . . 2.41 111.586 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 40.5 p90 -95.49 103.52 15.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.666 -0.697 . . . . 1.73 110.908 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -86.77 57.91 4.77 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.942 -0.762 . . . . 0.38 108.942 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.635 ' C ' ' HB3' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -107.13 149.44 27.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.716 -1.129 . . . . 2.8 113.121 -177.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.747 HG12 ' CB ' ' A' ' 30' ' ' LYS . 55.0 t -90.27 -36.1 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 113.068 -1.878 . . . . 0.42 110.109 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 4.3 m-20 -141.13 -37.04 0.44 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 2.19 112.125 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.1 mt-10 -153.52 168.98 24.33 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 112.15 0.426 . . . . 2.18 112.15 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.79 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -138.71 -170.22 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 0.34 109.807 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.986 ' CG2' HD13 ' A' ' 26' ' ' LEU . 65.7 t -152.32 -60.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.863 0.363 . . . . 0.67 111.624 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 40.9 tt0 -92.33 93.33 8.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.96 112.043 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 21.0 pttm -104.87 90.54 3.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 2.13 111.166 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.772 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.5 ttt180 -155.99 87.34 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.947 -0.301 . . . . 3.83 111.55 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.696 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.66 -138.38 2.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 118.896 -1.621 . . . . 0.41 115.001 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 67.1 mttm -106.48 -113.32 0.27 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.858 -0.671 . . . . 1.13 110.106 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -101.17 -41.77 2.53 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 107.688 -2.165 . . . . 0.51 107.688 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.786 ' HB3' ' HD3' ' B' ' 11' ' ' LYS . 36.6 mtmm -143.18 6.86 1.55 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.985 -1.608 . . . . 3.41 110.882 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 40.5 t0 -89.96 13.01 15.83 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.214 0.53 . . . . 1.22 111.253 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.772 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.9 p -88.07 156.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.536 -0.756 . . . . 0.34 112.28 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 8.4 pt-20 -115.1 92.17 3.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.17 -0.923 . . . . 1.26 110.182 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.627 ' HE1' HG21 ' A' ' 23' ' ' VAL . 6.0 m-85 -88.74 -168.05 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.65 110.074 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.986 HD13 ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -123.26 161.13 25.18 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.534 -0.913 . . . . 0.96 108.534 178.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -141.75 110.22 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 118.611 -1.236 . . . . 0.4 113.701 178.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 79.0 mtt180 -87.15 77.55 9.05 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.14 -1.43 . . . . 3.27 107.14 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.691 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -27.34 90.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.177 -1.374 . . . . 1.31 112.114 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.747 ' CB ' HG12 ' A' ' 10' ' ' VAL . 54.7 tptt -27.99 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.809 -1.087 . . . . 2.46 112.23 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.1 m-20 -119.48 55.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.026 0.441 . . . . 2.02 110.041 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -143.01 -153.96 6.01 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.59 112.734 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.09 21.2 1.24 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.811 -0.709 . . . . 0.86 112.463 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -149.82 -172.33 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.13 110.685 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HB2' HD11 ' A' ' 26' ' ' LEU . 27.8 p -148.86 106.35 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 1.6 111.272 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 1.1 mp0 -102.38 -169.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.973 -0.558 . . . . 2.27 110.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.4 m0 -114.21 152.79 30.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.439 0.638 . . . . 0.71 112.406 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 67.3 t -88.17 163.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.108 -0.951 . . . . 0.65 109.768 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 38' ' ' VAL . 35.9 tptt -82.81 107.53 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.914 0.709 . . . . 2.32 112.914 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.97 29.43 9.98 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.219 -0.9 . . . . 0.35 111.949 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.495 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.5 t -103.36 -3.11 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.71 -0.478 . . . . 0.68 109.71 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.203 ' O ' ' HE3' ' B' ' 11' ' ' LYS . 1.7 m-70 -68.5 75.61 0.27 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.328 0.585 . . . . 1.35 110.089 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' VAL . 39.9 t -58.84 70.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.083 -1.417 . . . . 1.49 113.7 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' B' ' 11' ' ' LYS . . . -92.01 50.89 1.73 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.666 -0.865 . . . . 0.48 108.666 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.27 -24.24 1.72 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.931 -1.031 . . . . 2.44 110.657 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.6 m-20 -66.01 -48.68 70.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.183 -0.462 . . . . 2.48 110.115 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.616 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.8 t -58.63 -28.73 37.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.88 111.035 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -86.7 -59.11 2.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.99 110.162 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 24.0 ttmm -56.37 -28.49 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.044 -0.724 . . . . 3.35 109.044 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 11.3 t70 -90.97 -25.24 19.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.448 -0.797 . . . . 2.0 109.504 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -70.1 -71.15 0.25 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.947 0.88 . . . . 1.87 110.638 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 11.5 pt-20 -81.04 -45.91 15.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 113.95 -1.477 . . . . 1.77 111.796 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.67 -24.81 36.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.976 -0.557 . . . . 2.3 111.59 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -79.12 -53.74 4.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.465 -0.874 . . . . 1.61 112.347 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.32 -56.93 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 2.34 110.468 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.93 53.99 2.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 2.95 110.618 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.251 -0.88 . . . . 2.23 110.84 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.607 0.242 . . . . 5.2 111.111 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 81.5 Cg_exo -47.66 102.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.629 2.219 . . . . 5.12 112.277 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.38 -30.05 91.73 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.712 2.275 . . . . 3.56 112.66 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . -60.14 92.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.553 -0.832 . . . . 2.11 112.573 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.444 HG21 ' NH2' ' B' ' 8' ' ' ARG . 56.2 p -152.85 151.35 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.44 0.163 . . . . 1.85 111.44 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.697 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -155.25 -80.4 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.361 0.875 . . . . 1.86 113.361 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 37.7 mmt180 -49.02 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.316 0.487 . . . . 7.29 112.316 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 68.0 mtt180 59.73 160.61 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.206 -0.597 . . . . 6.23 110.123 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -136.86 -162.73 1.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.668 0.27 . . . . 7.18 110.799 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -46.2 -26.8 0.84 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.418 -0.355 . . . . 4.33 111.259 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 1.203 ' HE3' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER 79.66 99.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.921 -0.581 . . . . 4.49 110.512 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -96.86 29.3 3.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.703 -0.681 . . . . 2.05 110.745 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.604 ' HB3' ' CE ' ' B' ' 11' ' ' LYS . 5.6 p-10 -108.42 45.15 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 3.8 110.568 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.182 -0.913 . . . . 3.91 111.064 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.682 -0.167 . . . . 2.97 112.682 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 30.0 t 175.15 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.649 0.262 . . . . 3.15 111.494 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.82 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.118 -0.327 . . . . 4.57 110.118 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 18' ' ' GLY . 2.3 t -91.83 48.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.906 0.384 . . . . 3.08 110.586 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 6.9 p90 178.64 148.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 2.16 111.202 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.6 tp10 -131.16 143.24 50.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 2.41 110.391 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 46.3 p90 -89.06 107.44 19.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.312 0.577 . . . . 1.73 112.43 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -90.23 53.09 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.248 -0.887 . . . . 0.38 109.051 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.89 152.45 27.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 122.186 0.993 . . . . 2.8 113.308 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG12 ' CB ' ' A' ' 30' ' ' LYS . 62.1 t -89.78 -34.42 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 113.52 -1.673 . . . . 0.42 110.582 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 15.7 t70 -142.57 -38.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.942 -0.572 . . . . 2.19 112.321 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.0 mm-40 -155.16 155.95 34.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.828 0.677 . . . . 2.18 112.828 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -129.65 -169.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.882 0.372 . . . . 0.34 110.595 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG2' HD13 ' A' ' 26' ' ' LEU . 81.6 t -150.99 -55.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.67 110.062 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.9 mt-10 -92.09 139.02 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 2.96 109.618 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 19.3 pttm -152.16 89.15 1.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.346 0.499 . . . . 2.13 112.346 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' C ' HG23 ' A' ' 23' ' ' VAL . 11.4 ptp180 -154.7 92.41 1.47 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.238 -0.289 . . . . 3.83 111.189 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.95 -132.46 1.76 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.098 -1.525 . . . . 0.41 114.975 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.7 mttm -117.85 -121.26 0.3 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.368 -0.916 . . . . 1.13 109.599 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.92 -42.05 4.5 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.801 -2.119 . . . . 0.51 107.801 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -137.51 4.17 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.103 -1.549 . . . . 3.41 110.94 177.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 29.9 t0 -87.67 10.1 19.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.158 0.504 . . . . 1.22 111.024 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.9 p -89.24 154.73 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.827 -0.624 . . . . 0.34 111.406 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -110.64 99.04 8.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.396 -0.82 . . . . 1.26 110.101 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 38' ' ' VAL . 8.2 m-85 -104.25 153.03 21.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.697 -0.683 . . . . 0.65 110.441 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.6 tt -88.71 156.94 18.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.527 -0.916 . . . . 0.96 108.527 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -142.33 108.53 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 118.874 -1.131 . . . . 0.4 113.907 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 56.2 ttt180 -81.78 76.31 8.69 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.125 -1.806 . . . . 3.27 106.125 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.6 t90 -27.54 89.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.156 -1.384 . . . . 1.31 112.371 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.849 ' CB ' HG12 ' A' ' 10' ' ' VAL . 58.7 tttm -28.67 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.665 -1.152 . . . . 2.46 112.081 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . 21.8 t70 -120.15 57.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 2.02 109.832 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.32 -167.4 12.73 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.821 -0.627 . . . . 0.59 112.821 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.43 -39.28 0.63 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.992 -0.623 . . . . 0.86 112.205 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -113.12 164.08 13.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.664 0.268 . . . . 2.13 110.554 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.19 143.15 47.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.6 111.156 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.459 ' CB ' ' HA3' ' B' ' 4' ' ' GLY . 0.5 OUTLIER -136.18 178.61 6.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 2.27 110.735 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 12.5 m0 -100.01 148.5 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.71 111.515 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.95 HG22 ' HA ' ' B' ' 5' ' ' THR . 61.8 t -88.67 161.35 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.65 109.777 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' HG12 ' A' ' 38' ' ' VAL . 22.5 ttmm -79.27 108.89 13.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.526 0.679 . . . . 2.32 112.322 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.28 42.62 2.93 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.811 -1.086 . . . . 0.35 112.466 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 t -115.45 -0.59 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.993 -0.373 . . . . 0.68 109.993 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.73 75.08 0.6 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.662 0.744 . . . . 1.35 110.906 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.465 HG23 ' HE3' ' A' ' 19' ' ' LYS . 7.7 p -59.5 72.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 113.552 -1.658 . . . . 1.49 113.376 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.12 51.48 1.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.532 -0.914 . . . . 0.48 108.532 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG2' ' CG ' ' A' ' 49' ' ' LYS . 42.5 tt0 -47.16 -25.95 1.02 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.84 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 31.7 t70 -68.75 -40.37 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.939 -0.573 . . . . 2.48 109.926 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 51' ' ' TYR . 91.3 t -66.47 -46.71 85.88 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 N-CA-C 109.67 -0.493 . . . . 0.88 109.67 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.09 -54.82 17.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.628 1.571 . . . . 0.99 111.516 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 72.0 mmtt -61.0 -32.01 71.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.504 0.668 . . . . 3.35 109.504 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.5 t70 -92.12 -11.88 34.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.376 -0.829 . . . . 2.0 110.46 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.568 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.4 m-30 -84.25 -63.63 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.39 0.614 . . . . 1.87 110.684 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -87.45 -46.48 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.1 -0.955 . . . . 1.77 110.654 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.0 m-20 -81.91 -20.92 37.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 2.3 111.431 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.15 -41.65 59.75 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.546 -0.835 . . . . 1.61 112.278 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -76.15 -63.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 2.34 110.586 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 60.84 6.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 2.95 110.762 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.5 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.232 -0.889 . . . . 2.23 110.935 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.48 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 111.922 0.341 . . . . 5.2 111.922 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.491 ' N ' ' CD ' ' B' ' 3' ' ' PRO . 88.7 Cg_exo -44.68 -43.7 14.41 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.366 2.044 . . . . 5.12 113.141 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' B' ' 2' ' ' PRO . 2.9 Cg_exo -76.35 117.06 4.48 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.775 2.317 . . . . 3.56 112.022 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.499 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 99.64 12.77 39.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.502 -0.856 . . . . 2.11 112.697 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.95 ' HA ' HG22 ' A' ' 38' ' ' VAL . 88.4 m -151.8 155.19 37.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.009 0.433 . . . . 1.85 112.132 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.609 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -171.06 47.45 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.839 -0.619 . . . . 1.86 111.724 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.511 ' N ' ' HB1' ' A' ' 8' ' ' ALA . 34.7 ptt180 -47.68 132.55 14.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.317 -0.253 . . . . 7.29 110.317 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.416 ' NH1' ' OH ' ' A' ' 7' ' ' TYR . 7.4 ptp180 -133.95 59.75 1.72 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.012 0.745 . . . . 6.23 113.012 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.454 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.85 -179.75 7.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.784 -0.451 . . . . 7.18 109.784 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -63.93 -28.39 69.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.24 0.543 . . . . 4.33 110.024 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' B' ' 13' ' ' ASP . 22.3 mttp 71.52 46.65 0.39 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.335 -0.848 . . . . 4.49 110.049 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -34.8 -33.07 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.383 -0.826 . . . . 2.05 112.41 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.459 ' CG ' HG13 ' A' ' 43' ' ' VAL . 17.1 t70 -115.9 76.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 3.8 110.833 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.279 -0.867 . . . . 3.91 110.935 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' HA2' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.646 -0.181 . . . . 2.97 112.646 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 31.9 t 177.12 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.686 0.279 . . . . 3.15 111.165 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 5' ' ' PHE . 16.7 pt20 -88.68 138.06 31.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.358 -0.383 . . . . 4.57 110.511 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.053 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -95.92 45.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.24 0.543 . . . . 3.08 109.796 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.053 ' CE2' ' O ' ' A' ' 4' ' ' VAL . 6.1 p90 -179.19 117.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.591 -0.731 . . . . 2.16 110.622 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.557 ' N ' HG11 ' A' ' 23' ' ' VAL . 9.8 tp10 -111.07 131.33 55.16 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 2.41 111.501 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' A' ' 13' ' ' ILE . 49.6 p90 -89.02 109.31 20.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.286 0.476 . . . . 1.73 112.286 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -91.99 56.1 2.8 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.38 109.063 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.12 151.74 25.48 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.168 0.985 . . . . 2.8 113.154 -176.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.786 HG12 ' CB ' ' A' ' 30' ' ' LYS . 84.5 t -89.66 -35.14 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 113.611 -1.632 . . . . 0.42 110.477 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -141.27 -39.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.658 -0.701 . . . . 2.19 111.997 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.7 mt-10 -154.46 157.79 38.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 2.18 112.484 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.49 -168.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.34 109.476 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 26' ' ' LEU . 71.4 t -151.04 -45.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 0.67 110.017 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.7 mt-10 -99.48 144.36 28.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.96 109.99 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.9 pttt -154.19 83.65 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.819 -0.352 . . . . 2.13 111.784 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' C ' HG23 ' A' ' 23' ' ' VAL . 74.9 ttt180 -154.03 86.64 1.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.714 -0.394 . . . . 3.83 111.362 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.691 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.0 -131.38 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.055 -1.545 . . . . 0.41 114.348 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HA ' HG12 ' A' ' 4' ' ' VAL . 55.9 mttt -124.51 -120.14 0.27 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.509 -0.846 . . . . 1.13 109.97 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.57 -41.27 4.5 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 108.904 -1.678 . . . . 0.51 108.904 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.061 ' HB2' ' CE ' ' B' ' 11' ' ' LYS . 49.9 mttp -136.39 0.12 2.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.22 -1.49 . . . . 3.41 111.029 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 19' ' ' LYS . 21.8 t0 -88.21 8.66 26.05 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.22 111.815 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.703 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.6 p -87.99 147.69 5.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.936 -0.574 . . . . 0.34 110.747 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.0 pt-20 -111.31 90.37 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.626 -0.715 . . . . 1.26 110.299 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.703 ' HE1' HG21 ' A' ' 23' ' ' VAL . 8.2 m-85 -89.21 -168.11 2.07 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.975 -0.557 . . . . 0.65 109.713 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.795 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tt -126.49 159.23 33.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.987 -1.116 . . . . 0.96 107.987 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -139.5 114.2 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 118.619 -1.233 . . . . 0.4 113.45 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.641 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 54.7 ttt85 -88.25 75.57 8.54 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.815 -1.55 . . . . 3.27 106.815 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.7 m0 -27.9 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.395 -1.275 . . . . 1.31 112.511 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.786 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.8 tttp -29.78 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.619 -1.173 . . . . 2.46 111.938 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' TRP . 15.0 m-20 -125.75 51.36 1.75 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.931 -0.577 . . . . 2.02 109.91 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -130.98 -138.91 4.34 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.722 -0.672 . . . . 0.59 112.538 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.2 -48.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.78 -0.724 . . . . 0.86 112.677 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.67 179.51 4.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 2.13 111.089 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.9 m -124.2 106.44 10.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.072 -0.513 . . . . 1.6 111.03 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 1.1 mp0 -101.47 -175.77 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 2.27 111.033 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 31.6 m0 -114.27 154.43 27.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.481 . . . . 0.71 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 79.7 t -88.27 162.37 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.554 -0.748 . . . . 0.65 109.591 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' HG12 ' A' ' 38' ' ' VAL . 19.8 tptm -80.76 99.88 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.698 0.629 . . . . 2.32 112.698 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -98.42 26.06 25.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.445 -0.798 . . . . 0.35 111.992 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.52 -3.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.687 -0.486 . . . . 0.68 109.687 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.953 ' O ' ' HE3' ' B' ' 11' ' ' LYS . 93.1 m-70 -73.88 78.84 1.62 Allowed 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.52 0.676 . . . . 1.35 109.919 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 43' ' ' VAL . 9.0 p -58.55 69.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.636 -1.62 . . . . 1.49 113.341 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.699 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.67 50.05 1.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.062 -0.972 . . . . 0.48 109.127 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -45.53 -27.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.066 -0.97 . . . . 2.44 110.655 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 11.2 m-20 -68.31 -47.69 66.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.272 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.699 HG23 ' HB1' ' A' ' 44' ' ' ALA . 56.3 t -54.72 -40.38 51.28 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 116.375 -0.375 . . . . 0.88 110.517 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -72.69 -59.75 2.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.751 1.22 . . . . 0.99 110.497 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 4.5 tppp? -56.25 -28.66 59.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.338 -0.616 . . . . 3.35 109.338 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.7 t70 -92.99 -21.82 19.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.355 -0.838 . . . . 2.0 110.482 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -74.19 -67.4 0.62 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.561 0.696 . . . . 1.87 110.569 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 17.0 pt-20 -83.87 -48.41 10.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.696 -1.138 . . . . 1.77 111.474 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' CB ' ' HD3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -76.28 -36.88 58.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 2.3 111.501 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -51.64 -43.26 53.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.212 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 55' ' ' LEU . 7.4 mp -84.02 -57.5 3.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 2.34 110.558 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.49 63.04 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 2.95 110.848 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.2 t80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.252 -0.88 . . . . 2.23 110.933 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.622 0.248 . . . . 5.2 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.83 112.67 3.15 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.693 2.262 . . . . 5.12 112.306 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.412 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 38.4 Cg_exo -61.33 93.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.704 2.269 . . . . 3.56 112.895 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.535 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . -147.67 86.65 0.16 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.952 -0.642 . . . . 2.11 112.083 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 1.182 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 95.1 m -152.04 151.25 30.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 1.85 111.983 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -146.53 -76.29 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.513 0.56 . . . . 1.86 112.513 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 7' ' ' TYR . 22.5 ttm180 -59.43 -103.3 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 119.702 -0.19 . . . . 7.29 111.381 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.452 HH12 HG21 ' B' ' 5' ' ' THR . 30.0 mtp180 52.28 177.35 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.466 -0.493 . . . . 6.23 110.48 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 45.3 mttp -151.77 -159.19 0.99 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.749 0.309 . . . . 7.18 111.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -44.43 -27.95 0.5 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.261 -0.427 . . . . 4.33 111.257 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 1.061 ' CE ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER 80.94 99.28 0.06 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.931 -0.577 . . . . 4.49 110.962 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.586 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . . . -93.44 51.81 1.66 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 2.05 110.835 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.39 31.83 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.03 0.443 . . . . 3.8 110.551 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.233 -0.889 . . . . 3.91 110.904 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.632 -0.187 . . . . 2.97 112.632 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 70.5 p 177.66 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.738 0.304 . . . . 3.15 111.201 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -88.71 146.41 25.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.764 -0.458 . . . . 4.57 109.764 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.936 HG22 ' O ' ' A' ' 18' ' ' GLY . 14.0 p -89.32 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.038 -0.528 . . . . 3.08 110.249 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.8 p90 -175.55 174.97 2.18 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.833 -0.621 . . . . 2.16 110.994 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.949 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.0 tp10 -152.97 124.33 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.233 -0.654 . . . . 2.41 109.233 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.562 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.5 p90 -87.45 104.42 16.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.466 0.543 . . . . 1.73 112.466 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -89.27 58.26 4.38 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.673 -0.862 . . . . 0.38 108.673 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.752 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.21 148.07 41.94 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.261 1.029 . . . . 2.8 113.33 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 30' ' ' LYS . 46.5 t -88.48 -33.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 113.22 -1.809 . . . . 0.42 110.334 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 11.7 t70 -144.68 -38.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.38 -0.827 . . . . 2.19 111.77 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 10.8 mm-40 -154.48 162.71 41.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.458 0.54 . . . . 2.18 112.458 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.23 -164.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.34 109.857 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.017 ' CG2' HD13 ' A' ' 26' ' ' LEU . 98.1 t -149.98 -60.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.5 tp10 -92.84 134.28 35.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.563 -0.902 . . . . 2.96 108.563 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.7 ptpt -151.32 79.13 1.29 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.786 0.662 . . . . 2.13 112.786 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -153.86 95.32 1.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.95 -0.469 . . . . 3.83 111.31 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.936 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.62 -130.52 1.56 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 118.891 -1.623 . . . . 0.41 114.231 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.9 mttm -116.14 -120.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.86 -0.67 . . . . 1.13 109.741 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.39 -40.3 4.25 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 108.07 -2.012 . . . . 0.51 108.07 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 19.5 mmtp -135.64 1.55 2.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 112.963 -1.618 . . . . 3.41 110.878 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 42' ' ' HIS . 22.1 t70 -88.74 9.44 24.42 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-O 121.301 0.572 . . . . 1.22 111.557 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.949 HG11 ' H ' ' A' ' 6' ' ' GLU . 8.4 p -95.45 145.71 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.323 -0.853 . . . . 0.34 111.268 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 1.3 pm0 -104.42 111.84 24.66 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.851 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.758 ' HE1' HG21 ' A' ' 23' ' ' VAL . 23.4 m-85 -113.97 147.84 37.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.808 -0.633 . . . . 0.65 110.375 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.017 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.6 tt -90.24 159.52 16.66 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.975 -1.12 . . . . 0.96 107.975 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.3 m -140.44 111.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 118.75 -1.18 . . . . 0.4 113.517 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HG2' HD21 ' A' ' 26' ' ' LEU . 66.5 mtt180 -89.29 78.68 7.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.169 -1.419 . . . . 3.27 107.169 176.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HD1' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -27.8 89.71 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.254 -1.339 . . . . 1.31 111.864 -178.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.639 ' HB3' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -28.74 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.918 -1.037 . . . . 2.46 112.254 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 32.4 m-20 -118.3 55.7 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 2.02 109.901 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.24 -154.66 6.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.581 . . . . 0.59 112.815 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.64 -45.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.353 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.17 162.98 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 2.13 110.824 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.31 137.3 52.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.6 110.97 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 18.3 mm-40 -130.67 167.18 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.689 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 37.4 m0 -107.05 147.16 30.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.71 111.536 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG22 ' O ' ' B' ' 4' ' ' GLY . 65.0 t -88.84 159.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.65 110.398 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.536 ' N ' HG12 ' A' ' 38' ' ' VAL . 82.8 tttt -79.6 96.43 6.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.078 0.466 . . . . 2.32 111.899 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.1 44.83 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.559 -0.746 . . . . 0.35 112.924 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.88 13.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.809 -0.441 . . . . 0.68 109.809 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' CE1' ' HE2' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -83.54 80.44 9.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.625 0.726 . . . . 1.35 111.118 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 43' ' ' VAL . 5.6 p -58.93 72.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.441 -1.708 . . . . 1.49 112.406 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.51 1.84 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.108 -0.951 . . . . 0.48 108.729 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 41.1 tt0 -44.78 -28.26 0.61 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.277 -0.874 . . . . 2.44 110.492 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.28 -50.19 55.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.746 . . . . 2.48 109.609 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 98.0 t -57.05 -46.62 84.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 CA-C-N 115.88 -0.6 . . . . 0.88 109.903 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -67.76 -59.21 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.99 111.11 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 73.0 mmtt -55.01 -33.56 62.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.191 0.52 . . . . 3.35 109.742 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.66 -19.43 22.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.802 -0.635 . . . . 2.0 110.738 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -73.2 -62.23 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.733 0.778 . . . . 1.87 109.724 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -92.06 -49.87 5.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.241 -1.345 . . . . 1.77 111.414 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -75.43 -20.24 58.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 2.3 111.435 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -67.96 -42.99 84.16 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.886 . . . . 1.61 112.085 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 77.4 mt -81.49 -64.1 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.886 0.374 . . . . 2.34 110.626 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -83.98 61.7 6.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 2.95 110.654 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.321 -0.847 . . . . 2.23 110.901 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.555 0.217 . . . . 5.2 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.19 139.47 29.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.508 2.138 . . . . 5.12 112.179 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.94 71.44 4.2 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.507 2.138 . . . . 3.56 112.285 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.806 ' O ' HG22 ' A' ' 38' ' ' VAL . . . 47.47 97.16 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 2.11 112.657 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 82.4 p -154.31 145.61 22.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 1.85 111.63 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.458 ' HB2' HG22 ' A' ' 10' ' ' VAL . . . -144.96 -86.03 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.647 0.61 . . . . 1.86 112.647 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 7' ' ' TYR . 31.3 mmm180 -52.34 -101.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.534 -0.303 . . . . 7.29 111.636 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.629 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 33.4 mtp180 53.65 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.436 -0.505 . . . . 6.23 110.193 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -147.97 -165.88 2.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.67 0.271 . . . . 7.18 110.961 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' B' ' 11' ' ' LYS . 30.0 ptt180 -49.18 -23.63 1.38 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.524 -0.307 . . . . 4.33 111.415 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 42' ' ' HIS . 27.5 mmmt 82.39 83.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.385 -0.37 . . . . 4.49 110.629 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -48.63 -30.72 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 2.05 111.204 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -109.67 62.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 3.8 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.22 -0.895 . . . . 3.91 110.912 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.751 -0.14 . . . . 2.97 112.751 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.9 p 178.25 -34.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 3.15 110.978 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -89.05 139.5 30.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.58 -0.526 . . . . 4.57 109.58 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG22 ' CD ' ' A' ' 52' ' ' GLU . 2.0 t -89.67 50.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 3.08 110.335 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 7.0 p90 177.78 144.38 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.877 -0.601 . . . . 2.16 110.93 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.6 tp10 -128.42 142.29 51.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 2.41 110.731 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 52.5 p90 -88.91 114.56 25.67 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.691 0.758 . . . . 1.73 112.124 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.934 ' O ' ' HB3' ' B' ' 6' ' ' ALA . . . -101.85 55.46 0.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.568 -1.196 . . . . 0.38 109.629 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -119.34 164.26 15.95 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.692 0.758 . . . . 2.8 112.222 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' HB3' ' A' ' 30' ' ' LYS . 18.4 t -99.05 -19.22 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.415 -1.266 . . . . 0.42 112.476 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 32.9 t70 -149.95 -43.13 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.046 0.388 . . . . 2.19 112.046 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 48.5 mt-10 -154.26 166.46 33.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 116.423 -0.353 . . . . 2.18 111.838 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -138.96 -171.66 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.5 0.191 . . . . 0.34 110.501 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.576 ' CG2' HD13 ' A' ' 26' ' ' LEU . 77.1 t -146.18 -60.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.67 110.05 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -94.36 136.71 34.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 2.96 109.717 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 41.8 pttt -150.85 94.66 2.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.791 0.293 . . . . 2.13 111.791 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' VAL . 80.7 mtp180 -155.98 92.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.229 -0.188 . . . . 3.83 111.044 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.714 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.82 -132.32 1.76 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 118.997 -1.573 . . . . 0.41 114.8 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.743 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -116.75 -123.32 0.29 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.182 -1.009 . . . . 1.13 109.243 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.77 -41.75 4.32 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 108.202 -1.959 . . . . 0.51 108.202 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.601 ' HZ1' ' HD3' ' B' ' 9' ' ' LYS . 28.8 mmtt -132.3 -1.7 3.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.031 -1.584 . . . . 3.41 110.766 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.563 ' OD2' HG22 ' A' ' 43' ' ' VAL . 27.0 t0 -87.71 10.18 19.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.016 0.436 . . . . 1.22 111.943 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 17' ' ' ARG . 8.3 p -89.85 153.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.811 -0.631 . . . . 0.34 112.58 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 7.7 pt-20 -105.38 114.43 28.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.03 -0.986 . . . . 1.26 109.447 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.742 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 m-85 -120.11 149.14 42.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.309 -0.405 . . . . 0.65 110.06 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.6 tt -88.63 156.57 18.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.009 -0.738 . . . . 0.96 109.009 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.629 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.22 110.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 113.826 1.047 . . . . 0.4 113.826 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 12' ' ' GLU . 62.7 mtp180 -81.91 69.5 8.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.056 -2.201 . . . . 3.27 105.056 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.635 ' CD1' HG21 ' A' ' 10' ' ' VAL . 3.5 t90 -25.17 90.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 113.768 -1.56 . . . . 1.31 112.317 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.695 ' HB3' HG12 ' A' ' 10' ' ' VAL . 27.8 tptp -28.42 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.286 -1.324 . . . . 2.46 112.196 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.1 m-20 -117.65 57.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 2.02 109.885 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -141.05 3.4 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.59 112.641 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.99 -48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.86 112.486 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -92.81 164.02 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 2.13 110.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.62 109.78 16.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 1.6 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' CG ' ' HB2' ' B' ' 2' ' ' PRO . 11.3 mm-40 -112.57 178.92 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 2.27 110.899 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 36.9 m0 -102.02 149.23 24.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 0.71 111.924 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 25' ' ' TYR . 46.5 t -89.38 161.21 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.65 109.883 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.4 tptt -72.75 103.08 3.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.546 0.572 . . . . 2.32 112.546 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.27 42.13 2.85 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.452 -0.794 . . . . 0.35 112.868 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.3 t -118.48 10.3 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.205 -0.294 . . . . 0.68 110.205 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CE1' ' CE ' ' B' ' 11' ' ' LYS . 0.3 OUTLIER -77.76 78.3 4.26 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.578 0.704 . . . . 1.35 111.052 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.743 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 97.7 t -57.78 71.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 113.346 -1.752 . . . . 1.49 113.065 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.54 49.83 1.53 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.789 -0.819 . . . . 0.48 108.789 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -42.16 -30.61 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.17 -0.923 . . . . 2.44 110.886 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 4.1 p30 -67.53 -47.0 71.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.376 -0.829 . . . . 2.48 109.968 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HB1' ' A' ' 44' ' ' ALA . 48.6 t -60.29 -40.07 82.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 109.894 -0.41 . . . . 0.88 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.82 -57.71 5.2 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.205 1.402 . . . . 0.99 110.999 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 7.5 mmpt? -60.59 -28.75 68.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.532 0.682 . . . . 3.35 109.343 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.3 t70 -92.53 -14.31 28.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.353 -0.84 . . . . 2.0 110.174 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE1' ' CG1' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -83.44 -68.63 0.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.536 0.684 . . . . 1.87 110.342 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.508 ' CD ' HG22 ' A' ' 4' ' ' VAL . 15.9 pt-20 -83.91 -47.25 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.677 -1.147 . . . . 1.77 111.048 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.9 t70 -82.06 -15.89 52.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 2.3 111.101 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -78.51 -36.12 30.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.534 -0.841 . . . . 1.61 112.034 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 55' ' ' LEU . 5.7 tt -85.31 -59.4 2.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 2.34 110.296 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -89.53 61.95 5.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 2.95 110.584 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.21 -0.9 . . . . 2.23 110.855 -179.874 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.62 0.248 . . . . 5.2 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . 66.6 Cg_exo -51.44 148.52 19.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.622 2.215 . . . . 5.12 112.44 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.01 122.78 11.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.615 2.21 . . . . 3.56 112.304 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 148.31 64.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 2.11 112.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.459 ' HA ' ' CG1' ' A' ' 27' ' ' VAL . 4.0 t -151.68 174.29 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 1.85 112.032 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.934 ' HB3' ' O ' ' A' ' 8' ' ' ALA . . . -170.45 -174.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.386 -0.825 . . . . 1.86 110.259 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.41 ' HG3' ' HD3' ' B' ' 11' ' ' LYS . 59.6 ttp180 -129.0 125.12 36.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.637 -0.256 . . . . 7.29 111.489 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.461 ' HB2' ' CG ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -47.37 -64.88 0.67 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.692 0.282 . . . . 6.23 111.296 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.601 ' HD3' ' HZ1' ' A' ' 21' ' ' LYS . 42.6 mtpt -156.62 -166.89 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 7.18 110.617 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -44.52 -28.7 0.61 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 4.33 111.451 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' CE ' ' CE1' ' A' ' 42' ' ' HIS . 28.0 mtmm 75.66 102.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 4.49 110.869 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.508 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -63.59 -23.83 67.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 2.05 111.218 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.81 57.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 3.8 110.866 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.268 -0.872 . . . . 3.91 110.913 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.709 -0.156 . . . . 2.97 112.709 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 30.9 t 175.12 -31.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.677 0.275 . . . . 3.15 111.383 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -88.98 141.68 28.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 4.57 110.488 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 18' ' ' GLY . 9.6 p -89.98 47.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 3.08 110.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 5.1 p90 179.82 171.61 1.06 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.75 -0.659 . . . . 2.16 110.473 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.005 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.3 tm-20 -153.15 128.0 9.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.151 -0.685 . . . . 2.41 109.151 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.566 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 38.7 p90 -88.4 102.85 15.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 111.933 0.346 . . . . 1.73 111.933 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.813 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -86.92 59.01 5.39 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.054 -0.721 . . . . 0.38 109.054 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.674 ' C ' ' HB3' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -112.09 149.55 31.97 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.32 1.057 . . . . 2.8 113.261 -176.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.744 ' CG2' ' HB2' ' B' ' 6' ' ' ALA . 55.8 t -89.09 -37.35 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.161 -1.836 . . . . 0.42 109.774 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 17.7 t70 -141.3 -37.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 2.19 111.926 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 24.6 mm-40 -154.3 157.12 38.19 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.572 0.582 . . . . 2.18 112.572 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.95 -166.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.826 -0.625 . . . . 0.34 109.431 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 99.4 t -150.88 -48.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.274 0.559 . . . . 0.67 109.513 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.5 mt-10 -99.97 144.91 28.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 2.96 109.643 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 22.6 pttm -154.38 78.36 1.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.371 0.508 . . . . 2.13 112.371 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.6 ttm180 -153.22 90.94 1.47 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.302 -0.559 . . . . 3.83 111.961 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.893 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -153.53 -132.42 1.71 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 118.95 -1.595 . . . . 0.41 114.789 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.3 mttm -116.59 -120.14 0.31 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.437 -0.882 . . . . 1.13 109.591 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -94.76 -40.41 4.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.067 -2.013 . . . . 0.51 108.067 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 16.7 mtmm -136.88 -1.1 2.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.137 -1.531 . . . . 3.41 111.41 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 15.9 t70 -85.66 8.9 17.87 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.262 0.553 . . . . 1.22 111.58 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.005 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.4 p -89.15 143.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.368 -0.833 . . . . 0.34 110.907 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 3.2 pt-20 -106.49 97.61 7.39 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.145 0.498 . . . . 1.26 111.188 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 18.5 m-85 -94.83 -169.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.598 -0.728 . . . . 0.65 109.774 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 2.2 tt -127.99 159.12 36.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.272 -1.01 . . . . 0.96 108.272 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.674 HG22 ' HA2' ' B' ' 4' ' ' GLY . 0.7 OUTLIER -141.24 112.76 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 118.388 -1.325 . . . . 0.4 113.844 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 30' ' ' LYS . 19.8 ttm180 -88.94 77.05 7.78 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.708 -1.59 . . . . 3.27 106.708 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.573 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.6 t90 -27.81 89.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.363 -1.29 . . . . 1.31 112.273 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 39.5 ttmt -28.24 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.038 -0.983 . . . . 2.46 112.15 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.2 t70 -117.58 55.96 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.817 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.27 -163.67 10.92 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.834 -0.621 . . . . 0.59 112.669 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.55 35.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.349 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -145.98 -169.05 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 2.13 110.988 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.7 113.25 6.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.6 111.013 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.463 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 7.9 mm-40 -121.62 175.61 6.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 2.27 110.74 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 27.5 m0 -116.17 151.99 34.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.078 0.465 . . . . 0.71 111.612 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.813 HG11 ' HB3' ' A' ' 8' ' ' ALA . 88.9 t -88.57 152.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.679 -0.692 . . . . 0.65 110.353 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HE2' ' CG2' ' A' ' 41' ' ' VAL . 22.7 tptm -72.58 97.1 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 2.32 112.16 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -93.92 40.54 2.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.706 -0.759 . . . . 0.35 113.014 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' CG2' ' HE2' ' A' ' 39' ' ' LYS . 1.1 t -120.45 4.16 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.68 109.801 177.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CD2' ' HG3' ' B' ' 11' ' ' LYS . 14.0 m80 -80.5 81.44 6.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.821 0.82 . . . . 1.35 110.722 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 61.8 t -56.57 74.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 112.754 -2.021 . . . . 1.49 112.507 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -90.88 51.06 1.89 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.408 -0.815 . . . . 0.48 109.268 177.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 39.1 tt0 -47.77 -27.12 1.86 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.204 -0.907 . . . . 2.44 110.116 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 8.4 m-20 -70.38 -46.87 63.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.471 -0.786 . . . . 2.48 109.882 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.533 HG13 ' CE1' ' A' ' 51' ' ' TYR . 60.1 t -61.8 -45.83 97.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.733 -0.469 . . . . 0.88 109.733 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.69 -57.82 5.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.439 1.496 . . . . 0.99 111.432 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -57.87 -31.78 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.362 0.601 . . . . 3.35 109.466 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.2 t70 -91.96 -16.51 26.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.351 -0.84 . . . . 2.0 110.563 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -79.14 -65.21 1.03 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.473 0.654 . . . . 1.87 110.941 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.8 pt-20 -87.91 -45.78 9.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.839 -1.073 . . . . 1.77 111.191 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.1 m-20 -82.69 -19.18 38.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.795 -0.639 . . . . 2.3 111.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -76.67 -34.17 44.76 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.368 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -80.21 -70.41 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.328 . . . . 2.34 110.686 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.0 64.4 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 2.95 111.027 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.222 -0.894 . . . . 2.23 110.867 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.559 0.219 . . . . 5.2 111.039 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.432 ' HA ' ' HD2' ' B' ' 3' ' ' PRO . 98.4 Cg_exo -44.29 105.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.67 2.246 . . . . 5.12 112.447 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' B' ' 2' ' ' PRO . 52.1 Cg_endo -69.61 67.46 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.521 2.147 . . . . 3.56 112.387 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.688 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -129.49 36.74 2.31 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.87 -0.681 . . . . 2.11 112.535 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 38' ' ' VAL . 53.3 p -152.78 153.46 33.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.948 0.351 . . . . 1.85 111.948 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -158.82 -81.28 0.06 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.522 0.934 . . . . 1.86 113.522 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 7' ' ' TYR . 23.9 tpt180 -42.21 -94.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.811 0.671 . . . . 7.29 112.811 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.467 ' CG ' ' HG3' ' A' ' 6' ' ' GLU . 18.6 mmm180 -98.9 118.65 36.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.336 -0.546 . . . . 6.23 112.217 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.81 50.5 1.12 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.396 -0.82 . . . . 7.18 110.741 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -110.0 -20.08 12.85 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.766 0.317 . . . . 4.33 111.049 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HG3' ' CD2' ' A' ' 42' ' ' HIS . 3.4 mppt? 65.6 95.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 4.49 111.121 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.87 -25.95 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.05 110.586 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 12.1 t70 -110.69 -33.3 6.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.799 -0.637 . . . . 3.8 110.819 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.281 -0.866 . . . . 3.91 110.816 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' O ' HD12 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.215 0 CA-C-O 120.293 -0.171 . . . . 2.97 112.838 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 8.3 p 163.58 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.262 0.468 . . . . 3.15 112.262 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.72 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 18.1 mp0 -87.55 142.52 27.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.061 0.458 . . . . 4.57 110.633 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.383 HG13 ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -89.52 48.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.683 -0.69 . . . . 3.08 110.78 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.536 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -177.59 173.77 1.61 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.923 -0.581 . . . . 2.16 111.485 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.961 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -152.56 129.36 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.719 -0.673 . . . . 2.41 109.31 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 53.3 p90 -87.5 109.85 19.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.629 0.603 . . . . 1.73 112.629 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.864 ' HB2' ' HB3' ' B' ' 8' ' ' ARG . . . -92.07 50.11 1.62 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.661 -0.7 . . . . 0.38 109.127 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.77 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.45 149.78 28.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.229 1.014 . . . . 2.8 113.528 -177.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.737 HG12 ' CB ' ' A' ' 30' ' ' LYS . 61.1 t -89.34 -36.11 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.342 -1.754 . . . . 0.42 110.11 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.63 ' CG ' ' O ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -141.61 -39.25 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.285 -0.87 . . . . 2.19 111.706 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.8 mt-10 -155.04 158.26 38.84 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.593 0.59 . . . . 2.18 112.593 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.77 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.35 -165.93 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.34 109.611 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 26' ' ' LEU . 94.1 t -150.59 -58.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.14 0.495 . . . . 0.67 109.956 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 6.8 pt-20 -97.24 133.68 41.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 2.96 109.175 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 49.2 pttt -151.03 89.07 1.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.435 0.531 . . . . 2.13 112.435 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -154.33 93.06 1.57 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.288 -0.257 . . . . 3.83 110.902 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.919 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.11 -134.2 2.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 118.769 -1.681 . . . . 0.41 114.757 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.9 mttm -114.17 -119.03 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.464 -0.868 . . . . 1.13 109.554 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -96.9 -41.97 3.42 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 107.83 -2.108 . . . . 0.51 107.83 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.617 ' CB ' ' CD ' ' B' ' 11' ' ' LYS . 44.1 mmtt -132.96 0.2 3.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.118 -1.541 . . . . 3.41 111.048 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 16.1 t70 -86.72 6.92 28.92 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 121.261 0.553 . . . . 1.22 111.668 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.961 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.4 p -90.06 145.64 7.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.348 -0.842 . . . . 0.34 111.32 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' HA3' ' A' ' 40' ' ' GLY . 3.0 pt-20 -104.64 111.6 24.37 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.762 -0.654 . . . . 1.26 110.61 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.62 ' O ' HG23 ' A' ' 38' ' ' VAL . 23.0 m-85 -114.02 148.97 36.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.722 -0.672 . . . . 0.65 110.676 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.981 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.7 tt -89.7 159.15 17.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.922 -1.14 . . . . 0.96 107.922 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -140.12 108.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.699 -1.2 . . . . 0.4 113.448 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 30' ' ' LYS . 4.3 tpt180 -83.13 74.84 9.96 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.569 -1.641 . . . . 3.27 106.569 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.63 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 4.3 t90 -27.83 89.4 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.665 1.228 . . . . 1.31 112.091 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 34.9 ttpt -28.92 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.838 -1.073 . . . . 2.46 112.168 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' TRP . 16.8 m-20 -119.61 56.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 2.02 109.816 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.12 -163.48 10.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.859 -0.61 . . . . 0.59 112.886 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.26 27.99 1.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.937 -0.649 . . . . 0.86 112.336 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -142.05 -178.48 5.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 2.13 111.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' CZ ' ' A' ' 28' ' ' ARG . 65.0 m -135.77 111.23 9.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 1.6 110.821 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -124.96 172.58 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.27 111.052 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -114.85 150.36 35.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.71 111.483 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.72 HG22 ' O ' ' B' ' 4' ' ' GLY . 89.0 t -89.68 160.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.55 . . . . 0.65 110.249 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 38' ' ' VAL . 24.2 ttmm -78.2 96.81 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.213 0.53 . . . . 2.32 112.269 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.83 46.82 2.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.463 -0.789 . . . . 0.35 112.509 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.51 3.24 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 0.68 110.368 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -75.04 79.56 2.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.689 0.756 . . . . 1.35 110.699 -179.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.4 t -58.04 66.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 113.04 -1.891 . . . . 1.49 113.362 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.42 53.67 2.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.857 -0.794 . . . . 0.48 108.857 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -48.95 -24.55 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.113 -0.949 . . . . 2.44 110.641 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.4 t70 -68.04 -49.8 59.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.606 . . . . 2.48 110.066 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG12 ' CE2' ' A' ' 51' ' ' TYR . 44.6 t -59.49 -32.01 47.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 116.287 -0.415 . . . . 0.88 110.594 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -80.03 -57.46 3.62 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.85 1.26 . . . . 0.99 109.866 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.3 tppt? -57.27 -29.57 63.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 3.35 108.679 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.9 t70 -92.12 -22.84 19.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.202 -0.908 . . . . 2.0 110.234 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.814 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.79 -68.25 0.47 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.791 0.805 . . . . 1.87 110.118 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -85.44 -50.4 7.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.266 -1.334 . . . . 1.77 111.765 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -74.47 -23.26 58.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 2.3 111.482 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -65.23 -47.31 81.87 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.108 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 1' ' ' GLY . 25.1 mt -77.7 -63.78 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 2.34 110.514 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -82.56 60.61 5.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 2.95 110.47 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.2 t80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.264 -0.874 . . . . 2.23 110.931 -179.557 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.687 0.279 . . . . 5.2 111.021 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' B' ' 3' ' ' PRO . 71.6 Cg_exo -49.28 104.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.722 2.281 . . . . 5.12 112.387 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' B' ' 2' ' ' PRO . 56.7 Cg_endo -70.53 127.04 13.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.505 2.137 . . . . 3.56 112.308 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.72 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -64.13 96.84 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 2.11 112.027 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' THR . . . . . 1.228 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 2.2 m -153.06 147.34 25.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.529 0.566 . . . . 1.85 112.529 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -148.18 -86.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 1.86 110.819 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -77.4 -153.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.014 -0.365 . . . . 7.29 110.014 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.864 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 41.65 71.74 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.596 0.236 . . . . 6.23 111.539 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -147.83 49.75 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 7.18 112.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.452 ' CD ' ' HE3' ' A' ' 21' ' ' LYS . 14.6 ptm180 -115.59 -25.4 7.89 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.819 0.342 . . . . 4.33 110.217 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 1.617 ' CD ' ' CB ' ' A' ' 21' ' ' LYS . 27.6 mttp 48.6 78.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 4.49 111.509 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 1.081 ' H ' ' HG2' ' B' ' 11' ' ' LYS . . . -73.81 -28.54 61.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.153 0.501 . . . . 2.05 110.037 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 24.0 t70 -111.17 42.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 3.8 110.413 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.654 ' OG ' ' HB3' ' B' ' 11' ' ' LYS . 68.6 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.192 -0.909 . . . . 3.91 110.889 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.802 -0.119 . . . . 2.97 112.802 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 91.5 p -179.71 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.725 0.298 . . . . 3.15 110.96 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.14 140.92 29.0 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.579 -0.526 . . . . 4.57 109.579 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.491 HG22 ' CD ' ' A' ' 52' ' ' GLU . 1.6 t -88.72 55.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.281 -0.418 . . . . 3.08 110.486 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' LYS . 10.9 p90 174.42 170.25 0.23 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.16 111.167 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.888 ' H ' HG11 ' A' ' 23' ' ' VAL . 19.8 mt-10 -150.85 145.62 25.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.883 -0.599 . . . . 2.41 109.546 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 37.2 p90 -90.61 110.04 21.2 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.93 0.715 . . . . 1.73 112.93 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.864 ' O ' ' HB3' ' B' ' 6' ' ' ALA . . . -93.04 52.4 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.251 -0.886 . . . . 0.38 108.897 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.708 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.24 158.45 22.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.286 1.041 . . . . 2.8 113.244 -177.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.841 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.8 t -94.21 -36.42 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 113.199 -1.819 . . . . 0.42 110.596 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 34.5 t70 -140.25 -38.9 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 2.19 112.304 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -155.72 154.51 31.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.994 0.739 . . . . 2.18 112.994 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.93 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.802 0.334 . . . . 0.34 110.623 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 26' ' ' LEU . 76.9 t -150.46 -58.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.67 110.202 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.8 tp10 -94.15 135.14 35.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 2.96 109.683 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 17.0 ptpt -151.02 90.6 1.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.734 -0.386 . . . . 2.13 111.904 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' C ' HG23 ' A' ' 23' ' ' VAL . 13.7 ptm180 -153.51 92.6 1.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.142 -0.349 . . . . 3.83 111.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 4' ' ' VAL . . . -152.68 -134.51 2.06 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.116 -1.516 . . . . 0.41 114.875 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HE3' HG23 ' A' ' 43' ' ' VAL . 68.5 mttm -111.02 -122.08 0.28 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.56 -0.82 . . . . 1.13 109.828 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.05 -41.55 4.58 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 108.009 -2.037 . . . . 0.51 108.009 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 10.6 mptt -136.58 2.57 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.094 -1.553 . . . . 3.41 110.651 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 28.8 t0 -87.68 10.27 18.74 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.263 0.554 . . . . 1.22 111.53 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.888 HG11 ' H ' ' A' ' 6' ' ' GLU . 12.2 p -91.31 153.84 3.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.302 -0.863 . . . . 0.34 111.899 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.0 pt-20 -106.19 116.57 32.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 1.26 110.186 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 38' ' ' VAL . 10.8 m-85 -119.48 147.49 44.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.65 110.422 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -88.49 156.74 18.93 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.563 -0.903 . . . . 0.96 108.563 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.708 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 m -141.11 113.38 4.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 113.725 1.009 . . . . 0.4 113.725 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -86.1 75.89 9.85 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 105.657 -1.979 . . . . 3.27 105.657 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.582 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.9 t90 -26.34 90.19 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.011 -1.449 . . . . 1.31 112.331 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.841 ' CB ' HG12 ' A' ' 10' ' ' VAL . 55.5 tptt -29.09 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.722 -1.127 . . . . 2.46 112.141 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.9 t70 -117.57 54.52 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.807 -0.442 . . . . 2.02 109.807 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.24 -160.29 9.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.878 -0.601 . . . . 0.59 112.919 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.16 29.12 0.99 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.114 -0.565 . . . . 0.86 112.128 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.96 176.73 9.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.697 0.284 . . . . 2.13 110.868 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.0 m -137.28 125.63 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 1.6 110.832 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.11 164.15 30.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.961 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 18.9 m0 -94.91 146.76 24.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.71 111.476 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 25' ' ' TYR . 40.5 t -89.59 161.33 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.65 109.812 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.534 ' N ' HG12 ' A' ' 38' ' ' VAL . 2.6 ttmp? -67.57 110.62 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 2.32 112.636 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -98.17 40.26 2.54 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.35 111.96 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 t -117.5 4.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.248 . . . . 0.68 110.521 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.584 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -73.51 76.4 1.45 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.73 0.776 . . . . 1.35 111.053 -179.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.4 p -59.11 72.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 113.394 -1.73 . . . . 1.49 113.333 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.4 50.1 1.58 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.48 108.511 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.4 tt0 -42.74 -30.16 0.36 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.088 -0.96 . . . . 2.44 111.055 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.27 -46.27 70.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.681 . . . . 2.48 110.069 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 51' ' ' TYR . 68.2 t -58.61 -44.74 90.21 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-N 116.016 -0.538 . . . . 0.88 109.719 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.87 -59.41 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.324 1.449 . . . . 0.99 111.386 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 11.9 mptt -56.49 -32.31 64.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.206 0.527 . . . . 3.35 109.781 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -91.79 -18.13 24.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.817 -0.629 . . . . 2.0 110.626 178.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -74.64 -62.61 1.47 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.677 0.751 . . . . 1.87 109.682 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' CD ' HG22 ' A' ' 4' ' ' VAL . 12.6 pt-20 -90.85 -50.58 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.283 -1.326 . . . . 1.77 111.362 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -74.44 -20.77 59.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 2.3 111.199 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.29 91.75 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.822 . . . . 1.61 112.036 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 43.5 mt -82.58 -61.78 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 2.34 110.531 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -87.68 61.81 6.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 2.95 110.598 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.278 -0.868 . . . . 2.23 110.878 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.687 0.28 . . . . 5.2 111.04 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.43 110.15 3.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.75 2.3 . . . . 5.12 112.529 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.23 62.93 5.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.525 2.15 . . . . 3.56 112.243 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 166.78 76.14 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.667 -0.778 . . . . 2.11 112.578 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.566 ' HA ' HG11 ' A' ' 27' ' ' VAL . 74.1 p -151.95 166.31 31.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 1.85 111.691 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 8' ' ' ALA . . . -162.03 -166.33 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.628 -0.714 . . . . 1.86 110.27 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -154.51 113.26 3.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 7.29 111.69 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.687 ' NH1' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -58.4 -47.6 83.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.786 -0.643 . . . . 6.23 111.717 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -151.1 -173.66 4.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 7.18 111.351 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.6 ptt180 -53.94 -30.1 45.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.08 0.467 . . . . 4.33 110.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.584 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 81.4 mttt 83.35 100.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.408 -0.815 . . . . 4.49 110.455 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.18 -24.73 1.84 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 2.05 111.395 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -109.65 49.03 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 3.8 110.851 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 3.91 110.886 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.707 -0.157 . . . . 2.97 112.707 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 81.7 p 178.47 -33.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.781 0.324 . . . . 3.15 111.066 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.765 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 97.0 mt-30 -88.62 140.71 29.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.834 -0.432 . . . . 4.57 109.834 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.643 HG13 ' CE2' ' A' ' 5' ' ' PHE . 10.8 p -89.02 49.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.14 -0.482 . . . . 3.08 110.811 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.643 ' CE2' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 175.06 146.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.912 -0.586 . . . . 2.16 111.423 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.533 ' H ' HG11 ' A' ' 23' ' ' VAL . 21.5 mt-10 -126.06 143.29 51.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 2.41 110.973 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.3 p90 -89.58 112.58 23.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.522 0.677 . . . . 1.73 111.567 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.687 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -101.51 56.2 0.83 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.922 -1.035 . . . . 0.38 109.729 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.722 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.08 165.07 13.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.151 0.977 . . . . 2.8 112.708 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.888 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.1 t -90.25 -30.15 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 113.665 -1.607 . . . . 0.42 112.081 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 12.8 t70 -150.32 -35.89 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.262 0.468 . . . . 2.19 112.262 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.9 mt-10 -152.71 165.38 35.48 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.78 -0.368 . . . . 2.18 111.94 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -140.98 -170.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.842 0.353 . . . . 0.34 110.374 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.613 ' CG2' HD22 ' A' ' 26' ' ' LEU . 76.6 t -150.12 -52.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.67 110.038 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.4 tp10 -92.89 137.98 31.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 2.96 109.749 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 16.4 ptpt -152.52 89.36 1.41 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.852 -0.339 . . . . 2.13 111.14 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' VAL . 12.5 tpp180 -155.1 91.07 1.32 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.818 -0.353 . . . . 3.83 111.022 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.64 -131.59 1.69 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.269 -1.443 . . . . 0.41 114.368 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.77 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -119.76 -122.61 0.29 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.456 -0.872 . . . . 1.13 109.621 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.52 -39.57 4.98 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 108.406 -1.878 . . . . 0.51 108.406 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' CG ' ' HB3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -137.07 0.42 2.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.228 -1.486 . . . . 3.41 111.18 177.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.9 t70 -87.35 10.33 17.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.996 0.427 . . . . 1.22 111.597 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.743 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.9 p -88.6 150.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.286 0.565 . . . . 0.34 111.876 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -109.08 101.9 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.23 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.7 m-85 -104.23 151.82 22.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.14 -0.482 . . . . 0.65 110.062 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tp -90.01 154.58 19.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.275 -1.009 . . . . 0.96 108.275 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -136.39 109.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 114.101 1.148 . . . . 0.4 114.101 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 53.2 mtt180 -82.84 77.78 9.53 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.627 -1.99 . . . . 3.27 105.627 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.624 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.1 t90 -27.09 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.268 -1.333 . . . . 1.31 111.95 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.888 ' CB ' HG12 ' A' ' 10' ' ' VAL . 59.0 tttm -27.17 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.271 -1.331 . . . . 2.46 112.355 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.0 m-20 -120.9 57.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 2.02 109.89 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -160.49 9.1 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.895 -0.593 . . . . 0.59 112.772 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.79 16.42 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.105 -0.569 . . . . 0.86 112.287 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -137.53 178.23 7.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.806 0.336 . . . . 2.13 110.777 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.24 108.93 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.965 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.33 166.88 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 2.27 111.069 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 40.4 m0 -89.01 145.78 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.651 . . . . 0.71 111.753 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 8' ' ' ALA . 89.1 t -88.76 162.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.65 109.855 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.6 tttt -75.45 103.82 5.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.771 0.656 . . . . 2.32 112.771 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.02 47.32 2.01 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.941 -1.027 . . . . 0.35 112.2 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.04 0.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.853 -0.425 . . . . 0.68 109.853 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.61 78.39 0.81 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.772 0.796 . . . . 1.35 110.004 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.77 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 94.9 t -57.33 69.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 113.047 -1.888 . . . . 1.49 113.426 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.51 51.88 2.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.312 -0.625 . . . . 0.48 109.312 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -47.34 -27.07 1.46 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.342 -0.845 . . . . 2.44 110.477 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 7.9 m-20 -70.99 -43.51 67.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.451 -0.795 . . . . 2.48 110.123 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' B' ' 12' ' ' ALA . 95.7 t -65.18 -39.97 87.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 109.737 -0.468 . . . . 0.88 109.737 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -71.95 -58.07 3.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.104 1.362 . . . . 0.99 110.741 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.8 tppt? -57.0 -30.66 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.228 -0.656 . . . . 3.35 109.228 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.8 t70 -92.09 -20.42 21.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.349 -0.841 . . . . 2.0 110.386 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.1 m-30 -75.4 -67.19 0.68 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.479 0.657 . . . . 1.87 110.606 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.0 pt-20 -86.46 -48.7 8.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.8 -1.091 . . . . 1.77 111.235 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 2.4 m-20 -77.52 -20.81 53.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.598 . . . . 2.3 111.162 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -82.52 -32.19 28.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.595 -0.812 . . . . 1.61 112.253 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -77.23 -68.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 2.34 110.472 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.52 55.87 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.077 0.465 . . . . 2.95 110.799 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.135 -0.936 . . . . 2.23 110.844 -179.855 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.689 0.28 . . . . 5.2 111.056 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.21 151.42 17.18 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.559 2.173 . . . . 5.12 112.341 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.15 60.7 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.716 2.277 . . . . 3.56 112.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.13 46.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.69 . . . . 2.11 112.249 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' THR . . . . . 1.14 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 15.4 p -150.72 161.21 43.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.43 . . . . 1.85 111.532 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -170.98 43.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.86 110.787 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.684 ' H ' HG23 ' B' ' 5' ' ' THR . 7.0 ptp180 -38.34 135.02 0.8 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.25 -0.432 . . . . 7.29 111.659 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.463 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 22.5 tpt180 -43.92 -44.39 7.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.876 0.37 . . . . 6.23 110.546 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 8' ' ' ARG . 81.4 tttt 85.07 -19.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.399 -0.819 . . . . 7.18 112.314 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.404 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 14.6 ptm180 -50.58 -31.84 16.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.985 0.422 . . . . 4.33 110.132 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt 38.92 53.69 2.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.748 -0.66 . . . . 4.49 111.968 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.557 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -48.6 -28.55 3.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 2.05 110.746 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 24.1 t70 -111.51 53.24 0.72 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.561 -0.745 . . . . 3.8 110.604 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.245 -0.884 . . . . 3.91 110.998 -179.801 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 120.234 -0.203 . . . . 2.97 112.661 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.9 p 176.29 -29.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.731 0.265 . . . . 3.15 111.605 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.36 143.29 27.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.045 0.45 . . . . 4.57 110.491 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.938 HG22 ' O ' ' A' ' 18' ' ' GLY . 13.8 p -92.95 40.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.804 -0.635 . . . . 3.08 110.54 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.1 p90 178.86 160.07 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.065 -0.516 . . . . 2.16 111.254 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.907 ' H ' HG11 ' A' ' 23' ' ' VAL . 1.2 mp0 -143.2 142.23 31.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.94 -0.573 . . . . 2.41 110.087 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.525 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 53.7 p90 -88.82 111.71 22.36 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.65 0.738 . . . . 1.73 111.741 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' C ' ' HB3' ' B' ' 6' ' ' ALA . . . -95.26 46.14 1.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.759 -1.11 . . . . 0.38 109.751 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.671 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.88 164.42 14.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.602 0.715 . . . . 2.8 112.73 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.699 ' CG2' ' HB2' ' B' ' 6' ' ' ALA . 8.7 t -102.95 -20.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.687 -1.142 . . . . 0.42 112.437 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 14.8 t70 -144.51 -44.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.027 0.38 . . . . 2.19 112.027 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.1 mt-10 -155.68 162.72 40.52 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 112.053 0.39 . . . . 2.18 112.053 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.49 -167.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.627 0.251 . . . . 0.34 110.356 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 26' ' ' LEU . 95.3 t -149.99 -53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.033 0.444 . . . . 0.67 109.907 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 12.5 mm-40 -96.71 135.46 38.61 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 48.3 pttt -153.06 85.09 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.352 -0.539 . . . . 2.13 112.37 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.588 ' C ' HG23 ' A' ' 23' ' ' VAL . 58.5 ttt85 -154.44 95.49 1.81 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.101 0.41 . . . . 3.83 111.658 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.938 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -153.34 -128.64 1.3 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 118.863 -1.637 . . . . 0.41 114.885 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 97.8 mttt -119.44 -122.17 0.29 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.557 -0.821 . . . . 1.13 110.238 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.84 -40.56 5.88 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 108.804 -1.718 . . . . 0.51 108.804 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -143.75 3.99 1.29 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.537 -1.332 . . . . 3.41 111.43 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 20.3 t70 -88.41 11.67 16.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.322 0.582 . . . . 1.22 111.055 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.907 HG11 ' H ' ' A' ' 6' ' ' GLU . 9.0 p -89.47 154.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.332 -0.849 . . . . 0.34 112.249 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' HA3' ' A' ' 40' ' ' GLY . 46.7 mt-10 -96.83 128.09 43.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.11 -0.95 . . . . 1.26 108.956 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.665 ' HD2' HG21 ' A' ' 13' ' ' ILE . 11.4 m-85 -138.76 139.74 38.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 0.65 109.976 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.883 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -89.91 157.39 17.89 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.247 -0.649 . . . . 0.96 109.247 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 m -143.76 112.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 114.262 1.208 . . . . 0.4 114.262 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 86.5 mtt180 -85.53 66.4 9.65 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 104.566 -2.383 . . . . 3.27 104.566 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 18.8 t90 -25.65 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.362 -1.745 . . . . 1.31 112.218 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HB3' HG12 ' A' ' 10' ' ' VAL . 62.4 tttp -28.33 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.264 -1.334 . . . . 2.46 112.528 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.6 t70 -108.83 54.26 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.983 0.42 . . . . 2.02 109.99 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.28 -139.28 3.02 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.105 -0.569 . . . . 0.59 112.803 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.36 -46.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.085 -0.579 . . . . 0.86 111.885 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.57 163.96 12.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 2.13 110.272 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 28.1 p -121.31 138.83 54.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 1.6 111.376 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HB3' ' HA3' ' B' ' 4' ' ' GLY . 7.1 tp10 -130.76 168.96 16.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 2.27 109.938 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 24.6 m0 -88.53 144.2 26.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.815 0.34 . . . . 0.71 111.023 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 25' ' ' TYR . 85.0 t -88.42 154.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.65 110.115 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 38' ' ' VAL . 38.7 ttpt -66.18 103.88 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 2.32 111.573 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 24' ' ' GLU . . . -92.56 37.9 3.29 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.522 -0.763 . . . . 0.35 112.408 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.69 8.5 8.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.69 -0.485 . . . . 0.68 109.69 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.503 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -73.7 76.81 1.54 Allowed 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.505 0.669 . . . . 1.35 110.181 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 57.2 t -56.85 74.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 113.442 -1.708 . . . . 1.49 113.439 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' B' ' 12' ' ' ALA . . . -92.98 49.54 1.44 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.48 109.297 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 9.7 tp10 -48.16 -26.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.339 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -73.79 -47.0 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.567 -0.742 . . . . 2.48 110.228 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 51' ' ' TYR . 85.0 t -58.06 -46.83 88.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 109.951 -0.389 . . . . 0.88 109.951 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -68.74 -58.49 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 125.068 1.347 . . . . 0.99 111.125 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.9 ttpt -54.51 -33.74 60.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.533 . . . . 3.35 109.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.9 -20.61 21.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.75 -0.659 . . . . 2.0 110.721 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.3 m-30 -71.7 -62.19 1.51 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.69 0.757 . . . . 1.87 110.479 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -91.82 -49.5 6.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.47 -1.241 . . . . 1.77 111.484 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -74.21 -25.12 59.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.835 -0.62 . . . . 2.3 111.285 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.86 -47.14 88.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.531 -0.842 . . . . 1.61 112.272 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.17 -72.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 2.34 110.665 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -77.49 61.47 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 2.95 110.603 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 91.1 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.215 -0.898 . . . . 2.23 110.893 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.633 0.254 . . . . 5.2 111.031 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.04 112.23 0.87 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.6 2.2 . . . . 5.12 112.34 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.64 -38.75 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.596 2.197 . . . . 3.56 112.383 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.49 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 47.57 84.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.986 -0.626 . . . . 2.11 112.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 73.5 p -151.89 157.83 42.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.032 0.444 . . . . 1.85 111.674 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.699 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -148.95 -42.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.848 -0.614 . . . . 1.86 111.748 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.417 ' HD3' ' HE3' ' B' ' 11' ' ' LYS . 89.5 mtt180 75.43 117.43 0.06 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.261 -0.427 . . . . 7.29 110.77 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.405 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -72.74 -53.95 10.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.916 0.339 . . . . 6.23 111.916 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -135.15 -168.07 2.11 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.873 -0.331 . . . . 7.18 111.389 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -46.53 -28.21 1.35 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.339 -0.391 . . . . 4.33 111.238 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.503 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 6.3 mtmp? 76.45 94.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 4.49 110.312 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -101.99 99.59 9.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.074 -0.512 . . . . 2.05 111.234 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.477 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 6.2 p-10 -122.84 47.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.962 0.41 . . . . 3.8 110.838 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 3.91 110.994 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.788 -0.125 . . . . 2.97 112.788 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 52' ' ' GLU . 57.8 p -167.4 -53.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 3.15 110.434 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.516 ' HG3' ' CZ ' ' A' ' 5' ' ' PHE . 24.9 tt0 -105.41 108.41 19.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.684 . . . . 4.57 109.89 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' C ' ' CG ' ' A' ' 5' ' ' PHE . 62.0 t -142.94 -56.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.916 0.71 . . . . 3.08 112.916 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CZ ' ' HG3' ' A' ' 3' ' ' GLN . 0.2 OUTLIER 68.66 -158.06 0.19 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.676 -0.861 . . . . 2.16 108.676 -177.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.797 ' H ' HG11 ' A' ' 23' ' ' VAL . 31.4 mt-10 -152.7 148.0 26.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.148 0.425 . . . . 2.41 112.148 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 32.6 p90 -101.27 102.61 13.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.503 0.668 . . . . 1.73 110.938 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.833 ' C ' ' HB3' ' B' ' 6' ' ' ALA . . . -89.32 53.42 2.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.186 -0.915 . . . . 0.38 110.303 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.92 167.78 10.82 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.468 0.651 . . . . 2.8 111.614 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 12.6 t -106.32 -16.69 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 115.111 -0.95 . . . . 0.42 112.387 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 17.3 t70 -148.3 -44.04 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.707 0.289 . . . . 2.19 111.754 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 18.7 mm-40 -154.18 168.44 26.52 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.363 -0.381 . . . . 2.18 111.593 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -139.46 -169.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.849 -0.426 . . . . 0.34 109.849 178.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 26' ' ' LEU . 96.3 t -149.79 -59.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.091 0.472 . . . . 0.67 109.97 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.5 tp10 -93.05 134.78 34.85 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.32 -0.622 . . . . 2.96 109.32 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 14.0 ptmt -150.83 92.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 2.13 111.089 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.628 ' C ' HG23 ' A' ' 23' ' ' VAL . 98.1 mtt180 -154.98 90.91 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.81 -0.356 . . . . 3.83 111.706 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.79 -134.98 2.29 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.057 -1.544 . . . . 0.41 114.702 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 62.3 mttm -106.77 -90.52 0.43 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.823 -0.688 . . . . 1.13 110.802 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -130.13 -44.38 0.18 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 107.755 -2.138 . . . . 0.51 107.755 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HA ' ' CE ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -132.56 -5.19 3.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.491 -1.354 . . . . 3.41 110.793 176.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 19.3 t70 -88.67 10.02 22.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.256 0.55 . . . . 1.22 111.397 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.797 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.5 p -89.01 158.15 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.472 -0.785 . . . . 0.34 111.404 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 23' ' ' VAL . 10.4 pt-20 -106.73 122.89 47.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.445 -0.798 . . . . 1.26 110.124 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 38' ' ' VAL . 9.8 m-85 -128.45 146.07 50.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.037 -0.528 . . . . 0.65 110.186 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.9 tt -88.72 157.81 18.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.318 -0.623 . . . . 0.96 109.318 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 m -142.69 113.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 113.881 1.067 . . . . 0.4 113.881 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -86.18 65.76 9.24 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.16 -2.533 . . . . 3.27 104.16 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.642 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 20.2 t90 -25.81 89.75 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 1.31 112.215 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HB3' HG12 ' A' ' 10' ' ' VAL . 88.8 tttt -28.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 114.113 -1.403 . . . . 2.46 112.421 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' O ' ' CE2' ' A' ' 29' ' ' TRP . 11.7 m-20 -110.93 55.37 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.417 . . . . 2.02 110.142 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -149.11 -158.4 8.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.08 -0.581 . . . . 0.59 112.688 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.5 21.18 1.34 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.331 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.82 -173.84 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.299 . . . . 2.13 110.798 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -145.61 136.34 24.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 1.6 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' OE2' ' HB2' ' B' ' 3' ' ' PRO . 43.6 mt-10 -149.96 176.88 10.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.816 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -98.11 148.52 23.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.71 111.324 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' TYR . 97.0 t -89.2 160.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 0.65 109.79 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.2 tttt -68.95 104.25 2.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.37 0.605 . . . . 2.32 112.174 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.65 37.99 3.29 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.108 -0.951 . . . . 0.35 112.667 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.5 t -115.85 3.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.672 0.272 . . . . 0.68 110.304 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.623 ' CD2' ' HB3' ' B' ' 13' ' ' ASP . 0.1 OUTLIER -69.75 77.6 0.45 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.578 0.704 . . . . 1.35 109.826 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 48.7 t -56.91 75.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 113.717 -1.583 . . . . 1.49 113.34 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.54 53.69 2.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.593 -0.891 . . . . 0.48 108.593 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 49' ' ' LYS . 39.0 tt0 -49.72 -22.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.916 -1.038 . . . . 2.44 110.435 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.03 -50.53 47.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 2.48 110.087 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.5 t -57.79 -29.88 36.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.88 111.282 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -87.45 -58.11 2.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.155 1.382 . . . . 0.99 109.97 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 25.4 ttmm -54.84 -31.12 59.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.307 -0.86 . . . . 3.35 109.262 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -91.16 -25.39 19.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.518 -0.764 . . . . 2.0 109.854 178.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.78 -65.18 0.71 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.144 0.974 . . . . 1.87 110.374 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CB ' ' HB2' ' A' ' 2' ' ' SER . 13.1 pt-20 -90.22 -50.87 5.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.692 -1.595 . . . . 1.77 111.775 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.0 OUTLIER -77.92 -9.4 59.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.696 -0.684 . . . . 2.3 111.321 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -90.12 -37.61 6.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.041 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.35 -64.0 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 2.34 110.489 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.22 58.74 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 2.95 110.653 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.28 -0.867 . . . . 2.23 110.902 -179.717 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.477 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 111.82 0.304 . . . . 5.2 111.82 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 58.0 Cg_exo -51.29 102.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.184 1.923 . . . . 5.12 112.248 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.401 ' HB2' ' OE2' ' A' ' 36' ' ' GLU . 3.4 Cg_exo -74.89 -51.41 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.835 2.356 . . . . 3.56 112.165 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 27' ' ' VAL . . . -134.39 62.26 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 2.11 112.495 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.578 ' HA ' HG22 ' A' ' 38' ' ' VAL . 50.8 p -152.33 173.9 14.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 1.85 111.777 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.833 ' HB3' ' C ' ' A' ' 8' ' ' ALA . . . -170.87 -158.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 1.86 110.85 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -162.09 124.9 2.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.662 -0.244 . . . . 7.29 110.775 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.483 ' HD3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.17 -35.19 49.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.494 -0.321 . . . . 6.23 111.293 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -139.33 -171.06 3.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.606 0.241 . . . . 7.18 110.67 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -53.31 -25.32 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.408 . . . . 4.33 110.496 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.622 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 37.4 mtmt 76.36 90.25 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.654 -0.703 . . . . 4.49 110.295 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -90.5 83.93 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 2.05 110.885 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.623 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 11.2 p-10 -109.59 101.67 10.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 3.8 110.626 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.17 -0.919 . . . . 3.91 111.31 -179.586 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 112.433 -0.267 . . . . 2.97 112.433 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 9.4 t 169.32 -10.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.132 0.79 . . . . 3.15 113.132 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.35 138.66 31.29 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.849 -0.426 . . . . 4.57 109.849 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.473 HG13 ' CE2' ' A' ' 5' ' ' PHE . 9.8 p -96.32 43.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 3.08 110.571 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.63 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -177.92 152.96 0.79 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.887 -0.597 . . . . 2.16 111.282 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.709 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.6 mp0 -134.55 144.07 47.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 2.41 111.067 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.0 p90 -89.52 105.38 17.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.17 0.509 . . . . 1.73 111.902 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB1' ' H ' ' B' ' 7' ' ' ARG . . . -89.9 53.35 2.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.457 -0.792 . . . . 0.38 109.022 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.739 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.81 158.57 20.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.12 0.962 . . . . 2.8 112.96 -177.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.818 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.9 t -97.21 -35.28 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 113.66 -1.609 . . . . 0.42 110.503 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.6 t70 -139.3 -39.36 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.735 -0.666 . . . . 2.19 112.048 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.4 mt-10 -155.98 157.36 36.07 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 112.787 0.662 . . . . 2.18 112.787 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.29 -169.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.34 109.972 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.4 t -150.24 -49.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.67 110.13 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.9 tp10 -98.97 139.1 35.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.715 -0.675 . . . . 2.96 109.689 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 11.3 ptmm? -151.6 87.85 1.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.652 -0.419 . . . . 2.13 112.1 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.647 ' C ' HG23 ' A' ' 23' ' ' VAL . 79.7 ttt180 -153.74 92.36 1.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.042 -0.263 . . . . 3.83 111.101 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.21 -130.21 1.57 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.15 -1.5 . . . . 0.41 114.946 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 68.4 mttm -124.52 -121.62 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.894 0.878 . . . . 1.13 110.082 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.71 -40.03 6.07 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.141 -1.983 . . . . 0.51 108.141 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 2.0 mptp? -143.87 7.02 1.42 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.187 -1.506 . . . . 3.41 111.161 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 17.9 t70 -87.43 9.06 22.0 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.129 0.49 . . . . 1.22 111.066 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.2 p -88.4 152.87 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.6 -0.727 . . . . 0.34 111.561 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.6 pt-20 -109.29 99.36 8.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.511 -0.768 . . . . 1.26 110.015 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HE1' HG21 ' A' ' 23' ' ' VAL . 9.4 m-85 -104.44 149.94 24.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.76 -0.655 . . . . 0.65 110.182 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.784 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 tt -88.97 157.16 18.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.658 -0.867 . . . . 0.96 108.658 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -143.21 110.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 118.953 -1.099 . . . . 0.4 113.894 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 77.2 mtt180 -83.91 75.71 10.09 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.895 -1.891 . . . . 3.27 105.895 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.588 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.4 t90 -26.9 89.68 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.922 -1.49 . . . . 1.31 112.28 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.818 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.3 tttp -29.02 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.654 -1.157 . . . . 2.46 112.209 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 19.4 t70 -119.41 55.59 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 2.02 109.885 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -142.27 -140.4 3.75 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.59 112.641 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.23 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.844 -0.693 . . . . 0.86 112.331 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.69 -174.28 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 2.13 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.8 m -143.97 126.39 15.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.6 110.915 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HA3' ' B' ' 4' ' ' GLY . 43.1 mt-10 -132.06 179.68 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 2.27 110.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.9 m0 -100.19 150.91 22.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.71 111.846 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 25' ' ' TYR . 73.8 t -89.49 162.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.672 -0.694 . . . . 0.65 109.768 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.4 tttt -78.34 104.53 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.739 0.644 . . . . 2.32 112.739 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.62 45.05 2.73 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.076 -0.965 . . . . 0.35 112.516 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -118.3 0.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.999 -0.371 . . . . 0.68 109.999 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -72.76 76.46 1.13 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.595 0.712 . . . . 1.35 110.633 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 52.0 t -56.41 76.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 113.249 -1.796 . . . . 1.49 113.227 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -91.56 49.59 1.6 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.206 -0.906 . . . . 0.48 108.944 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -47.81 -27.83 2.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.13 -0.941 . . . . 2.44 110.509 -178.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 12.0 t70 -77.95 -44.03 28.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 2.48 109.424 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 49.2 t -65.18 -27.72 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.099 -0.501 . . . . 0.88 110.704 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -93.92 -57.78 2.44 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.997 1.436 . . . . 0.99 112.565 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 38.8 ttpt -51.73 -45.29 63.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.207 0.527 . . . . 3.35 110.556 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 1.8 t70 -79.42 -20.6 47.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.104 -0.702 . . . . 2.0 109.104 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.421 -0.809 . . . . 1.87 110.474 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -86.04 -48.71 8.4 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.324 -1.307 . . . . 1.77 111.684 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -77.34 -42.82 35.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.823 -0.626 . . . . 2.3 111.541 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -50.32 -52.14 28.89 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.542 -0.837 . . . . 1.61 112.394 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.06 -69.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 2.34 110.803 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 63.63 6.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 2.95 110.831 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.5 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.184 -0.912 . . . . 2.23 110.919 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' B' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.302 0.096 . . . . 5.2 110.824 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.59 109.91 2.39 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.297 1.998 . . . . 5.12 112.153 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' B' ' 1' ' ' ALA . 72.9 Cg_endo -75.54 91.73 1.05 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.442 2.095 . . . . 3.56 112.403 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.458 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 47.35 81.04 0.05 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.888 -0.672 . . . . 2.11 112.476 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.985 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -151.82 159.9 43.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 1.85 111.687 -179.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 10' ' ' VAL . . . -147.07 -47.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 1.86 110.444 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.64 ' H ' ' HB1' ' A' ' 8' ' ' ALA . 72.2 mtm180 68.36 118.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 7.29 111.685 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -69.23 -42.41 75.71 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 6.23 110.838 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -147.88 -168.69 3.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.549 -0.296 . . . . 7.18 110.44 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 11' ' ' LYS . 12.6 ptm180 -52.95 -25.11 10.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.351 . . . . 4.33 110.691 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.503 ' HB3' ' CG ' ' A' ' 42' ' ' HIS . 86.6 mttt 69.24 93.05 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.9 -0.591 . . . . 4.49 110.785 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -82.69 121.41 26.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 2.05 110.755 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' CE1' ' A' ' 42' ' ' HIS . 5.3 p-10 -126.29 53.33 1.64 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.974 0.416 . . . . 3.8 111.021 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 3.91 110.856 179.744 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 120.309 -0.162 . . . . 2.97 112.757 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 70.2 p 179.87 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.154 0.428 . . . . 3.15 112.154 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 8.5 pt20 -87.03 130.77 34.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.153 -0.314 . . . . 4.57 110.153 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 4' ' ' VAL . 10.7 p -89.88 66.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.046 0.45 . . . . 3.08 111.751 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.431 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 9.3 p90 165.67 164.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.912 -0.585 . . . . 2.16 110.932 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.583 ' H ' HG11 ' A' ' 23' ' ' VAL . 11.0 tp10 -142.43 145.11 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 2.41 110.275 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 44.4 p90 -89.76 105.5 17.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.079 0.466 . . . . 1.73 111.878 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.773 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.93 55.55 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.146 -0.687 . . . . 0.38 109.146 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.743 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.31 163.17 15.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.087 0.946 . . . . 2.8 112.433 -177.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.828 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.7 t -96.71 -37.54 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 113.595 -1.639 . . . . 0.42 110.741 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 17.4 t70 -142.57 -34.56 0.44 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.038 -0.528 . . . . 2.19 112.244 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 44.8 mt-10 -156.0 151.06 26.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.25 0.833 . . . . 2.18 113.25 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -125.98 -171.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.331 -0.395 . . . . 0.34 110.561 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 26' ' ' LEU . 94.7 t -147.19 -48.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.069 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.9 mt-10 -97.72 141.77 30.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.821 -0.627 . . . . 2.96 109.751 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.4 ptmt -152.02 84.92 1.28 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.687 -0.405 . . . . 2.13 111.898 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.881 ' C ' HG23 ' A' ' 23' ' ' VAL . 51.9 ttp180 -153.38 97.12 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.085 -0.246 . . . . 3.83 111.027 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.21 -130.23 1.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 118.94 -1.6 . . . . 0.41 114.978 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.967 ' HE3' HG13 ' A' ' 43' ' ' VAL . 54.1 mttm -117.04 -72.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.333 1.063 . . . . 1.13 110.738 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.31 -47.81 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 106.835 -2.506 . . . . 0.51 106.835 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' CE ' ' HD3' ' B' ' 10' ' ' ARG . 1.8 mptt -127.6 -6.27 5.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.076 -1.562 . . . . 3.41 109.831 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.0 t70 -86.75 9.73 18.05 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.125 0.488 . . . . 1.22 111.291 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.881 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.0 p -87.22 152.37 3.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.78 -0.645 . . . . 0.34 111.086 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.99 94.56 5.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.654 -0.703 . . . . 1.26 110.689 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.657 ' HD2' HG21 ' A' ' 13' ' ' ILE . 7.0 m-85 -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.153 -0.476 . . . . 0.65 110.38 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.81 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.2 tt -89.31 157.73 18.08 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.366 -0.976 . . . . 0.96 108.366 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.743 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.41 110.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.022 -1.071 . . . . 0.4 113.499 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' CD ' HD21 ' A' ' 26' ' ' LEU . 13.3 mmm180 -84.75 79.39 9.63 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.142 -1.799 . . . . 3.27 106.142 175.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.823 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -27.19 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.535 -1.211 . . . . 1.31 111.966 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.828 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.0 ttpt -27.62 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.307 -1.315 . . . . 2.46 112.26 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' TRP . 6.0 m-20 -123.94 57.07 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.005 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -140.97 -159.65 7.99 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.017 -0.611 . . . . 0.59 112.999 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.23 19.8 1.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.121 -0.561 . . . . 0.86 112.376 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -139.9 -176.56 4.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.741 0.305 . . . . 2.13 110.636 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . 29.0 p -150.19 111.16 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 1.6 111.232 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 6.5 mm-40 -123.99 -176.85 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 2.27 110.922 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' HG22 ' B' ' 5' ' ' THR . 4.7 m-90 -108.71 153.24 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.108 0.48 . . . . 0.71 111.697 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 8' ' ' ALA . 49.0 t -88.43 162.18 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.704 -0.68 . . . . 0.65 109.52 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.5 tttt -80.73 103.62 10.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.461 0.648 . . . . 2.32 112.075 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -88.83 45.05 3.18 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.027 -0.988 . . . . 0.35 112.647 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -120.2 0.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.076 -0.342 . . . . 0.68 110.076 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.85 77.83 0.88 Allowed 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.46 0.648 . . . . 1.35 109.775 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.967 HG13 ' HE3' ' A' ' 19' ' ' LYS . 49.5 t -56.09 72.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.406 -1.724 . . . . 1.49 113.805 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.62 49.52 1.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.565 -0.743 . . . . 0.48 109.354 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.46 -28.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.209 -0.905 . . . . 2.44 110.58 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 6.8 m-20 -66.7 -49.97 64.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.493 -0.776 . . . . 2.48 109.875 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.806 HG12 ' CD2' ' A' ' 51' ' ' TYR . 42.2 t -58.23 -30.52 40.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.593 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -79.32 -59.99 2.54 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.754 1.221 . . . . 0.99 109.954 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.7 ttpt -56.97 -27.84 61.7 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.758 -0.83 . . . . 3.35 108.758 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.2 t70 -91.85 -22.68 19.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.148 -0.933 . . . . 2.0 110.108 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.806 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.46 -71.09 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.837 0.827 . . . . 1.87 110.087 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.3 pt-20 -81.53 -47.16 13.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.143 -1.39 . . . . 1.77 112.012 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.3 m-20 -80.78 -18.73 46.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.043 -0.526 . . . . 2.3 111.703 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 50' ' ' ASP . . . -75.19 -43.16 26.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.408 -0.901 . . . . 1.61 112.391 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.5 tp -76.08 -63.64 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 2.34 110.534 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -87.94 59.77 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 2.95 110.492 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 54.9 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.307 -0.854 . . . . 2.23 110.929 -179.828 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 111.803 0.298 . . . . 5.2 111.803 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 74.0 Cg_exo -47.67 107.2 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.225 1.95 . . . . 5.12 112.3 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.17 67.66 4.19 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.488 2.125 . . . . 3.56 112.358 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.454 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 137.99 61.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.677 -0.773 . . . . 2.11 112.517 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 37' ' ' TRP . 28.1 p -152.42 174.23 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.089 0.471 . . . . 1.85 111.782 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.696 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -170.44 42.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.673 -0.694 . . . . 1.86 110.628 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 12.4 ptm180 -41.84 134.97 2.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.824 -0.625 . . . . 7.29 111.932 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.42 ' HG2' ' HE2' ' A' ' 21' ' ' LYS . 27.4 tpt180 -55.21 133.7 49.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.489 -0.56 . . . . 6.23 109.489 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' B' ' 9' ' ' LYS . 3.4 ptmm? -111.85 34.29 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.183 0.438 . . . . 7.18 112.183 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.466 ' HD3' ' CE ' ' A' ' 21' ' ' LYS . 12.2 ptm180 -97.66 -21.07 17.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 4.33 110.417 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.424 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 36.35 63.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.459 0.54 . . . . 4.49 112.459 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.473 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -52.65 -28.45 21.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.143 0.497 . . . . 2.05 110.282 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 22.7 t70 -109.39 38.25 2.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.423 -0.808 . . . . 3.8 110.317 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.246 -0.883 . . . . 3.91 111.008 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.718 -0.153 . . . . 2.97 112.718 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 83.5 p 179.52 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.089 0.403 . . . . 3.15 112.089 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 1.113 ' C ' ' CE1' ' A' ' 5' ' ' PHE . 90.3 mt-30 -88.79 137.96 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.799 -0.445 . . . . 4.57 109.799 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.374 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 13.5 p -89.54 72.41 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.047 0.388 . . . . 3.08 112.047 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.374 ' CE1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER 163.39 177.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.032 0.444 . . . . 2.16 111.6 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.748 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.4 tp10 -152.72 146.73 25.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.846 -0.615 . . . . 2.41 109.717 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -89.52 109.0 19.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 1.73 110.966 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' O ' ' OE2' ' A' ' 9' ' ' GLU . . . -94.32 33.13 1.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.482 -0.781 . . . . 0.38 110.698 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 1.233 ' OE2' ' N ' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -102.75 175.06 5.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.043 0.925 . . . . 2.8 112.815 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.669 HG21 ' CD1' ' A' ' 29' ' ' TRP . 21.3 t -109.49 -17.52 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 113.699 -1.591 . . . . 0.42 112.402 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 21.1 t70 -150.14 -43.33 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 2.19 111.468 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.6 mt-10 -153.3 168.45 25.99 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.091 -0.504 . . . . 2.18 111.545 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -141.52 -169.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.695 -0.483 . . . . 0.34 109.695 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.713 HG23 HD23 ' A' ' 26' ' ' LEU . 90.5 t -149.97 -57.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.67 110.092 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 20.6 mm-40 -91.02 133.98 34.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.931 -0.577 . . . . 2.96 109.447 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 pttm -151.07 87.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.708 -0.397 . . . . 2.13 111.442 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.636 ' C ' HG23 ' A' ' 23' ' ' VAL . 2.3 mpt_? -153.65 94.79 1.82 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.752 0.279 . . . . 3.83 111.752 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.07 -128.19 1.38 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 119.415 -1.374 . . . . 0.41 114.065 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.902 ' NZ ' HG23 ' A' ' 43' ' ' VAL . 86.0 mttt -109.49 -74.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.117 0.961 . . . . 1.13 110.659 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -151.7 -47.76 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 107.167 -2.373 . . . . 0.51 107.167 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' B' ' 8' ' ' ARG . 2.1 ttpt -124.59 -9.62 7.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.067 -1.566 . . . . 3.41 109.802 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -86.47 7.71 24.82 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 121.232 0.539 . . . . 1.22 111.376 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG11 ' H ' ' A' ' 6' ' ' GLU . 10.8 p -89.25 157.71 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.409 -0.814 . . . . 0.34 110.63 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.7 pt-20 -110.26 115.83 30.4 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 1.26 110.864 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 13' ' ' ILE . 8.0 m-85 -115.71 148.5 39.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.607 -0.724 . . . . 0.65 110.131 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 37' ' ' TRP . 18.3 tp -90.7 159.0 16.59 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.781 -1.192 . . . . 0.96 107.781 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.163 HG11 ' CD ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -143.79 111.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 114.449 1.277 . . . . 0.4 114.449 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 81.7 mtt180 -83.23 70.0 10.04 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.068 -1.827 . . . . 3.27 106.068 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.2 t90 -26.28 89.7 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 113.761 -1.563 . . . . 1.31 112.036 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HB3' HG12 ' A' ' 10' ' ' VAL . 63.8 tttm -28.46 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.368 -1.287 . . . . 2.46 112.416 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.9 m-20 -111.76 54.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 2.02 110.076 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.13 -161.5 9.92 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.59 112.737 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.73 -38.9 0.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.984 -0.627 . . . . 0.86 112.237 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -114.09 176.22 5.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 2.13 110.628 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 26.9 p -126.67 130.53 50.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.361 . . . . 1.6 110.912 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.779 ' C ' HD12 ' A' ' 26' ' ' LEU . 31.1 mm-40 -117.13 165.6 13.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.066 0.46 . . . . 2.27 111.591 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CD1' HD13 ' A' ' 26' ' ' LEU . 12.3 m0 -87.97 140.32 29.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.617 -0.72 . . . . 0.71 111.138 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 25' ' ' TYR . 89.3 t -87.37 160.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.65 110.127 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.2 ttmt -77.23 108.08 10.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.118 0.785 . . . . 2.32 113.118 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -89.57 44.46 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.933 -1.03 . . . . 0.35 112.487 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG23 ' HG3' ' A' ' 39' ' ' LYS . 2.6 t -117.77 -5.19 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.332 . . . . 0.68 110.248 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -66.02 79.0 0.09 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.892 0.853 . . . . 1.35 110.057 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.902 HG23 ' NZ ' ' A' ' 19' ' ' LYS . 6.1 p -56.16 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 113.296 -1.774 . . . . 1.49 113.756 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.86 49.15 1.41 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.8 -1.091 . . . . 0.48 109.617 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' N ' ' HB3' ' B' ' 13' ' ' ASP . 38.1 tt0 -45.18 -26.65 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.133 -0.939 . . . . 2.44 111.312 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HB3' ' HB1' ' B' ' 12' ' ' ALA . 16.2 t70 -70.5 -46.86 62.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.594 . . . . 2.48 110.059 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.903 HG12 ' CE2' ' A' ' 51' ' ' TYR . 25.4 t -56.03 -35.5 41.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 116.073 -0.512 . . . . 0.88 109.875 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.07 -60.65 2.28 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.835 1.254 . . . . 0.99 110.344 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 26.5 ttpp -54.4 -30.6 52.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.25 -0.648 . . . . 3.35 109.25 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -92.95 -22.79 19.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.671 -0.695 . . . . 2.0 110.869 178.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.903 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.9 -66.08 0.6 Allowed 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.255 1.026 . . . . 1.87 109.018 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 2' ' ' SER . 33.3 mt-10 -81.28 -67.78 0.75 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.178 -1.828 . . . . 1.77 110.904 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -57.31 -43.2 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.027 -0.988 . . . . 2.3 111.185 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -52.75 -39.34 54.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.53 -0.843 . . . . 1.61 112.164 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 1' ' ' GLY . 66.8 tp -84.38 -59.26 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.783 0.325 . . . . 2.34 110.287 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.87 60.01 4.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 2.95 110.55 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.7 t80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.216 -0.897 . . . . 2.23 110.943 -179.848 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.732 0.301 . . . . 5.2 111.072 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' B' ' 3' ' ' PRO . 2.2 Cg_endo -42.92 -58.12 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.952 2.434 . . . . 5.12 112.577 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' B' ' 2' ' ' PRO . 26.9 Cg_endo -62.77 92.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.34 2.027 . . . . 3.56 112.217 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . 131.86 -41.79 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 2.11 112.45 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.949 HG23 ' H ' ' B' ' 7' ' ' ARG . 4.8 p -88.57 172.3 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 1.85 111.433 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 1.233 ' N ' ' OE2' ' A' ' 9' ' ' GLU . . . -141.68 57.03 1.5 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.218 -0.447 . . . . 1.86 111.851 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.949 ' H ' HG23 ' B' ' 5' ' ' THR . 39.1 ptt180 -48.86 129.08 16.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.443 -0.344 . . . . 7.29 110.637 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 1.096 HH22 ' CD ' ' B' ' 9' ' ' LYS . 28.0 tpt180 -50.55 164.85 0.11 Allowed 'General case' 0 C--N 1.338 0.093 0 N-CA-C 109.927 -0.397 . . . . 6.23 109.927 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 1.096 ' CD ' HH22 ' B' ' 8' ' ' ARG . 0.0 OUTLIER -136.1 46.29 2.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.765 0.654 . . . . 7.18 112.765 -178.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.452 ' HG2' ' CD ' ' A' ' 21' ' ' LYS . 17.5 ptp180 -99.9 -36.87 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.113 0.482 . . . . 4.33 110.074 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.457 ' HD3' ' NE2' ' A' ' 42' ' ' HIS . 11.4 mmmm 49.54 85.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.699 -0.682 . . . . 4.49 111.129 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.804 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -88.28 -27.87 21.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 2.05 110.54 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.631 ' OD1' HG22 ' A' ' 43' ' ' VAL . 7.3 t70 -135.7 159.84 40.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 3.8 110.878 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.283 -0.865 . . . . 3.91 110.865 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.698 -0.161 . . . . 2.97 112.698 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HB2' ' CB ' ' A' ' 52' ' ' GLU . 58.1 p -153.26 -57.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 3.15 110.558 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -99.92 118.94 37.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.983 -0.553 . . . . 4.57 110.143 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.5 t -146.36 -54.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.056 0.391 . . . . 3.08 112.056 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER 63.59 -163.31 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.934 -0.765 . . . . 2.16 108.934 -178.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.752 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -151.16 139.61 20.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 2.41 111.798 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 47.1 p90 -91.42 106.58 18.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.174 0.511 . . . . 1.73 110.921 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.772 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -88.69 60.58 5.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.954 -0.758 . . . . 0.38 108.954 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.903 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -114.81 150.34 35.61 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.348 1.07 . . . . 2.8 113.181 -177.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.887 HG23 ' CG2' ' A' ' 27' ' ' VAL . 57.8 t -89.53 -36.78 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.25 -1.795 . . . . 0.42 109.212 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -144.47 -33.68 0.39 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.983 -1.008 . . . . 2.19 111.615 177.271 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' HD23 ' A' ' 26' ' ' LEU . 43.7 mt-10 -152.81 159.17 43.06 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.131 0.419 . . . . 2.18 112.131 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -128.67 -168.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.173 -0.677 . . . . 0.34 109.173 178.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.6 t -151.38 -60.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.218 0.533 . . . . 0.67 109.742 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 22.0 mm-40 -92.5 143.57 26.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.346 -0.843 . . . . 2.96 109.729 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.9 pttm -152.66 93.43 1.77 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.075 -0.25 . . . . 2.13 111.297 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.626 ' C ' HG23 ' A' ' 23' ' ' VAL . 1.7 tmt_? -155.16 88.64 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.469 -0.492 . . . . 3.83 111.205 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.589 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.92 -137.88 2.75 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 118.863 -1.636 . . . . 0.41 115.269 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 22' ' ' ASP . 90.6 mttt -108.36 -88.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.312 -0.944 . . . . 1.13 110.767 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -131.95 -44.79 0.15 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.928 -2.069 . . . . 0.51 107.928 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -131.33 -6.3 3.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.26 -1.47 . . . . 3.41 110.693 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 20.7 t70 -89.13 12.0 17.0 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 121.125 0.488 . . . . 1.22 111.347 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.752 HG11 ' H ' ' A' ' 6' ' ' GLU . 14.6 p -87.92 157.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.533 -0.758 . . . . 0.34 111.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.0 pt-20 -108.83 109.4 20.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.285 -0.87 . . . . 1.26 110.256 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.741 ' HE1' HG21 ' A' ' 23' ' ' VAL . 11.1 m-85 -118.68 152.93 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.935 -0.575 . . . . 0.65 110.605 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 3.1 tt -87.68 157.07 19.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.828 -0.804 . . . . 0.96 108.828 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.86 97.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.121 -0.631 . . . . 0.4 112.087 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 30' ' ' LYS . 48.3 ttt180 -79.17 82.45 5.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.737 -1.209 . . . . 3.27 107.737 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t90 -28.66 91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.803 -1.089 . . . . 1.31 112.085 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 18.6 pttp -26.97 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.55 -1.204 . . . . 2.46 112.557 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 29' ' ' TRP . 18.0 m-20 -120.63 57.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 2.02 110.087 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -139.28 -143.54 4.43 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.845 -0.616 . . . . 0.59 112.527 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.34 -48.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.855 -0.688 . . . . 0.86 112.307 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.76 179.7 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 2.13 110.804 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 26' ' ' LEU . 26.9 p -125.94 138.11 53.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.382 . . . . 1.6 111.014 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' B' ' 3' ' ' PRO . 9.5 tp10 -133.53 158.86 42.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.607 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 41.7 m0 -97.18 149.26 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.71 111.368 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.783 HG23 HG12 ' A' ' 27' ' ' VAL . 77.0 t -88.77 159.31 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.65 110.009 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.3 tppt? -79.17 110.86 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.27 0.557 . . . . 2.32 112.159 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -87.95 36.76 3.33 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.232 -0.894 . . . . 0.35 112.914 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 39' ' ' LYS . 3.1 t -112.39 0.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.34 -0.245 . . . . 0.68 110.34 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.132 ' NE2' ' CG ' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -66.86 76.27 0.12 Allowed 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.688 0.756 . . . . 1.35 109.609 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.1 p -57.17 75.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 113.715 -1.584 . . . . 1.49 113.982 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 50.83 1.83 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.589 -0.893 . . . . 0.48 108.589 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -24.14 1.93 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.982 -1.008 . . . . 2.44 110.54 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 16.0 t70 -66.0 -49.77 66.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 2.48 109.91 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.822 HG12 ' CD2' ' A' ' 51' ' ' TYR . 60.3 t -55.05 -38.47 46.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 116.251 -0.431 . . . . 0.88 110.546 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -76.61 -59.86 2.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.188 1.395 . . . . 0.99 110.665 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.2 tmmm? -56.73 -28.44 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.157 -0.683 . . . . 3.35 109.157 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.9 t70 -91.54 -24.52 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.582 -0.736 . . . . 2.0 109.452 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.86 -70.28 0.3 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.817 0.817 . . . . 1.87 110.59 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 2' ' ' SER . 13.0 pt-20 -82.4 -48.17 11.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.21 -1.359 . . . . 1.77 111.714 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -78.19 -25.49 47.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.839 -0.619 . . . . 2.3 111.599 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -77.0 -55.65 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.313 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.54 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 2.34 110.564 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -87.99 58.42 4.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 2.95 110.577 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.236 -0.888 . . . . 2.23 110.949 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.66 0.267 . . . . 5.2 111.038 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' B' ' 3' ' ' PRO . 97.1 Cg_endo -79.33 111.66 2.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 5.12 112.348 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 41.0 Cg_endo -67.92 62.42 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.58 2.187 . . . . 3.56 112.272 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.426 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . 148.97 94.91 0.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.728 -0.749 . . . . 2.11 112.518 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.613 ' N ' HG21 ' A' ' 27' ' ' VAL . 64.1 p -154.55 151.61 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.813 0.34 . . . . 1.85 111.739 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -150.02 -61.51 0.21 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.211 -0.45 . . . . 1.86 111.841 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? 62.34 129.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.027 -0.36 . . . . 7.29 110.027 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.522 ' CZ ' ' CE2' ' A' ' 7' ' ' TYR . 13.5 ptt180 -132.67 46.2 2.65 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.671 0.619 . . . . 6.23 112.671 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -154.48 177.71 10.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.901 -0.319 . . . . 7.18 110.791 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -68.39 -27.19 66.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.182 0.515 . . . . 4.33 110.564 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 1.132 ' CG ' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER 77.4 67.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.325 -0.852 . . . . 4.49 109.941 -179.214 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . . . -39.84 -28.91 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.519 -0.764 . . . . 2.05 112.225 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' VAL . 22.3 t70 -108.97 -28.37 9.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 3.8 111.006 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.465 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 47.8 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.189 -0.91 . . . . 3.91 111.11 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.6 p90 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.953 0.406 . . . . 2.16 111.888 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -134.75 142.41 46.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.957 -0.565 . . . . 2.41 111.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 31.7 p90 -89.78 122.26 32.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.73 111.424 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.776 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -107.25 53.45 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.816 -0.629 . . . . 0.38 110.651 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.696 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -106.41 176.79 5.05 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.934 0.873 . . . . 2.8 112.779 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.714 HG12 ' CB ' ' A' ' 30' ' ' LYS . 54.4 t -104.07 -24.28 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.021 -1.445 . . . . 0.42 111.505 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 5.3 t70 -150.52 -39.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.917 -0.583 . . . . 2.19 111.114 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 47.4 mt-10 -152.47 162.7 40.83 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.197 0.443 . . . . 2.18 112.197 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -131.73 -168.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.487 -0.56 . . . . 0.34 109.487 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 HD23 ' A' ' 26' ' ' LEU . 69.4 t -150.24 -49.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.67 110.836 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 43.6 tt0 -98.64 146.11 26.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.162 -0.472 . . . . 2.96 110.465 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 18.8 pttm -152.9 89.62 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.005 0.372 . . . . 2.13 112.005 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.78 ' C ' HG23 ' A' ' 23' ' ' VAL . 30.4 ttm180 -154.54 87.63 1.18 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 121.059 -0.256 . . . . 3.83 111.104 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.797 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.26 -137.74 2.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.084 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.6 mttm -115.63 -122.49 0.29 Allowed 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.65 -0.775 . . . . 1.13 110.325 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -90.28 -42.13 5.32 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.036 -2.026 . . . . 0.51 108.036 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 1.4 mptp? -140.67 7.29 2.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.023 -1.588 . . . . 3.41 110.675 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 30.3 t0 -88.85 10.07 22.45 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.893 0.377 . . . . 1.22 111.091 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.797 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.1 p -88.01 150.0 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 116.021 -0.536 . . . . 0.34 111.398 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.9 pt-20 -112.33 93.08 4.26 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.488 -0.778 . . . . 1.26 110.393 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 5.6 m-85 -88.16 -167.7 1.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.263 -0.643 . . . . 0.65 109.263 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.844 HD13 ' CD1' ' A' ' 37' ' ' TRP . 29.4 tp -126.48 160.63 30.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.064 -1.087 . . . . 0.96 108.064 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -139.19 110.72 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 118.924 -1.111 . . . . 0.4 113.529 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 52.0 mtt180 -84.85 74.19 10.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 105.668 -1.975 . . . . 3.27 105.668 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.7 t90 -26.72 90.81 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 113.867 -1.515 . . . . 1.31 111.833 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.714 ' CB ' HG12 ' A' ' 10' ' ' VAL . 83.5 tttt -27.39 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.352 -1.295 . . . . 2.46 112.341 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 4.7 p-10 -120.01 56.76 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.796 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.56 -178.02 23.3 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.59 112.628 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.06 -13.37 9.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.851 -0.69 . . . . 0.86 112.567 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -126.65 162.49 25.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 2.13 110.89 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 28' ' ' ARG . 61.2 m -116.1 118.72 33.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 1.6 110.71 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.782 ' O ' HD12 ' A' ' 26' ' ' LEU . 31.9 mt-10 -108.64 163.88 12.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.207 0.527 . . . . 2.27 111.68 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.844 ' CD1' HD13 ' A' ' 26' ' ' LEU . 16.2 m0 -87.95 148.37 24.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.71 112.015 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.776 HG11 ' HB3' ' A' ' 8' ' ' ALA . 40.1 t -87.6 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.018 -0.992 . . . . 0.65 109.751 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 86.9 tttt -80.76 106.89 13.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.284 0.564 . . . . 2.32 112.436 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -99.22 39.32 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.298 -0.864 . . . . 0.35 112.363 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.29 0.0 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.824 -0.436 . . . . 0.68 109.824 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -77.05 77.79 3.6 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.734 0.778 . . . . 1.35 110.918 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 43' ' ' VAL . 6.0 p -57.28 77.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.325 -1.761 . . . . 1.49 112.663 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -92.43 49.25 1.47 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.872 -1.058 . . . . 0.48 109.241 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 42.0 tt0 -48.28 -27.53 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.171 -0.922 . . . . 2.44 110.187 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 15.8 t70 -75.02 -43.12 55.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.477 -0.783 . . . . 2.48 109.73 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 51' ' ' TYR . 95.3 t -63.93 -46.79 93.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 109.34 -0.615 . . . . 0.88 109.34 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.4 -54.96 18.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.539 1.536 . . . . 0.99 111.331 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 23.3 ttmm -60.27 -33.28 72.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.406 0.622 . . . . 3.35 109.464 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.1 t70 -91.67 -11.4 37.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.276 -0.874 . . . . 2.0 110.428 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -84.02 -63.25 1.38 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.428 0.633 . . . . 1.87 110.262 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.7 pt-20 -87.64 -46.68 9.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.046 -0.979 . . . . 1.77 110.83 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -80.99 -22.51 39.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 2.3 111.425 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.244 179.806 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.3 p90 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.649 0.261 . . . . 2.16 110.39 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.567 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.4 tp10 -130.15 142.98 50.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 2.41 110.935 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.6 p90 -88.27 109.37 19.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.6 0.714 . . . . 1.73 112.034 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -95.02 50.82 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.758 -1.11 . . . . 0.38 109.611 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.12 169.23 9.26 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.984 0.897 . . . . 2.8 112.369 -178.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.912 HG12 ' CB ' ' A' ' 30' ' ' LYS . 51.7 t -97.53 -34.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-N 113.769 -1.559 . . . . 0.42 112.096 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 11.3 t70 -144.87 -33.67 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.508 0.558 . . . . 2.19 112.508 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 33.2 mm-40 -154.07 159.79 41.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.297 0.481 . . . . 2.18 112.297 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.4 -169.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.34 110.485 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG23 HD22 ' A' ' 26' ' ' LEU . 94.0 t -149.97 -54.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.431 . . . . 0.67 110.068 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 41.5 mt-10 -92.25 138.32 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 2.96 109.375 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 19.7 pttm -152.43 87.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.262 0.467 . . . . 2.13 112.262 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.783 ' C ' HG23 ' A' ' 23' ' ' VAL . 73.4 mtp180 -154.24 93.08 1.58 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.324 -0.235 . . . . 3.83 111.422 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.709 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.28 -128.87 1.32 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.19 -1.481 . . . . 0.41 114.786 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.6 mttm -121.55 -122.79 0.28 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.341 -0.93 . . . . 1.13 109.481 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.12 -40.58 5.14 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.291 -1.924 . . . . 0.51 108.291 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 12.0 mptt -137.14 1.95 2.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.187 -1.507 . . . . 3.41 110.922 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.665 ' OD2' HG22 ' A' ' 43' ' ' VAL . 35.9 t0 -87.6 9.48 21.09 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.12 0.486 . . . . 1.22 111.465 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.3 p -89.36 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.867 -0.606 . . . . 0.34 111.705 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.9 pt-20 -107.73 101.15 10.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.483 -0.781 . . . . 1.26 110.035 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.675 ' HE1' HG21 ' A' ' 23' ' ' VAL . 7.2 m-85 -107.02 150.14 26.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.822 -0.626 . . . . 0.65 110.302 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.1 tt -88.64 156.99 18.71 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.593 -0.892 . . . . 0.96 108.593 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.0 m -141.21 112.04 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 114.07 1.137 . . . . 0.4 114.07 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' TRP . 77.6 mtt180 -87.38 79.29 8.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.666 -1.975 . . . . 3.27 105.666 175.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.565 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.2 t90 -26.87 91.65 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.284 -1.326 . . . . 1.31 112.246 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.912 ' CB ' HG12 ' A' ' 10' ' ' VAL . 61.6 tttp -27.62 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.308 -1.315 . . . . 2.46 112.257 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.8 t70 -119.3 57.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 2.02 109.903 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -147.6 -145.25 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.59 112.735 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -144.97 -45.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.949 -0.644 . . . . 0.86 112.213 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.07 -177.33 4.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 2.13 110.535 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.58 139.42 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 1.6 111.214 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -134.35 -177.46 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.081 -0.509 . . . . 2.27 110.779 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -104.25 146.27 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.71 111.338 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 25' ' ' TYR . 92.0 t -89.19 159.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.65 109.792 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' N ' HG12 ' A' ' 38' ' ' VAL . 23.5 ttmm -75.46 107.46 7.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.325 0.583 . . . . 2.32 112.5 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.75 40.77 2.8 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.069 -0.969 . . . . 0.35 112.392 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 1.9 t -116.85 3.94 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.044 -0.354 . . . . 0.68 110.044 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -75.85 76.49 2.78 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.879 0.847 . . . . 1.35 110.799 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG22 ' OD2' ' A' ' 22' ' ' ASP . 58.6 t -58.12 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 113.219 -1.81 . . . . 1.49 113.249 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.75 51.34 1.83 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.595 -0.891 . . . . 0.48 108.595 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -45.85 -27.28 0.83 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.196 -0.911 . . . . 2.44 110.818 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.28 -46.94 63.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.775 -0.648 . . . . 2.48 109.785 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.584 HG23 ' HB1' ' A' ' 44' ' ' ALA . 59.7 t -58.98 -47.39 90.01 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-N 116.002 -0.545 . . . . 0.88 109.539 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.44 -56.69 9.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.175 1.39 . . . . 0.99 110.976 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.6 ttmm -56.59 -35.3 68.07 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.289 0.566 . . . . 3.35 109.682 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -91.56 -14.77 29.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.0 111.152 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.556 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -77.08 -59.95 2.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.718 0.771 . . . . 1.87 110.453 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.1 pt-20 -90.19 -41.75 11.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.3 -1.318 . . . . 1.77 111.482 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -87.69 -30.78 20.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.752 -0.658 . . . . 2.3 111.524 -179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.492 -0.861 . . . . 1.61 112.368 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.695 0.283 . . . . 2.16 110.973 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.2 mp0 -130.94 150.51 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.882 0.372 . . . . 2.41 111.202 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.519 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 50.3 p90 -92.5 113.64 25.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.802 0.668 . . . . 1.73 112.802 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -100.55 54.14 0.88 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.949 -1.023 . . . . 0.38 109.254 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.73 164.33 14.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.992 0.901 . . . . 2.8 112.085 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 29' ' ' TRP . 39.1 t -98.34 -22.07 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 114.004 -1.453 . . . . 0.42 112.117 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 13.7 t70 -149.94 -40.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.385 0.513 . . . . 2.19 112.385 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 8.2 mm-40 -154.23 163.31 40.32 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 111.942 0.349 . . . . 2.18 111.942 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.93 -169.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.575 0.226 . . . . 0.34 110.582 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.4 t -150.13 -59.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.67 110.233 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 16.3 mm-40 -91.9 138.74 31.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.833 -0.622 . . . . 2.96 109.891 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 8.4 ptpp? -151.06 92.99 1.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.008 -0.277 . . . . 2.13 111.652 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.769 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.8 ttt180 -154.44 91.12 1.38 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.352 -0.217 . . . . 3.83 110.969 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.751 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.16 -134.11 1.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.111 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 69.0 mttm -117.28 -126.01 0.28 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.263 -0.968 . . . . 1.13 109.526 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.21 -38.7 6.66 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.551 -1.82 . . . . 0.51 108.551 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 20.8 mmtp -140.51 2.5 1.83 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.215 -1.492 . . . . 3.41 111.084 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 16.1 t70 -88.26 11.26 17.03 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.211 0.529 . . . . 1.22 111.462 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' C ' ' A' ' 17' ' ' ARG . 6.3 p -88.75 154.03 3.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.802 -0.636 . . . . 0.34 112.199 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.9 pt-20 -107.33 105.61 15.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.313 -0.858 . . . . 1.26 110.098 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.709 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 m-85 -110.52 150.82 28.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.654 . . . . 0.65 110.177 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.8 tt -88.74 157.26 18.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.07 -0.715 . . . . 0.96 109.07 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.9 m -143.07 110.55 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 114.428 1.27 . . . . 0.4 114.428 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.2 ttp180 -82.1 72.97 9.16 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 105.465 -2.05 . . . . 3.27 105.465 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.787 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -26.49 89.47 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.86 -1.518 . . . . 1.31 112.207 -177.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.726 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.2 ttpt -29.21 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.596 -1.184 . . . . 2.46 112.089 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.6 m-20 -117.95 56.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 2.02 109.796 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.13 -163.71 10.26 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.59 112.72 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.34 -43.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.006 -0.616 . . . . 0.86 112.054 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -97.75 -173.67 2.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 2.13 110.518 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 26' ' ' LEU . 44.6 t -142.69 144.1 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 1.6 111.087 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -147.68 -176.22 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 2.27 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 34.8 m0 -104.62 152.28 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.71 111.589 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 25' ' ' TYR . 72.1 t -88.95 161.06 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.993 -0.548 . . . . 0.65 109.942 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.3 tttp -75.48 104.36 6.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.343 0.592 . . . . 2.32 112.332 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.51 44.19 2.91 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.136 -0.938 . . . . 0.35 112.511 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.426 ' HB ' ' HE3' ' A' ' 39' ' ' LYS . 2.0 t -120.18 8.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.835 -0.431 . . . . 0.68 109.835 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -75.81 75.81 2.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.43 0.633 . . . . 1.35 110.433 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 60.5 t -57.87 73.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.609 -1.632 . . . . 1.49 113.5 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.71 49.55 1.48 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.799 -0.815 . . . . 0.48 108.799 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -44.16 -29.24 0.6 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.181 -0.918 . . . . 2.44 110.734 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 12.1 t70 -70.53 -43.76 68.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.488 -0.778 . . . . 2.48 110.117 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.6 t -63.04 -47.57 92.06 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 109.514 -0.551 . . . . 0.88 109.514 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -65.88 -54.79 21.98 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.99 111.062 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 27.9 ttpp -60.12 -33.16 71.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.456 0.646 . . . . 3.35 109.65 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 6.9 t70 -92.56 -9.37 41.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.278 -0.874 . . . . 2.0 110.652 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -86.53 -63.67 1.28 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.484 0.659 . . . . 1.87 110.749 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.4 pt-20 -85.79 -42.95 13.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.892 -1.049 . . . . 1.77 110.763 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -87.61 -18.92 28.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.607 -0.724 . . . . 2.3 111.42 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.454 -0.879 . . . . 1.61 112.369 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.579 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.143 0.497 . . . . 2.16 111.157 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.017 ' H ' HG11 ' A' ' 23' ' ' VAL . 7.9 tp10 -154.11 124.32 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 2.41 109.731 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 43.0 p90 -89.21 105.01 17.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.815 0.302 . . . . 1.73 111.815 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.788 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.58 56.1 3.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.55 -0.537 . . . . 0.38 109.55 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.616 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.71 149.51 32.82 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.813 0.816 . . . . 2.8 113.028 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 18.2 t -90.45 -32.49 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 114.222 -1.353 . . . . 0.42 110.647 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.5 t70 -138.43 -43.15 0.5 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 2.19 111.814 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.4 mm-40 -155.43 157.59 37.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.81 0.67 . . . . 2.18 112.81 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -126.87 -165.9 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.325 -0.62 . . . . 0.34 109.325 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.802 HG22 ' CB ' ' A' ' 26' ' ' LEU . 31.5 m -150.1 -51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.67 111.199 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.1 tp10 -105.23 134.71 47.89 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.897 -0.592 . . . . 2.96 109.448 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 13.2 ptmm? -150.9 88.98 1.5 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.134 -0.627 . . . . 2.13 112.63 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 15.0 ptp180 -153.6 91.34 1.47 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.85 -0.34 . . . . 3.83 111.383 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.61 -135.28 2.18 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 118.876 -1.631 . . . . 0.41 114.851 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.7 mttm -111.28 -120.26 0.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.46 -0.87 . . . . 1.13 109.909 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.95 -41.0 3.91 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 108.19 -1.964 . . . . 0.51 108.19 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 46.2 mmtm -135.08 0.46 2.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 112.978 -1.611 . . . . 3.41 110.871 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -88.54 9.88 22.33 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 121.297 0.57 . . . . 1.22 111.458 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.017 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.3 p -93.99 143.18 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.148 -0.933 . . . . 0.34 110.58 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 11.8 pt-20 -104.9 119.4 38.92 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.421 -0.512 . . . . 1.26 110.865 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 19.4 m-85 -113.8 -175.23 2.63 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.652 -0.704 . . . . 0.65 110.237 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CB ' HG22 ' A' ' 14' ' ' VAL . 2.1 tt -128.75 157.89 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.108 -0.951 . . . . 0.96 108.502 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.18 113.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 118.848 -1.141 . . . . 0.4 113.149 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -87.78 66.44 8.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 104.734 -2.321 . . . . 3.27 104.734 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 16.7 t90 -25.97 89.71 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.263 -1.79 . . . . 1.31 112.496 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 57.3 tttp -27.49 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.134 -1.394 . . . . 2.46 112.392 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' OD2' ' CZ2' ' A' ' 29' ' ' TRP . 7.8 p-10 -119.81 57.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 2.02 109.903 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -140.85 -147.16 4.89 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.753 -0.658 . . . . 0.59 112.887 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.67 -45.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.095 -0.574 . . . . 0.86 112.197 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.72 172.21 7.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 2.13 110.652 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.26 138.94 52.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 1.6 111.05 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -138.13 179.4 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 2.27 110.678 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 26.0 m0 -113.29 154.2 27.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.372 . . . . 0.71 111.747 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 8' ' ' ALA . 13.5 t -88.88 151.77 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.998 -0.546 . . . . 0.65 110.042 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.66 91.43 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 2.32 111.175 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 24' ' ' GLU . . . -90.11 42.48 2.95 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.759 -0.734 . . . . 0.35 113.14 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.33 11.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -81.78 81.52 7.78 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.76 0.79 . . . . 1.35 111.201 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 58.3 t -58.05 71.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.169 -1.832 . . . . 1.49 112.243 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.85 1.9 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.281 -0.872 . . . . 0.48 109.111 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.38 0.49 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.344 -0.843 . . . . 2.44 110.489 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 18.2 m-20 -70.33 -48.46 56.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.425 -0.807 . . . . 2.48 109.99 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.559 HG23 ' HB1' ' A' ' 44' ' ' ALA . 64.0 t -59.41 -42.25 87.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 116.385 -0.37 . . . . 0.88 110.286 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.64 -58.07 4.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.03 1.332 . . . . 0.99 110.842 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' GLY . 40.6 ttmt -58.98 -30.05 67.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.397 0.618 . . . . 3.35 109.406 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.9 t70 -91.67 -16.36 27.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.381 -0.827 . . . . 2.0 110.374 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -80.58 -67.7 0.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.591 0.71 . . . . 1.87 110.362 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 12.8 pt-20 -86.31 -44.29 12.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.884 -1.053 . . . . 1.77 111.149 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 8.5 t70 -86.94 -9.1 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.781 -0.645 . . . . 2.3 111.513 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.406 -0.902 . . . . 1.61 112.123 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.765 0.317 . . . . 2.16 111.402 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -140.07 145.52 37.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.278 -0.419 . . . . 2.41 110.972 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 17.9 p90 -88.39 124.6 34.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 1.73 111.28 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.723 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -107.15 49.54 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.459 -0.791 . . . . 0.38 110.348 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.75 176.97 4.98 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.846 0.831 . . . . 2.8 112.509 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 14.1 t -112.69 -14.5 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.157 -1.383 . . . . 0.42 112.225 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 16.8 t70 -150.16 -44.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.395 . . . . 2.19 111.171 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -153.16 173.84 15.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.039 -0.528 . . . . 2.18 111.447 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -143.22 -171.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.34 109.36 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.71 HG23 HD23 ' A' ' 26' ' ' LEU . 64.1 t -150.46 -48.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.67 110.699 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 14.3 mm-40 -93.51 145.6 24.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.118 -0.492 . . . . 2.96 110.445 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 20.0 ptmt -152.83 86.32 1.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.7 -0.4 . . . . 2.13 111.534 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.851 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.0 mmt180 -153.44 91.87 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 121.092 -0.243 . . . . 3.83 111.43 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.778 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.31 -130.77 1.71 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.644 -1.265 . . . . 0.41 114.912 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HE3' HG23 ' A' ' 43' ' ' VAL . 51.1 mttm -116.58 -74.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.279 1.038 . . . . 1.13 110.644 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.2 -47.1 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 107.021 -2.431 . . . . 0.51 107.021 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HE2' HG11 ' A' ' 47' ' ' VAL . 50.6 mmtt -125.21 -10.46 7.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 112.954 -1.623 . . . . 3.41 109.705 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 11.0 t70 -87.06 11.2 14.33 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.141 0.495 . . . . 1.22 111.833 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 17' ' ' ARG . 5.4 p -86.71 151.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.853 -0.612 . . . . 0.34 110.852 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 91.29 3.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.573 -0.739 . . . . 1.26 110.658 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 5.5 m-85 -88.16 -166.31 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.011 -0.54 . . . . 0.65 109.973 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 13' ' ' ILE . 15.1 tp -127.78 159.78 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.711 -0.848 . . . . 0.96 108.711 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -141.16 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 113.696 0.998 . . . . 0.4 113.696 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 29' ' ' TRP . 82.7 mtt180 -88.78 65.72 7.77 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 104.439 -2.43 . . . . 3.27 104.439 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 22.2 t90 -25.64 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.529 -1.669 . . . . 1.31 111.965 -177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 65.8 tttm -28.49 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.051 -1.431 . . . . 2.46 112.799 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.9 m-20 -108.49 49.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.806 0.336 . . . . 2.02 110.655 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.27 -162.17 10.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.16 -0.543 . . . . 0.59 112.538 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.48 27.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.86 112.589 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.48 179.43 7.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.936 0.398 . . . . 2.13 111.078 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.79 130.44 54.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 1.6 110.742 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.8 mm-40 -134.36 137.84 44.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 2.27 111.045 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.67 ' CD1' HD13 ' A' ' 26' ' ' LEU . 7.7 m0 -89.08 148.82 23.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.47 0.652 . . . . 0.71 111.889 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.723 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 14.6 t -87.23 158.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.947 -1.024 . . . . 0.65 109.777 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 88.2 tttt -81.21 111.58 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.314 0.578 . . . . 2.32 112.277 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 23' ' ' VAL . . . -96.37 38.7 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.186 -0.915 . . . . 0.35 112.844 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 1.9 t -114.34 -1.64 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 110.111 -0.329 . . . . 0.68 110.111 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.18 76.87 1.28 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.431 0.634 . . . . 1.35 110.238 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.2 p -56.22 69.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 113.441 -1.709 . . . . 1.49 114.086 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -89.5 51.23 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.48 109.143 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -48.78 -27.13 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.311 -0.859 . . . . 2.44 110.272 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 28.1 t70 -69.38 -48.36 61.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 2.48 110.058 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.876 HG11 ' HE2' ' A' ' 21' ' ' LYS . 35.4 t -59.69 -31.1 46.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 116.323 -0.399 . . . . 0.88 110.219 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.77 -59.47 2.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.875 1.27 . . . . 0.99 109.903 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 8.0 mtmp? -57.51 -27.23 62.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.922 -0.77 . . . . 3.35 108.922 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.5 t70 -92.71 -22.44 19.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.428 -0.805 . . . . 2.0 110.184 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.866 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.3 -70.17 0.38 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.858 0.837 . . . . 1.87 110.468 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 16.1 pt-20 -84.94 -50.36 7.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.077 -1.419 . . . . 1.77 111.813 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.3 t70 -73.99 -24.73 59.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.826 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 120.399 -0.905 . . . . 1.61 111.773 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 N-CA-C 109.392 -0.595 . . . . 2.16 109.392 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' H ' ' CG1' ' A' ' 23' ' ' VAL . 11.5 tp10 -140.88 129.16 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.009 0.433 . . . . 2.41 111.586 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 40.5 p90 -95.49 103.52 15.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.666 -0.697 . . . . 1.73 110.908 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -86.77 57.91 4.77 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.942 -0.762 . . . . 0.38 108.942 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.617 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -107.13 149.44 27.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.716 -1.129 . . . . 2.8 113.121 -177.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.747 HG12 ' CB ' ' A' ' 30' ' ' LYS . 55.0 t -90.27 -36.1 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 113.068 -1.878 . . . . 0.42 110.109 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 4.3 m-20 -141.13 -37.04 0.44 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 2.19 112.125 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.1 mt-10 -153.52 168.98 24.33 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 112.15 0.426 . . . . 2.18 112.15 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.79 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -138.71 -170.22 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 0.34 109.807 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.986 ' CG2' HD13 ' A' ' 26' ' ' LEU . 65.7 t -152.32 -60.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.863 0.363 . . . . 0.67 111.624 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 40.9 tt0 -92.33 93.33 8.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.96 112.043 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 21.0 pttm -104.87 90.54 3.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 2.13 111.166 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.772 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.5 ttt180 -155.99 87.34 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.947 -0.301 . . . . 3.83 111.55 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.696 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.66 -138.38 2.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 118.896 -1.621 . . . . 0.41 115.001 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 67.1 mttm -106.48 -113.32 0.27 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.858 -0.671 . . . . 1.13 110.106 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -101.17 -41.77 2.53 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 107.688 -2.165 . . . . 0.51 107.688 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 36.6 mtmm -143.18 6.86 1.55 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.985 -1.608 . . . . 3.41 110.882 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 40.5 t0 -89.96 13.01 15.83 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.214 0.53 . . . . 1.22 111.253 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.772 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.9 p -88.07 156.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.536 -0.756 . . . . 0.34 112.28 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 8.4 pt-20 -115.1 92.17 3.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.17 -0.923 . . . . 1.26 110.182 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.627 ' HE1' HG21 ' A' ' 23' ' ' VAL . 6.0 m-85 -88.74 -168.05 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.65 110.074 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.986 HD13 ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -123.26 161.13 25.18 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.534 -0.913 . . . . 0.96 108.534 178.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -141.75 110.22 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 118.611 -1.236 . . . . 0.4 113.701 178.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 79.0 mtt180 -87.15 77.55 9.05 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.14 -1.43 . . . . 3.27 107.14 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.691 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -27.34 90.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.177 -1.374 . . . . 1.31 112.114 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.747 ' CB ' HG12 ' A' ' 10' ' ' VAL . 54.7 tptt -27.99 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.809 -1.087 . . . . 2.46 112.23 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.1 m-20 -119.48 55.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.026 0.441 . . . . 2.02 110.041 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -143.01 -153.96 6.01 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.59 112.734 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.09 21.2 1.24 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.811 -0.709 . . . . 0.86 112.463 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -149.82 -172.33 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.13 110.685 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HB2' HD11 ' A' ' 26' ' ' LEU . 27.8 p -148.86 106.35 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 1.6 111.272 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.1 mp0 -102.38 -169.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.973 -0.558 . . . . 2.27 110.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.4 m0 -114.21 152.79 30.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.439 0.638 . . . . 0.71 112.406 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 67.3 t -88.17 163.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.108 -0.951 . . . . 0.65 109.768 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 38' ' ' VAL . 35.9 tptt -82.81 107.53 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.914 0.709 . . . . 2.32 112.914 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.97 29.43 9.98 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.219 -0.9 . . . . 0.35 111.949 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.495 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.5 t -103.36 -3.11 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.71 -0.478 . . . . 0.68 109.71 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 6.2 m170 -68.5 75.61 0.27 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.328 0.585 . . . . 1.35 110.089 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' VAL . 39.9 t -58.84 70.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.083 -1.417 . . . . 1.49 113.7 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.01 50.89 1.73 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.666 -0.865 . . . . 0.48 108.666 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.27 -24.24 1.72 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.931 -1.031 . . . . 2.44 110.657 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.6 m-20 -66.01 -48.68 70.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.183 -0.462 . . . . 2.48 110.115 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.616 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.8 t -58.63 -28.73 37.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.88 111.035 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -86.7 -59.11 2.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.99 110.162 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 24.0 ttmm -56.37 -28.49 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.044 -0.724 . . . . 3.35 109.044 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 11.3 t70 -90.97 -25.24 19.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.448 -0.797 . . . . 2.0 109.504 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -70.1 -71.15 0.25 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.947 0.88 . . . . 1.87 110.638 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.5 pt-20 -81.04 -45.91 15.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 113.95 -1.477 . . . . 1.77 111.796 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.67 -24.81 36.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.976 -0.557 . . . . 2.3 111.59 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.465 -0.874 . . . . 1.61 112.347 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 6.9 p90 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.764 0.316 . . . . 2.16 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.563 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.6 tp10 -131.16 143.24 50.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 2.41 110.391 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 46.3 p90 -89.06 107.44 19.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.312 0.577 . . . . 1.73 112.43 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -90.23 53.09 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.248 -0.887 . . . . 0.38 109.051 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.89 152.45 27.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 122.186 0.993 . . . . 2.8 113.308 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG12 ' CB ' ' A' ' 30' ' ' LYS . 62.1 t -89.78 -34.42 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 113.52 -1.673 . . . . 0.42 110.582 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 15.7 t70 -142.57 -38.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.942 -0.572 . . . . 2.19 112.321 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.0 mm-40 -155.16 155.95 34.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.828 0.677 . . . . 2.18 112.828 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -129.65 -169.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.882 0.372 . . . . 0.34 110.595 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG2' HD13 ' A' ' 26' ' ' LEU . 81.6 t -150.99 -55.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.67 110.062 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.9 mt-10 -92.09 139.02 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 2.96 109.618 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 19.3 pttm -152.16 89.15 1.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.346 0.499 . . . . 2.13 112.346 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' C ' HG23 ' A' ' 23' ' ' VAL . 11.4 ptp180 -154.7 92.41 1.47 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.238 -0.289 . . . . 3.83 111.189 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.95 -132.46 1.76 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.098 -1.525 . . . . 0.41 114.975 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.7 mttm -117.85 -121.26 0.3 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.368 -0.916 . . . . 1.13 109.599 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.92 -42.05 4.5 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.801 -2.119 . . . . 0.51 107.801 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -137.51 4.17 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.103 -1.549 . . . . 3.41 110.94 177.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 29.9 t0 -87.67 10.1 19.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.158 0.504 . . . . 1.22 111.024 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.9 p -89.24 154.73 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.827 -0.624 . . . . 0.34 111.406 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -110.64 99.04 8.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.396 -0.82 . . . . 1.26 110.101 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 38' ' ' VAL . 8.2 m-85 -104.25 153.03 21.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.697 -0.683 . . . . 0.65 110.441 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.6 tt -88.71 156.94 18.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.527 -0.916 . . . . 0.96 108.527 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -142.33 108.53 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 118.874 -1.131 . . . . 0.4 113.907 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 56.2 ttt180 -81.78 76.31 8.69 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.125 -1.806 . . . . 3.27 106.125 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.6 t90 -27.54 89.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.156 -1.384 . . . . 1.31 112.371 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.849 ' CB ' HG12 ' A' ' 10' ' ' VAL . 58.7 tttm -28.67 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.665 -1.152 . . . . 2.46 112.081 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . 21.8 t70 -120.15 57.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 2.02 109.832 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.32 -167.4 12.73 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.821 -0.627 . . . . 0.59 112.821 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.43 -39.28 0.63 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.992 -0.623 . . . . 0.86 112.205 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -113.12 164.08 13.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.664 0.268 . . . . 2.13 110.554 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.19 143.15 47.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.6 111.156 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.18 178.61 6.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 2.27 110.735 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 12.5 m0 -100.01 148.5 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.71 111.515 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 25' ' ' TYR . 61.8 t -88.67 161.35 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.65 109.777 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' HG12 ' A' ' 38' ' ' VAL . 22.5 ttmm -79.27 108.89 13.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.526 0.679 . . . . 2.32 112.322 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.28 42.62 2.93 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.811 -1.086 . . . . 0.35 112.466 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 t -115.45 -0.59 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.993 -0.373 . . . . 0.68 109.993 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.73 75.08 0.6 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.662 0.744 . . . . 1.35 110.906 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG23 ' HE3' ' A' ' 19' ' ' LYS . 7.7 p -59.5 72.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 113.552 -1.658 . . . . 1.49 113.376 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.12 51.48 1.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.532 -0.914 . . . . 0.48 108.532 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG2' ' CG ' ' A' ' 49' ' ' LYS . 42.5 tt0 -47.16 -25.95 1.02 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.84 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 31.7 t70 -68.75 -40.37 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.939 -0.573 . . . . 2.48 109.926 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 51' ' ' TYR . 91.3 t -66.47 -46.71 85.88 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 N-CA-C 109.67 -0.493 . . . . 0.88 109.67 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.09 -54.82 17.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.628 1.571 . . . . 0.99 111.516 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 72.0 mmtt -61.0 -32.01 71.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.504 0.668 . . . . 3.35 109.504 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.5 t70 -92.12 -11.88 34.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.376 -0.829 . . . . 2.0 110.46 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.568 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.4 m-30 -84.25 -63.63 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.39 0.614 . . . . 1.87 110.684 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -87.45 -46.48 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.1 -0.955 . . . . 1.77 110.654 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.0 m-20 -81.91 -20.92 37.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 2.3 111.431 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.218 0 C-N-CA 120.546 -0.835 . . . . 1.61 112.278 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.029 ' CE1' ' CE2' ' A' ' 5' ' ' PHE . 6.1 p90 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.65 0.262 . . . . 2.16 110.622 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.557 ' N ' HG11 ' A' ' 23' ' ' VAL . 9.8 tp10 -111.07 131.33 55.16 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 2.41 111.501 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' A' ' 13' ' ' ILE . 49.6 p90 -89.02 109.31 20.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.286 0.476 . . . . 1.73 112.286 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -91.99 56.1 2.8 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.38 109.063 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.12 151.74 25.48 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.168 0.985 . . . . 2.8 113.154 -176.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.786 HG12 ' CB ' ' A' ' 30' ' ' LYS . 84.5 t -89.66 -35.14 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 113.611 -1.632 . . . . 0.42 110.477 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -141.27 -39.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.658 -0.701 . . . . 2.19 111.997 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.7 mt-10 -154.46 157.79 38.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 2.18 112.484 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.49 -168.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.34 109.476 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 26' ' ' LEU . 71.4 t -151.04 -45.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 0.67 110.017 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.7 mt-10 -99.48 144.36 28.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.96 109.99 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.9 pttt -154.19 83.65 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.819 -0.352 . . . . 2.13 111.784 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.675 ' C ' HG23 ' A' ' 23' ' ' VAL . 74.9 ttt180 -154.03 86.64 1.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.714 -0.394 . . . . 3.83 111.362 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.691 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.0 -131.38 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.055 -1.545 . . . . 0.41 114.348 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 55.9 mttt -124.51 -120.14 0.27 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.509 -0.846 . . . . 1.13 109.97 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.57 -41.27 4.5 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 108.904 -1.678 . . . . 0.51 108.904 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 49.9 mttp -136.39 0.12 2.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.22 -1.49 . . . . 3.41 111.029 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 19' ' ' LYS . 21.8 t0 -88.21 8.66 26.05 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.22 111.815 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.703 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.6 p -87.99 147.69 5.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.936 -0.574 . . . . 0.34 110.747 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.0 pt-20 -111.31 90.37 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.626 -0.715 . . . . 1.26 110.299 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.703 ' HE1' HG21 ' A' ' 23' ' ' VAL . 8.2 m-85 -89.21 -168.11 2.07 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.975 -0.557 . . . . 0.65 109.713 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.795 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tt -126.49 159.23 33.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.987 -1.116 . . . . 0.96 107.987 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -139.5 114.2 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 118.619 -1.233 . . . . 0.4 113.45 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.641 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 54.7 ttt85 -88.25 75.57 8.54 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.815 -1.55 . . . . 3.27 106.815 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.7 m0 -27.9 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.395 -1.275 . . . . 1.31 112.511 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.786 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.8 tttp -29.78 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.619 -1.173 . . . . 2.46 111.938 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' TRP . 15.0 m-20 -125.75 51.36 1.75 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.931 -0.577 . . . . 2.02 109.91 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -130.98 -138.91 4.34 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.722 -0.672 . . . . 0.59 112.538 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.2 -48.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.78 -0.724 . . . . 0.86 112.677 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.67 179.51 4.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 2.13 111.089 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.9 m -124.2 106.44 10.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.072 -0.513 . . . . 1.6 111.03 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 1.1 mp0 -101.47 -175.77 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 2.27 111.033 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 31.6 m0 -114.27 154.43 27.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.481 . . . . 0.71 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 79.7 t -88.27 162.37 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.554 -0.748 . . . . 0.65 109.591 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' HG12 ' A' ' 38' ' ' VAL . 19.8 tptm -80.76 99.88 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.698 0.629 . . . . 2.32 112.698 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -98.42 26.06 25.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.445 -0.798 . . . . 0.35 111.992 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.52 -3.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.687 -0.486 . . . . 0.68 109.687 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' ALA . 93.1 m-70 -73.88 78.84 1.62 Allowed 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.52 0.676 . . . . 1.35 109.919 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 43' ' ' VAL . 9.0 p -58.55 69.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.636 -1.62 . . . . 1.49 113.341 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.699 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.67 50.05 1.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.062 -0.972 . . . . 0.48 109.127 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -45.53 -27.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.066 -0.97 . . . . 2.44 110.655 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 11.2 m-20 -68.31 -47.69 66.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.272 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.699 HG23 ' HB1' ' A' ' 44' ' ' ALA . 56.3 t -54.72 -40.38 51.28 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 116.375 -0.375 . . . . 0.88 110.517 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -72.69 -59.75 2.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.751 1.22 . . . . 0.99 110.497 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 4.5 tppp? -56.25 -28.66 59.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.338 -0.616 . . . . 3.35 109.338 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.7 t70 -92.99 -21.82 19.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.355 -0.838 . . . . 2.0 110.482 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -74.19 -67.4 0.62 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.561 0.696 . . . . 1.87 110.569 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 17.0 pt-20 -83.87 -48.41 10.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.696 -1.138 . . . . 1.77 111.474 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' CB ' ' HD3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -76.28 -36.88 58.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 2.3 111.501 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.212 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.8 p90 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 120.94 0.4 . . . . 2.16 110.994 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.949 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.0 tp10 -152.97 124.33 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.233 -0.654 . . . . 2.41 109.233 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.562 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.5 p90 -87.45 104.42 16.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.466 0.543 . . . . 1.73 112.466 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -89.27 58.26 4.38 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.673 -0.862 . . . . 0.38 108.673 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.752 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.21 148.07 41.94 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.261 1.029 . . . . 2.8 113.33 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 30' ' ' LYS . 46.5 t -88.48 -33.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 113.22 -1.809 . . . . 0.42 110.334 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 11.7 t70 -144.68 -38.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.38 -0.827 . . . . 2.19 111.77 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 10.8 mm-40 -154.48 162.71 41.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.458 0.54 . . . . 2.18 112.458 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.23 -164.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.34 109.857 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.017 ' CG2' HD13 ' A' ' 26' ' ' LEU . 98.1 t -149.98 -60.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.5 tp10 -92.84 134.28 35.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.563 -0.902 . . . . 2.96 108.563 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.7 ptpt -151.32 79.13 1.29 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.786 0.662 . . . . 2.13 112.786 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -153.86 95.32 1.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.95 -0.469 . . . . 3.83 111.31 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.62 -130.52 1.56 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 118.891 -1.623 . . . . 0.41 114.231 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.9 mttm -116.14 -120.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.86 -0.67 . . . . 1.13 109.741 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.39 -40.3 4.25 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 108.07 -2.012 . . . . 0.51 108.07 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 19.5 mmtp -135.64 1.55 2.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 112.963 -1.618 . . . . 3.41 110.878 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 42' ' ' HIS . 22.1 t70 -88.74 9.44 24.42 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-O 121.301 0.572 . . . . 1.22 111.557 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.949 HG11 ' H ' ' A' ' 6' ' ' GLU . 8.4 p -95.45 145.71 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.323 -0.853 . . . . 0.34 111.268 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 1.3 pm0 -104.42 111.84 24.66 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.851 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.758 ' HE1' HG21 ' A' ' 23' ' ' VAL . 23.4 m-85 -113.97 147.84 37.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.808 -0.633 . . . . 0.65 110.375 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.017 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.6 tt -90.24 159.52 16.66 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.975 -1.12 . . . . 0.96 107.975 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.3 m -140.44 111.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 118.75 -1.18 . . . . 0.4 113.517 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HG2' HD21 ' A' ' 26' ' ' LEU . 66.5 mtt180 -89.29 78.68 7.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.169 -1.419 . . . . 3.27 107.169 176.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HD1' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -27.8 89.71 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.254 -1.339 . . . . 1.31 111.864 -178.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.639 ' HB3' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -28.74 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.918 -1.037 . . . . 2.46 112.254 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 32.4 m-20 -118.3 55.7 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 2.02 109.901 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.24 -154.66 6.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.581 . . . . 0.59 112.815 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.64 -45.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.353 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.17 162.98 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 2.13 110.824 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.31 137.3 52.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.6 110.97 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -130.67 167.18 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.689 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 37.4 m0 -107.05 147.16 30.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.71 111.536 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.729 HG21 ' HB3' ' A' ' 8' ' ' ALA . 65.0 t -88.84 159.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.65 110.398 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.536 ' N ' HG12 ' A' ' 38' ' ' VAL . 82.8 tttt -79.6 96.43 6.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.078 0.466 . . . . 2.32 111.899 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.1 44.83 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.559 -0.746 . . . . 0.35 112.924 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.88 13.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.809 -0.441 . . . . 0.68 109.809 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -83.54 80.44 9.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.625 0.726 . . . . 1.35 111.118 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 43' ' ' VAL . 5.6 p -58.93 72.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.441 -1.708 . . . . 1.49 112.406 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.51 1.84 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.108 -0.951 . . . . 0.48 108.729 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 41.1 tt0 -44.78 -28.26 0.61 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.277 -0.874 . . . . 2.44 110.492 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.28 -50.19 55.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.746 . . . . 2.48 109.609 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 98.0 t -57.05 -46.62 84.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 CA-C-N 115.88 -0.6 . . . . 0.88 109.903 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -67.76 -59.21 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.99 111.11 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 73.0 mmtt -55.01 -33.56 62.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.191 0.52 . . . . 3.35 109.742 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.66 -19.43 22.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.802 -0.635 . . . . 2.0 110.738 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -73.2 -62.23 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.733 0.778 . . . . 1.87 109.724 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -92.06 -49.87 5.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.241 -1.345 . . . . 1.77 111.414 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -75.43 -20.24 58.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 2.3 111.435 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.886 . . . . 1.61 112.085 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 7.0 p90 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.758 0.313 . . . . 2.16 110.93 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.6 tp10 -128.42 142.29 51.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 2.41 110.731 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 52.5 p90 -88.91 114.56 25.67 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.691 0.758 . . . . 1.73 112.124 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.672 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -101.85 55.46 0.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.568 -1.196 . . . . 0.38 109.629 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -119.34 164.26 15.95 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.692 0.758 . . . . 2.8 112.222 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' HB3' ' A' ' 30' ' ' LYS . 18.4 t -99.05 -19.22 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.415 -1.266 . . . . 0.42 112.476 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 32.9 t70 -149.95 -43.13 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.046 0.388 . . . . 2.19 112.046 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 48.5 mt-10 -154.26 166.46 33.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 116.423 -0.353 . . . . 2.18 111.838 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -138.96 -171.66 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.5 0.191 . . . . 0.34 110.501 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.576 ' CG2' HD13 ' A' ' 26' ' ' LEU . 77.1 t -146.18 -60.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.67 110.05 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -94.36 136.71 34.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 2.96 109.717 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 41.8 pttt -150.85 94.66 2.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.791 0.293 . . . . 2.13 111.791 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' VAL . 80.7 mtp180 -155.98 92.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.229 -0.188 . . . . 3.83 111.044 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.714 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.82 -132.32 1.76 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 118.997 -1.573 . . . . 0.41 114.8 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.743 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -116.75 -123.32 0.29 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.182 -1.009 . . . . 1.13 109.243 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.77 -41.75 4.32 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 108.202 -1.959 . . . . 0.51 108.202 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.565 ' HE2' HG11 ' A' ' 47' ' ' VAL . 28.8 mmtt -132.3 -1.7 3.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.031 -1.584 . . . . 3.41 110.766 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.563 ' OD2' HG22 ' A' ' 43' ' ' VAL . 27.0 t0 -87.71 10.18 19.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.016 0.436 . . . . 1.22 111.943 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 17' ' ' ARG . 8.3 p -89.85 153.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.811 -0.631 . . . . 0.34 112.58 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 7.7 pt-20 -105.38 114.43 28.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.03 -0.986 . . . . 1.26 109.447 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.742 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 m-85 -120.11 149.14 42.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.309 -0.405 . . . . 0.65 110.06 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.6 tt -88.63 156.57 18.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.009 -0.738 . . . . 0.96 109.009 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.629 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.22 110.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 113.826 1.047 . . . . 0.4 113.826 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 12' ' ' GLU . 62.7 mtp180 -81.91 69.5 8.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.056 -2.201 . . . . 3.27 105.056 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.635 ' CD1' HG21 ' A' ' 10' ' ' VAL . 3.5 t90 -25.17 90.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 113.768 -1.56 . . . . 1.31 112.317 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.695 ' HB3' HG12 ' A' ' 10' ' ' VAL . 27.8 tptp -28.42 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.286 -1.324 . . . . 2.46 112.196 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.1 m-20 -117.65 57.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 2.02 109.885 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -141.05 3.4 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.59 112.641 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.99 -48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.86 112.486 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -92.81 164.02 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 2.13 110.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.62 109.78 16.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 1.6 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -112.57 178.92 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 2.27 110.899 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 36.9 m0 -102.02 149.23 24.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 0.71 111.924 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 25' ' ' TYR . 46.5 t -89.38 161.21 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.65 109.883 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.4 tptt -72.75 103.08 3.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.546 0.572 . . . . 2.32 112.546 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.27 42.13 2.85 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.452 -0.794 . . . . 0.35 112.868 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.3 t -118.48 10.3 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.205 -0.294 . . . . 0.68 110.205 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -77.76 78.3 4.26 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.578 0.704 . . . . 1.35 111.052 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.743 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 97.7 t -57.78 71.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 113.346 -1.752 . . . . 1.49 113.065 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.54 49.83 1.53 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.789 -0.819 . . . . 0.48 108.789 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -42.16 -30.61 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.17 -0.923 . . . . 2.44 110.886 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 4.1 p30 -67.53 -47.0 71.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.376 -0.829 . . . . 2.48 109.968 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HB1' ' A' ' 44' ' ' ALA . 48.6 t -60.29 -40.07 82.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 109.894 -0.41 . . . . 0.88 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.82 -57.71 5.2 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.205 1.402 . . . . 0.99 110.999 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 7.5 mmpt? -60.59 -28.75 68.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.532 0.682 . . . . 3.35 109.343 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.3 t70 -92.53 -14.31 28.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.353 -0.84 . . . . 2.0 110.174 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE1' ' CG1' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -83.44 -68.63 0.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.536 0.684 . . . . 1.87 110.342 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.9 pt-20 -83.91 -47.25 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.677 -1.147 . . . . 1.77 111.048 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.9 t70 -82.06 -15.89 52.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 2.3 111.101 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.534 -0.841 . . . . 1.61 112.034 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 5.1 p90 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.908 0.385 . . . . 2.16 110.473 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.005 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.3 tm-20 -153.15 128.0 9.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.151 -0.685 . . . . 2.41 109.151 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.566 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 38.7 p90 -88.4 102.85 15.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 111.933 0.346 . . . . 1.73 111.933 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.813 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -86.92 59.01 5.39 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.054 -0.721 . . . . 0.38 109.054 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.667 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.09 149.55 31.97 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.32 1.057 . . . . 2.8 113.261 -176.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.737 HG12 ' CB ' ' A' ' 30' ' ' LYS . 55.8 t -89.09 -37.35 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.161 -1.836 . . . . 0.42 109.774 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 17.7 t70 -141.3 -37.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 2.19 111.926 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 24.6 mm-40 -154.3 157.12 38.19 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.572 0.582 . . . . 2.18 112.572 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.95 -166.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.826 -0.625 . . . . 0.34 109.431 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 99.4 t -150.88 -48.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.274 0.559 . . . . 0.67 109.513 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.5 mt-10 -99.97 144.91 28.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 2.96 109.643 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 22.6 pttm -154.38 78.36 1.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.371 0.508 . . . . 2.13 112.371 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.6 ttm180 -153.22 90.94 1.47 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.302 -0.559 . . . . 3.83 111.961 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.53 -132.42 1.71 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 118.95 -1.595 . . . . 0.41 114.789 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.3 mttm -116.59 -120.14 0.31 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.437 -0.882 . . . . 1.13 109.591 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -94.76 -40.41 4.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.067 -2.013 . . . . 0.51 108.067 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 16.7 mtmm -136.88 -1.1 2.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.137 -1.531 . . . . 3.41 111.41 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 15.9 t70 -85.66 8.9 17.87 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.262 0.553 . . . . 1.22 111.58 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.005 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.4 p -89.15 143.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.368 -0.833 . . . . 0.34 110.907 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 3.2 pt-20 -106.49 97.61 7.39 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.145 0.498 . . . . 1.26 111.188 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 18.5 m-85 -94.83 -169.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.598 -0.728 . . . . 0.65 109.774 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 2.2 tt -127.99 159.12 36.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.272 -1.01 . . . . 0.96 108.272 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -141.24 112.76 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 118.388 -1.325 . . . . 0.4 113.844 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 30' ' ' LYS . 19.8 ttm180 -88.94 77.05 7.78 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.708 -1.59 . . . . 3.27 106.708 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.573 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.6 t90 -27.81 89.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.363 -1.29 . . . . 1.31 112.273 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 39.5 ttmt -28.24 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.038 -0.983 . . . . 2.46 112.15 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.2 t70 -117.58 55.96 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.817 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.27 -163.67 10.92 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.834 -0.621 . . . . 0.59 112.669 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.55 35.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.349 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -145.98 -169.05 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 2.13 110.988 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.7 113.25 6.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.6 111.013 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mm-40 -121.62 175.61 6.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 2.27 110.74 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 27.5 m0 -116.17 151.99 34.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.078 0.465 . . . . 0.71 111.612 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.813 HG11 ' HB3' ' A' ' 8' ' ' ALA . 88.9 t -88.57 152.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.679 -0.692 . . . . 0.65 110.353 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HE2' ' CG2' ' A' ' 41' ' ' VAL . 22.7 tptm -72.58 97.1 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 2.32 112.16 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -93.92 40.54 2.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.706 -0.759 . . . . 0.35 113.014 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' CG2' ' HE2' ' A' ' 39' ' ' LYS . 1.1 t -120.45 4.16 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.68 109.801 177.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 14.0 m80 -80.5 81.44 6.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.821 0.82 . . . . 1.35 110.722 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 61.8 t -56.57 74.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 112.754 -2.021 . . . . 1.49 112.507 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -90.88 51.06 1.89 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.408 -0.815 . . . . 0.48 109.268 177.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 39.1 tt0 -47.77 -27.12 1.86 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.204 -0.907 . . . . 2.44 110.116 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 8.4 m-20 -70.38 -46.87 63.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.471 -0.786 . . . . 2.48 109.882 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.533 HG13 ' CE1' ' A' ' 51' ' ' TYR . 60.1 t -61.8 -45.83 97.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.733 -0.469 . . . . 0.88 109.733 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.69 -57.82 5.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.439 1.496 . . . . 0.99 111.432 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -57.87 -31.78 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.362 0.601 . . . . 3.35 109.466 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.2 t70 -91.96 -16.51 26.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.351 -0.84 . . . . 2.0 110.563 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -79.14 -65.21 1.03 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.473 0.654 . . . . 1.87 110.941 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.8 pt-20 -87.91 -45.78 9.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.839 -1.073 . . . . 1.77 111.191 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.1 m-20 -82.69 -19.18 38.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.795 -0.639 . . . . 2.3 111.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.368 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.536 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.039 0.447 . . . . 2.16 111.485 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.961 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -152.56 129.36 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.719 -0.673 . . . . 2.41 109.31 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 53.3 p90 -87.5 109.85 19.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.629 0.603 . . . . 1.73 112.629 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.657 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -92.07 50.11 1.62 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.661 -0.7 . . . . 0.38 109.127 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.77 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.45 149.78 28.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.229 1.014 . . . . 2.8 113.528 -177.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.737 HG12 ' CB ' ' A' ' 30' ' ' LYS . 61.1 t -89.34 -36.11 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.342 -1.754 . . . . 0.42 110.11 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.63 ' CG ' ' O ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -141.61 -39.25 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.285 -0.87 . . . . 2.19 111.706 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.8 mt-10 -155.04 158.26 38.84 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.593 0.59 . . . . 2.18 112.593 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.77 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.35 -165.93 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.34 109.611 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 26' ' ' LEU . 94.1 t -150.59 -58.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.14 0.495 . . . . 0.67 109.956 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 6.8 pt-20 -97.24 133.68 41.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 2.96 109.175 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 49.2 pttt -151.03 89.07 1.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.435 0.531 . . . . 2.13 112.435 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -154.33 93.06 1.57 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.288 -0.257 . . . . 3.83 110.902 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.11 -134.2 2.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 118.769 -1.681 . . . . 0.41 114.757 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.9 mttm -114.17 -119.03 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.464 -0.868 . . . . 1.13 109.554 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -96.9 -41.97 3.42 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 107.83 -2.108 . . . . 0.51 107.83 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 44.1 mmtt -132.96 0.2 3.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.118 -1.541 . . . . 3.41 111.048 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 16.1 t70 -86.72 6.92 28.92 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 121.261 0.553 . . . . 1.22 111.668 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.961 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.4 p -90.06 145.64 7.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.348 -0.842 . . . . 0.34 111.32 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' HA3' ' A' ' 40' ' ' GLY . 3.0 pt-20 -104.64 111.6 24.37 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.762 -0.654 . . . . 1.26 110.61 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.62 ' O ' HG23 ' A' ' 38' ' ' VAL . 23.0 m-85 -114.02 148.97 36.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.722 -0.672 . . . . 0.65 110.676 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.981 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.7 tt -89.7 159.15 17.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.922 -1.14 . . . . 0.96 107.922 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -140.12 108.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.699 -1.2 . . . . 0.4 113.448 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 30' ' ' LYS . 4.3 tpt180 -83.13 74.84 9.96 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.569 -1.641 . . . . 3.27 106.569 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.63 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 4.3 t90 -27.83 89.4 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.665 1.228 . . . . 1.31 112.091 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 34.9 ttpt -28.92 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.838 -1.073 . . . . 2.46 112.168 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' TRP . 16.8 m-20 -119.61 56.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 2.02 109.816 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.12 -163.48 10.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.859 -0.61 . . . . 0.59 112.886 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.26 27.99 1.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.937 -0.649 . . . . 0.86 112.336 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -142.05 -178.48 5.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 2.13 111.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' CZ ' ' A' ' 28' ' ' ARG . 65.0 m -135.77 111.23 9.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 1.6 110.821 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -124.96 172.58 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.27 111.052 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -114.85 150.36 35.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.71 111.483 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 ' HB3' ' A' ' 8' ' ' ALA . 89.0 t -89.68 160.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.55 . . . . 0.65 110.249 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 38' ' ' VAL . 24.2 ttmm -78.2 96.81 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.213 0.53 . . . . 2.32 112.269 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.83 46.82 2.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.463 -0.789 . . . . 0.35 112.509 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.51 3.24 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 0.68 110.368 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -75.04 79.56 2.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.689 0.756 . . . . 1.35 110.699 -179.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.4 t -58.04 66.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 113.04 -1.891 . . . . 1.49 113.362 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.42 53.67 2.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.857 -0.794 . . . . 0.48 108.857 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -48.95 -24.55 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.113 -0.949 . . . . 2.44 110.641 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.4 t70 -68.04 -49.8 59.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.606 . . . . 2.48 110.066 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG12 ' CE2' ' A' ' 51' ' ' TYR . 44.6 t -59.49 -32.01 47.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 116.287 -0.415 . . . . 0.88 110.594 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -80.03 -57.46 3.62 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.85 1.26 . . . . 0.99 109.866 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.3 tppt? -57.27 -29.57 63.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 3.35 108.679 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.9 t70 -92.12 -22.84 19.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.202 -0.908 . . . . 2.0 110.234 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.814 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.79 -68.25 0.47 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.791 0.805 . . . . 1.87 110.118 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -85.44 -50.4 7.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.266 -1.334 . . . . 1.77 111.765 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -74.47 -23.26 58.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 2.3 111.482 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.108 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' LYS . 10.9 p90 . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.957 0.408 . . . . 2.16 111.167 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.888 ' H ' HG11 ' A' ' 23' ' ' VAL . 19.8 mt-10 -150.85 145.62 25.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.883 -0.599 . . . . 2.41 109.546 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 37.2 p90 -90.61 110.04 21.2 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.93 0.715 . . . . 1.73 112.93 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.673 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -93.04 52.4 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.251 -0.886 . . . . 0.38 108.897 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.708 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.24 158.45 22.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.286 1.041 . . . . 2.8 113.244 -177.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.841 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.8 t -94.21 -36.42 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 113.199 -1.819 . . . . 0.42 110.596 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 34.5 t70 -140.25 -38.9 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 2.19 112.304 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -155.72 154.51 31.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.994 0.739 . . . . 2.18 112.994 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.93 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.802 0.334 . . . . 0.34 110.623 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 26' ' ' LEU . 76.9 t -150.46 -58.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.67 110.202 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.8 tp10 -94.15 135.14 35.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 2.96 109.683 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 17.0 ptpt -151.02 90.6 1.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.734 -0.386 . . . . 2.13 111.904 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' C ' HG23 ' A' ' 23' ' ' VAL . 13.7 ptm180 -153.51 92.6 1.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.142 -0.349 . . . . 3.83 111.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.68 -134.51 2.06 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.116 -1.516 . . . . 0.41 114.875 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HE3' HG23 ' A' ' 43' ' ' VAL . 68.5 mttm -111.02 -122.08 0.28 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.56 -0.82 . . . . 1.13 109.828 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.05 -41.55 4.58 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 108.009 -2.037 . . . . 0.51 108.009 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 10.6 mptt -136.58 2.57 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.094 -1.553 . . . . 3.41 110.651 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 28.8 t0 -87.68 10.27 18.74 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.263 0.554 . . . . 1.22 111.53 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.888 HG11 ' H ' ' A' ' 6' ' ' GLU . 12.2 p -91.31 153.84 3.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.302 -0.863 . . . . 0.34 111.899 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.0 pt-20 -106.19 116.57 32.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 1.26 110.186 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 38' ' ' VAL . 10.8 m-85 -119.48 147.49 44.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.65 110.422 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -88.49 156.74 18.93 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.563 -0.903 . . . . 0.96 108.563 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.708 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 m -141.11 113.38 4.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 113.725 1.009 . . . . 0.4 113.725 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -86.1 75.89 9.85 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 105.657 -1.979 . . . . 3.27 105.657 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.582 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.9 t90 -26.34 90.19 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.011 -1.449 . . . . 1.31 112.331 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.841 ' CB ' HG12 ' A' ' 10' ' ' VAL . 55.5 tptt -29.09 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.722 -1.127 . . . . 2.46 112.141 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.9 t70 -117.57 54.52 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.807 -0.442 . . . . 2.02 109.807 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.24 -160.29 9.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.878 -0.601 . . . . 0.59 112.919 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.16 29.12 0.99 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.114 -0.565 . . . . 0.86 112.128 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.96 176.73 9.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.697 0.284 . . . . 2.13 110.868 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.0 m -137.28 125.63 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 1.6 110.832 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.11 164.15 30.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.961 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 18.9 m0 -94.91 146.76 24.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.71 111.476 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 25' ' ' TYR . 40.5 t -89.59 161.33 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.65 109.812 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' N ' HG12 ' A' ' 38' ' ' VAL . 2.6 ttmp? -67.57 110.62 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 2.32 112.636 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -98.17 40.26 2.54 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.35 111.96 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 t -117.5 4.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.248 . . . . 0.68 110.521 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -73.51 76.4 1.45 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.73 0.776 . . . . 1.35 111.053 -179.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.4 p -59.11 72.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 113.394 -1.73 . . . . 1.49 113.333 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.4 50.1 1.58 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.48 108.511 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.4 tt0 -42.74 -30.16 0.36 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.088 -0.96 . . . . 2.44 111.055 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.27 -46.27 70.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.681 . . . . 2.48 110.069 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 51' ' ' TYR . 68.2 t -58.61 -44.74 90.21 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-N 116.016 -0.538 . . . . 0.88 109.719 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.87 -59.41 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.324 1.449 . . . . 0.99 111.386 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 11.9 mptt -56.49 -32.31 64.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.206 0.527 . . . . 3.35 109.781 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -91.79 -18.13 24.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.817 -0.629 . . . . 2.0 110.626 178.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -74.64 -62.61 1.47 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.677 0.751 . . . . 1.87 109.682 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 12.6 pt-20 -90.85 -50.58 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.283 -1.326 . . . . 1.77 111.362 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -74.44 -20.77 59.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 2.3 111.199 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.822 . . . . 1.61 112.036 179.49 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.27 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.833 0.349 . . . . 2.16 111.423 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.533 ' H ' HG11 ' A' ' 23' ' ' VAL . 21.5 mt-10 -126.06 143.29 51.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 2.41 110.973 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.527 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.3 p90 -89.58 112.58 23.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.522 0.677 . . . . 1.73 111.567 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.687 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -101.51 56.2 0.83 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.922 -1.035 . . . . 0.38 109.729 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.722 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.08 165.07 13.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.151 0.977 . . . . 2.8 112.708 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.888 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.1 t -90.25 -30.15 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 113.665 -1.607 . . . . 0.42 112.081 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 12.8 t70 -150.32 -35.89 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.262 0.468 . . . . 2.19 112.262 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.9 mt-10 -152.71 165.38 35.48 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.78 -0.368 . . . . 2.18 111.94 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -140.98 -170.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.842 0.353 . . . . 0.34 110.374 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.613 ' CG2' HD22 ' A' ' 26' ' ' LEU . 76.6 t -150.12 -52.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.67 110.038 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.4 tp10 -92.89 137.98 31.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 2.96 109.749 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 16.4 ptpt -152.52 89.36 1.41 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.852 -0.339 . . . . 2.13 111.14 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' VAL . 12.5 tpp180 -155.1 91.07 1.32 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.818 -0.353 . . . . 3.83 111.022 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.743 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.64 -131.59 1.69 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.269 -1.443 . . . . 0.41 114.368 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.77 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -119.76 -122.61 0.29 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.456 -0.872 . . . . 1.13 109.621 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.52 -39.57 4.98 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 108.406 -1.878 . . . . 0.51 108.406 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -137.07 0.42 2.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.228 -1.486 . . . . 3.41 111.18 177.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.9 t70 -87.35 10.33 17.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.996 0.427 . . . . 1.22 111.597 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.743 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.9 p -88.6 150.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.286 0.565 . . . . 0.34 111.876 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -109.08 101.9 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.23 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.7 m-85 -104.23 151.82 22.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.14 -0.482 . . . . 0.65 110.062 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tp -90.01 154.58 19.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.275 -1.009 . . . . 0.96 108.275 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -136.39 109.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 114.101 1.148 . . . . 0.4 114.101 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 53.2 mtt180 -82.84 77.78 9.53 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.627 -1.99 . . . . 3.27 105.627 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.624 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.1 t90 -27.09 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.268 -1.333 . . . . 1.31 111.95 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.888 ' CB ' HG12 ' A' ' 10' ' ' VAL . 59.0 tttm -27.17 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.271 -1.331 . . . . 2.46 112.355 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.0 m-20 -120.9 57.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 2.02 109.89 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -160.49 9.1 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.895 -0.593 . . . . 0.59 112.772 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.79 16.42 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.105 -0.569 . . . . 0.86 112.287 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -137.53 178.23 7.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.806 0.336 . . . . 2.13 110.777 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.24 108.93 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.965 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.33 166.88 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 2.27 111.069 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 40.4 m0 -89.01 145.78 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.651 . . . . 0.71 111.753 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 8' ' ' ALA . 89.1 t -88.76 162.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.65 109.855 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.6 tttt -75.45 103.82 5.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.771 0.656 . . . . 2.32 112.771 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.02 47.32 2.01 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.941 -1.027 . . . . 0.35 112.2 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.04 0.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.853 -0.425 . . . . 0.68 109.853 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.61 78.39 0.81 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.772 0.796 . . . . 1.35 110.004 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.77 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 94.9 t -57.33 69.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 113.047 -1.888 . . . . 1.49 113.426 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.51 51.88 2.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.312 -0.625 . . . . 0.48 109.312 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -47.34 -27.07 1.46 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.342 -0.845 . . . . 2.44 110.477 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 7.9 m-20 -70.99 -43.51 67.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.451 -0.795 . . . . 2.48 110.123 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.506 HG13 ' CE1' ' A' ' 51' ' ' TYR . 95.7 t -65.18 -39.97 87.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 109.737 -0.468 . . . . 0.88 109.737 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -71.95 -58.07 3.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.104 1.362 . . . . 0.99 110.741 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.8 tppt? -57.0 -30.66 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.228 -0.656 . . . . 3.35 109.228 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.8 t70 -92.09 -20.42 21.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.349 -0.841 . . . . 2.0 110.386 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.1 m-30 -75.4 -67.19 0.68 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.479 0.657 . . . . 1.87 110.606 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.0 pt-20 -86.46 -48.7 8.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.8 -1.091 . . . . 1.77 111.235 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 2.4 m-20 -77.52 -20.81 53.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.598 . . . . 2.3 111.162 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.405 0 C-N-CA 120.595 -0.812 . . . . 1.61 112.253 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.1 p90 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 120.792 0.33 . . . . 2.16 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.907 ' H ' HG11 ' A' ' 23' ' ' VAL . 1.2 mp0 -143.2 142.23 31.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.94 -0.573 . . . . 2.41 110.087 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.525 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 53.7 p90 -88.82 111.71 22.36 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.65 0.738 . . . . 1.73 111.741 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' HG21 ' A' ' 38' ' ' VAL . . . -95.26 46.14 1.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.759 -1.11 . . . . 0.38 109.751 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.671 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.88 164.42 14.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.602 0.715 . . . . 2.8 112.73 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 8.7 t -102.95 -20.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.687 -1.142 . . . . 0.42 112.437 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 14.8 t70 -144.51 -44.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.027 0.38 . . . . 2.19 112.027 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.1 mt-10 -155.68 162.72 40.52 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 112.053 0.39 . . . . 2.18 112.053 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.49 -167.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.627 0.251 . . . . 0.34 110.356 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 26' ' ' LEU . 95.3 t -149.99 -53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.033 0.444 . . . . 0.67 109.907 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 12.5 mm-40 -96.71 135.46 38.61 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 48.3 pttt -153.06 85.09 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.352 -0.539 . . . . 2.13 112.37 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.588 ' C ' HG23 ' A' ' 23' ' ' VAL . 58.5 ttt85 -154.44 95.49 1.81 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.101 0.41 . . . . 3.83 111.658 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.485 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -153.34 -128.64 1.3 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 118.863 -1.637 . . . . 0.41 114.885 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 97.8 mttt -119.44 -122.17 0.29 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.557 -0.821 . . . . 1.13 110.238 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.84 -40.56 5.88 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 108.804 -1.718 . . . . 0.51 108.804 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -143.75 3.99 1.29 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.537 -1.332 . . . . 3.41 111.43 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 20.3 t70 -88.41 11.67 16.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.322 0.582 . . . . 1.22 111.055 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.907 HG11 ' H ' ' A' ' 6' ' ' GLU . 9.0 p -89.47 154.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.332 -0.849 . . . . 0.34 112.249 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' HA3' ' A' ' 40' ' ' GLY . 46.7 mt-10 -96.83 128.09 43.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.11 -0.95 . . . . 1.26 108.956 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.665 ' HD2' HG21 ' A' ' 13' ' ' ILE . 11.4 m-85 -138.76 139.74 38.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 0.65 109.976 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.883 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -89.91 157.39 17.89 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.247 -0.649 . . . . 0.96 109.247 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 m -143.76 112.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 114.262 1.208 . . . . 0.4 114.262 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 86.5 mtt180 -85.53 66.4 9.65 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 104.566 -2.383 . . . . 3.27 104.566 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 18.8 t90 -25.65 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.362 -1.745 . . . . 1.31 112.218 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HB3' HG12 ' A' ' 10' ' ' VAL . 62.4 tttp -28.33 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.264 -1.334 . . . . 2.46 112.528 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.6 t70 -108.83 54.26 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.983 0.42 . . . . 2.02 109.99 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.28 -139.28 3.02 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.105 -0.569 . . . . 0.59 112.803 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.36 -46.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.085 -0.579 . . . . 0.86 111.885 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.57 163.96 12.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 2.13 110.272 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 28.1 p -121.31 138.83 54.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 1.6 111.376 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -130.76 168.96 16.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 2.27 109.938 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 24.6 m0 -88.53 144.2 26.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.815 0.34 . . . . 0.71 111.023 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 25' ' ' TYR . 85.0 t -88.42 154.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.65 110.115 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 38' ' ' VAL . 38.7 ttpt -66.18 103.88 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 2.32 111.573 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 24' ' ' GLU . . . -92.56 37.9 3.29 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.522 -0.763 . . . . 0.35 112.408 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.69 8.5 8.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.69 -0.485 . . . . 0.68 109.69 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.7 76.81 1.54 Allowed 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.505 0.669 . . . . 1.35 110.181 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 57.2 t -56.85 74.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 113.442 -1.708 . . . . 1.49 113.439 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -92.98 49.54 1.44 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.48 109.297 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 9.7 tp10 -48.16 -26.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.339 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -73.79 -47.0 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.567 -0.742 . . . . 2.48 110.228 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 51' ' ' TYR . 85.0 t -58.06 -46.83 88.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 109.951 -0.389 . . . . 0.88 109.951 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -68.74 -58.49 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 125.068 1.347 . . . . 0.99 111.125 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.9 ttpt -54.51 -33.74 60.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.533 . . . . 3.35 109.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.9 -20.61 21.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.75 -0.659 . . . . 2.0 110.721 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.3 m-30 -71.7 -62.19 1.51 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.69 0.757 . . . . 1.87 110.479 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -91.82 -49.5 6.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.47 -1.241 . . . . 1.77 111.484 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -74.21 -25.12 59.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.835 -0.62 . . . . 2.3 111.285 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.531 -0.842 . . . . 1.61 112.272 179.788 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 108.676 -0.861 . . . . 2.16 108.676 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.797 ' H ' HG11 ' A' ' 23' ' ' VAL . 31.4 mt-10 -152.7 148.0 26.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.148 0.425 . . . . 2.41 112.148 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.549 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 32.6 p90 -101.27 102.61 13.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.503 0.668 . . . . 1.73 110.938 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.643 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.32 53.42 2.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.186 -0.915 . . . . 0.38 110.303 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.92 167.78 10.82 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.468 0.651 . . . . 2.8 111.614 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 12.6 t -106.32 -16.69 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 115.111 -0.95 . . . . 0.42 112.387 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 17.3 t70 -148.3 -44.04 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.707 0.289 . . . . 2.19 111.754 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 18.7 mm-40 -154.18 168.44 26.52 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.363 -0.381 . . . . 2.18 111.593 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -139.46 -169.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.849 -0.426 . . . . 0.34 109.849 178.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 26' ' ' LEU . 96.3 t -149.79 -59.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.091 0.472 . . . . 0.67 109.97 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.5 tp10 -93.05 134.78 34.85 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.32 -0.622 . . . . 2.96 109.32 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 14.0 ptmt -150.83 92.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 2.13 111.089 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.628 ' C ' HG23 ' A' ' 23' ' ' VAL . 98.1 mtt180 -154.98 90.91 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.81 -0.356 . . . . 3.83 111.706 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.79 -134.98 2.29 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.057 -1.544 . . . . 0.41 114.702 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 62.3 mttm -106.77 -90.52 0.43 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.823 -0.688 . . . . 1.13 110.802 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -130.13 -44.38 0.18 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 107.755 -2.138 . . . . 0.51 107.755 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HA ' ' CE ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -132.56 -5.19 3.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.491 -1.354 . . . . 3.41 110.793 176.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 19.3 t70 -88.67 10.02 22.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.256 0.55 . . . . 1.22 111.397 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.797 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.5 p -89.01 158.15 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.472 -0.785 . . . . 0.34 111.404 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 23' ' ' VAL . 10.4 pt-20 -106.73 122.89 47.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.445 -0.798 . . . . 1.26 110.124 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 38' ' ' VAL . 9.8 m-85 -128.45 146.07 50.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.037 -0.528 . . . . 0.65 110.186 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.9 tt -88.72 157.81 18.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.318 -0.623 . . . . 0.96 109.318 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 m -142.69 113.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 113.881 1.067 . . . . 0.4 113.881 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -86.18 65.76 9.24 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.16 -2.533 . . . . 3.27 104.16 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.642 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 20.2 t90 -25.81 89.75 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 1.31 112.215 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HB3' HG12 ' A' ' 10' ' ' VAL . 88.8 tttt -28.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 114.113 -1.403 . . . . 2.46 112.421 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' O ' ' CE2' ' A' ' 29' ' ' TRP . 11.7 m-20 -110.93 55.37 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.417 . . . . 2.02 110.142 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -149.11 -158.4 8.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.08 -0.581 . . . . 0.59 112.688 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.5 21.18 1.34 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.331 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.82 -173.84 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.299 . . . . 2.13 110.798 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -145.61 136.34 24.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 1.6 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -149.96 176.88 10.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.816 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -98.11 148.52 23.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.71 111.324 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' TYR . 97.0 t -89.2 160.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 0.65 109.79 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.2 tttt -68.95 104.25 2.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.37 0.605 . . . . 2.32 112.174 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.65 37.99 3.29 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.108 -0.951 . . . . 0.35 112.667 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.5 t -115.85 3.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.672 0.272 . . . . 0.68 110.304 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -69.75 77.6 0.45 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.578 0.704 . . . . 1.35 109.826 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 48.7 t -56.91 75.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 113.717 -1.583 . . . . 1.49 113.34 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.54 53.69 2.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.593 -0.891 . . . . 0.48 108.593 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 49' ' ' LYS . 39.0 tt0 -49.72 -22.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.916 -1.038 . . . . 2.44 110.435 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.03 -50.53 47.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 2.48 110.087 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.5 t -57.79 -29.88 36.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.88 111.282 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -87.45 -58.11 2.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.155 1.382 . . . . 0.99 109.97 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 25.4 ttmm -54.84 -31.12 59.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.307 -0.86 . . . . 3.35 109.262 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -91.16 -25.39 19.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.518 -0.764 . . . . 2.0 109.854 178.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.78 -65.18 0.71 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.144 0.974 . . . . 1.87 110.374 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.1 pt-20 -90.22 -50.87 5.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.692 -1.595 . . . . 1.77 111.775 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.0 OUTLIER -77.92 -9.4 59.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.696 -0.684 . . . . 2.3 111.321 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.041 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.63 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.827 0.346 . . . . 2.16 111.282 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.709 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.6 mp0 -134.55 144.07 47.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 2.41 111.067 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.0 p90 -89.52 105.38 17.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.17 0.509 . . . . 1.73 111.902 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.9 53.35 2.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.457 -0.792 . . . . 0.38 109.022 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.739 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.81 158.57 20.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.12 0.962 . . . . 2.8 112.96 -177.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.818 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.9 t -97.21 -35.28 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 113.66 -1.609 . . . . 0.42 110.503 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.6 t70 -139.3 -39.36 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.735 -0.666 . . . . 2.19 112.048 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.4 mt-10 -155.98 157.36 36.07 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 112.787 0.662 . . . . 2.18 112.787 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.29 -169.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.34 109.972 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.4 t -150.24 -49.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.67 110.13 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.9 tp10 -98.97 139.1 35.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.715 -0.675 . . . . 2.96 109.689 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 11.3 ptmm? -151.6 87.85 1.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.652 -0.419 . . . . 2.13 112.1 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.647 ' C ' HG23 ' A' ' 23' ' ' VAL . 79.7 ttt180 -153.74 92.36 1.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.042 -0.263 . . . . 3.83 111.101 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.21 -130.21 1.57 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.15 -1.5 . . . . 0.41 114.946 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 68.4 mttm -124.52 -121.62 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.894 0.878 . . . . 1.13 110.082 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.71 -40.03 6.07 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.141 -1.983 . . . . 0.51 108.141 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 2.0 mptp? -143.87 7.02 1.42 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.187 -1.506 . . . . 3.41 111.161 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 17.9 t70 -87.43 9.06 22.0 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.129 0.49 . . . . 1.22 111.066 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.2 p -88.4 152.87 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.6 -0.727 . . . . 0.34 111.561 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.6 pt-20 -109.29 99.36 8.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.511 -0.768 . . . . 1.26 110.015 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HE1' HG21 ' A' ' 23' ' ' VAL . 9.4 m-85 -104.44 149.94 24.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.76 -0.655 . . . . 0.65 110.182 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.784 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 tt -88.97 157.16 18.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.658 -0.867 . . . . 0.96 108.658 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -143.21 110.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 118.953 -1.099 . . . . 0.4 113.894 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 77.2 mtt180 -83.91 75.71 10.09 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.895 -1.891 . . . . 3.27 105.895 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.588 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.4 t90 -26.9 89.68 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.922 -1.49 . . . . 1.31 112.28 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.818 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.3 tttp -29.02 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.654 -1.157 . . . . 2.46 112.209 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 19.4 t70 -119.41 55.59 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 2.02 109.885 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -142.27 -140.4 3.75 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.59 112.641 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.23 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.844 -0.693 . . . . 0.86 112.331 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.69 -174.28 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 2.13 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.8 m -143.97 126.39 15.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.6 110.915 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.06 179.68 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 2.27 110.89 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.9 m0 -100.19 150.91 22.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.71 111.846 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 25' ' ' TYR . 73.8 t -89.49 162.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.672 -0.694 . . . . 0.65 109.768 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.4 tttt -78.34 104.53 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.739 0.644 . . . . 2.32 112.739 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.62 45.05 2.73 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.076 -0.965 . . . . 0.35 112.516 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -118.3 0.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.999 -0.371 . . . . 0.68 109.999 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -72.76 76.46 1.13 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.595 0.712 . . . . 1.35 110.633 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 52.0 t -56.41 76.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 113.249 -1.796 . . . . 1.49 113.227 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -91.56 49.59 1.6 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.206 -0.906 . . . . 0.48 108.944 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -47.81 -27.83 2.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.13 -0.941 . . . . 2.44 110.509 -178.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 12.0 t70 -77.95 -44.03 28.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 2.48 109.424 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 49.2 t -65.18 -27.72 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.099 -0.501 . . . . 0.88 110.704 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -93.92 -57.78 2.44 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.997 1.436 . . . . 0.99 112.565 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 38.8 ttpt -51.73 -45.29 63.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.207 0.527 . . . . 3.35 110.556 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 1.8 t70 -79.42 -20.6 47.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.104 -0.702 . . . . 2.0 109.104 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.421 -0.809 . . . . 1.87 110.474 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -86.04 -48.71 8.4 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.324 -1.307 . . . . 1.77 111.684 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -77.34 -42.82 35.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.823 -0.626 . . . . 2.3 111.541 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.172 0 C-N-CA 120.542 -0.837 . . . . 1.61 112.394 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.431 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 9.3 p90 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.921 0.391 . . . . 2.16 110.932 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.583 ' H ' HG11 ' A' ' 23' ' ' VAL . 11.0 tp10 -142.43 145.11 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 2.41 110.275 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 44.4 p90 -89.76 105.5 17.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.079 0.466 . . . . 1.73 111.878 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.773 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.93 55.55 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.146 -0.687 . . . . 0.38 109.146 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.743 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.31 163.17 15.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.087 0.946 . . . . 2.8 112.433 -177.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.828 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.7 t -96.71 -37.54 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 113.595 -1.639 . . . . 0.42 110.741 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 17.4 t70 -142.57 -34.56 0.44 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.038 -0.528 . . . . 2.19 112.244 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 44.8 mt-10 -156.0 151.06 26.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.25 0.833 . . . . 2.18 113.25 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -125.98 -171.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.331 -0.395 . . . . 0.34 110.561 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 26' ' ' LEU . 94.7 t -147.19 -48.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.069 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.9 mt-10 -97.72 141.77 30.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.821 -0.627 . . . . 2.96 109.751 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.4 ptmt -152.02 84.92 1.28 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.687 -0.405 . . . . 2.13 111.898 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.881 ' C ' HG23 ' A' ' 23' ' ' VAL . 51.9 ttp180 -153.38 97.12 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.085 -0.246 . . . . 3.83 111.027 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.21 -130.23 1.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 118.94 -1.6 . . . . 0.41 114.978 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.967 ' HE3' HG13 ' A' ' 43' ' ' VAL . 54.1 mttm -117.04 -72.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.333 1.063 . . . . 1.13 110.738 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.31 -47.81 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 106.835 -2.506 . . . . 0.51 106.835 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 1.8 mptt -127.6 -6.27 5.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.076 -1.562 . . . . 3.41 109.831 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.0 t70 -86.75 9.73 18.05 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.125 0.488 . . . . 1.22 111.291 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.881 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.0 p -87.22 152.37 3.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.78 -0.645 . . . . 0.34 111.086 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.99 94.56 5.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.654 -0.703 . . . . 1.26 110.689 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.657 ' HD2' HG21 ' A' ' 13' ' ' ILE . 7.0 m-85 -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.153 -0.476 . . . . 0.65 110.38 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.81 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.2 tt -89.31 157.73 18.08 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.366 -0.976 . . . . 0.96 108.366 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.743 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.41 110.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.022 -1.071 . . . . 0.4 113.499 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' CD ' HD21 ' A' ' 26' ' ' LEU . 13.3 mmm180 -84.75 79.39 9.63 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.142 -1.799 . . . . 3.27 106.142 175.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.823 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -27.19 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.535 -1.211 . . . . 1.31 111.966 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.828 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.0 ttpt -27.62 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.307 -1.315 . . . . 2.46 112.26 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' TRP . 6.0 m-20 -123.94 57.07 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.005 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -140.97 -159.65 7.99 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.017 -0.611 . . . . 0.59 112.999 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.23 19.8 1.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.121 -0.561 . . . . 0.86 112.376 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -139.9 -176.56 4.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.741 0.305 . . . . 2.13 110.636 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . 29.0 p -150.19 111.16 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 1.6 111.232 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -123.99 -176.85 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 2.27 110.922 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 4.7 m-90 -108.71 153.24 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.108 0.48 . . . . 0.71 111.697 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 8' ' ' ALA . 49.0 t -88.43 162.18 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.704 -0.68 . . . . 0.65 109.52 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.5 tttt -80.73 103.62 10.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.461 0.648 . . . . 2.32 112.075 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -88.83 45.05 3.18 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.027 -0.988 . . . . 0.35 112.647 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -120.2 0.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.076 -0.342 . . . . 0.68 110.076 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.85 77.83 0.88 Allowed 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.46 0.648 . . . . 1.35 109.775 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.967 HG13 ' HE3' ' A' ' 19' ' ' LYS . 49.5 t -56.09 72.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.406 -1.724 . . . . 1.49 113.805 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.62 49.52 1.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.565 -0.743 . . . . 0.48 109.354 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.46 -28.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.209 -0.905 . . . . 2.44 110.58 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 6.8 m-20 -66.7 -49.97 64.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.493 -0.776 . . . . 2.48 109.875 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.806 HG12 ' CD2' ' A' ' 51' ' ' TYR . 42.2 t -58.23 -30.52 40.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.593 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -79.32 -59.99 2.54 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.754 1.221 . . . . 0.99 109.954 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.7 ttpt -56.97 -27.84 61.7 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.758 -0.83 . . . . 3.35 108.758 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.2 t70 -91.85 -22.68 19.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.148 -0.933 . . . . 2.0 110.108 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.806 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.46 -71.09 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.837 0.827 . . . . 1.87 110.087 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.3 pt-20 -81.53 -47.16 13.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.143 -1.39 . . . . 1.77 112.012 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.3 m-20 -80.78 -18.73 46.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.043 -0.526 . . . . 2.3 111.703 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.408 -0.901 . . . . 1.61 112.391 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.127 ' CE1' ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 121.032 0.444 . . . . 2.16 111.6 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.748 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.4 tp10 -152.72 146.73 25.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.846 -0.615 . . . . 2.41 109.717 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -89.52 109.0 19.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 1.73 110.966 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' O ' ' OE2' ' A' ' 9' ' ' GLU . . . -94.32 33.13 1.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.482 -0.781 . . . . 0.38 110.698 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 1.163 ' CD ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -102.75 175.06 5.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.043 0.925 . . . . 2.8 112.815 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.669 HG21 ' CD1' ' A' ' 29' ' ' TRP . 21.3 t -109.49 -17.52 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 113.699 -1.591 . . . . 0.42 112.402 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 21.1 t70 -150.14 -43.33 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 2.19 111.468 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.6 mt-10 -153.3 168.45 25.99 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.091 -0.504 . . . . 2.18 111.545 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -141.52 -169.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.695 -0.483 . . . . 0.34 109.695 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.713 HG23 HD23 ' A' ' 26' ' ' LEU . 90.5 t -149.97 -57.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.67 110.092 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 20.6 mm-40 -91.02 133.98 34.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.931 -0.577 . . . . 2.96 109.447 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 pttm -151.07 87.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.708 -0.397 . . . . 2.13 111.442 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.636 ' C ' HG23 ' A' ' 23' ' ' VAL . 2.3 mpt_? -153.65 94.79 1.82 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.752 0.279 . . . . 3.83 111.752 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CA ' ' A' ' 23' ' ' VAL . . . -152.07 -128.19 1.38 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 119.415 -1.374 . . . . 0.41 114.065 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.902 ' NZ ' HG23 ' A' ' 43' ' ' VAL . 86.0 mttt -109.49 -74.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.117 0.961 . . . . 1.13 110.659 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -151.7 -47.76 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 107.167 -2.373 . . . . 0.51 107.167 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 44' ' ' ALA . 2.1 ttpt -124.59 -9.62 7.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.067 -1.566 . . . . 3.41 109.802 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -86.47 7.71 24.82 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 121.232 0.539 . . . . 1.22 111.376 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG11 ' H ' ' A' ' 6' ' ' GLU . 10.8 p -89.25 157.71 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.409 -0.814 . . . . 0.34 110.63 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.7 pt-20 -110.26 115.83 30.4 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 1.26 110.864 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 13' ' ' ILE . 8.0 m-85 -115.71 148.5 39.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.607 -0.724 . . . . 0.65 110.131 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 37' ' ' TRP . 18.3 tp -90.7 159.0 16.59 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.781 -1.192 . . . . 0.96 107.781 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.163 HG11 ' CD ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -143.79 111.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 114.449 1.277 . . . . 0.4 114.449 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 81.7 mtt180 -83.23 70.0 10.04 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.068 -1.827 . . . . 3.27 106.068 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.2 t90 -26.28 89.7 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 113.761 -1.563 . . . . 1.31 112.036 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HB3' HG12 ' A' ' 10' ' ' VAL . 63.8 tttm -28.46 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.368 -1.287 . . . . 2.46 112.416 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.9 m-20 -111.76 54.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 2.02 110.076 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.13 -161.5 9.92 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.59 112.737 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.73 -38.9 0.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.984 -0.627 . . . . 0.86 112.237 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -114.09 176.22 5.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 2.13 110.628 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 26.9 p -126.67 130.53 50.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.361 . . . . 1.6 110.912 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.779 ' C ' HD12 ' A' ' 26' ' ' LEU . 31.1 mm-40 -117.13 165.6 13.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.066 0.46 . . . . 2.27 111.591 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CD1' HD13 ' A' ' 26' ' ' LEU . 12.3 m0 -87.97 140.32 29.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.617 -0.72 . . . . 0.71 111.138 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 25' ' ' TYR . 89.3 t -87.37 160.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.65 110.127 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.2 ttmt -77.23 108.08 10.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.118 0.785 . . . . 2.32 113.118 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -89.57 44.46 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.933 -1.03 . . . . 0.35 112.487 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG23 ' HG3' ' A' ' 39' ' ' LYS . 2.6 t -117.77 -5.19 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.332 . . . . 0.68 110.248 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -66.02 79.0 0.09 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.892 0.853 . . . . 1.35 110.057 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.902 HG23 ' NZ ' ' A' ' 19' ' ' LYS . 6.1 p -56.16 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 113.296 -1.774 . . . . 1.49 113.756 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.86 49.15 1.41 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.8 -1.091 . . . . 0.48 109.617 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 38.1 tt0 -45.18 -26.65 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.133 -0.939 . . . . 2.44 111.312 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.5 -46.86 62.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.594 . . . . 2.48 110.059 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.903 HG12 ' CE2' ' A' ' 51' ' ' TYR . 25.4 t -56.03 -35.5 41.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 116.073 -0.512 . . . . 0.88 109.875 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.07 -60.65 2.28 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.835 1.254 . . . . 0.99 110.344 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 26.5 ttpp -54.4 -30.6 52.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.25 -0.648 . . . . 3.35 109.25 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -92.95 -22.79 19.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.671 -0.695 . . . . 2.0 110.869 178.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.903 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.9 -66.08 0.6 Allowed 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.255 1.026 . . . . 1.87 109.018 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -81.28 -67.78 0.75 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.178 -1.828 . . . . 1.77 110.904 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -57.31 -43.2 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.027 -0.988 . . . . 2.3 111.185 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.53 -0.843 . . . . 1.61 112.164 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.934 -0.765 . . . . 2.16 108.934 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.752 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -151.16 139.61 20.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 2.41 111.798 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 47.1 p90 -91.42 106.58 18.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.174 0.511 . . . . 1.73 110.921 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.772 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -88.69 60.58 5.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.954 -0.758 . . . . 0.38 108.954 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.903 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -114.81 150.34 35.61 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.348 1.07 . . . . 2.8 113.181 -177.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.887 HG23 ' CG2' ' A' ' 27' ' ' VAL . 57.8 t -89.53 -36.78 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.25 -1.795 . . . . 0.42 109.212 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -144.47 -33.68 0.39 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.983 -1.008 . . . . 2.19 111.615 177.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' HD23 ' A' ' 26' ' ' LEU . 43.7 mt-10 -152.81 159.17 43.06 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.131 0.419 . . . . 2.18 112.131 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -128.67 -168.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.173 -0.677 . . . . 0.34 109.173 178.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.6 t -151.38 -60.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.218 0.533 . . . . 0.67 109.742 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 22.0 mm-40 -92.5 143.57 26.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.346 -0.843 . . . . 2.96 109.729 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.9 pttm -152.66 93.43 1.77 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.075 -0.25 . . . . 2.13 111.297 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.626 ' C ' HG23 ' A' ' 23' ' ' VAL . 1.7 tmt_? -155.16 88.64 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.469 -0.492 . . . . 3.83 111.205 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.589 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.92 -137.88 2.75 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 118.863 -1.636 . . . . 0.41 115.269 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 22' ' ' ASP . 90.6 mttt -108.36 -88.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.312 -0.944 . . . . 1.13 110.767 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -131.95 -44.79 0.15 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.928 -2.069 . . . . 0.51 107.928 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -131.33 -6.3 3.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.26 -1.47 . . . . 3.41 110.693 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 20.7 t70 -89.13 12.0 17.0 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 121.125 0.488 . . . . 1.22 111.347 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.752 HG11 ' H ' ' A' ' 6' ' ' GLU . 14.6 p -87.92 157.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.533 -0.758 . . . . 0.34 111.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.0 pt-20 -108.83 109.4 20.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.285 -0.87 . . . . 1.26 110.256 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.741 ' HE1' HG21 ' A' ' 23' ' ' VAL . 11.1 m-85 -118.68 152.93 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.935 -0.575 . . . . 0.65 110.605 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 3.1 tt -87.68 157.07 19.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.828 -0.804 . . . . 0.96 108.828 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.86 97.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.121 -0.631 . . . . 0.4 112.087 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 30' ' ' LYS . 48.3 ttt180 -79.17 82.45 5.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.737 -1.209 . . . . 3.27 107.737 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t90 -28.66 91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.803 -1.089 . . . . 1.31 112.085 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 18.6 pttp -26.97 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.55 -1.204 . . . . 2.46 112.557 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 29' ' ' TRP . 18.0 m-20 -120.63 57.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 2.02 110.087 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -139.28 -143.54 4.43 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.845 -0.616 . . . . 0.59 112.527 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.34 -48.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.855 -0.688 . . . . 0.86 112.307 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.76 179.7 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 2.13 110.804 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 26' ' ' LEU . 26.9 p -125.94 138.11 53.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.382 . . . . 1.6 111.014 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.53 158.86 42.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.607 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 41.7 m0 -97.18 149.26 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.71 111.368 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.783 HG23 HG12 ' A' ' 27' ' ' VAL . 77.0 t -88.77 159.31 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.65 110.009 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.3 tppt? -79.17 110.86 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.27 0.557 . . . . 2.32 112.159 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -87.95 36.76 3.33 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.232 -0.894 . . . . 0.35 112.914 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 39' ' ' LYS . 3.1 t -112.39 0.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.34 -0.245 . . . . 0.68 110.34 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -66.86 76.27 0.12 Allowed 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.688 0.756 . . . . 1.35 109.609 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.1 p -57.17 75.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 113.715 -1.584 . . . . 1.49 113.982 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 50.83 1.83 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.589 -0.893 . . . . 0.48 108.589 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -24.14 1.93 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.982 -1.008 . . . . 2.44 110.54 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 16.0 t70 -66.0 -49.77 66.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 2.48 109.91 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.822 HG12 ' CD2' ' A' ' 51' ' ' TYR . 60.3 t -55.05 -38.47 46.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 116.251 -0.431 . . . . 0.88 110.546 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -76.61 -59.86 2.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.188 1.395 . . . . 0.99 110.665 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.2 tmmm? -56.73 -28.44 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.157 -0.683 . . . . 3.35 109.157 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.9 t70 -91.54 -24.52 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.582 -0.736 . . . . 2.0 109.452 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.86 -70.28 0.3 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.817 0.817 . . . . 1.87 110.59 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.0 pt-20 -82.4 -48.17 11.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.21 -1.359 . . . . 1.77 111.714 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -78.19 -25.49 47.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.839 -0.619 . . . . 2.3 111.599 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.313 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.735 -0.146 . . . . 2.97 112.735 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p 177.0 -32.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 3.15 111.059 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' NE2' ' CE2' ' A' ' 51' ' ' TYR . 4.9 pm0 -87.44 136.66 32.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.175 -0.466 . . . . 4.57 109.852 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG22 ' CD ' ' A' ' 52' ' ' GLU . 2.1 t -90.91 48.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.371 -0.377 . . . . 3.08 111.325 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 19' ' ' LYS . 3.6 p90 171.07 154.14 0.06 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.953 0.406 . . . . 2.16 111.888 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -134.75 142.41 46.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.957 -0.565 . . . . 2.41 111.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 31.7 p90 -89.78 122.26 32.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.73 111.424 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.776 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -107.25 53.45 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.816 -0.629 . . . . 0.38 110.651 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.696 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -106.41 176.79 5.05 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.934 0.873 . . . . 2.8 112.779 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.714 HG12 ' CB ' ' A' ' 30' ' ' LYS . 54.4 t -104.07 -24.28 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 114.021 -1.445 . . . . 0.42 111.505 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 5.3 t70 -150.52 -39.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.917 -0.583 . . . . 2.19 111.114 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 47.4 mt-10 -152.47 162.7 40.83 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.197 0.443 . . . . 2.18 112.197 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -131.73 -168.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.487 -0.56 . . . . 0.34 109.487 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.797 HG23 HD23 ' A' ' 26' ' ' LEU . 69.4 t -150.24 -49.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.67 110.836 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 43.6 tt0 -98.64 146.11 26.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.162 -0.472 . . . . 2.96 110.465 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 18.8 pttm -152.9 89.62 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.005 0.372 . . . . 2.13 112.005 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.78 ' C ' HG23 ' A' ' 23' ' ' VAL . 30.4 ttm180 -154.54 87.63 1.18 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 121.059 -0.256 . . . . 3.83 111.104 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.797 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.26 -137.74 2.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.084 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.6 mttm -115.63 -122.49 0.29 Allowed 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.65 -0.775 . . . . 1.13 110.325 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -90.28 -42.13 5.32 Favored Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 108.036 -2.026 . . . . 0.51 108.036 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 1.4 mptp? -140.67 7.29 2.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.023 -1.588 . . . . 3.41 110.675 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 30.3 t0 -88.85 10.07 22.45 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.893 0.377 . . . . 1.22 111.091 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.797 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.1 p -88.01 150.0 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 116.021 -0.536 . . . . 0.34 111.398 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.9 pt-20 -112.33 93.08 4.26 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.488 -0.778 . . . . 1.26 110.393 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 7' ' ' TYR . 5.6 m-85 -88.16 -167.7 1.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.263 -0.643 . . . . 0.65 109.263 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.844 HD13 ' CD1' ' A' ' 37' ' ' TRP . 29.4 tp -126.48 160.63 30.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.064 -1.087 . . . . 0.96 108.064 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -139.19 110.72 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 118.924 -1.111 . . . . 0.4 113.529 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 52.0 mtt180 -84.85 74.19 10.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 105.668 -1.975 . . . . 3.27 105.668 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.7 t90 -26.72 90.81 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 113.867 -1.515 . . . . 1.31 111.833 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.714 ' CB ' HG12 ' A' ' 10' ' ' VAL . 83.5 tttt -27.39 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.352 -1.295 . . . . 2.46 112.341 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 4.7 p-10 -120.01 56.76 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.796 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.56 -178.02 23.3 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.59 112.628 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.06 -13.37 9.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.851 -0.69 . . . . 0.86 112.567 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -126.65 162.49 25.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 2.13 110.89 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 28' ' ' ARG . 61.2 m -116.1 118.72 33.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 1.6 110.71 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.782 ' O ' HD12 ' A' ' 26' ' ' LEU . 31.9 mt-10 -108.64 163.88 12.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.207 0.527 . . . . 2.27 111.68 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.844 ' CD1' HD13 ' A' ' 26' ' ' LEU . 16.2 m0 -87.95 148.37 24.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.71 112.015 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.776 HG11 ' HB3' ' A' ' 8' ' ' ALA . 40.1 t -87.6 161.9 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.018 -0.992 . . . . 0.65 109.751 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' CG1' ' A' ' 38' ' ' VAL . 86.9 tttt -80.76 106.89 13.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.284 0.564 . . . . 2.32 112.436 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -99.22 39.32 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.298 -0.864 . . . . 0.35 112.363 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.29 0.0 9.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.824 -0.436 . . . . 0.68 109.824 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.53 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -77.05 77.79 3.6 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.734 0.778 . . . . 1.35 110.918 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 43' ' ' VAL . 6.0 p -57.28 77.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 113.325 -1.761 . . . . 1.49 112.663 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 12' ' ' ALA . . . -92.43 49.25 1.47 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.872 -1.058 . . . . 0.48 109.241 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 42.0 tt0 -48.28 -27.53 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.171 -0.922 . . . . 2.44 110.187 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 15.8 t70 -75.02 -43.12 55.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.477 -0.783 . . . . 2.48 109.73 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 51' ' ' TYR . 95.3 t -63.93 -46.79 93.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 109.34 -0.615 . . . . 0.88 109.34 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.4 -54.96 18.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.539 1.536 . . . . 0.99 111.331 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 23.3 ttmm -60.27 -33.28 72.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.406 0.622 . . . . 3.35 109.464 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.1 t70 -91.67 -11.4 37.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.276 -0.874 . . . . 2.0 110.428 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -84.02 -63.25 1.38 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.428 0.633 . . . . 1.87 110.262 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.7 pt-20 -87.64 -46.68 9.31 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.046 -0.979 . . . . 1.77 110.83 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -80.99 -22.51 39.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 2.3 111.425 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.75 90.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.244 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.31 -58.81 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 2.34 110.861 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -88.38 63.32 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 2.95 110.917 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.9 t80 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.23 -0.89 . . . . 2.23 110.859 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.54 0.2 . . . . 5.2 111.54 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' B' ' 1' ' ' ALA . 90.5 Cg_endo -77.12 110.04 2.94 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.925 1.75 . . . . 5.12 112.569 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.09 106.11 1.66 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.49 2.126 . . . . 3.56 112.216 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . 133.86 -91.09 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 2.11 112.125 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.506 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.3 t -88.27 169.41 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.974 0.416 . . . . 1.85 111.475 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.588 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -132.46 174.74 9.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.909 -0.587 . . . . 1.86 110.988 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.43 ' CA ' ' HE3' ' B' ' 11' ' ' LYS . 40.1 ptt180 -124.3 125.19 43.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 7.29 110.82 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.498 ' NH1' ' CE1' ' A' ' 7' ' ' TYR . 29.7 tpt180 -43.22 -58.14 2.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.937 0.398 . . . . 6.23 111.314 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' B' ' 11' ' ' LYS . 62.1 mttp -154.88 -157.76 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.806 -0.634 . . . . 7.18 109.322 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -52.43 -25.0 8.83 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.728 -0.471 . . . . 4.33 109.728 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 88.6 mttt 55.11 100.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.708 -0.678 . . . . 4.49 111.013 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -81.69 117.23 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 2.05 110.595 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 10.1 p-10 -129.08 54.45 1.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.973 0.416 . . . . 3.8 110.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.209 -0.9 . . . . 3.91 110.998 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.662 -0.175 . . . . 2.97 112.662 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 71.2 p 176.38 -30.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.239 . . . . 3.15 111.477 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -88.91 141.99 28.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.826 0.346 . . . . 4.57 110.193 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 18' ' ' GLY . 2.5 t -92.54 45.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 3.08 110.035 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.3 p90 -177.48 142.31 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.772 -0.649 . . . . 2.16 110.39 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.4 tp10 -130.15 142.98 50.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 2.41 110.935 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.541 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.6 p90 -88.27 109.37 19.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.6 0.714 . . . . 1.73 112.034 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.648 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -95.02 50.82 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.758 -1.11 . . . . 0.38 109.611 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.12 169.23 9.26 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.984 0.897 . . . . 2.8 112.369 -178.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.912 HG12 ' CB ' ' A' ' 30' ' ' LYS . 51.7 t -97.53 -34.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-N 113.769 -1.559 . . . . 0.42 112.096 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 11.3 t70 -144.87 -33.67 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.508 0.558 . . . . 2.19 112.508 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 33.2 mm-40 -154.07 159.79 41.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.297 0.481 . . . . 2.18 112.297 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.4 -169.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.755 0.312 . . . . 0.34 110.485 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG23 HD22 ' A' ' 26' ' ' LEU . 94.0 t -149.97 -54.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.431 . . . . 0.67 110.068 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 41.5 mt-10 -92.25 138.32 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 2.96 109.375 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 19.7 pttm -152.43 87.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.262 0.467 . . . . 2.13 112.262 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.783 ' C ' HG23 ' A' ' 23' ' ' VAL . 73.4 mtp180 -154.24 93.08 1.58 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.324 -0.235 . . . . 3.83 111.422 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.709 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.28 -128.87 1.32 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.19 -1.481 . . . . 0.41 114.786 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.6 mttm -121.55 -122.79 0.28 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.341 -0.93 . . . . 1.13 109.481 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.12 -40.58 5.14 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 108.291 -1.924 . . . . 0.51 108.291 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 12.0 mptt -137.14 1.95 2.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.187 -1.507 . . . . 3.41 110.922 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.665 ' OD2' HG22 ' A' ' 43' ' ' VAL . 35.9 t0 -87.6 9.48 21.09 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.12 0.486 . . . . 1.22 111.465 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.3 p -89.36 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.867 -0.606 . . . . 0.34 111.705 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.9 pt-20 -107.73 101.15 10.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.483 -0.781 . . . . 1.26 110.035 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.675 ' HE1' HG21 ' A' ' 23' ' ' VAL . 7.2 m-85 -107.02 150.14 26.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.822 -0.626 . . . . 0.65 110.302 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.1 tt -88.64 156.99 18.71 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.593 -0.892 . . . . 0.96 108.593 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.0 m -141.21 112.04 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 114.07 1.137 . . . . 0.4 114.07 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' TRP . 77.6 mtt180 -87.38 79.29 8.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.666 -1.975 . . . . 3.27 105.666 175.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.565 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.2 t90 -26.87 91.65 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.284 -1.326 . . . . 1.31 112.246 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.912 ' CB ' HG12 ' A' ' 10' ' ' VAL . 61.6 tttp -27.62 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.308 -1.315 . . . . 2.46 112.257 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.8 t70 -119.3 57.07 0.9 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 2.02 109.903 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -147.6 -145.25 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.986 -0.552 . . . . 0.59 112.735 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -144.97 -45.69 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.949 -0.644 . . . . 0.86 112.213 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.07 -177.33 4.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 2.13 110.535 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.58 139.42 26.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 1.6 111.214 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 21.9 mm-40 -134.35 -177.46 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.081 -0.509 . . . . 2.27 110.779 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -104.25 146.27 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.71 111.338 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 25' ' ' TYR . 92.0 t -89.19 159.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.65 109.792 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' N ' HG12 ' A' ' 38' ' ' VAL . 23.5 ttmm -75.46 107.46 7.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.325 0.583 . . . . 2.32 112.5 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.75 40.77 2.8 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.069 -0.969 . . . . 0.35 112.392 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 1.9 t -116.85 3.94 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.044 -0.354 . . . . 0.68 110.044 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -75.85 76.49 2.78 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.879 0.847 . . . . 1.35 110.799 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG22 ' OD2' ' A' ' 22' ' ' ASP . 58.6 t -58.12 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 113.219 -1.81 . . . . 1.49 113.249 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.75 51.34 1.83 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.595 -0.891 . . . . 0.48 108.595 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -45.85 -27.28 0.83 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.196 -0.911 . . . . 2.44 110.818 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.28 -46.94 63.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.775 -0.648 . . . . 2.48 109.785 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.584 HG23 ' HB1' ' A' ' 44' ' ' ALA . 59.7 t -58.98 -47.39 90.01 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 CA-C-N 116.002 -0.545 . . . . 0.88 109.539 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -66.44 -56.69 9.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.175 1.39 . . . . 0.99 110.976 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 24.6 ttmm -56.59 -35.3 68.07 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.289 0.566 . . . . 3.35 109.682 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.47 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -91.56 -14.77 29.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.647 -0.706 . . . . 2.0 111.152 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.556 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -77.08 -59.95 2.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.718 0.771 . . . . 1.87 110.453 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' SER . 15.1 pt-20 -90.19 -41.75 11.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.3 -1.318 . . . . 1.77 111.482 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -87.69 -30.78 20.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.752 -0.658 . . . . 2.3 111.524 -179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -65.03 -48.84 66.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.492 -0.861 . . . . 1.61 112.368 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.9 tp -64.84 -71.41 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 2.34 110.955 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.19 62.9 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 2.95 111.058 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 t80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.28 -0.867 . . . . 2.23 110.798 179.87 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.62 0.248 . . . . 5.2 111.048 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.11 111.86 2.98 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.595 2.197 . . . . 5.12 112.298 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.91 -29.52 67.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.403 2.069 . . . . 3.56 112.355 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.511 ' C ' HG22 ' A' ' 27' ' ' VAL . . . -66.58 77.94 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.642 -0.79 . . . . 2.11 112.311 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.58 ' HA ' HG22 ' A' ' 38' ' ' VAL . 68.0 p -152.14 160.56 43.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.885 0.374 . . . . 1.85 111.653 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -170.58 66.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.01 -0.541 . . . . 1.86 110.795 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.585 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -45.08 131.28 7.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 7.29 111.432 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.473 ' HG3' ' HG3' ' B' ' 9' ' ' LYS . 7.9 tpm_? -47.43 -70.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.225 0.454 . . . . 6.23 112.225 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.473 ' HG3' ' HG3' ' B' ' 8' ' ' ARG . 30.0 mtpt -130.49 -162.39 1.21 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.148 0.499 . . . . 7.18 112.151 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.418 ' O ' ' HD2' ' B' ' 11' ' ' LYS . 26.9 ptt180 -57.3 -16.49 8.82 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 115.711 -0.677 . . . . 4.33 111.817 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 2.8 mptt 78.91 90.94 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.973 0.416 . . . . 4.49 110.44 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.97 -24.99 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 2.05 111.9 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 13.6 t70 -108.8 -25.15 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 3.8 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.476 ' OXT' ' CD2' ' A' ' 42' ' ' HIS . 77.8 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.183 -0.913 . . . . 3.91 111.275 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.707 -0.157 . . . . 2.97 112.707 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 77.3 p 177.37 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.754 0.311 . . . . 3.15 111.187 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 14.6 mm100 -88.64 138.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.001 -0.37 . . . . 4.57 110.001 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.245 ' N ' ' HE1' ' A' ' 5' ' ' PHE . 2.0 t -91.79 48.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 3.08 110.101 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER 175.41 144.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 2.16 110.973 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.2 mp0 -130.94 150.51 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.882 0.372 . . . . 2.41 111.202 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 50.3 p90 -92.5 113.64 25.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.802 0.668 . . . . 1.73 112.802 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.83 ' HB2' ' NE ' ' B' ' 8' ' ' ARG . . . -100.55 54.14 0.88 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.949 -1.023 . . . . 0.38 109.254 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.73 164.33 14.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.992 0.901 . . . . 2.8 112.085 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.787 HG21 ' CD1' ' A' ' 29' ' ' TRP . 39.1 t -98.34 -22.07 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-N 114.004 -1.453 . . . . 0.42 112.117 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 13.7 t70 -149.94 -40.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.385 0.513 . . . . 2.19 112.385 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 8.2 mm-40 -154.23 163.31 40.32 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 111.942 0.349 . . . . 2.18 111.942 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -136.93 -169.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.575 0.226 . . . . 0.34 110.582 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.4 t -150.13 -59.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.67 110.233 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 16.3 mm-40 -91.9 138.74 31.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.833 -0.622 . . . . 2.96 109.891 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 8.4 ptpp? -151.06 92.99 1.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.008 -0.277 . . . . 2.13 111.652 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.769 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.8 ttt180 -154.44 91.12 1.38 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.352 -0.217 . . . . 3.83 110.969 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.751 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -153.16 -134.11 1.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 118.956 -1.592 . . . . 0.41 115.111 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 69.0 mttm -117.28 -126.01 0.28 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 114.263 -0.968 . . . . 1.13 109.526 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.21 -38.7 6.66 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.551 -1.82 . . . . 0.51 108.551 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 20.8 mmtp -140.51 2.5 1.83 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.215 -1.492 . . . . 3.41 111.084 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 16.1 t70 -88.26 11.26 17.03 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.211 0.529 . . . . 1.22 111.462 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.769 HG23 ' C ' ' A' ' 17' ' ' ARG . 6.3 p -88.75 154.03 3.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.802 -0.636 . . . . 0.34 112.199 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.9 pt-20 -107.33 105.61 15.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.313 -0.858 . . . . 1.26 110.098 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.709 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.0 m-85 -110.52 150.82 28.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.762 -0.654 . . . . 0.65 110.177 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.84 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.8 tt -88.74 157.26 18.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.07 -0.715 . . . . 0.96 109.07 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.9 m -143.07 110.55 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 114.428 1.27 . . . . 0.4 114.428 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 30' ' ' LYS . 54.2 ttp180 -82.1 72.97 9.16 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 105.465 -2.05 . . . . 3.27 105.465 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.787 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -26.49 89.47 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.86 -1.518 . . . . 1.31 112.207 -177.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.726 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.2 ttpt -29.21 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 114.596 -1.184 . . . . 2.46 112.089 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.6 m-20 -117.95 56.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 2.02 109.796 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.13 -163.71 10.26 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.849 -0.614 . . . . 0.59 112.72 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.34 -43.48 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.006 -0.616 . . . . 0.86 112.054 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -97.75 -173.67 2.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.744 0.307 . . . . 2.13 110.518 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 26' ' ' LEU . 44.6 t -142.69 144.1 32.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 1.6 111.087 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -147.68 -176.22 5.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 2.27 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 34.8 m0 -104.62 152.28 22.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.71 111.589 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 25' ' ' TYR . 72.1 t -88.95 161.06 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.993 -0.548 . . . . 0.65 109.942 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.3 tttp -75.48 104.36 6.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.343 0.592 . . . . 2.32 112.332 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.51 44.19 2.91 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.136 -0.938 . . . . 0.35 112.511 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.426 ' HB ' ' HE3' ' A' ' 39' ' ' LYS . 2.0 t -120.18 8.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.835 -0.431 . . . . 0.68 109.835 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -75.81 75.81 2.75 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.43 0.633 . . . . 1.35 110.433 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 60.5 t -57.87 73.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.609 -1.632 . . . . 1.49 113.5 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.71 49.55 1.48 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.799 -0.815 . . . . 0.48 108.799 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -44.16 -29.24 0.6 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.181 -0.918 . . . . 2.44 110.734 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 12.1 t70 -70.53 -43.76 68.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.488 -0.778 . . . . 2.48 110.117 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 95.6 t -63.04 -47.57 92.06 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.045 0 N-CA-C 109.514 -0.551 . . . . 0.88 109.514 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -65.88 -54.79 21.98 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.99 111.062 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 27.9 ttpp -60.12 -33.16 71.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.456 0.646 . . . . 3.35 109.65 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 6.9 t70 -92.56 -9.37 41.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.278 -0.874 . . . . 2.0 110.652 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m-30 -86.53 -63.67 1.28 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.484 0.659 . . . . 1.87 110.749 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' CD ' HG22 ' A' ' 4' ' ' VAL . 14.4 pt-20 -85.79 -42.95 13.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.892 -1.049 . . . . 1.77 110.763 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -87.61 -18.92 28.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.607 -0.724 . . . . 2.3 111.42 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -80.14 -28.91 47.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.454 -0.879 . . . . 1.61 112.369 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 55' ' ' LEU . 1.6 tm? -86.6 -64.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.771 0.32 . . . . 2.34 110.41 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 pt-20 -88.38 58.14 4.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.056 0.455 . . . . 2.95 110.709 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.344 -0.836 . . . . 2.23 110.88 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.537 0.208 . . . . 5.2 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.05 118.32 4.37 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.651 2.234 . . . . 5.12 112.305 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.26 86.55 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.528 2.152 . . . . 3.56 112.556 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.506 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 159.9 64.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 2.11 112.651 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 1.437 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 0.4 OUTLIER -152.13 172.29 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 1.85 111.556 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 8' ' ' ALA . . . -170.93 -160.81 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.944 -0.571 . . . . 1.86 110.71 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -140.31 133.88 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 7.29 111.119 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.83 ' NE ' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -79.02 -33.5 44.81 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.091 -0.504 . . . . 6.23 111.557 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' B' ' 11' ' ' LYS . 90.4 mttt -156.96 -171.64 3.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.6 0.238 . . . . 7.18 111.143 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' B' ' 11' ' ' LYS . 24.3 ptt180 -52.36 -23.02 5.21 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.732 0.301 . . . . 4.33 111.423 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 12.7 mmmm 80.95 89.49 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.007 0.432 . . . . 4.49 110.331 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -60.13 -15.32 22.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 2.05 112.412 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 42' ' ' HIS . 4.7 p-10 -109.49 -24.77 10.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 3.8 111.328 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.476 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 46.9 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.316 -0.85 . . . . 3.91 111.118 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.554 -0.219 . . . . 2.97 112.554 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 27.4 t 174.14 -33.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.695 0.284 . . . . 3.15 111.001 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 20.0 mp0 -89.19 139.29 30.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.372 -0.376 . . . . 4.57 110.067 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.999 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 1.5 t -89.68 50.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.971 0.415 . . . . 3.08 110.307 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.579 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -179.36 177.63 0.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.843 -0.617 . . . . 2.16 111.157 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.017 ' H ' HG11 ' A' ' 23' ' ' VAL . 7.9 tp10 -154.11 124.32 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 2.41 109.731 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 43.0 p90 -89.21 105.01 17.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.815 0.302 . . . . 1.73 111.815 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.788 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.58 56.1 3.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.55 -0.537 . . . . 0.38 109.55 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.616 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -112.71 149.51 32.82 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.813 0.816 . . . . 2.8 113.028 -177.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.682 ' CG2' ' HB2' ' B' ' 6' ' ' ALA . 18.2 t -90.45 -32.49 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 114.222 -1.353 . . . . 0.42 110.647 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.5 t70 -138.43 -43.15 0.5 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 2.19 111.814 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.4 mm-40 -155.43 157.59 37.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.81 0.67 . . . . 2.18 112.81 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -126.87 -165.9 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.325 -0.62 . . . . 0.34 109.325 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.802 HG22 ' CB ' ' A' ' 26' ' ' LEU . 31.5 m -150.1 -51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.94 0.4 . . . . 0.67 111.199 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.1 tp10 -105.23 134.71 47.89 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.897 -0.592 . . . . 2.96 109.448 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 13.2 ptmm? -150.9 88.98 1.5 Allowed 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.134 -0.627 . . . . 2.13 112.63 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 15.0 ptp180 -153.6 91.34 1.47 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.85 -0.34 . . . . 3.83 111.383 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 4' ' ' VAL . . . -152.61 -135.28 2.18 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 118.876 -1.631 . . . . 0.41 114.851 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.7 mttm -111.28 -120.26 0.29 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.46 -0.87 . . . . 1.13 109.909 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.95 -41.0 3.91 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 108.19 -1.964 . . . . 0.51 108.19 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 46.2 mmtm -135.08 0.46 2.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 112.978 -1.611 . . . . 3.41 110.871 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -88.54 9.88 22.33 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 121.297 0.57 . . . . 1.22 111.458 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.017 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.3 p -93.99 143.18 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.148 -0.933 . . . . 0.34 110.58 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 11.8 pt-20 -104.9 119.4 38.92 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.421 -0.512 . . . . 1.26 110.865 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 19.4 m-85 -113.8 -175.23 2.63 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.652 -0.704 . . . . 0.65 110.237 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CB ' HG22 ' A' ' 14' ' ' VAL . 2.1 tt -128.75 157.89 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.108 -0.951 . . . . 0.96 108.502 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.587 HG22 ' HA2' ' B' ' 4' ' ' GLY . 0.7 OUTLIER -141.18 113.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 118.848 -1.141 . . . . 0.4 113.149 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -87.78 66.44 8.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 104.734 -2.321 . . . . 3.27 104.734 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 16.7 t90 -25.97 89.71 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.263 -1.79 . . . . 1.31 112.496 -176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' CA ' ' HB2' ' A' ' 11' ' ' ASP . 57.3 tttp -27.49 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.134 -1.394 . . . . 2.46 112.392 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' OD2' ' CZ2' ' A' ' 29' ' ' TRP . 7.8 p-10 -119.81 57.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 2.02 109.903 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -140.85 -147.16 4.89 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.753 -0.658 . . . . 0.59 112.887 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.67 -45.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.095 -0.574 . . . . 0.86 112.197 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.72 172.21 7.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 2.13 110.652 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.26 138.94 52.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 1.6 111.05 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 11.1 mm-40 -138.13 179.4 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.478 . . . . 2.27 110.678 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 26.0 m0 -113.29 154.2 27.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.372 . . . . 0.71 111.747 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 8' ' ' ALA . 13.5 t -88.88 151.77 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.998 -0.546 . . . . 0.65 110.042 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.66 91.43 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 2.32 111.175 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA3' ' CA ' ' A' ' 24' ' ' GLU . . . -90.11 42.48 2.95 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.759 -0.734 . . . . 0.35 113.14 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 t -117.33 11.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.507 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -81.78 81.52 7.78 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.76 0.79 . . . . 1.35 111.201 -178.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 58.3 t -58.05 71.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 113.169 -1.832 . . . . 1.49 112.243 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.85 1.9 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.281 -0.872 . . . . 0.48 109.111 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.38 0.49 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.344 -0.843 . . . . 2.44 110.489 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 18.2 m-20 -70.33 -48.46 56.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.425 -0.807 . . . . 2.48 109.99 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.559 HG23 ' HB1' ' A' ' 44' ' ' ALA . 64.0 t -59.41 -42.25 87.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 116.385 -0.37 . . . . 0.88 110.286 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.64 -58.07 4.8 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.03 1.332 . . . . 0.99 110.842 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' GLY . 40.6 ttmt -58.98 -30.05 67.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.397 0.618 . . . . 3.35 109.406 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.9 t70 -91.67 -16.36 27.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.381 -0.827 . . . . 2.0 110.374 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -80.58 -67.7 0.75 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.591 0.71 . . . . 1.87 110.362 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' CD ' HG22 ' A' ' 4' ' ' VAL . 12.8 pt-20 -86.31 -44.29 12.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.884 -1.053 . . . . 1.77 111.149 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 8.5 t70 -86.94 -9.1 56.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.781 -0.645 . . . . 2.3 111.513 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -84.85 -33.85 17.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.406 -0.902 . . . . 1.61 112.123 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.5 tp -83.93 -66.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 2.34 110.845 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -87.64 60.07 5.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 2.95 110.904 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.0 t80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.291 -0.861 . . . . 2.23 111.002 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.647 0.261 . . . . 5.2 111.009 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.87 149.32 34.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.643 2.229 . . . . 5.12 112.222 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.49 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 55.6 Cg_endo -69.18 76.69 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.587 2.191 . . . . 3.56 112.45 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -143.37 12.67 2.27 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.048 -0.596 . . . . 2.11 112.717 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 1.015 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 30.3 m -152.67 147.48 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 1.85 111.642 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.682 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -148.99 -76.28 0.16 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.843 0.682 . . . . 1.86 112.843 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' B' ' 7' ' ' ARG . 5.7 mmp_? -59.85 -102.02 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.627 0.232 . . . . 7.29 111.627 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.843 ' NH1' HG21 ' B' ' 5' ' ' THR . 28.2 mtp180 55.25 169.07 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.17 0.441 . . . . 6.23 110.198 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' B' ' 11' ' ' LYS . 66.6 mttm -144.66 -168.71 2.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.62 0.247 . . . . 7.18 111.274 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -45.93 -28.88 1.23 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 121.036 0.446 . . . . 4.33 111.122 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 30.6 mttp 74.69 100.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 4.49 110.542 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.554 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -60.0 -26.53 66.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 2.05 111.326 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 17.7 t70 -113.08 78.22 1.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 3.8 110.948 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.249 -0.882 . . . . 3.91 110.868 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.292 0 CA-C-O 120.158 -0.246 . . . . 2.97 112.534 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 15.5 t 174.74 -24.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.212 0.506 . . . . 3.15 112.355 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.526 ' CG ' ' CE1' ' A' ' 5' ' ' PHE . 34.3 tt0 -87.25 133.95 33.61 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 110.148 -0.316 . . . . 4.57 110.148 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' CG2' ' OE2' ' A' ' 52' ' ' GLU . 8.4 t -92.6 53.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.337 0.495 . . . . 3.08 112.337 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.8 OUTLIER 163.97 162.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.765 0.317 . . . . 2.16 111.402 179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -140.07 145.52 37.79 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.278 -0.419 . . . . 2.41 110.972 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 17.9 p90 -88.39 124.6 34.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 1.73 111.28 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.723 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -107.15 49.54 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.459 -0.791 . . . . 0.38 110.348 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -104.75 176.97 4.98 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.846 0.831 . . . . 2.8 112.509 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 14.1 t -112.69 -14.5 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 114.157 -1.383 . . . . 0.42 112.225 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 16.8 t70 -150.16 -44.57 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.395 . . . . 2.19 111.171 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -153.16 173.84 15.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.039 -0.528 . . . . 2.18 111.447 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -143.22 -171.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.36 -0.607 . . . . 0.34 109.36 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.71 HG23 HD23 ' A' ' 26' ' ' LEU . 64.1 t -150.46 -48.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.67 110.699 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 14.3 mm-40 -93.51 145.6 24.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.118 -0.492 . . . . 2.96 110.445 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 20.0 ptmt -152.83 86.32 1.25 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.7 -0.4 . . . . 2.13 111.534 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.851 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.0 mmt180 -153.44 91.87 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 121.092 -0.243 . . . . 3.83 111.43 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.778 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.31 -130.77 1.71 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.644 -1.265 . . . . 0.41 114.912 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HE3' HG23 ' A' ' 43' ' ' VAL . 51.1 mttm -116.58 -74.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.279 1.038 . . . . 1.13 110.644 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.2 -47.1 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 107.021 -2.431 . . . . 0.51 107.021 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.876 ' HE2' HG11 ' A' ' 47' ' ' VAL . 50.6 mmtt -125.21 -10.46 7.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 112.954 -1.623 . . . . 3.41 109.705 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 11.0 t70 -87.06 11.2 14.33 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.141 0.495 . . . . 1.22 111.833 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 17' ' ' ARG . 5.4 p -86.71 151.49 3.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.853 -0.612 . . . . 0.34 110.852 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 91.29 3.6 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.573 -0.739 . . . . 1.26 110.658 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 7' ' ' TYR . 5.5 m-85 -88.16 -166.31 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.011 -0.54 . . . . 0.65 109.973 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 13' ' ' ILE . 15.1 tp -127.78 159.78 33.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.711 -0.848 . . . . 0.96 108.711 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -141.16 116.35 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 113.696 0.998 . . . . 0.4 113.696 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 29' ' ' TRP . 82.7 mtt180 -88.78 65.72 7.77 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 104.439 -2.43 . . . . 3.27 104.439 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 22.2 t90 -25.64 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.529 -1.669 . . . . 1.31 111.965 -177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 65.8 tttm -28.49 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.051 -1.431 . . . . 2.46 112.799 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.9 m-20 -108.49 49.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.806 0.336 . . . . 2.02 110.655 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.27 -162.17 10.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.16 -0.543 . . . . 0.59 112.538 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.48 27.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.86 112.589 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -145.48 179.43 7.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.936 0.398 . . . . 2.13 111.078 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.79 130.44 54.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 1.6 110.742 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.8 mm-40 -134.36 137.84 44.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 2.27 111.045 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.67 ' CD1' HD13 ' A' ' 26' ' ' LEU . 7.7 m0 -89.08 148.82 23.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.47 0.652 . . . . 0.71 111.889 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.723 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 14.6 t -87.23 158.93 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.947 -1.024 . . . . 0.65 109.777 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 88.2 tttt -81.21 111.58 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.314 0.578 . . . . 2.32 112.277 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 23' ' ' VAL . . . -96.37 38.7 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.186 -0.915 . . . . 0.35 112.844 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 1.9 t -114.34 -1.64 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 110.111 -0.329 . . . . 0.68 110.111 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.502 ' CE1' ' HD3' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -73.18 76.87 1.28 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.431 0.634 . . . . 1.35 110.238 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.61 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.2 p -56.22 69.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 113.441 -1.709 . . . . 1.49 114.086 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -89.5 51.23 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.328 -0.851 . . . . 0.48 109.143 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -48.78 -27.13 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.311 -0.859 . . . . 2.44 110.272 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 28.1 t70 -69.38 -48.36 61.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 2.48 110.058 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.876 HG11 ' HE2' ' A' ' 21' ' ' LYS . 35.4 t -59.69 -31.1 46.34 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 116.323 -0.399 . . . . 0.88 110.219 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.77 -59.47 2.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.875 1.27 . . . . 0.99 109.903 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 8.0 mtmp? -57.51 -27.23 62.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.922 -0.77 . . . . 3.35 108.922 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.5 t70 -92.71 -22.44 19.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.428 -0.805 . . . . 2.0 110.184 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.866 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.3 -70.17 0.38 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.858 0.837 . . . . 1.87 110.468 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 16.1 pt-20 -84.94 -50.36 7.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.077 -1.419 . . . . 1.77 111.813 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.3 t70 -73.99 -24.73 59.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.826 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -58.48 -40.27 94.16 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.399 -0.905 . . . . 1.61 111.773 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 12.6 mt -86.54 -54.96 4.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 2.34 110.267 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.2 60.67 5.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 2.95 110.776 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.221 -0.895 . . . . 2.23 110.767 -179.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 111.834 0.309 . . . . 5.2 111.834 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' B' ' 1' ' ' ALA . 84.7 Cg_exo -46.42 102.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.386 2.057 . . . . 5.12 112.68 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.26 100.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.559 2.173 . . . . 3.56 112.322 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.9 -95.19 1.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 2.11 112.402 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.496 ' HA ' HG21 ' A' ' 27' ' ' VAL . 9.8 t -89.61 167.32 13.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 1.85 111.293 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.592 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -121.46 51.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 1.86 111.154 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.551 ' HA ' HG13 ' A' ' 38' ' ' VAL . 52.8 ptt85 -42.74 136.93 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.094 -0.503 . . . . 7.29 111.45 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.436 ' HG2' ' HD2' ' A' ' 21' ' ' LYS . 25.8 tpt180 -51.87 142.45 15.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.462 -0.495 . . . . 6.23 109.738 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -125.09 43.75 2.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.039 0.385 . . . . 7.18 112.039 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.401 ' HG2' ' HG3' ' B' ' 8' ' ' ARG . 17.1 ptm180 -112.72 -28.96 7.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.905 0.383 . . . . 4.33 110.197 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.502 ' HD3' ' CE1' ' A' ' 42' ' ' HIS . 18.5 tptm 42.03 67.03 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.033 -0.53 . . . . 4.49 111.39 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.457 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . . . -52.34 -23.17 5.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.489 -0.778 . . . . 2.05 111.807 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.488 ' CB ' ' HA ' ' A' ' 44' ' ' ALA . 7.5 t70 -108.4 -71.37 0.76 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.98 -0.555 . . . . 3.8 111.268 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' B' ' 11' ' ' LYS . 23.2 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.244 -0.884 . . . . 3.91 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.761 -0.136 . . . . 2.97 112.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.439 ' HA ' ' CA ' ' A' ' 52' ' ' GLU . 45.8 p -149.24 -57.01 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.399 . . . . 3.15 110.797 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.06 117.21 34.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 4.57 110.569 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.28 -53.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 3.08 111.798 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 58.09 -174.19 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.392 -0.595 . . . . 2.16 109.392 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' H ' ' CG1' ' A' ' 23' ' ' VAL . 11.5 tp10 -140.88 129.16 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.009 0.433 . . . . 2.41 111.586 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 40.5 p90 -95.49 103.52 15.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.666 -0.697 . . . . 1.73 110.908 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -86.77 57.91 4.77 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.942 -0.762 . . . . 0.38 108.942 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.635 ' C ' ' HB3' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -107.13 149.44 27.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 114.716 -1.129 . . . . 2.8 113.121 -177.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.747 HG12 ' CB ' ' A' ' 30' ' ' LYS . 55.0 t -90.27 -36.1 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 113.068 -1.878 . . . . 0.42 110.109 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 4.3 m-20 -141.13 -37.04 0.44 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.517 -0.765 . . . . 2.19 112.125 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.1 mt-10 -153.52 168.98 24.33 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 112.15 0.426 . . . . 2.18 112.15 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.79 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -138.71 -170.22 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.465 . . . . 0.34 109.807 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.986 ' CG2' HD13 ' A' ' 26' ' ' LEU . 65.7 t -152.32 -60.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.863 0.363 . . . . 0.67 111.624 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 40.9 tt0 -92.33 93.33 8.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.96 112.043 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 21.0 pttm -104.87 90.54 3.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 2.13 111.166 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.772 ' C ' HG23 ' A' ' 23' ' ' VAL . 78.5 ttt180 -155.99 87.34 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.947 -0.301 . . . . 3.83 111.55 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.696 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.66 -138.38 2.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 118.896 -1.621 . . . . 0.41 115.001 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 67.1 mttm -106.48 -113.32 0.27 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.858 -0.671 . . . . 1.13 110.106 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -101.17 -41.77 2.53 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 107.688 -2.165 . . . . 0.51 107.688 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.786 ' HB3' ' HD3' ' B' ' 11' ' ' LYS . 36.6 mtmm -143.18 6.86 1.55 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 112.985 -1.608 . . . . 3.41 110.882 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 40.5 t0 -89.96 13.01 15.83 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.214 0.53 . . . . 1.22 111.253 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.772 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.9 p -88.07 156.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.536 -0.756 . . . . 0.34 112.28 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 8.4 pt-20 -115.1 92.17 3.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.17 -0.923 . . . . 1.26 110.182 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.627 ' HE1' HG21 ' A' ' 23' ' ' VAL . 6.0 m-85 -88.74 -168.05 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.65 110.074 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.986 HD13 ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -123.26 161.13 25.18 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.534 -0.913 . . . . 0.96 108.534 178.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -141.75 110.22 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 118.611 -1.236 . . . . 0.4 113.701 178.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 79.0 mtt180 -87.15 77.55 9.05 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.14 -1.43 . . . . 3.27 107.14 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.691 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -27.34 90.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.177 -1.374 . . . . 1.31 112.114 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.747 ' CB ' HG12 ' A' ' 10' ' ' VAL . 54.7 tptt -27.99 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.809 -1.087 . . . . 2.46 112.23 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 11.1 m-20 -119.48 55.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.026 0.441 . . . . 2.02 110.041 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -143.01 -153.96 6.01 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.868 -0.605 . . . . 0.59 112.734 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.09 21.2 1.24 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.811 -0.709 . . . . 0.86 112.463 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -149.82 -172.33 4.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.13 110.685 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HB2' HD11 ' A' ' 26' ' ' LEU . 27.8 p -148.86 106.35 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 1.6 111.272 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 1.1 mp0 -102.38 -169.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.973 -0.558 . . . . 2.27 110.553 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.4 m0 -114.21 152.79 30.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.439 0.638 . . . . 0.71 112.406 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 67.3 t -88.17 163.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.108 -0.951 . . . . 0.65 109.768 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 38' ' ' VAL . 35.9 tptt -82.81 107.53 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.914 0.709 . . . . 2.32 112.914 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.97 29.43 9.98 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.219 -0.9 . . . . 0.35 111.949 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.495 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.5 t -103.36 -3.11 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.71 -0.478 . . . . 0.68 109.71 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.203 ' O ' ' HE3' ' B' ' 11' ' ' LYS . 6.2 m170 -68.5 75.61 0.27 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.328 0.585 . . . . 1.35 110.089 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 41' ' ' VAL . 39.9 t -58.84 70.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.083 -1.417 . . . . 1.49 113.7 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' B' ' 11' ' ' LYS . . . -92.01 50.89 1.73 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.666 -0.865 . . . . 0.48 108.666 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.27 -24.24 1.72 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 114.931 -1.031 . . . . 2.44 110.657 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.6 m-20 -66.01 -48.68 70.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.183 -0.462 . . . . 2.48 110.115 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.616 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.8 t -58.63 -28.73 37.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.996 -0.547 . . . . 0.88 111.035 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -86.7 -59.11 2.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.99 110.162 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 24.0 ttmm -56.37 -28.49 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.044 -0.724 . . . . 3.35 109.044 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 11.3 t70 -90.97 -25.24 19.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.448 -0.797 . . . . 2.0 109.504 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -70.1 -71.15 0.25 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.947 0.88 . . . . 1.87 110.638 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' CA ' ' HA ' ' A' ' 2' ' ' SER . 11.5 pt-20 -81.04 -45.91 15.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 113.95 -1.477 . . . . 1.77 111.796 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.67 -24.81 36.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.976 -0.557 . . . . 2.3 111.59 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -79.12 -53.74 4.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.465 -0.874 . . . . 1.61 112.347 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.32 -56.93 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 2.34 110.468 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.93 53.99 2.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 2.95 110.618 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.0 t80 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.251 -0.88 . . . . 2.23 110.84 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.607 0.242 . . . . 5.2 111.111 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 81.5 Cg_exo -47.66 102.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.629 2.219 . . . . 5.12 112.277 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.38 -30.05 91.73 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.712 2.275 . . . . 3.56 112.66 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . -60.14 92.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.553 -0.832 . . . . 2.11 112.573 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.444 HG21 ' NH2' ' B' ' 8' ' ' ARG . 56.2 p -152.85 151.35 30.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.44 0.163 . . . . 1.85 111.44 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.697 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -155.25 -80.4 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.361 0.875 . . . . 1.86 113.361 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 37.7 mmt180 -49.02 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.316 0.487 . . . . 7.29 112.316 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.559 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 68.0 mtt180 59.73 160.61 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.206 -0.597 . . . . 6.23 110.123 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -136.86 -162.73 1.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.668 0.27 . . . . 7.18 110.799 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -46.2 -26.8 0.84 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.418 -0.355 . . . . 4.33 111.259 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 1.203 ' HE3' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER 79.66 99.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.921 -0.581 . . . . 4.49 110.512 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -96.86 29.3 3.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.703 -0.681 . . . . 2.05 110.745 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.604 ' HB3' ' CE ' ' B' ' 11' ' ' LYS . 5.6 p-10 -108.42 45.15 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.102 0.477 . . . . 3.8 110.568 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.182 -0.913 . . . . 3.91 111.064 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.682 -0.167 . . . . 2.97 112.682 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 30.0 t 175.15 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.649 0.262 . . . . 3.15 111.494 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.82 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.118 -0.327 . . . . 4.57 110.118 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 18' ' ' GLY . 2.3 t -91.83 48.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.906 0.384 . . . . 3.08 110.586 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 6.9 p90 178.64 148.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 2.16 111.202 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.6 tp10 -131.16 143.24 50.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 2.41 110.391 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 46.3 p90 -89.06 107.44 19.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.312 0.577 . . . . 1.73 112.43 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -90.23 53.09 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.248 -0.887 . . . . 0.38 109.051 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.89 152.45 27.97 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 122.186 0.993 . . . . 2.8 113.308 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG12 ' CB ' ' A' ' 30' ' ' LYS . 62.1 t -89.78 -34.42 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 113.52 -1.673 . . . . 0.42 110.582 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 15.7 t70 -142.57 -38.82 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.942 -0.572 . . . . 2.19 112.321 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 28.0 mm-40 -155.16 155.95 34.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.828 0.677 . . . . 2.18 112.828 -177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -129.65 -169.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.882 0.372 . . . . 0.34 110.595 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.568 ' CG2' HD13 ' A' ' 26' ' ' LEU . 81.6 t -150.99 -55.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.67 110.062 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.9 mt-10 -92.09 139.02 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 2.96 109.618 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 19.3 pttm -152.16 89.15 1.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.346 0.499 . . . . 2.13 112.346 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' C ' HG23 ' A' ' 23' ' ' VAL . 11.4 ptp180 -154.7 92.41 1.47 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.238 -0.289 . . . . 3.83 111.189 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.95 -132.46 1.76 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.098 -1.525 . . . . 0.41 114.975 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' PHE . 68.7 mttm -117.85 -121.26 0.3 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.368 -0.916 . . . . 1.13 109.599 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -92.92 -42.05 4.5 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.801 -2.119 . . . . 0.51 107.801 176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -137.51 4.17 2.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.103 -1.549 . . . . 3.41 110.94 177.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 29.9 t0 -87.67 10.1 19.25 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.158 0.504 . . . . 1.22 111.024 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG23 ' C ' ' A' ' 17' ' ' ARG . 9.9 p -89.24 154.73 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.827 -0.624 . . . . 0.34 111.406 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -110.64 99.04 8.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.396 -0.82 . . . . 1.26 110.101 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 38' ' ' VAL . 8.2 m-85 -104.25 153.03 21.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.697 -0.683 . . . . 0.65 110.441 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.6 tt -88.71 156.94 18.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.527 -0.916 . . . . 0.96 108.527 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -142.33 108.53 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 118.874 -1.131 . . . . 0.4 113.907 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 56.2 ttt180 -81.78 76.31 8.69 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.125 -1.806 . . . . 3.27 106.125 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.574 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.6 t90 -27.54 89.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.156 -1.384 . . . . 1.31 112.371 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.849 ' CB ' HG12 ' A' ' 10' ' ' VAL . 58.7 tttm -28.67 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.665 -1.152 . . . . 2.46 112.081 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . 21.8 t70 -120.15 57.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 2.02 109.832 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.32 -167.4 12.73 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.821 -0.627 . . . . 0.59 112.821 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.43 -39.28 0.63 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.992 -0.623 . . . . 0.86 112.205 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -113.12 164.08 13.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.664 0.268 . . . . 2.13 110.554 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -119.19 143.15 47.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.6 111.156 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.459 ' CB ' ' HA3' ' B' ' 4' ' ' GLY . 0.5 OUTLIER -136.18 178.61 6.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 2.27 110.735 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 12.5 m0 -100.01 148.5 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.71 111.515 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.95 HG22 ' HA ' ' B' ' 5' ' ' THR . 61.8 t -88.67 161.35 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.65 109.777 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' HG12 ' A' ' 38' ' ' VAL . 22.5 ttmm -79.27 108.89 13.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.526 0.679 . . . . 2.32 112.322 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.28 42.62 2.93 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.811 -1.086 . . . . 0.35 112.466 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 t -115.45 -0.59 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.993 -0.373 . . . . 0.68 109.993 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.464 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -70.73 75.08 0.6 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.662 0.744 . . . . 1.35 110.906 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.465 HG23 ' HE3' ' A' ' 19' ' ' LYS . 7.7 p -59.5 72.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 113.552 -1.658 . . . . 1.49 113.376 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.12 51.48 1.95 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.532 -0.914 . . . . 0.48 108.532 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG2' ' CG ' ' A' ' 49' ' ' LYS . 42.5 tt0 -47.16 -25.95 1.02 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.84 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 31.7 t70 -68.75 -40.37 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.939 -0.573 . . . . 2.48 109.926 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 51' ' ' TYR . 91.3 t -66.47 -46.71 85.88 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 N-CA-C 109.67 -0.493 . . . . 0.88 109.67 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.09 -54.82 17.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.628 1.571 . . . . 0.99 111.516 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 72.0 mmtt -61.0 -32.01 71.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.504 0.668 . . . . 3.35 109.504 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.5 t70 -92.12 -11.88 34.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.376 -0.829 . . . . 2.0 110.46 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.568 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.4 m-30 -84.25 -63.63 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.39 0.614 . . . . 1.87 110.684 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -87.45 -46.48 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.1 -0.955 . . . . 1.77 110.654 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.0 m-20 -81.91 -20.92 37.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 2.3 111.431 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.15 -41.65 59.75 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.546 -0.835 . . . . 1.61 112.278 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 tp -76.15 -63.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 2.34 110.586 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 60.84 6.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 2.95 110.762 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.5 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.232 -0.889 . . . . 2.23 110.935 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.48 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 111.922 0.341 . . . . 5.2 111.922 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.491 ' N ' ' CD ' ' B' ' 3' ' ' PRO . 88.7 Cg_exo -44.68 -43.7 14.41 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.366 2.044 . . . . 5.12 113.141 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' B' ' 2' ' ' PRO . 2.9 Cg_exo -76.35 117.06 4.48 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.775 2.317 . . . . 3.56 112.022 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.499 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 99.64 12.77 39.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.502 -0.856 . . . . 2.11 112.697 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.95 ' HA ' HG22 ' A' ' 38' ' ' VAL . 88.4 m -151.8 155.19 37.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.009 0.433 . . . . 1.85 112.132 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.609 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -171.06 47.45 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.839 -0.619 . . . . 1.86 111.724 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.511 ' N ' ' HB1' ' A' ' 8' ' ' ALA . 34.7 ptt180 -47.68 132.55 14.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.317 -0.253 . . . . 7.29 110.317 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.416 ' NH1' ' OH ' ' A' ' 7' ' ' TYR . 7.4 ptp180 -133.95 59.75 1.72 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.012 0.745 . . . . 6.23 113.012 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.454 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.85 -179.75 7.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.784 -0.451 . . . . 7.18 109.784 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -63.93 -28.39 69.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.24 0.543 . . . . 4.33 110.024 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' B' ' 13' ' ' ASP . 22.3 mttp 71.52 46.65 0.39 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.335 -0.848 . . . . 4.49 110.049 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -34.8 -33.07 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.383 -0.826 . . . . 2.05 112.41 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.459 ' CG ' HG13 ' A' ' 43' ' ' VAL . 17.1 t70 -115.9 76.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 3.8 110.833 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.279 -0.867 . . . . 3.91 110.935 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' HA2' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.646 -0.181 . . . . 2.97 112.646 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 31.9 t 177.12 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.686 0.279 . . . . 3.15 111.165 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.68 138.06 31.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.358 -0.383 . . . . 4.57 110.511 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.053 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -95.92 45.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.24 0.543 . . . . 3.08 109.796 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.053 ' CE2' ' O ' ' A' ' 4' ' ' VAL . 6.1 p90 -179.19 117.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.591 -0.731 . . . . 2.16 110.622 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.557 ' N ' HG11 ' A' ' 23' ' ' VAL . 9.8 tp10 -111.07 131.33 55.16 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.993 0.425 . . . . 2.41 111.501 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' A' ' 13' ' ' ILE . 49.6 p90 -89.02 109.31 20.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.286 0.476 . . . . 1.73 112.286 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -91.99 56.1 2.8 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.38 109.063 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.12 151.74 25.48 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.168 0.985 . . . . 2.8 113.154 -176.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.786 HG12 ' CB ' ' A' ' 30' ' ' LYS . 84.5 t -89.66 -35.14 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 113.611 -1.632 . . . . 0.42 110.477 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -141.27 -39.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.658 -0.701 . . . . 2.19 111.997 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 42.7 mt-10 -154.46 157.79 38.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.55 . . . . 2.18 112.484 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.49 -168.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.34 109.476 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 26' ' ' LEU . 71.4 t -151.04 -45.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 0.67 110.017 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 38.7 mt-10 -99.48 144.36 28.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.96 109.99 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.9 pttt -154.19 83.65 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.819 -0.352 . . . . 2.13 111.784 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' C ' HG23 ' A' ' 23' ' ' VAL . 74.9 ttt180 -154.03 86.64 1.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.714 -0.394 . . . . 3.83 111.362 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.691 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.0 -131.38 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.055 -1.545 . . . . 0.41 114.348 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HA ' HG12 ' A' ' 4' ' ' VAL . 55.9 mttt -124.51 -120.14 0.27 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.509 -0.846 . . . . 1.13 109.97 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.57 -41.27 4.5 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 108.904 -1.678 . . . . 0.51 108.904 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.061 ' HB2' ' CE ' ' B' ' 11' ' ' LYS . 49.9 mttp -136.39 0.12 2.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.22 -1.49 . . . . 3.41 111.029 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 19' ' ' LYS . 21.8 t0 -88.21 8.66 26.05 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.015 0.436 . . . . 1.22 111.815 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.703 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.6 p -87.99 147.69 5.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.936 -0.574 . . . . 0.34 110.747 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 4.0 pt-20 -111.31 90.37 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.626 -0.715 . . . . 1.26 110.299 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.703 ' HE1' HG21 ' A' ' 23' ' ' VAL . 8.2 m-85 -89.21 -168.11 2.07 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.975 -0.557 . . . . 0.65 109.713 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.795 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tt -126.49 159.23 33.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.987 -1.116 . . . . 0.96 107.987 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -139.5 114.2 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 118.619 -1.233 . . . . 0.4 113.45 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.641 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 54.7 ttt85 -88.25 75.57 8.54 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.815 -1.55 . . . . 3.27 106.815 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.7 m0 -27.9 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.395 -1.275 . . . . 1.31 112.511 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.786 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.8 tttp -29.78 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.619 -1.173 . . . . 2.46 111.938 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' TRP . 15.0 m-20 -125.75 51.36 1.75 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.931 -0.577 . . . . 2.02 109.91 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -130.98 -138.91 4.34 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.722 -0.672 . . . . 0.59 112.538 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.2 -48.46 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.78 -0.724 . . . . 0.86 112.677 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.67 179.51 4.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 2.13 111.089 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.9 m -124.2 106.44 10.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.072 -0.513 . . . . 1.6 111.03 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 1.1 mp0 -101.47 -175.77 2.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.06 -0.518 . . . . 2.27 111.033 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 31.6 m0 -114.27 154.43 27.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.481 . . . . 0.71 111.745 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 8' ' ' ALA . 79.7 t -88.27 162.37 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.554 -0.748 . . . . 0.65 109.591 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' HG12 ' A' ' 38' ' ' VAL . 19.8 tptm -80.76 99.88 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.698 0.629 . . . . 2.32 112.698 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 24' ' ' GLU . . . -98.42 26.06 25.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.445 -0.798 . . . . 0.35 111.992 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.52 -3.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.687 -0.486 . . . . 0.68 109.687 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.953 ' O ' ' HE3' ' B' ' 11' ' ' LYS . 93.1 m-70 -73.88 78.84 1.62 Allowed 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.52 0.676 . . . . 1.35 109.919 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 43' ' ' VAL . 9.0 p -58.55 69.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.636 -1.62 . . . . 1.49 113.341 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.699 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.67 50.05 1.54 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.062 -0.972 . . . . 0.48 109.127 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -45.53 -27.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.066 -0.97 . . . . 2.44 110.655 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 11.2 m-20 -68.31 -47.69 66.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.272 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.699 HG23 ' HB1' ' A' ' 44' ' ' ALA . 56.3 t -54.72 -40.38 51.28 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 116.375 -0.375 . . . . 0.88 110.517 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -72.69 -59.75 2.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.751 1.22 . . . . 0.99 110.497 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HD3' ' CB ' ' A' ' 53' ' ' ASP . 4.5 tppp? -56.25 -28.66 59.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.338 -0.616 . . . . 3.35 109.338 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.7 t70 -92.99 -21.82 19.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.355 -0.838 . . . . 2.0 110.482 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -74.19 -67.4 0.62 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.561 0.696 . . . . 1.87 110.569 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 17.0 pt-20 -83.87 -48.41 10.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.696 -1.138 . . . . 1.77 111.474 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' CB ' ' HD3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -76.28 -36.88 58.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 2.3 111.501 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -51.64 -43.26 53.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.212 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 55' ' ' LEU . 7.4 mp -84.02 -57.5 3.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 2.34 110.558 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.49 63.04 5.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.98 -0.555 . . . . 2.95 110.848 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.2 t80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.252 -0.88 . . . . 2.23 110.933 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.622 0.248 . . . . 5.2 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.83 112.67 3.15 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.693 2.262 . . . . 5.12 112.306 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.412 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 38.4 Cg_exo -61.33 93.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.704 2.269 . . . . 3.56 112.895 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.535 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . -147.67 86.65 0.16 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.952 -0.642 . . . . 2.11 112.083 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 1.182 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 95.1 m -152.04 151.25 30.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.879 0.371 . . . . 1.85 111.983 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -146.53 -76.29 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.513 0.56 . . . . 1.86 112.513 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.42 ' NH2' ' OH ' ' A' ' 7' ' ' TYR . 22.5 ttm180 -59.43 -103.3 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 119.702 -0.19 . . . . 7.29 111.381 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.452 HH12 HG21 ' B' ' 5' ' ' THR . 30.0 mtp180 52.28 177.35 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.466 -0.493 . . . . 6.23 110.48 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 45.3 mttp -151.77 -159.19 0.99 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.749 0.309 . . . . 7.18 111.151 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -44.43 -27.95 0.5 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.261 -0.427 . . . . 4.33 111.257 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 1.061 ' CE ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER 80.94 99.28 0.06 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.931 -0.577 . . . . 4.49 110.962 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.586 ' HB3' ' CG2' ' A' ' 47' ' ' VAL . . . -93.44 51.81 1.66 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.441 -0.8 . . . . 2.05 110.835 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.39 31.83 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.03 0.443 . . . . 3.8 110.551 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.233 -0.889 . . . . 3.91 110.904 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.632 -0.187 . . . . 2.97 112.632 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 70.5 p 177.66 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.738 0.304 . . . . 3.15 111.201 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -88.71 146.41 25.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.764 -0.458 . . . . 4.57 109.764 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.936 HG22 ' O ' ' A' ' 18' ' ' GLY . 14.0 p -89.32 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.038 -0.528 . . . . 3.08 110.249 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 19' ' ' LYS . 8.8 p90 -175.55 174.97 2.18 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.833 -0.621 . . . . 2.16 110.994 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.949 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.0 tp10 -152.97 124.33 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.233 -0.654 . . . . 2.41 109.233 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.562 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.5 p90 -87.45 104.42 16.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.466 0.543 . . . . 1.73 112.466 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -89.27 58.26 4.38 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.673 -0.862 . . . . 0.38 108.673 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.752 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.21 148.07 41.94 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.261 1.029 . . . . 2.8 113.33 -176.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.639 HG12 ' HB3' ' A' ' 30' ' ' LYS . 46.5 t -88.48 -33.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 113.22 -1.809 . . . . 0.42 110.334 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 11.7 t70 -144.68 -38.35 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.38 -0.827 . . . . 2.19 111.77 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 10.8 mm-40 -154.48 162.71 41.01 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 112.458 0.54 . . . . 2.18 112.458 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.23 -164.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.878 -0.601 . . . . 0.34 109.857 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.017 ' CG2' HD13 ' A' ' 26' ' ' LEU . 98.1 t -149.98 -60.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.5 tp10 -92.84 134.28 35.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.563 -0.902 . . . . 2.96 108.563 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.7 ptpt -151.32 79.13 1.29 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.786 0.662 . . . . 2.13 112.786 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -153.86 95.32 1.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.95 -0.469 . . . . 3.83 111.31 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.936 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.62 -130.52 1.56 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 118.891 -1.623 . . . . 0.41 114.231 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 67.9 mttm -116.14 -120.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.86 -0.67 . . . . 1.13 109.741 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -95.39 -40.3 4.25 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 108.07 -2.012 . . . . 0.51 108.07 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 19.5 mmtp -135.64 1.55 2.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 112.963 -1.618 . . . . 3.41 110.878 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 42' ' ' HIS . 22.1 t70 -88.74 9.44 24.42 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-O 121.301 0.572 . . . . 1.22 111.557 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.949 HG11 ' H ' ' A' ' 6' ' ' GLU . 8.4 p -95.45 145.71 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 115.323 -0.853 . . . . 0.34 111.268 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' CA ' ' HA3' ' A' ' 40' ' ' GLY . 1.3 pm0 -104.42 111.84 24.66 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.851 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.758 ' HE1' HG21 ' A' ' 23' ' ' VAL . 23.4 m-85 -113.97 147.84 37.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.808 -0.633 . . . . 0.65 110.375 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.017 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.6 tt -90.24 159.52 16.66 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.975 -1.12 . . . . 0.96 107.975 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.3 m -140.44 111.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 118.75 -1.18 . . . . 0.4 113.517 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HG2' HD21 ' A' ' 26' ' ' LEU . 66.5 mtt180 -89.29 78.68 7.21 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.169 -1.419 . . . . 3.27 107.169 176.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HD1' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -27.8 89.71 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 114.254 -1.339 . . . . 1.31 111.864 -178.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.639 ' HB3' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -28.74 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.918 -1.037 . . . . 2.46 112.254 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 32.4 m-20 -118.3 55.7 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 2.02 109.901 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -146.24 -154.66 6.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.581 . . . . 0.59 112.815 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.64 -45.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.038 -0.601 . . . . 0.86 112.353 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.17 162.98 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 2.13 110.824 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.5 m -115.31 137.3 52.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 1.6 110.97 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 18.3 mm-40 -130.67 167.18 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.689 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 37.4 m0 -107.05 147.16 30.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.71 111.536 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG22 ' O ' ' B' ' 4' ' ' GLY . 65.0 t -88.84 159.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.65 110.398 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.536 ' N ' HG12 ' A' ' 38' ' ' VAL . 82.8 tttt -79.6 96.43 6.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.078 0.466 . . . . 2.32 111.899 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -92.1 44.83 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.559 -0.746 . . . . 0.35 112.924 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.88 13.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.809 -0.441 . . . . 0.68 109.809 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' CE1' ' HE2' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -83.54 80.44 9.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.625 0.726 . . . . 1.35 111.118 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 43' ' ' VAL . 5.6 p -58.93 72.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.441 -1.708 . . . . 1.49 112.406 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.94 51.51 1.84 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.108 -0.951 . . . . 0.48 108.729 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 49' ' ' LYS . 41.1 tt0 -44.78 -28.26 0.61 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.277 -0.874 . . . . 2.44 110.492 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.28 -50.19 55.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.746 . . . . 2.48 109.609 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 98.0 t -57.05 -46.62 84.32 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 CA-C-N 115.88 -0.6 . . . . 0.88 109.903 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -67.76 -59.21 3.49 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.99 111.11 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 73.0 mmtt -55.01 -33.56 62.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.191 0.52 . . . . 3.35 109.742 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -91.66 -19.43 22.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.802 -0.635 . . . . 2.0 110.738 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CZ ' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -73.2 -62.23 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.733 0.778 . . . . 1.87 109.724 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -92.06 -49.87 5.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.241 -1.345 . . . . 1.77 111.414 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -75.43 -20.24 58.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 2.3 111.435 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -67.96 -42.99 84.16 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.438 -0.886 . . . . 1.61 112.085 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 77.4 mt -81.49 -64.1 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.886 0.374 . . . . 2.34 110.626 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -83.98 61.7 6.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 2.95 110.654 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.9 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.321 -0.847 . . . . 2.23 110.901 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.555 0.217 . . . . 5.2 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.19 139.47 29.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.508 2.138 . . . . 5.12 112.179 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.94 71.44 4.2 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.507 2.138 . . . . 3.56 112.285 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.806 ' O ' HG22 ' A' ' 38' ' ' VAL . . . 47.47 97.16 0.01 OUTLIER Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 2.11 112.657 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 82.4 p -154.31 145.61 22.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.63 0.233 . . . . 1.85 111.63 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.458 ' HB2' HG22 ' A' ' 10' ' ' VAL . . . -144.96 -86.03 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.647 0.61 . . . . 1.86 112.647 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 7' ' ' TYR . 31.3 mmm180 -52.34 -101.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.534 -0.303 . . . . 7.29 111.636 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.629 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 33.4 mtp180 53.65 173.8 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.436 -0.505 . . . . 6.23 110.193 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -147.97 -165.88 2.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.67 0.271 . . . . 7.18 110.961 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' B' ' 11' ' ' LYS . 30.0 ptt180 -49.18 -23.63 1.38 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.524 -0.307 . . . . 4.33 111.415 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 42' ' ' HIS . 27.5 mmmt 82.39 83.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.385 -0.37 . . . . 4.49 110.629 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -48.63 -30.72 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 2.05 111.204 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -109.67 62.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 3.8 110.74 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.22 -0.895 . . . . 3.91 110.912 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.751 -0.14 . . . . 2.97 112.751 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.9 p 178.25 -34.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 3.15 110.978 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -89.05 139.5 30.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.58 -0.526 . . . . 4.57 109.58 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.508 HG22 ' CD ' ' A' ' 52' ' ' GLU . 2.0 t -89.67 50.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 3.08 110.335 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' LYS . 7.0 p90 177.78 144.38 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.877 -0.601 . . . . 2.16 110.93 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' H ' HG11 ' A' ' 23' ' ' VAL . 10.6 tp10 -128.42 142.29 51.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 2.41 110.731 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 52.5 p90 -88.91 114.56 25.67 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.691 0.758 . . . . 1.73 112.124 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.934 ' O ' ' HB3' ' B' ' 6' ' ' ALA . . . -101.85 55.46 0.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.568 -1.196 . . . . 0.38 109.629 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -119.34 164.26 15.95 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.692 0.758 . . . . 2.8 112.222 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 ' HB3' ' A' ' 30' ' ' LYS . 18.4 t -99.05 -19.22 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.415 -1.266 . . . . 0.42 112.476 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 32.9 t70 -149.95 -43.13 0.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.046 0.388 . . . . 2.19 112.046 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 48.5 mt-10 -154.26 166.46 33.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 116.423 -0.353 . . . . 2.18 111.838 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -138.96 -171.66 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.5 0.191 . . . . 0.34 110.501 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.576 ' CG2' HD13 ' A' ' 26' ' ' LEU . 77.1 t -146.18 -60.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.67 110.05 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 0.9 OUTLIER -94.36 136.71 34.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 2.96 109.717 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 41.8 pttt -150.85 94.66 2.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.791 0.293 . . . . 2.13 111.791 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' VAL . 80.7 mtp180 -155.98 92.61 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 121.229 -0.188 . . . . 3.83 111.044 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.714 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -152.82 -132.32 1.76 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 118.997 -1.573 . . . . 0.41 114.8 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.743 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -116.75 -123.32 0.29 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.182 -1.009 . . . . 1.13 109.243 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.77 -41.75 4.32 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 108.202 -1.959 . . . . 0.51 108.202 177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.601 ' HZ1' ' HD3' ' B' ' 9' ' ' LYS . 28.8 mmtt -132.3 -1.7 3.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.031 -1.584 . . . . 3.41 110.766 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.563 ' OD2' HG22 ' A' ' 43' ' ' VAL . 27.0 t0 -87.71 10.18 19.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.016 0.436 . . . . 1.22 111.943 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 17' ' ' ARG . 8.3 p -89.85 153.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.811 -0.631 . . . . 0.34 112.58 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 7.7 pt-20 -105.38 114.43 28.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.03 -0.986 . . . . 1.26 109.447 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.742 ' O ' HG23 ' A' ' 38' ' ' VAL . 7.4 m-85 -120.11 149.14 42.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.309 -0.405 . . . . 0.65 110.06 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.6 tt -88.63 156.57 18.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.009 -0.738 . . . . 0.96 109.009 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.629 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.22 110.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 113.826 1.047 . . . . 0.4 113.826 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 12' ' ' GLU . 62.7 mtp180 -81.91 69.5 8.62 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.056 -2.201 . . . . 3.27 105.056 174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.635 ' CD1' HG21 ' A' ' 10' ' ' VAL . 3.5 t90 -25.17 90.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 113.768 -1.56 . . . . 1.31 112.317 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.695 ' HB3' HG12 ' A' ' 10' ' ' VAL . 27.8 tptp -28.42 -36.46 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.286 -1.324 . . . . 2.46 112.196 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.1 m-20 -117.65 57.02 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 2.02 109.885 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -141.05 3.4 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.59 112.641 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.99 -48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.86 112.486 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -92.81 164.02 13.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 2.13 110.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.62 109.78 16.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 1.6 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' CG ' ' HB2' ' B' ' 2' ' ' PRO . 11.3 mm-40 -112.57 178.92 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 2.27 110.899 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 36.9 m0 -102.02 149.23 24.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 0.71 111.924 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 25' ' ' TYR . 46.5 t -89.38 161.21 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.65 109.883 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.4 tptt -72.75 103.08 3.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.546 0.572 . . . . 2.32 112.546 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.27 42.13 2.85 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.452 -0.794 . . . . 0.35 112.868 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG21 ' HE3' ' A' ' 39' ' ' LYS . 2.3 t -118.48 10.3 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.205 -0.294 . . . . 0.68 110.205 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CE1' ' CE ' ' B' ' 11' ' ' LYS . 0.3 OUTLIER -77.76 78.3 4.26 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.578 0.704 . . . . 1.35 111.052 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.743 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 97.7 t -57.78 71.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 113.346 -1.752 . . . . 1.49 113.065 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.54 49.83 1.53 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.789 -0.819 . . . . 0.48 108.789 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -42.16 -30.61 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.17 -0.923 . . . . 2.44 110.886 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 4.1 p30 -67.53 -47.0 71.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.376 -0.829 . . . . 2.48 109.968 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HB1' ' A' ' 44' ' ' ALA . 48.6 t -60.29 -40.07 82.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 109.894 -0.41 . . . . 0.88 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -68.82 -57.71 5.2 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.205 1.402 . . . . 0.99 110.999 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 7.5 mmpt? -60.59 -28.75 68.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.532 0.682 . . . . 3.35 109.343 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.3 t70 -92.53 -14.31 28.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.353 -0.84 . . . . 2.0 110.174 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' CE1' ' CG1' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -83.44 -68.63 0.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.536 0.684 . . . . 1.87 110.342 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.508 ' CD ' HG22 ' A' ' 4' ' ' VAL . 15.9 pt-20 -83.91 -47.25 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.677 -1.147 . . . . 1.77 111.048 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 5.9 t70 -82.06 -15.89 52.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 2.3 111.101 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -78.51 -36.12 30.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.534 -0.841 . . . . 1.61 112.034 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 55' ' ' LEU . 5.7 tt -85.31 -59.4 2.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 2.34 110.296 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -89.53 61.95 5.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 2.95 110.584 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.21 -0.9 . . . . 2.23 110.855 -179.874 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.62 0.248 . . . . 5.2 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 36' ' ' GLU . 66.6 Cg_exo -51.44 148.52 19.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.622 2.215 . . . . 5.12 112.44 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.01 122.78 11.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.615 2.21 . . . . 3.56 112.304 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 148.31 64.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.769 -0.729 . . . . 2.11 112.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.459 ' HA ' ' CG1' ' A' ' 27' ' ' VAL . 4.0 t -151.68 174.29 13.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 1.85 112.032 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.934 ' HB3' ' O ' ' A' ' 8' ' ' ALA . . . -170.45 -174.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.386 -0.825 . . . . 1.86 110.259 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.41 ' HG3' ' HD3' ' B' ' 11' ' ' LYS . 59.6 ttp180 -129.0 125.12 36.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.637 -0.256 . . . . 7.29 111.489 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.461 ' HB2' ' CG ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -47.37 -64.88 0.67 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.692 0.282 . . . . 6.23 111.296 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.601 ' HD3' ' HZ1' ' A' ' 21' ' ' LYS . 42.6 mtpt -156.62 -166.89 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 7.18 110.617 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -44.52 -28.7 0.61 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.871 0.367 . . . . 4.33 111.451 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' CE ' ' CE1' ' A' ' 42' ' ' HIS . 28.0 mtmm 75.66 102.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 4.49 110.869 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.508 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -63.59 -23.83 67.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.972 -0.558 . . . . 2.05 111.218 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.81 57.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 3.8 110.866 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.268 -0.872 . . . . 3.91 110.913 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 112.709 -0.156 . . . . 2.97 112.709 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 30.9 t 175.12 -31.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.677 0.275 . . . . 3.15 111.383 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -88.98 141.68 28.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.393 . . . . 4.57 110.488 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 18' ' ' GLY . 9.6 p -89.98 47.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.016 -0.538 . . . . 3.08 110.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 5.1 p90 179.82 171.61 1.06 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.75 -0.659 . . . . 2.16 110.473 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.005 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.3 tm-20 -153.15 128.0 9.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.151 -0.685 . . . . 2.41 109.151 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.566 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 38.7 p90 -88.4 102.85 15.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 111.933 0.346 . . . . 1.73 111.933 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.813 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -86.92 59.01 5.39 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.054 -0.721 . . . . 0.38 109.054 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.674 ' C ' ' HB3' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -112.09 149.55 31.97 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.32 1.057 . . . . 2.8 113.261 -176.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.744 ' CG2' ' HB2' ' B' ' 6' ' ' ALA . 55.8 t -89.09 -37.35 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.161 -1.836 . . . . 0.42 109.774 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 17.7 t70 -141.3 -37.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.39 -0.823 . . . . 2.19 111.926 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 24.6 mm-40 -154.3 157.12 38.19 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.572 0.582 . . . . 2.18 112.572 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.95 -166.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.826 -0.625 . . . . 0.34 109.431 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 99.4 t -150.88 -48.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.274 0.559 . . . . 0.67 109.513 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.5 mt-10 -99.97 144.91 28.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 2.96 109.643 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 22.6 pttm -154.38 78.36 1.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.371 0.508 . . . . 2.13 112.371 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' C ' HG23 ' A' ' 23' ' ' VAL . 40.6 ttm180 -153.22 90.94 1.47 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.302 -0.559 . . . . 3.83 111.961 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.893 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -153.53 -132.42 1.71 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 118.95 -1.595 . . . . 0.41 114.789 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.3 mttm -116.59 -120.14 0.31 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.437 -0.882 . . . . 1.13 109.591 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -94.76 -40.41 4.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.067 -2.013 . . . . 0.51 108.067 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 16.7 mtmm -136.88 -1.1 2.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.137 -1.531 . . . . 3.41 111.41 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 15.9 t70 -85.66 8.9 17.87 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.262 0.553 . . . . 1.22 111.58 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.005 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.4 p -89.15 143.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.368 -0.833 . . . . 0.34 110.907 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 3.2 pt-20 -106.49 97.61 7.39 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.145 0.498 . . . . 1.26 111.188 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CG ' ' HA ' ' A' ' 7' ' ' TYR . 18.5 m-85 -94.83 -169.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.598 -0.728 . . . . 0.65 109.774 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 2.2 tt -127.99 159.12 36.0 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.272 -1.01 . . . . 0.96 108.272 177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.674 HG22 ' HA2' ' B' ' 4' ' ' GLY . 0.7 OUTLIER -141.24 112.76 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 118.388 -1.325 . . . . 0.4 113.844 179.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 30' ' ' LYS . 19.8 ttm180 -88.94 77.05 7.78 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.708 -1.59 . . . . 3.27 106.708 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.573 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.6 t90 -27.81 89.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.363 -1.29 . . . . 1.31 112.273 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 39.5 ttmt -28.24 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.038 -0.983 . . . . 2.46 112.15 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.2 t70 -117.58 55.96 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.081 -0.509 . . . . 2.02 109.817 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.27 -163.67 10.92 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.834 -0.621 . . . . 0.59 112.669 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.55 35.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.349 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -145.98 -169.05 3.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 2.13 110.988 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.7 113.25 6.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.6 111.013 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.463 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 7.9 mm-40 -121.62 175.61 6.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 2.27 110.74 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 27.5 m0 -116.17 151.99 34.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.078 0.465 . . . . 0.71 111.612 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.813 HG11 ' HB3' ' A' ' 8' ' ' ALA . 88.9 t -88.57 152.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.679 -0.692 . . . . 0.65 110.353 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HE2' ' CG2' ' A' ' 41' ' ' VAL . 22.7 tptm -72.58 97.1 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 2.32 112.16 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -93.92 40.54 2.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.706 -0.759 . . . . 0.35 113.014 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' CG2' ' HE2' ' A' ' 39' ' ' LYS . 1.1 t -120.45 4.16 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.801 -0.444 . . . . 0.68 109.801 177.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CD2' ' HG3' ' B' ' 11' ' ' LYS . 14.0 m80 -80.5 81.44 6.75 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.821 0.82 . . . . 1.35 110.722 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 61.8 t -56.57 74.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 112.754 -2.021 . . . . 1.49 112.507 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -90.88 51.06 1.89 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.408 -0.815 . . . . 0.48 109.268 177.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 39.1 tt0 -47.77 -27.12 1.86 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.204 -0.907 . . . . 2.44 110.116 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 8.4 m-20 -70.38 -46.87 63.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.471 -0.786 . . . . 2.48 109.882 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.533 HG13 ' CE1' ' A' ' 51' ' ' TYR . 60.1 t -61.8 -45.83 97.84 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.733 -0.469 . . . . 0.88 109.733 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.69 -57.82 5.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.439 1.496 . . . . 0.99 111.432 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -57.87 -31.78 67.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.362 0.601 . . . . 3.35 109.466 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.2 t70 -91.96 -16.51 26.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.351 -0.84 . . . . 2.0 110.563 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.2 m-30 -79.14 -65.21 1.03 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.473 0.654 . . . . 1.87 110.941 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.8 pt-20 -87.91 -45.78 9.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.839 -1.073 . . . . 1.77 111.191 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 3.1 m-20 -82.69 -19.18 38.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.795 -0.639 . . . . 2.3 111.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -76.67 -34.17 44.76 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.368 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -80.21 -70.41 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.328 . . . . 2.34 110.686 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.0 64.4 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 2.95 111.027 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.222 -0.894 . . . . 2.23 110.867 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.559 0.219 . . . . 5.2 111.039 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.432 ' HA ' ' HD2' ' B' ' 3' ' ' PRO . 98.4 Cg_exo -44.29 105.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.67 2.246 . . . . 5.12 112.447 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' B' ' 2' ' ' PRO . 52.1 Cg_endo -69.61 67.46 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.521 2.147 . . . . 3.56 112.387 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.688 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -129.49 36.74 2.31 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.87 -0.681 . . . . 2.11 112.535 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.463 HG22 HG13 ' A' ' 38' ' ' VAL . 53.3 p -152.78 153.46 33.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.948 0.351 . . . . 1.85 111.948 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -158.82 -81.28 0.06 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.522 0.934 . . . . 1.86 113.522 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 7' ' ' TYR . 23.9 tpt180 -42.21 -94.89 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.811 0.671 . . . . 7.29 112.811 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.467 ' CG ' ' HG3' ' A' ' 6' ' ' GLU . 18.6 mmm180 -98.9 118.65 36.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.336 -0.546 . . . . 6.23 112.217 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.81 50.5 1.12 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.396 -0.82 . . . . 7.18 110.741 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -110.0 -20.08 12.85 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.766 0.317 . . . . 4.33 111.049 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.506 ' HG3' ' CD2' ' A' ' 42' ' ' HIS . 3.4 mppt? 65.6 95.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 4.49 111.121 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -74.87 -25.95 59.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.05 110.586 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 12.1 t70 -110.69 -33.3 6.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.799 -0.637 . . . . 3.8 110.819 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.281 -0.866 . . . . 3.91 110.816 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' O ' HD12 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.215 0 CA-C-O 120.293 -0.171 . . . . 2.97 112.838 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 8.3 p 163.58 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.262 0.468 . . . . 3.15 112.262 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.72 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 18.1 mp0 -87.55 142.52 27.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.061 0.458 . . . . 4.57 110.633 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.383 HG13 ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -89.52 48.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.683 -0.69 . . . . 3.08 110.78 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.536 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -177.59 173.77 1.61 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.923 -0.581 . . . . 2.16 111.485 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.961 ' H ' HG11 ' A' ' 23' ' ' VAL . 8.2 tp10 -152.56 129.36 10.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.719 -0.673 . . . . 2.41 109.31 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.547 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 53.3 p90 -87.5 109.85 19.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.629 0.603 . . . . 1.73 112.629 -178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.864 ' HB2' ' HB3' ' B' ' 8' ' ' ARG . . . -92.07 50.11 1.62 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.661 -0.7 . . . . 0.38 109.127 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.77 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -108.45 149.78 28.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.229 1.014 . . . . 2.8 113.528 -177.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.737 HG12 ' CB ' ' A' ' 30' ' ' LYS . 61.1 t -89.34 -36.11 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-N 113.342 -1.754 . . . . 0.42 110.11 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.63 ' CG ' ' O ' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -141.61 -39.25 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.285 -0.87 . . . . 2.19 111.706 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.8 mt-10 -155.04 158.26 38.84 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.593 0.59 . . . . 2.18 112.593 -177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.77 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -127.35 -165.93 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.34 109.611 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.981 ' CG2' HD13 ' A' ' 26' ' ' LEU . 94.1 t -150.59 -58.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.14 0.495 . . . . 0.67 109.956 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 6.8 pt-20 -97.24 133.68 41.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 2.96 109.175 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 49.2 pttt -151.03 89.07 1.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.435 0.531 . . . . 2.13 112.435 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -154.33 93.06 1.57 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.288 -0.257 . . . . 3.83 110.902 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.919 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.11 -134.2 2.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 118.769 -1.681 . . . . 0.41 114.757 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.541 ' HE3' HG13 ' A' ' 43' ' ' VAL . 67.9 mttm -114.17 -119.03 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.464 -0.868 . . . . 1.13 109.554 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -96.9 -41.97 3.42 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 107.83 -2.108 . . . . 0.51 107.83 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.617 ' CB ' ' CD ' ' B' ' 11' ' ' LYS . 44.1 mmtt -132.96 0.2 3.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.118 -1.541 . . . . 3.41 111.048 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 16.1 t70 -86.72 6.92 28.92 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 121.261 0.553 . . . . 1.22 111.668 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.961 HG11 ' H ' ' A' ' 6' ' ' GLU . 7.4 p -90.06 145.64 7.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.348 -0.842 . . . . 0.34 111.32 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' HA3' ' A' ' 40' ' ' GLY . 3.0 pt-20 -104.64 111.6 24.37 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.762 -0.654 . . . . 1.26 110.61 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.62 ' O ' HG23 ' A' ' 38' ' ' VAL . 23.0 m-85 -114.02 148.97 36.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.722 -0.672 . . . . 0.65 110.676 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.981 HD13 ' CG2' ' A' ' 14' ' ' VAL . 1.7 tt -89.7 159.15 17.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.922 -1.14 . . . . 0.96 107.922 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -140.12 108.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.699 -1.2 . . . . 0.4 113.448 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 30' ' ' LYS . 4.3 tpt180 -83.13 74.84 9.96 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.569 -1.641 . . . . 3.27 106.569 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.63 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 4.3 t90 -27.83 89.4 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.665 1.228 . . . . 1.31 112.091 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.737 ' CB ' HG12 ' A' ' 10' ' ' VAL . 34.9 ttpt -28.92 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.838 -1.073 . . . . 2.46 112.168 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' TRP . 16.8 m-20 -119.61 56.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 2.02 109.816 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -145.12 -163.48 10.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.859 -0.61 . . . . 0.59 112.886 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.26 27.99 1.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.937 -0.649 . . . . 0.86 112.336 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -142.05 -178.48 5.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 2.13 111.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' CZ ' ' A' ' 28' ' ' ARG . 65.0 m -135.77 111.23 9.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 1.6 110.821 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -124.96 172.58 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.27 111.052 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 18.8 m0 -114.85 150.36 35.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.71 111.483 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.72 HG22 ' O ' ' B' ' 4' ' ' GLY . 89.0 t -89.68 160.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.55 . . . . 0.65 110.249 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 38' ' ' VAL . 24.2 ttmm -78.2 96.81 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.213 0.53 . . . . 2.32 112.269 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.83 46.82 2.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.463 -0.789 . . . . 0.35 112.509 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.51 3.24 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 0.68 110.368 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -75.04 79.56 2.22 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.689 0.756 . . . . 1.35 110.699 -179.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG12 ' A' ' 43' ' ' VAL . 87.4 t -58.04 66.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 113.04 -1.891 . . . . 1.49 113.362 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.42 53.67 2.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.857 -0.794 . . . . 0.48 108.857 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -48.95 -24.55 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.113 -0.949 . . . . 2.44 110.641 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 17.4 t70 -68.04 -49.8 59.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.868 -0.606 . . . . 2.48 110.066 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG12 ' CE2' ' A' ' 51' ' ' TYR . 44.6 t -59.49 -32.01 47.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 116.287 -0.415 . . . . 0.88 110.594 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -80.03 -57.46 3.62 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.85 1.26 . . . . 0.99 109.866 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.3 tppt? -57.27 -29.57 63.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 3.35 108.679 178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 7.9 t70 -92.12 -22.84 19.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.202 -0.908 . . . . 2.0 110.234 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.814 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -71.79 -68.25 0.47 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.791 0.805 . . . . 1.87 110.118 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 14.6 pt-20 -85.44 -50.4 7.32 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.266 -1.334 . . . . 1.77 111.765 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -74.47 -23.26 58.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 2.3 111.482 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -65.23 -47.31 81.87 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.456 -0.878 . . . . 1.61 112.108 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 1' ' ' GLY . 25.1 mt -77.7 -63.78 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.932 0.396 . . . . 2.34 110.514 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -82.56 60.61 5.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 2.95 110.47 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.2 t80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.264 -0.874 . . . . 2.23 110.931 -179.557 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.687 0.279 . . . . 5.2 111.021 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' B' ' 3' ' ' PRO . 71.6 Cg_exo -49.28 104.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.722 2.281 . . . . 5.12 112.387 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' B' ' 2' ' ' PRO . 56.7 Cg_endo -70.53 127.04 13.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.505 2.137 . . . . 3.56 112.308 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.72 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -64.13 96.84 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 2.11 112.027 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 1.228 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 2.2 m -153.06 147.34 25.75 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.529 0.566 . . . . 1.85 112.529 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -148.18 -86.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 1.86 110.819 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -77.4 -153.82 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.014 -0.365 . . . . 7.29 110.014 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.864 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 41.65 71.74 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.596 0.236 . . . . 6.23 111.539 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -147.83 49.75 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 7.18 112.142 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.452 ' CD ' ' HE3' ' A' ' 21' ' ' LYS . 14.6 ptm180 -115.59 -25.4 7.89 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.819 0.342 . . . . 4.33 110.217 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 1.617 ' CD ' ' CB ' ' A' ' 21' ' ' LYS . 27.6 mttp 48.6 78.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 4.49 111.509 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 1.081 ' H ' ' HG2' ' B' ' 11' ' ' LYS . . . -73.81 -28.54 61.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.153 0.501 . . . . 2.05 110.037 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 24.0 t70 -111.17 42.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.627 -0.715 . . . . 3.8 110.413 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.654 ' OG ' ' HB3' ' B' ' 11' ' ' LYS . 68.6 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.192 -0.909 . . . . 3.91 110.889 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.802 -0.119 . . . . 2.97 112.802 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 91.5 p -179.71 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.725 0.298 . . . . 3.15 110.96 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.14 140.92 29.0 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.579 -0.526 . . . . 4.57 109.579 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.491 HG22 ' CD ' ' A' ' 52' ' ' GLU . 1.6 t -88.72 55.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.281 -0.418 . . . . 3.08 110.486 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' LYS . 10.9 p90 174.42 170.25 0.23 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.82 -0.627 . . . . 2.16 111.167 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.888 ' H ' HG11 ' A' ' 23' ' ' VAL . 19.8 mt-10 -150.85 145.62 25.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.883 -0.599 . . . . 2.41 109.546 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 37.2 p90 -90.61 110.04 21.2 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.93 0.715 . . . . 1.73 112.93 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.864 ' O ' ' HB3' ' B' ' 6' ' ' ALA . . . -93.04 52.4 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.251 -0.886 . . . . 0.38 108.897 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.708 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.24 158.45 22.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.286 1.041 . . . . 2.8 113.244 -177.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.841 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.8 t -94.21 -36.42 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 113.199 -1.819 . . . . 0.42 110.596 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 34.5 t70 -140.25 -38.9 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 2.19 112.304 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -155.72 154.51 31.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.994 0.739 . . . . 2.18 112.994 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -127.93 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.802 0.334 . . . . 0.34 110.623 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 26' ' ' LEU . 76.9 t -150.46 -58.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.67 110.202 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.8 tp10 -94.15 135.14 35.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.57 . . . . 2.96 109.683 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 17.0 ptpt -151.02 90.6 1.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.734 -0.386 . . . . 2.13 111.904 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' C ' HG23 ' A' ' 23' ' ' VAL . 13.7 ptm180 -153.51 92.6 1.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.142 -0.349 . . . . 3.83 111.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 4' ' ' VAL . . . -152.68 -134.51 2.06 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.116 -1.516 . . . . 0.41 114.875 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HE3' HG23 ' A' ' 43' ' ' VAL . 68.5 mttm -111.02 -122.08 0.28 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.56 -0.82 . . . . 1.13 109.828 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.05 -41.55 4.58 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 108.009 -2.037 . . . . 0.51 108.009 177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 10.6 mptt -136.58 2.57 2.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.094 -1.553 . . . . 3.41 110.651 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 28.8 t0 -87.68 10.27 18.74 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.263 0.554 . . . . 1.22 111.53 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.888 HG11 ' H ' ' A' ' 6' ' ' GLU . 12.2 p -91.31 153.84 3.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.302 -0.863 . . . . 0.34 111.899 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 7.0 pt-20 -106.19 116.57 32.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 1.26 110.186 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 38' ' ' VAL . 10.8 m-85 -119.48 147.49 44.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.65 110.422 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -88.49 156.74 18.93 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.563 -0.903 . . . . 0.96 108.563 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.708 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 m -141.11 113.38 4.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 113.725 1.009 . . . . 0.4 113.725 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 62.3 ttt180 -86.1 75.89 9.85 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 105.657 -1.979 . . . . 3.27 105.657 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.582 ' HD1' HG11 ' A' ' 10' ' ' VAL . 1.9 t90 -26.34 90.19 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.011 -1.449 . . . . 1.31 112.331 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.841 ' CB ' HG12 ' A' ' 10' ' ' VAL . 55.5 tptt -29.09 -35.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.722 -1.127 . . . . 2.46 112.141 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . 23.9 t70 -117.57 54.52 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.807 -0.442 . . . . 2.02 109.807 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.24 -160.29 9.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.878 -0.601 . . . . 0.59 112.919 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -151.16 29.12 0.99 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.114 -0.565 . . . . 0.86 112.128 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.96 176.73 9.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.697 0.284 . . . . 2.13 110.868 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.0 m -137.28 125.63 23.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 1.6 110.832 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.11 164.15 30.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.961 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 18.9 m0 -94.91 146.76 24.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.71 111.476 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 25' ' ' TYR . 40.5 t -89.59 161.33 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.65 109.812 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.534 ' N ' HG12 ' A' ' 38' ' ' VAL . 2.6 ttmp? -67.57 110.62 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.636 0.606 . . . . 2.32 112.636 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -98.17 40.26 2.54 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.189 -0.914 . . . . 0.35 111.96 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 t -117.5 4.45 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.248 . . . . 0.68 110.521 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.2 OUTLIER -73.51 76.4 1.45 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.73 0.776 . . . . 1.35 111.053 -179.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 19' ' ' LYS . 6.4 p -59.11 72.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 113.394 -1.73 . . . . 1.49 113.333 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.4 50.1 1.58 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.48 108.511 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.4 tt0 -42.74 -30.16 0.36 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.088 -0.96 . . . . 2.44 111.055 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.27 -46.27 70.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.681 . . . . 2.48 110.069 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 51' ' ' TYR . 68.2 t -58.61 -44.74 90.21 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-N 116.016 -0.538 . . . . 0.88 109.719 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -67.87 -59.41 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.324 1.449 . . . . 0.99 111.386 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 11.9 mptt -56.49 -32.31 64.9 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.206 0.527 . . . . 3.35 109.781 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -91.79 -18.13 24.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.817 -0.629 . . . . 2.0 110.626 178.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -74.64 -62.61 1.47 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.677 0.751 . . . . 1.87 109.682 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' CD ' HG22 ' A' ' 4' ' ' VAL . 12.6 pt-20 -90.85 -50.58 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.283 -1.326 . . . . 1.77 111.362 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -74.44 -20.77 59.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 2.3 111.199 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.29 91.75 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.822 . . . . 1.61 112.036 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 43.5 mt -82.58 -61.78 1.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 2.34 110.531 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -87.68 61.81 6.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 2.95 110.598 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.278 -0.868 . . . . 2.23 110.878 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.687 0.28 . . . . 5.2 111.04 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.43 110.15 3.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.75 2.3 . . . . 5.12 112.529 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.23 62.93 5.23 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.525 2.15 . . . . 3.56 112.243 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 166.78 76.14 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.667 -0.778 . . . . 2.11 112.578 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.566 ' HA ' HG11 ' A' ' 27' ' ' VAL . 74.1 p -151.95 166.31 31.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 1.85 111.691 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 8' ' ' ALA . . . -162.03 -166.33 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.628 -0.714 . . . . 1.86 110.27 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -154.51 113.26 3.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.067 0.461 . . . . 7.29 111.69 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.687 ' NH1' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -58.4 -47.6 83.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.786 -0.643 . . . . 6.23 111.717 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -151.1 -173.66 4.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 7.18 111.351 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.6 ptt180 -53.94 -30.1 45.28 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.08 0.467 . . . . 4.33 110.567 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.518 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 81.4 mttt 83.35 100.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.408 -0.815 . . . . 4.49 110.455 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.18 -24.73 1.84 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 2.05 111.395 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.468 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 19.9 t70 -109.65 49.03 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 3.8 110.851 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.181 -0.914 . . . . 3.91 110.886 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.707 -0.157 . . . . 2.97 112.707 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 81.7 p 178.47 -33.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.781 0.324 . . . . 3.15 111.066 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.765 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 97.0 mt-30 -88.62 140.71 29.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.834 -0.432 . . . . 4.57 109.834 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.643 HG13 ' CE2' ' A' ' 5' ' ' PHE . 10.8 p -89.02 49.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.14 -0.482 . . . . 3.08 110.811 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.643 ' CE2' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER 175.06 146.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.912 -0.586 . . . . 2.16 111.423 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.533 ' H ' HG11 ' A' ' 23' ' ' VAL . 21.5 mt-10 -126.06 143.29 51.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 2.41 110.973 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 50.3 p90 -89.58 112.58 23.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.522 0.677 . . . . 1.73 111.567 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.687 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -101.51 56.2 0.83 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.922 -1.035 . . . . 0.38 109.729 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.722 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -117.08 165.07 13.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 122.151 0.977 . . . . 2.8 112.708 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.888 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.1 t -90.25 -30.15 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-N 113.665 -1.607 . . . . 0.42 112.081 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 12.8 t70 -150.32 -35.89 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.262 0.468 . . . . 2.19 112.262 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.9 mt-10 -152.71 165.38 35.48 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 120.78 -0.368 . . . . 2.18 111.94 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -140.98 -170.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.842 0.353 . . . . 0.34 110.374 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.613 ' CG2' HD22 ' A' ' 26' ' ' LEU . 76.6 t -150.12 -52.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.67 110.038 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 10.4 tp10 -92.89 137.98 31.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 2.96 109.749 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 16.4 ptpt -152.52 89.36 1.41 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.852 -0.339 . . . . 2.13 111.14 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' VAL . 12.5 tpp180 -155.1 91.07 1.32 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.818 -0.353 . . . . 3.83 111.022 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.64 -131.59 1.69 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.269 -1.443 . . . . 0.41 114.368 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.77 ' NZ ' HG13 ' A' ' 43' ' ' VAL . 98.7 mttt -119.76 -122.61 0.29 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.456 -0.872 . . . . 1.13 109.621 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -93.52 -39.57 4.98 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 108.406 -1.878 . . . . 0.51 108.406 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' CG ' ' HB3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -137.07 0.42 2.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.228 -1.486 . . . . 3.41 111.18 177.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.9 t70 -87.35 10.33 17.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 120.996 0.427 . . . . 1.22 111.597 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.743 HG23 ' N ' ' A' ' 18' ' ' GLY . 4.9 p -88.6 150.96 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.286 0.565 . . . . 0.34 111.876 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -109.08 101.9 10.92 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.286 -0.87 . . . . 1.26 110.23 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.7 m-85 -104.23 151.82 22.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.14 -0.482 . . . . 0.65 110.062 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.7 tp -90.01 154.58 19.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.275 -1.009 . . . . 0.96 108.275 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 m -136.39 109.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 114.101 1.148 . . . . 0.4 114.101 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' CG ' ' HB2' ' A' ' 12' ' ' GLU . 53.2 mtt180 -82.84 77.78 9.53 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.627 -1.99 . . . . 3.27 105.627 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.624 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.1 t90 -27.09 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.268 -1.333 . . . . 1.31 111.95 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.888 ' CB ' HG12 ' A' ' 10' ' ' VAL . 59.0 tttm -27.17 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 114.271 -1.331 . . . . 2.46 112.355 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 29' ' ' TRP . 10.0 m-20 -120.9 57.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 2.02 109.89 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -148.7 -160.49 9.1 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.895 -0.593 . . . . 0.59 112.772 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.79 16.42 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.105 -0.569 . . . . 0.86 112.287 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -137.53 178.23 7.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.806 0.336 . . . . 2.13 110.777 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -146.24 108.93 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.965 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.33 166.88 12.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 2.27 111.069 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 40.4 m0 -89.01 145.78 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.767 -0.651 . . . . 0.71 111.753 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 8' ' ' ALA . 89.1 t -88.76 162.05 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.594 -0.73 . . . . 0.65 109.855 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.6 tttt -75.45 103.82 5.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.771 0.656 . . . . 2.32 112.771 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -95.02 47.32 2.01 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.941 -1.027 . . . . 0.35 112.2 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.04 0.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.853 -0.425 . . . . 0.68 109.853 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.61 78.39 0.81 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.772 0.796 . . . . 1.35 110.004 -179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.77 HG13 ' NZ ' ' A' ' 19' ' ' LYS . 94.9 t -57.33 69.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 113.047 -1.888 . . . . 1.49 113.426 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -90.51 51.88 2.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.312 -0.625 . . . . 0.48 109.312 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -47.34 -27.07 1.46 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.342 -0.845 . . . . 2.44 110.477 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 7.9 m-20 -70.99 -43.51 67.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.451 -0.795 . . . . 2.48 110.123 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' B' ' 12' ' ' ALA . 95.7 t -65.18 -39.97 87.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 N-CA-C 109.737 -0.468 . . . . 0.88 109.737 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -71.95 -58.07 3.77 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.104 1.362 . . . . 0.99 110.741 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.8 tppt? -57.0 -30.66 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.228 -0.656 . . . . 3.35 109.228 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 8.8 t70 -92.09 -20.42 21.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.349 -0.841 . . . . 2.0 110.386 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.1 m-30 -75.4 -67.19 0.68 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.479 0.657 . . . . 1.87 110.606 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 15.0 pt-20 -86.46 -48.7 8.19 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.8 -1.091 . . . . 1.77 111.235 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 2.4 m-20 -77.52 -20.81 53.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.883 -0.598 . . . . 2.3 111.162 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -82.52 -32.19 28.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.595 -0.812 . . . . 1.61 112.253 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -77.23 -68.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.337 . . . . 2.34 110.472 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.52 55.87 3.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.077 0.465 . . . . 2.95 110.799 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.135 -0.936 . . . . 2.23 110.844 -179.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.689 0.28 . . . . 5.2 111.056 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.21 151.42 17.18 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.559 2.173 . . . . 5.12 112.341 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.15 60.7 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.716 2.277 . . . . 3.56 112.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.13 46.07 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.85 -0.69 . . . . 2.11 112.249 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 1.14 ' CB ' ' OG1' ' B' ' 5' ' ' THR . 15.4 p -150.72 161.21 43.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.43 . . . . 1.85 111.532 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -170.98 43.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.86 110.787 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.684 ' H ' HG23 ' B' ' 5' ' ' THR . 7.0 ptp180 -38.34 135.02 0.8 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.25 -0.432 . . . . 7.29 111.659 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.463 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 22.5 tpt180 -43.92 -44.39 7.06 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.876 0.37 . . . . 6.23 110.546 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 8' ' ' ARG . 81.4 tttt 85.07 -19.38 0.34 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.399 -0.819 . . . . 7.18 112.314 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.404 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 14.6 ptm180 -50.58 -31.84 16.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.985 0.422 . . . . 4.33 110.132 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt 38.92 53.69 2.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.748 -0.66 . . . . 4.49 111.968 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.557 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -48.6 -28.55 3.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.18 0.514 . . . . 2.05 110.746 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 24.1 t70 -111.51 53.24 0.72 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.561 -0.745 . . . . 3.8 110.604 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.245 -0.884 . . . . 3.91 110.998 -179.801 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 120.234 -0.203 . . . . 2.97 112.661 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.9 p 176.29 -29.02 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.731 0.265 . . . . 3.15 111.605 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.36 143.29 27.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.045 0.45 . . . . 4.57 110.491 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.938 HG22 ' O ' ' A' ' 18' ' ' GLY . 13.8 p -92.95 40.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.804 -0.635 . . . . 3.08 110.54 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.1 p90 178.86 160.07 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.065 -0.516 . . . . 2.16 111.254 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.907 ' H ' HG11 ' A' ' 23' ' ' VAL . 1.2 mp0 -143.2 142.23 31.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.94 -0.573 . . . . 2.41 110.087 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.525 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 53.7 p90 -88.82 111.71 22.36 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.65 0.738 . . . . 1.73 111.741 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' C ' ' HB3' ' B' ' 6' ' ' ALA . . . -95.26 46.14 1.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.759 -1.11 . . . . 0.38 109.751 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.671 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.88 164.42 14.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.602 0.715 . . . . 2.8 112.73 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.699 ' CG2' ' HB2' ' B' ' 6' ' ' ALA . 8.7 t -102.95 -20.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.687 -1.142 . . . . 0.42 112.437 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.448 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 14.8 t70 -144.51 -44.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.027 0.38 . . . . 2.19 112.027 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 46.1 mt-10 -155.68 162.72 40.52 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 112.053 0.39 . . . . 2.18 112.053 -177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.49 -167.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.627 0.251 . . . . 0.34 110.356 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 26' ' ' LEU . 95.3 t -149.99 -53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.033 0.444 . . . . 0.67 109.907 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 12.5 mm-40 -96.71 135.46 38.61 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.812 -0.81 . . . . 2.96 108.812 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 48.3 pttt -153.06 85.09 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.352 -0.539 . . . . 2.13 112.37 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.588 ' C ' HG23 ' A' ' 23' ' ' VAL . 58.5 ttt85 -154.44 95.49 1.81 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.101 0.41 . . . . 3.83 111.658 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.938 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -153.34 -128.64 1.3 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 118.863 -1.637 . . . . 0.41 114.885 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 97.8 mttt -119.44 -122.17 0.29 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.557 -0.821 . . . . 1.13 110.238 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.84 -40.56 5.88 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 108.804 -1.718 . . . . 0.51 108.804 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -143.75 3.99 1.29 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.537 -1.332 . . . . 3.41 111.43 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 20.3 t70 -88.41 11.67 16.28 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.322 0.582 . . . . 1.22 111.055 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.907 HG11 ' H ' ' A' ' 6' ' ' GLU . 9.0 p -89.47 154.55 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.332 -0.849 . . . . 0.34 112.249 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' HA3' ' A' ' 40' ' ' GLY . 46.7 mt-10 -96.83 128.09 43.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.11 -0.95 . . . . 1.26 108.956 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.665 ' HD2' HG21 ' A' ' 13' ' ' ILE . 11.4 m-85 -138.76 139.74 38.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.912 0.387 . . . . 0.65 109.976 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.883 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.9 tt -89.91 157.39 17.89 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.247 -0.649 . . . . 0.96 109.247 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 m -143.76 112.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 114.262 1.208 . . . . 0.4 114.262 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 86.5 mtt180 -85.53 66.4 9.65 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 104.566 -2.383 . . . . 3.27 104.566 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 18.8 t90 -25.65 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.362 -1.745 . . . . 1.31 112.218 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HB3' HG12 ' A' ' 10' ' ' VAL . 62.4 tttp -28.33 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.264 -1.334 . . . . 2.46 112.528 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' TRP . 20.6 t70 -108.83 54.26 0.66 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.983 0.42 . . . . 2.02 109.99 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.28 -139.28 3.02 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.105 -0.569 . . . . 0.59 112.803 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.36 -46.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.085 -0.579 . . . . 0.86 111.885 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.57 163.96 12.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 2.13 110.272 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 28.1 p -121.31 138.83 54.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 1.6 111.376 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HB3' ' HA3' ' B' ' 4' ' ' GLY . 7.1 tp10 -130.76 168.96 16.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.93 -0.577 . . . . 2.27 109.938 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 24.6 m0 -88.53 144.2 26.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.815 0.34 . . . . 0.71 111.023 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 25' ' ' TYR . 85.0 t -88.42 154.37 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.65 110.115 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 38' ' ' VAL . 38.7 ttpt -66.18 103.88 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 2.32 111.573 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 24' ' ' GLU . . . -92.56 37.9 3.29 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.522 -0.763 . . . . 0.35 112.408 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.69 8.5 8.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.69 -0.485 . . . . 0.68 109.69 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.503 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -73.7 76.81 1.54 Allowed 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.505 0.669 . . . . 1.35 110.181 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 57.2 t -56.85 74.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 113.442 -1.708 . . . . 1.49 113.439 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' B' ' 12' ' ' ALA . . . -92.98 49.54 1.44 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.48 109.297 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 9.7 tp10 -48.16 -26.67 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.165 -0.925 . . . . 2.44 110.339 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -73.79 -47.0 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.567 -0.742 . . . . 2.48 110.228 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 51' ' ' TYR . 85.0 t -58.06 -46.83 88.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 109.951 -0.389 . . . . 0.88 109.951 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -68.74 -58.49 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 125.068 1.347 . . . . 0.99 111.125 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.9 ttpt -54.51 -33.74 60.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.218 0.533 . . . . 3.35 109.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.9 -20.61 21.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.75 -0.659 . . . . 2.0 110.721 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 47' ' ' VAL . 1.3 m-30 -71.7 -62.19 1.51 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.69 0.757 . . . . 1.87 110.479 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -91.82 -49.5 6.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.47 -1.241 . . . . 1.77 111.484 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -74.21 -25.12 59.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.835 -0.62 . . . . 2.3 111.285 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.86 -47.14 88.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.531 -0.842 . . . . 1.61 112.272 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.17 -72.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.739 0.304 . . . . 2.34 110.665 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -77.49 61.47 2.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 2.95 110.603 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 91.1 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.215 -0.898 . . . . 2.23 110.893 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.633 0.254 . . . . 5.2 111.031 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.04 112.23 0.87 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.6 2.2 . . . . 5.12 112.34 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.64 -38.75 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.596 2.197 . . . . 3.56 112.383 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.49 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 47.57 84.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.986 -0.626 . . . . 2.11 112.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 73.5 p -151.89 157.83 42.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.032 0.444 . . . . 1.85 111.674 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.699 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . . . -148.95 -42.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.848 -0.614 . . . . 1.86 111.748 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.417 ' HD3' ' HE3' ' B' ' 11' ' ' LYS . 89.5 mtt180 75.43 117.43 0.06 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.261 -0.427 . . . . 7.29 110.77 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.405 ' HG3' ' HG3' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -72.74 -53.95 10.24 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.916 0.339 . . . . 6.23 111.916 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -135.15 -168.07 2.11 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.873 -0.331 . . . . 7.18 111.389 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -46.53 -28.21 1.35 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.339 -0.391 . . . . 4.33 111.238 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.503 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 6.3 mtmp? 76.45 94.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 4.49 110.312 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -101.99 99.59 9.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.074 -0.512 . . . . 2.05 111.234 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.477 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 6.2 p-10 -122.84 47.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.962 0.41 . . . . 3.8 110.838 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 3.91 110.994 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.788 -0.125 . . . . 2.97 112.788 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 52' ' ' GLU . 57.8 p -167.4 -53.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 3.15 110.434 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.516 ' HG3' ' CZ ' ' A' ' 5' ' ' PHE . 24.9 tt0 -105.41 108.41 19.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.694 -0.684 . . . . 4.57 109.89 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' C ' ' CG ' ' A' ' 5' ' ' PHE . 62.0 t -142.94 -56.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.916 0.71 . . . . 3.08 112.916 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CZ ' ' HG3' ' A' ' 3' ' ' GLN . 0.2 OUTLIER 68.66 -158.06 0.19 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.676 -0.861 . . . . 2.16 108.676 -177.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.797 ' H ' HG11 ' A' ' 23' ' ' VAL . 31.4 mt-10 -152.7 148.0 26.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 112.148 0.425 . . . . 2.41 112.148 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 32.6 p90 -101.27 102.61 13.52 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.503 0.668 . . . . 1.73 110.938 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.833 ' C ' ' HB3' ' B' ' 6' ' ' ALA . . . -89.32 53.42 2.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.186 -0.915 . . . . 0.38 110.303 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.686 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -116.92 167.78 10.82 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.468 0.651 . . . . 2.8 111.614 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 29' ' ' TRP . 12.6 t -106.32 -16.69 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 115.111 -0.95 . . . . 0.42 112.387 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 17.3 t70 -148.3 -44.04 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.707 0.289 . . . . 2.19 111.754 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 18.7 mm-40 -154.18 168.44 26.52 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.363 -0.381 . . . . 2.18 111.593 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.847 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -139.46 -169.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.849 -0.426 . . . . 0.34 109.849 178.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.655 ' CG2' HD13 ' A' ' 26' ' ' LEU . 96.3 t -149.79 -59.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.091 0.472 . . . . 0.67 109.97 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.5 tp10 -93.05 134.78 34.85 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.32 -0.622 . . . . 2.96 109.32 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 14.0 ptmt -150.83 92.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 2.13 111.089 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.628 ' C ' HG23 ' A' ' 23' ' ' VAL . 98.1 mtt180 -154.98 90.91 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.81 -0.356 . . . . 3.83 111.706 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.79 -134.98 2.29 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.057 -1.544 . . . . 0.41 114.702 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 62.3 mttm -106.77 -90.52 0.43 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.823 -0.688 . . . . 1.13 110.802 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -130.13 -44.38 0.18 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 107.755 -2.138 . . . . 0.51 107.755 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HA ' ' CE ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -132.56 -5.19 3.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.491 -1.354 . . . . 3.41 110.793 176.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 19.3 t70 -88.67 10.02 22.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.256 0.55 . . . . 1.22 111.397 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.797 HG11 ' H ' ' A' ' 6' ' ' GLU . 11.5 p -89.01 158.15 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 115.472 -0.785 . . . . 0.34 111.404 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 23' ' ' VAL . 10.4 pt-20 -106.73 122.89 47.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.445 -0.798 . . . . 1.26 110.124 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 38' ' ' VAL . 9.8 m-85 -128.45 146.07 50.91 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.037 -0.528 . . . . 0.65 110.186 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HG22 ' A' ' 13' ' ' ILE . 1.9 tt -88.72 157.81 18.4 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.318 -0.623 . . . . 0.96 109.318 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 m -142.69 113.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 113.881 1.067 . . . . 0.4 113.881 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -86.18 65.76 9.24 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.16 -2.533 . . . . 3.27 104.16 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.642 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 20.2 t90 -25.81 89.75 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 1.31 112.215 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HB3' HG12 ' A' ' 10' ' ' VAL . 88.8 tttt -28.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 114.113 -1.403 . . . . 2.46 112.421 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' O ' ' CE2' ' A' ' 29' ' ' TRP . 11.7 m-20 -110.93 55.37 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.977 0.417 . . . . 2.02 110.142 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA3' ' CE3' ' A' ' 29' ' ' TRP . . . -149.11 -158.4 8.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.08 -0.581 . . . . 0.59 112.688 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.5 21.18 1.34 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.902 -0.666 . . . . 0.86 112.331 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.82 -173.84 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.299 . . . . 2.13 110.798 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -145.61 136.34 24.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.422 . . . . 1.6 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' OE2' ' HB2' ' B' ' 3' ' ' PRO . 43.6 mt-10 -149.96 176.88 10.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.816 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -98.11 148.52 23.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.71 111.324 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' TYR . 97.0 t -89.2 160.02 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 0.65 109.79 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.2 tttt -68.95 104.25 2.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.37 0.605 . . . . 2.32 112.174 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -90.65 37.99 3.29 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.108 -0.951 . . . . 0.35 112.667 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 43' ' ' VAL . 2.5 t -115.85 3.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.672 0.272 . . . . 0.68 110.304 178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.526 ' CE1' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -69.75 77.6 0.45 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.578 0.704 . . . . 1.35 109.826 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 48.7 t -56.91 75.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 113.717 -1.583 . . . . 1.49 113.34 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.54 53.69 2.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.593 -0.891 . . . . 0.48 108.593 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG2' ' HE2' ' A' ' 49' ' ' LYS . 39.0 tt0 -49.72 -22.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.916 -1.038 . . . . 2.44 110.435 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.03 -50.53 47.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 2.48 110.087 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 51' ' ' TYR . 43.5 t -57.79 -29.88 36.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.88 111.282 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -87.45 -58.11 2.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.155 1.382 . . . . 0.99 109.97 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 25.4 ttmm -54.84 -31.12 59.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.307 -0.86 . . . . 3.35 109.262 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -91.16 -25.39 19.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.518 -0.764 . . . . 2.0 109.854 178.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.78 -65.18 0.71 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.144 0.974 . . . . 1.87 110.374 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CB ' ' HB2' ' A' ' 2' ' ' SER . 13.1 pt-20 -90.22 -50.87 5.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.692 -1.595 . . . . 1.77 111.775 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.0 OUTLIER -77.92 -9.4 59.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.696 -0.684 . . . . 2.3 111.321 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -90.12 -37.61 6.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.593 -0.813 . . . . 1.61 112.041 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.35 -64.0 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 2.34 110.489 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.22 58.74 4.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 2.95 110.653 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.7 t80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.28 -0.867 . . . . 2.23 110.902 -179.717 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.477 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 111.82 0.304 . . . . 5.2 111.82 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 58.0 Cg_exo -51.29 102.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.184 1.923 . . . . 5.12 112.248 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.401 ' HB2' ' OE2' ' A' ' 36' ' ' GLU . 3.4 Cg_exo -74.89 -51.41 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.835 2.356 . . . . 3.56 112.165 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 27' ' ' VAL . . . -134.39 62.26 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 2.11 112.495 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.578 ' HA ' HG22 ' A' ' 38' ' ' VAL . 50.8 p -152.33 173.9 14.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.825 0.345 . . . . 1.85 111.777 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.833 ' HB3' ' C ' ' A' ' 8' ' ' ALA . . . -170.87 -158.69 0.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 1.86 110.85 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -162.09 124.9 2.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.662 -0.244 . . . . 7.29 110.775 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.483 ' HD3' ' CZ ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.17 -35.19 49.09 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.494 -0.321 . . . . 6.23 111.293 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -139.33 -171.06 3.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.606 0.241 . . . . 7.18 110.67 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -53.31 -25.32 14.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.408 . . . . 4.33 110.496 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 37.4 mtmt 76.36 90.25 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.654 -0.703 . . . . 4.49 110.295 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -90.5 83.93 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 2.05 110.885 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.482 ' OD1' ' CE1' ' A' ' 42' ' ' HIS . 11.2 p-10 -109.59 101.67 10.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 3.8 110.626 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.17 -0.919 . . . . 3.91 111.31 -179.586 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 112.433 -0.267 . . . . 2.97 112.433 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 9.4 t 169.32 -10.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.132 0.79 . . . . 3.15 113.132 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.35 138.66 31.29 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.849 -0.426 . . . . 4.57 109.849 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.473 HG13 ' CE2' ' A' ' 5' ' ' PHE . 9.8 p -96.32 43.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.904 -0.589 . . . . 3.08 110.571 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.63 ' CZ ' ' CD1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -177.92 152.96 0.79 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.887 -0.597 . . . . 2.16 111.282 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.709 ' H ' HG11 ' A' ' 23' ' ' VAL . 2.6 mp0 -134.55 144.07 47.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 2.41 111.067 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 46.0 p90 -89.52 105.38 17.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.17 0.509 . . . . 1.73 111.902 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB1' ' H ' ' B' ' 7' ' ' ARG . . . -89.9 53.35 2.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.457 -0.792 . . . . 0.38 109.022 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.739 ' HB2' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -113.81 158.57 20.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.12 0.962 . . . . 2.8 112.96 -177.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.818 HG12 ' CB ' ' A' ' 30' ' ' LYS . 57.9 t -97.21 -35.28 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 113.66 -1.609 . . . . 0.42 110.503 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' HB2' ' CA ' ' A' ' 30' ' ' LYS . 23.6 t70 -139.3 -39.36 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.735 -0.666 . . . . 2.19 112.048 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 45.4 mt-10 -155.98 157.36 36.07 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 112.787 0.662 . . . . 2.18 112.787 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -130.29 -169.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.34 109.972 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.4 t -150.24 -49.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.67 110.13 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 9.9 tp10 -98.97 139.1 35.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.715 -0.675 . . . . 2.96 109.689 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 11.3 ptmm? -151.6 87.85 1.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.652 -0.419 . . . . 2.13 112.1 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.647 ' C ' HG23 ' A' ' 23' ' ' VAL . 79.7 ttt180 -153.74 92.36 1.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.042 -0.263 . . . . 3.83 111.101 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.21 -130.21 1.57 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.15 -1.5 . . . . 0.41 114.946 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 68.4 mttm -124.52 -121.62 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.894 0.878 . . . . 1.13 110.082 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -89.71 -40.03 6.07 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 108.141 -1.983 . . . . 0.51 108.141 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' HIS . 2.0 mptp? -143.87 7.02 1.42 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.187 -1.506 . . . . 3.41 111.161 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 17.9 t70 -87.43 9.06 22.0 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.129 0.49 . . . . 1.22 111.066 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG21 ' HE1' ' A' ' 25' ' ' TYR . 7.2 p -88.4 152.87 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 115.6 -0.727 . . . . 0.34 111.561 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HA3' ' A' ' 40' ' ' GLY . 6.6 pt-20 -109.29 99.36 8.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.511 -0.768 . . . . 1.26 110.015 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HE1' HG21 ' A' ' 23' ' ' VAL . 9.4 m-85 -104.44 149.94 24.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.76 -0.655 . . . . 0.65 110.182 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.784 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 tt -88.97 157.16 18.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.658 -0.867 . . . . 0.96 108.658 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -143.21 110.13 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 118.953 -1.099 . . . . 0.4 113.894 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 11' ' ' ASP . 77.2 mtt180 -83.91 75.71 10.09 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.895 -1.891 . . . . 3.27 105.895 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.588 ' HD1' HG11 ' A' ' 10' ' ' VAL . 3.4 t90 -26.9 89.68 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.922 -1.49 . . . . 1.31 112.28 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.818 ' CB ' HG12 ' A' ' 10' ' ' VAL . 60.3 tttp -29.02 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.654 -1.157 . . . . 2.46 112.209 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' TRP . 19.4 t70 -119.41 55.59 0.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 2.02 109.885 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -142.27 -140.4 3.75 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.59 112.641 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.23 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.844 -0.693 . . . . 0.86 112.331 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.69 -174.28 3.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.86 0.362 . . . . 2.13 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.8 m -143.97 126.39 15.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.6 110.915 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HA3' ' B' ' 4' ' ' GLY . 43.1 mt-10 -132.06 179.68 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 2.27 110.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 28.9 m0 -100.19 150.91 22.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.71 111.846 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 25' ' ' TYR . 73.8 t -89.49 162.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.672 -0.694 . . . . 0.65 109.768 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.4 tttt -78.34 104.53 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.739 0.644 . . . . 2.32 112.739 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -91.62 45.05 2.73 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.076 -0.965 . . . . 0.35 112.516 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -118.3 0.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.999 -0.371 . . . . 0.68 109.999 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.525 ' CD2' ' HB3' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -72.76 76.46 1.13 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.595 0.712 . . . . 1.35 110.633 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 52.0 t -56.41 76.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 113.249 -1.796 . . . . 1.49 113.227 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -91.56 49.59 1.6 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.206 -0.906 . . . . 0.48 108.944 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -47.81 -27.83 2.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.13 -0.941 . . . . 2.44 110.509 -178.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 12.0 t70 -77.95 -44.03 28.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 2.48 109.424 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 49.2 t -65.18 -27.72 42.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.099 -0.501 . . . . 0.88 110.704 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -93.92 -57.78 2.44 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.997 1.436 . . . . 0.99 112.565 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLU . 38.8 ttpt -51.73 -45.29 63.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.207 0.527 . . . . 3.35 110.556 -178.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 1.8 t70 -79.42 -20.6 47.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.104 -0.702 . . . . 2.0 109.104 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.66 -67.35 0.44 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.421 -0.809 . . . . 1.87 110.474 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 13.2 pt-20 -86.04 -48.71 8.4 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.324 -1.307 . . . . 1.77 111.684 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -77.34 -42.82 35.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.823 -0.626 . . . . 2.3 111.541 -179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 50' ' ' ASP . . . -50.32 -52.14 28.89 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.542 -0.837 . . . . 1.61 112.394 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.06 -69.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.769 0.319 . . . . 2.34 110.803 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.2 63.63 6.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 2.95 110.831 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.5 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.184 -0.912 . . . . 2.23 110.919 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' B' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.302 0.096 . . . . 5.2 110.824 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.59 109.91 2.39 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.297 1.998 . . . . 5.12 112.153 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' B' ' 1' ' ' ALA . 72.9 Cg_endo -75.54 91.73 1.05 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.442 2.095 . . . . 3.56 112.403 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.458 ' CA ' HG22 ' A' ' 27' ' ' VAL . . . 47.35 81.04 0.05 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.888 -0.672 . . . . 2.11 112.476 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.985 ' CG2' ' CB ' ' B' ' 5' ' ' THR . 1.0 OUTLIER -151.82 159.9 43.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 1.85 111.687 -179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 10' ' ' VAL . . . -147.07 -47.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 1.86 110.444 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.64 ' H ' ' HB1' ' A' ' 8' ' ' ALA . 72.2 mtm180 68.36 118.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 7.29 111.685 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -69.23 -42.41 75.71 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 6.23 110.838 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -147.88 -168.69 3.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.549 -0.296 . . . . 7.18 110.44 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 11' ' ' LYS . 12.6 ptm180 -52.95 -25.11 10.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.351 . . . . 4.33 110.691 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 86.6 mttt 69.24 93.05 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.9 -0.591 . . . . 4.49 110.785 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -82.69 121.41 26.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 2.05 110.755 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' CD2' ' A' ' 42' ' ' HIS . 5.3 p-10 -126.29 53.33 1.64 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.974 0.416 . . . . 3.8 111.021 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.206 -0.902 . . . . 3.91 110.856 179.744 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 120.309 -0.162 . . . . 2.97 112.757 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 70.2 p 179.87 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.154 0.428 . . . . 3.15 112.154 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.7 pt20 -87.03 130.77 34.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.153 -0.314 . . . . 4.57 110.153 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 4' ' ' VAL . 10.7 p -89.88 66.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.046 0.45 . . . . 3.08 111.751 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.431 ' CD1' ' OH ' ' A' ' 25' ' ' TYR . 9.3 p90 165.67 164.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.912 -0.585 . . . . 2.16 110.932 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.583 ' H ' HG11 ' A' ' 23' ' ' VAL . 11.0 tp10 -142.43 145.11 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 2.41 110.275 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.55 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 44.4 p90 -89.76 105.5 17.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.079 0.466 . . . . 1.73 111.878 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.773 ' HB3' HG11 ' A' ' 38' ' ' VAL . . . -89.93 55.55 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.146 -0.687 . . . . 0.38 109.146 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.743 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -113.31 163.17 15.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.087 0.946 . . . . 2.8 112.433 -177.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.828 HG12 ' CB ' ' A' ' 30' ' ' LYS . 60.7 t -96.71 -37.54 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 113.595 -1.639 . . . . 0.42 110.741 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 30' ' ' LYS . 17.4 t70 -142.57 -34.56 0.44 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.038 -0.528 . . . . 2.19 112.244 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 44.8 mt-10 -156.0 151.06 26.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.25 0.833 . . . . 2.18 113.25 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -125.98 -171.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.331 -0.395 . . . . 0.34 110.561 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 26' ' ' LEU . 94.7 t -147.19 -48.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.069 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 42.9 mt-10 -97.72 141.77 30.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.821 -0.627 . . . . 2.96 109.751 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 17.4 ptmt -152.02 84.92 1.28 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.687 -0.405 . . . . 2.13 111.898 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.881 ' C ' HG23 ' A' ' 23' ' ' VAL . 51.9 ttp180 -153.38 97.12 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.085 -0.246 . . . . 3.83 111.027 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -151.21 -130.23 1.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 118.94 -1.6 . . . . 0.41 114.978 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.967 ' HE3' HG13 ' A' ' 43' ' ' VAL . 54.1 mttm -117.04 -72.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.333 1.063 . . . . 1.13 110.738 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 6' ' ' GLU . . . -151.31 -47.81 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 106.835 -2.506 . . . . 0.51 106.835 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' CE ' ' HD3' ' B' ' 10' ' ' ARG . 1.8 mptt -127.6 -6.27 5.77 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 113.076 -1.562 . . . . 3.41 109.831 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.0 t70 -86.75 9.73 18.05 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 121.125 0.488 . . . . 1.22 111.291 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.881 HG23 ' C ' ' A' ' 17' ' ' ARG . 7.0 p -87.22 152.37 3.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.78 -0.645 . . . . 0.34 111.086 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.99 94.56 5.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.654 -0.703 . . . . 1.26 110.689 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.657 ' HD2' HG21 ' A' ' 13' ' ' ILE . 7.0 m-85 -100.29 150.65 22.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.153 -0.476 . . . . 0.65 110.38 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.81 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.2 tt -89.31 157.73 18.08 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.366 -0.976 . . . . 0.96 108.366 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.743 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 m -141.41 110.82 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.022 -1.071 . . . . 0.4 113.499 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' CD ' HD21 ' A' ' 26' ' ' LEU . 13.3 mmm180 -84.75 79.39 9.63 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.142 -1.799 . . . . 3.27 106.142 175.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.823 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -27.19 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 114.535 -1.211 . . . . 1.31 111.966 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.828 ' CB ' HG12 ' A' ' 10' ' ' VAL . 38.0 ttpt -27.62 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.307 -1.315 . . . . 2.46 112.26 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' TRP . 6.0 m-20 -123.94 57.07 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 2.02 110.005 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -140.97 -159.65 7.99 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.017 -0.611 . . . . 0.59 112.999 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.23 19.8 1.55 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.121 -0.561 . . . . 0.86 112.376 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -139.9 -176.56 4.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.741 0.305 . . . . 2.13 110.636 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . 29.0 p -150.19 111.16 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 1.6 111.232 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' HB2' ' CA ' ' B' ' 4' ' ' GLY . 6.5 mm-40 -123.99 -176.85 3.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 2.27 110.922 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' HG22 ' B' ' 5' ' ' THR . 4.7 m-90 -108.71 153.24 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.108 0.48 . . . . 0.71 111.697 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 8' ' ' ALA . 49.0 t -88.43 162.18 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.704 -0.68 . . . . 0.65 109.52 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 38' ' ' VAL . 88.5 tttt -80.73 103.62 10.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.461 0.648 . . . . 2.32 112.075 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -88.83 45.05 3.18 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.027 -0.988 . . . . 0.35 112.647 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 2.0 t -120.2 0.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.076 -0.342 . . . . 0.68 110.076 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.482 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.85 77.83 0.88 Allowed 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.46 0.648 . . . . 1.35 109.775 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.967 HG13 ' HE3' ' A' ' 19' ' ' LYS . 49.5 t -56.09 72.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.406 -1.724 . . . . 1.49 113.805 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -91.62 49.52 1.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.565 -0.743 . . . . 0.48 109.354 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -45.46 -28.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.209 -0.905 . . . . 2.44 110.58 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 6.8 m-20 -66.7 -49.97 64.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.493 -0.776 . . . . 2.48 109.875 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.806 HG12 ' CD2' ' A' ' 51' ' ' TYR . 42.2 t -58.23 -30.52 40.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.117 -0.492 . . . . 0.88 110.593 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -79.32 -59.99 2.54 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.754 1.221 . . . . 0.99 109.954 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 37.7 ttpt -56.97 -27.84 61.7 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.758 -0.83 . . . . 3.35 108.758 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.2 t70 -91.85 -22.68 19.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.148 -0.933 . . . . 2.0 110.108 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.806 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -73.46 -71.09 0.33 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.837 0.827 . . . . 1.87 110.087 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 53' ' ' ASP . 11.3 pt-20 -81.53 -47.16 13.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.143 -1.39 . . . . 1.77 112.012 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 1.3 m-20 -80.78 -18.73 46.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.043 -0.526 . . . . 2.3 111.703 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 50' ' ' ASP . . . -75.19 -43.16 26.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.408 -0.901 . . . . 1.61 112.391 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.5 tp -76.08 -63.64 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 2.34 110.534 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -87.94 59.77 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 2.95 110.492 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 54.9 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.307 -0.854 . . . . 2.23 110.929 -179.828 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' B' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 111.803 0.298 . . . . 5.2 111.803 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' B' ' 1' ' ' ALA . 74.0 Cg_exo -47.67 107.2 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.225 1.95 . . . . 5.12 112.3 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.17 67.66 4.19 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.488 2.125 . . . . 3.56 112.358 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.454 ' C ' HG22 ' A' ' 27' ' ' VAL . . . 137.99 61.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.677 -0.773 . . . . 2.11 112.517 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 37' ' ' TRP . 28.1 p -152.42 174.23 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.089 0.471 . . . . 1.85 111.782 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.696 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -170.44 42.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.673 -0.694 . . . . 1.86 110.628 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 12.4 ptm180 -41.84 134.97 2.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.824 -0.625 . . . . 7.29 111.932 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.42 ' HG2' ' HE2' ' A' ' 21' ' ' LYS . 27.4 tpt180 -55.21 133.7 49.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.489 -0.56 . . . . 6.23 109.489 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' B' ' 9' ' ' LYS . 3.4 ptmm? -111.85 34.29 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.183 0.438 . . . . 7.18 112.183 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.466 ' HD3' ' CE ' ' A' ' 21' ' ' LYS . 12.2 ptm180 -97.66 -21.07 17.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 4.33 110.417 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.424 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 0.0 OUTLIER 36.35 63.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.459 0.54 . . . . 4.49 112.459 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.473 ' CB ' ' CG2' ' A' ' 47' ' ' VAL . . . -52.65 -28.45 21.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.143 0.497 . . . . 2.05 110.282 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 22.7 t70 -109.39 38.25 2.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.423 -0.808 . . . . 3.8 110.317 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.246 -0.883 . . . . 3.91 111.008 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.718 -0.153 . . . . 2.97 112.718 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 83.5 p 179.52 -28.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.089 0.403 . . . . 3.15 112.089 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 1.113 ' C ' ' CE1' ' A' ' 5' ' ' PHE . 27.5 mt-30 -88.79 137.96 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.799 -0.445 . . . . 4.57 109.799 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.374 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 13.5 p -89.54 72.41 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.047 0.388 . . . . 3.08 112.047 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.374 ' CE1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER 163.39 177.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.032 0.444 . . . . 2.16 111.6 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.748 ' H ' HG11 ' A' ' 23' ' ' VAL . 9.4 tp10 -152.72 146.73 25.36 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.846 -0.615 . . . . 2.41 109.717 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -89.52 109.0 19.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 1.73 110.966 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' O ' ' OE2' ' A' ' 9' ' ' GLU . . . -94.32 33.13 1.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.482 -0.781 . . . . 0.38 110.698 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 1.233 ' OE2' ' N ' ' B' ' 6' ' ' ALA . 0.0 OUTLIER -102.75 175.06 5.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.043 0.925 . . . . 2.8 112.815 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.669 HG21 ' CD1' ' A' ' 29' ' ' TRP . 21.3 t -109.49 -17.52 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 113.699 -1.591 . . . . 0.42 112.402 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 30' ' ' LYS . 21.1 t70 -150.14 -43.33 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.811 0.339 . . . . 2.19 111.468 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 27' ' ' VAL . 43.6 mt-10 -153.3 168.45 25.99 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.091 -0.504 . . . . 2.18 111.545 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -141.52 -169.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.695 -0.483 . . . . 0.34 109.695 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.713 HG23 HD23 ' A' ' 26' ' ' LEU . 90.5 t -149.97 -57.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.67 110.092 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 20.6 mm-40 -91.02 133.98 34.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.931 -0.577 . . . . 2.96 109.447 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 25' ' ' TYR . 20.0 pttm -151.07 87.0 1.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.708 -0.397 . . . . 2.13 111.442 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.636 ' C ' HG23 ' A' ' 23' ' ' VAL . 2.3 mpt_? -153.65 94.79 1.82 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.752 0.279 . . . . 3.83 111.752 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 4' ' ' VAL . . . -152.07 -128.19 1.38 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 119.415 -1.374 . . . . 0.41 114.065 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.902 ' NZ ' HG23 ' A' ' 43' ' ' VAL . 86.0 mttt -109.49 -74.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.117 0.961 . . . . 1.13 110.659 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -151.7 -47.76 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 107.167 -2.373 . . . . 0.51 107.167 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' CG ' ' HB3' ' B' ' 8' ' ' ARG . 2.1 ttpt -124.59 -9.62 7.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.067 -1.566 . . . . 3.41 109.802 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 12.3 t70 -86.47 7.71 24.82 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-O 121.232 0.539 . . . . 1.22 111.376 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG11 ' H ' ' A' ' 6' ' ' GLU . 10.8 p -89.25 157.71 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.409 -0.814 . . . . 0.34 110.63 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.7 pt-20 -110.26 115.83 30.4 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 1.26 110.864 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 13' ' ' ILE . 8.0 m-85 -115.71 148.5 39.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.607 -0.724 . . . . 0.65 110.131 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 37' ' ' TRP . 18.3 tp -90.7 159.0 16.59 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 107.781 -1.192 . . . . 0.96 107.781 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.163 HG11 ' CD ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER -143.79 111.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 114.449 1.277 . . . . 0.4 114.449 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 81.7 mtt180 -83.23 70.0 10.04 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.068 -1.827 . . . . 3.27 106.068 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.669 ' CD1' HG21 ' A' ' 10' ' ' VAL . 2.2 t90 -26.28 89.7 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 113.761 -1.563 . . . . 1.31 112.036 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HB3' HG12 ' A' ' 10' ' ' VAL . 63.8 tttm -28.46 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.368 -1.287 . . . . 2.46 112.416 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 29' ' ' TRP . 5.9 m-20 -111.76 54.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 2.02 110.076 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -150.13 -161.5 9.92 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.59 112.737 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.73 -38.9 0.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.984 -0.627 . . . . 0.86 112.237 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -114.09 176.22 5.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 2.13 110.628 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 28' ' ' ARG . 26.9 p -126.67 130.53 50.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.361 . . . . 1.6 110.912 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.779 ' C ' HD12 ' A' ' 26' ' ' LEU . 31.1 mm-40 -117.13 165.6 13.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.066 0.46 . . . . 2.27 111.591 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CD1' HD13 ' A' ' 26' ' ' LEU . 12.3 m0 -87.97 140.32 29.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.617 -0.72 . . . . 0.71 111.138 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 25' ' ' TYR . 89.3 t -87.37 160.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.65 110.127 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' N ' HG12 ' A' ' 38' ' ' VAL . 40.2 ttmt -77.23 108.08 10.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.118 0.785 . . . . 2.32 113.118 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -89.57 44.46 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.933 -1.03 . . . . 0.35 112.487 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG23 ' HG3' ' A' ' 39' ' ' LYS . 2.6 t -117.77 -5.19 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.332 . . . . 0.68 110.248 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -66.02 79.0 0.09 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.892 0.853 . . . . 1.35 110.057 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.902 HG23 ' NZ ' ' A' ' 19' ' ' LYS . 6.1 p -56.16 72.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 113.296 -1.774 . . . . 1.49 113.756 -178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.738 ' HB1' HG23 ' A' ' 47' ' ' VAL . . . -92.86 49.15 1.41 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.8 -1.091 . . . . 0.48 109.617 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' N ' ' HB3' ' B' ' 13' ' ' ASP . 38.1 tt0 -45.18 -26.65 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.133 -0.939 . . . . 2.44 111.312 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HB3' ' HB1' ' B' ' 12' ' ' ALA . 16.2 t70 -70.5 -46.86 62.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.594 . . . . 2.48 110.059 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.903 HG12 ' CE2' ' A' ' 51' ' ' TYR . 25.4 t -56.03 -35.5 41.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 116.073 -0.512 . . . . 0.88 109.875 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -78.07 -60.65 2.28 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.835 1.254 . . . . 0.99 110.344 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 26.5 ttpp -54.4 -30.6 52.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.25 -0.648 . . . . 3.35 109.25 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -92.95 -22.79 19.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.671 -0.695 . . . . 2.0 110.869 178.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.903 ' CE2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -66.9 -66.08 0.6 Allowed 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.255 1.026 . . . . 1.87 109.018 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 2' ' ' SER . 33.3 mt-10 -81.28 -67.78 0.75 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.178 -1.828 . . . . 1.77 110.904 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -57.31 -43.2 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.027 -0.988 . . . . 2.3 111.185 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -52.75 -39.34 54.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.53 -0.843 . . . . 1.61 112.164 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 1' ' ' GLY . 66.8 tp -84.38 -59.26 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.783 0.325 . . . . 2.34 110.287 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.87 60.01 4.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 2.95 110.55 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.7 t80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.216 -0.897 . . . . 2.23 110.943 -179.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.732 0.301 . . . . 5.2 111.072 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' B' ' 3' ' ' PRO . 2.2 Cg_endo -42.92 -58.12 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.952 2.434 . . . . 5.12 112.577 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' B' ' 2' ' ' PRO . 26.9 Cg_endo -62.77 92.68 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.34 2.027 . . . . 3.56 112.217 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . 131.86 -41.79 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 2.11 112.45 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.949 HG23 ' H ' ' B' ' 7' ' ' ARG . 4.8 p -88.57 172.3 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 1.85 111.433 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 1.233 ' N ' ' OE2' ' A' ' 9' ' ' GLU . . . -141.68 57.03 1.5 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.218 -0.447 . . . . 1.86 111.851 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.949 ' H ' HG23 ' B' ' 5' ' ' THR . 39.1 ptt180 -48.86 129.08 16.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.443 -0.344 . . . . 7.29 110.637 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 1.096 HH22 ' CD ' ' B' ' 9' ' ' LYS . 28.0 tpt180 -50.55 164.85 0.11 Allowed 'General case' 0 C--N 1.338 0.093 0 N-CA-C 109.927 -0.397 . . . . 6.23 109.927 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 1.096 ' CD ' HH22 ' B' ' 8' ' ' ARG . 0.0 OUTLIER -136.1 46.29 2.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.765 0.654 . . . . 7.18 112.765 -178.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.452 ' HG2' ' CD ' ' A' ' 21' ' ' LYS . 17.5 ptp180 -99.9 -36.87 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.113 0.482 . . . . 4.33 110.074 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.457 ' HD3' ' NE2' ' A' ' 42' ' ' HIS . 11.4 mmmm 49.54 85.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.699 -0.682 . . . . 4.49 111.129 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.804 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -88.28 -27.87 21.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 2.05 110.54 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.631 ' OD1' HG22 ' A' ' 43' ' ' VAL . 7.3 t70 -135.7 159.84 40.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 3.8 110.878 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.283 -0.865 . . . . 3.91 110.865 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.698 -0.161 . . . . 2.97 112.698 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HB2' ' CB ' ' A' ' 52' ' ' GLU . 58.1 p -153.26 -57.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 3.15 110.558 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.92 118.94 37.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.983 -0.553 . . . . 4.57 110.143 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.5 t -146.36 -54.69 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.056 0.391 . . . . 3.08 112.056 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER 63.59 -163.31 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.934 -0.765 . . . . 2.16 108.934 -178.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.752 ' H ' HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -151.16 139.61 20.47 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 2.41 111.798 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.564 ' HA ' ' CG ' ' A' ' 25' ' ' TYR . 47.1 p90 -91.42 106.58 18.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.174 0.511 . . . . 1.73 110.921 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.772 ' HB3' HG21 ' A' ' 38' ' ' VAL . . . -88.69 60.58 5.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.954 -0.758 . . . . 0.38 108.954 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.903 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -114.81 150.34 35.61 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.348 1.07 . . . . 2.8 113.181 -177.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.887 HG23 ' CG2' ' A' ' 27' ' ' VAL . 57.8 t -89.53 -36.78 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.25 -1.795 . . . . 0.42 109.212 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -144.47 -33.68 0.39 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.983 -1.008 . . . . 2.19 111.615 177.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' HD23 ' A' ' 26' ' ' LEU . 43.7 mt-10 -152.81 159.17 43.06 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.131 0.419 . . . . 2.18 112.131 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -128.67 -168.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.173 -0.677 . . . . 0.34 109.173 178.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.007 ' CG2' HD13 ' A' ' 26' ' ' LEU . 89.6 t -151.38 -60.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.218 0.533 . . . . 0.67 109.742 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 22.0 mm-40 -92.5 143.57 26.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.346 -0.843 . . . . 2.96 109.729 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 18.9 pttm -152.66 93.43 1.77 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.075 -0.25 . . . . 2.13 111.297 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.626 ' C ' HG23 ' A' ' 23' ' ' VAL . 1.7 tmt_? -155.16 88.64 1.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.469 -0.492 . . . . 3.83 111.205 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.589 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -150.92 -137.88 2.75 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 118.863 -1.636 . . . . 0.41 115.269 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 22' ' ' ASP . 90.6 mttt -108.36 -88.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.312 -0.944 . . . . 1.13 110.767 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' ' CG1' ' A' ' 47' ' ' VAL . . . -131.95 -44.79 0.15 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.928 -2.069 . . . . 0.51 107.928 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 42' ' ' HIS . 9.9 mmmt -131.33 -6.3 3.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.26 -1.47 . . . . 3.41 110.693 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 20.7 t70 -89.13 12.0 17.0 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 121.125 0.488 . . . . 1.22 111.347 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.752 HG11 ' H ' ' A' ' 6' ' ' GLU . 14.6 p -87.92 157.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.533 -0.758 . . . . 0.34 111.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 23' ' ' VAL . 8.0 pt-20 -108.83 109.4 20.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.285 -0.87 . . . . 1.26 110.256 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.741 ' HE1' HG21 ' A' ' 23' ' ' VAL . 11.1 m-85 -118.68 152.93 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.935 -0.575 . . . . 0.65 110.605 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.007 HD13 ' CG2' ' A' ' 14' ' ' VAL . 3.1 tt -87.68 157.07 19.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.828 -0.804 . . . . 0.96 108.828 178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -139.86 97.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.121 -0.631 . . . . 0.4 112.087 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 30' ' ' LYS . 48.3 ttt180 -79.17 82.45 5.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.737 -1.209 . . . . 3.27 107.737 177.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t90 -28.66 91.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.803 -1.089 . . . . 1.31 112.085 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.742 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 18.6 pttp -26.97 -37.36 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.55 -1.204 . . . . 2.46 112.557 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 29' ' ' TRP . 18.0 m-20 -120.63 57.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 2.02 110.087 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . -139.28 -143.54 4.43 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.845 -0.616 . . . . 0.59 112.527 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.34 -48.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.855 -0.688 . . . . 0.86 112.307 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.76 179.7 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 2.13 110.804 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 26' ' ' LEU . 26.9 p -125.94 138.11 53.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.382 . . . . 1.6 111.014 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' B' ' 3' ' ' PRO . 9.5 tp10 -133.53 158.86 42.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 2.27 110.607 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 41.7 m0 -97.18 149.26 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.71 111.368 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.783 HG23 HG12 ' A' ' 27' ' ' VAL . 77.0 t -88.77 159.31 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.65 110.009 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.3 tppt? -79.17 110.86 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.27 0.557 . . . . 2.32 112.159 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . -87.95 36.76 3.33 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.232 -0.894 . . . . 0.35 112.914 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.467 HG23 ' CD ' ' A' ' 39' ' ' LYS . 3.1 t -112.39 0.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.34 -0.245 . . . . 0.68 110.34 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.132 ' NE2' ' CG ' ' B' ' 11' ' ' LYS . 0.1 OUTLIER -66.86 76.27 0.12 Allowed 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.688 0.756 . . . . 1.35 109.609 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.1 p -57.17 75.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 113.715 -1.584 . . . . 1.49 113.982 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 42' ' ' HIS . . . -91.12 50.83 1.83 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.589 -0.893 . . . . 0.48 108.589 176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -24.14 1.93 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 114.982 -1.008 . . . . 2.44 110.54 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 16.0 t70 -66.0 -49.77 66.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 2.48 109.91 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.822 HG12 ' CD2' ' A' ' 51' ' ' TYR . 60.3 t -55.05 -38.47 46.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 116.251 -0.431 . . . . 0.88 110.546 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 51' ' ' TYR . . . -76.61 -59.86 2.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.188 1.395 . . . . 0.99 110.665 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.2 tmmm? -56.73 -28.44 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.157 -0.683 . . . . 3.35 109.157 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 10.9 t70 -91.54 -24.52 19.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.582 -0.736 . . . . 2.0 109.452 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CD2' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.86 -70.28 0.3 Allowed 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.817 0.817 . . . . 1.87 110.59 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 2' ' ' SER . 13.0 pt-20 -82.4 -48.17 11.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.21 -1.359 . . . . 1.77 111.714 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -78.19 -25.49 47.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.839 -0.619 . . . . 2.3 111.599 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -77.0 -55.65 4.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.441 -0.885 . . . . 1.61 112.313 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.54 -65.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 2.34 110.564 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -87.99 58.42 4.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 2.95 110.577 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.236 -0.888 . . . . 2.23 110.949 -179.871 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.66 0.267 . . . . 5.2 111.038 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' B' ' 3' ' ' PRO . 97.1 Cg_endo -79.33 111.66 2.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.66 2.24 . . . . 5.12 112.348 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 41.0 Cg_endo -67.92 62.42 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.58 2.187 . . . . 3.56 112.272 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.426 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . 148.97 94.91 0.14 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.728 -0.749 . . . . 2.11 112.518 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.613 ' N ' HG21 ' A' ' 27' ' ' VAL . 64.1 p -154.55 151.61 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.813 0.34 . . . . 1.85 111.739 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -150.02 -61.51 0.21 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.211 -0.45 . . . . 1.86 111.841 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? 62.34 129.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.027 -0.36 . . . . 7.29 110.027 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.522 ' CZ ' ' CE2' ' A' ' 7' ' ' TYR . 13.5 ptt180 -132.67 46.2 2.65 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.671 0.619 . . . . 6.23 112.671 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -154.48 177.71 10.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.901 -0.319 . . . . 7.18 110.791 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -68.39 -27.19 66.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.182 0.515 . . . . 4.33 110.564 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 1.132 ' CG ' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER 77.4 67.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.325 -0.852 . . . . 4.49 109.941 -179.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 44' ' ' ALA . . . -39.84 -28.91 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.519 -0.764 . . . . 2.05 112.225 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' VAL . 22.3 t70 -108.97 -28.37 9.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 3.8 111.006 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.465 ' O ' ' CE1' ' A' ' 42' ' ' HIS . 47.8 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.189 -0.91 . . . . 3.91 111.11 179.859 . . . . . . . . 1 1 . 1 stop_ save_